Citrus Sinensis ID: 007969
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.725 | 0.626 | 0.436 | 2e-94 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.778 | 0.681 | 0.410 | 6e-90 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.837 | 0.756 | 0.388 | 8e-89 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.754 | 0.657 | 0.4 | 1e-87 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.744 | 0.692 | 0.387 | 2e-83 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.758 | 0.653 | 0.397 | 2e-83 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.782 | 0.691 | 0.390 | 5e-83 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.710 | 0.620 | 0.377 | 9e-81 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.701 | 0.606 | 0.385 | 1e-79 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.804 | 0.693 | 0.378 | 5e-79 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 347 bits (889), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 208/477 (43%), Positives = 269/477 (56%), Gaps = 54/477 (11%)
Query: 105 AGKSLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY 162
A SL+ NA+ GE DS VYG++LC+ +VS + C++C+ A N LQ+C K A IWY
Sbjct: 63 AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122
Query: 163 QVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFN--------DVIAMPSLS 214
ECMVR+S+ S I+ N N+T++ FN DV +LS
Sbjct: 123 D--ECMVRYSNQS--IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALS 178
Query: 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFP 274
S + AT++ N + + + QC P L+ DC CL I ++ RC D +G GR++ P
Sbjct: 179 SRKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAP 236
Query: 275 SCIMGFELYRY---------------SKVPAVGALAPSSAPGGKRGRAISIAIGTTLSAL 319
SC +ELY + S V A PS GK I AI +S +
Sbjct: 237 SCSFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVS-V 295
Query: 320 IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFP 379
V+L G+ W RR + S E + L +G S E
Sbjct: 296 CVLLLGAMCWLLARRR-----NNKLSAETEDLDEDG-----------------ITSTETL 333
Query: 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
F ATN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+
Sbjct: 334 QFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVD 393
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++AKLQH+NL +LLG CL+G+E +L+YE++PNKSLD LFD + LDW+RR II GI
Sbjct: 394 VVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGI 453
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
ARGILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT I
Sbjct: 454 ARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIV 510
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 203/494 (41%), Positives = 280/494 (56%), Gaps = 40/494 (8%)
Query: 77 SCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSF 134
+C+++ +SN T+++NL L + A S + NA+ G+ PD V GL+LC+ NVS
Sbjct: 32 NCSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSP 91
Query: 135 QSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNT 193
+ C++CI +VN L +C +EA +Y+ +CM+R+S+ + S ++T + M QN
Sbjct: 92 EVCRSCIALSVNESLSRCPNEREAVFYYE--QCMLRYSNRNILSTLNTDGGVFM---QNA 146
Query: 194 YNVTKSLAQSFNDVIAMP--------SLSSFRNATKRTNISNIIRLETFGQCIPVLSVDD 245
N F D++ P + S R A + +++ + L QC P L+ D
Sbjct: 147 RNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206
Query: 246 CRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRG 305
C DCL +I Q +D G GR PSC ++ Y + VG SS GK G
Sbjct: 207 CLDCLQQSIN--QVTYDKIG---GRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGG 261
Query: 306 RA-ISIAIGTTLSALIVVLFGSFLWYRRRRHARDQ------EEKRNSQEVQFLHWEGRIR 358
+ + + ++ +LF +F RR + + + KR EV E
Sbjct: 262 NSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVT----EPPAE 317
Query: 359 NHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAI 418
+I G Q F + + AT+ F NKLGQGGFG VYKGT G +
Sbjct: 318 TTDGDDITTAGSLQ--------FDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQV 369
Query: 419 AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
AVKRLS+ SGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD L
Sbjct: 370 AVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFL 429
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
FD T QLDW RR II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG
Sbjct: 430 FDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFG 489
Query: 539 LARIFGGNQNQANT 552
+ARIFG +Q +ANT
Sbjct: 490 MARIFGMDQTEANT 503
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 8e-89, Method: Compositional matrix adjust.
Identities = 208/535 (38%), Positives = 300/535 (56%), Gaps = 47/535 (8%)
Query: 59 SIVSSVMSQYFAEEDMVLSCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL--YYNASE 115
SI +S + ++ + +C+V+ +SN T+++NL L + A + A+
Sbjct: 15 SITASAQNTFY----LYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATA 70
Query: 116 GEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS 175
G+ PD V GL+LC+ +VS + C++C+ AVN L +C KE +Y+ +C++R+S+ +
Sbjct: 71 GQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYE--QCLLRYSNRN 128
Query: 176 -SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMP-------SLSSFRN-ATKRTNIS 226
+ ++T + M+ +N +V + F D++ P + SF+ A ++ +++
Sbjct: 129 IVATLNTDGGMFMQSARNPLSVKQ---DQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLN 185
Query: 227 NIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYS 286
L +C P L DC DCL I Q +D G GRIL PSC ++ Y +
Sbjct: 186 ASQSLYGMVRCTPDLREQDCLDCLKIGIN--QVTYDKIG---GRILLPSCASRYDNYAFY 240
Query: 287 KVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQ 346
VG SS GK G + I I + ++ L ++ R ++ R EK
Sbjct: 241 NESNVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVA 300
Query: 347 EVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGP 406
E +G +I G Q F + ATN F NKLGQGGFG
Sbjct: 301 E------DGN-------DITTAGSLQ--------FDFKAIEAATNCFLPINKLGQGGFGE 339
Query: 407 VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466
VYKGTL+ G +AVKRLS+TSGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+Y
Sbjct: 340 VYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVY 399
Query: 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
E++PNKSLD LFD+T ++LDW RR II GIARGILYLH+DSRL IIHRDLKA NILL
Sbjct: 400 EFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILL 459
Query: 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581
DDDMNPKI+DFG+ARIFG +Q +A T + S ++ Y ++ V F
Sbjct: 460 DDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSF 514
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 324 bits (830), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 200/500 (40%), Positives = 275/500 (55%), Gaps = 60/500 (12%)
Query: 80 VSNNTASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQ 138
+N T+++T+ +NL L A S + NA+ G+ PD V GL+ C+ +VS + C+
Sbjct: 47 TANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCR 106
Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
C+ AVN L +C KEA ++Y EC++R+S+ + I+ T I NT NVT
Sbjct: 107 RCVSFAVNDTLTRCPNQKEATLYYD--ECVLRYSNQN--ILSTLITTGGVILVNTRNVTS 162
Query: 199 SLAQSFNDVIAMPSL---------SSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
+ +D++ +P+L SS + T++ N + + QC P L+ DC C
Sbjct: 163 NQLDLLSDLV-LPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQDCSRC 221
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL-------------AP 296
L I I P RI+ PSC +E+Y + AV P
Sbjct: 222 LQLVINQI-----PTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSAPP 276
Query: 297 SSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGR 356
S G + + + A+++ + G RR R
Sbjct: 277 RSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRAR---------------------- 314
Query: 357 IRNHYAYNILRGGK-QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
+++Y + G A+S + R AT+ F + NK+GQGGFG VYKGTL+DG
Sbjct: 315 -KSYYTPSAFAGDDITTADSLQLDY---RTIQTATDDFVESNKIGQGGFGEVYKGTLSDG 370
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
+AVKRLS++SGQG EFKNEV L+AKLQH+NLVRLLG CL+G+E +L+YEY+PNKSLD
Sbjct: 371 TEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLD 430
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535
LFD + QLDW RR II G+ARGILYLH+DSRL IIHRDLKASNILLD DMNPKI+
Sbjct: 431 YFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 490
Query: 536 DFGLARIFGGNQNQANTNII 555
DFG+ARIFG +Q + NT+ I
Sbjct: 491 DFGMARIFGLDQTEENTSRI 510
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 190/490 (38%), Positives = 266/490 (54%), Gaps = 56/490 (11%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ +NL L + A S + +A G+ PD V GL+LC+ +VS C+NC+ ++N
Sbjct: 43 YLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSIND 102
Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHS--SSIMDTSAPLCM----KIFQNTYNVTKSLA 201
L +C +++ +Y ECM+R+SD + S++ A + M I QN N K
Sbjct: 103 TLVQCPSERKSVFYY--DECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDFV 160
Query: 202 QSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRC 260
S + A+ + SS R T + + + L QC P L+ DC CL ++I+ +
Sbjct: 161 SSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLM--- 217
Query: 261 FDPPGMGFGRILFPSCIMGFELYRYSKVPAV--------------GALAPSSAPGGK-RG 305
P GR L+ SC +EL+ + V + S PG
Sbjct: 218 --PLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSWNS 275
Query: 306 RAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNI 365
+ +AI T+ ++L + + +R +++ D + ++
Sbjct: 276 NVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAFDGDDI----------------- 318
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 425
+ E R+ ATN FS+ NK+GQGGFG VYKGT ++G +AVKRLS+
Sbjct: 319 ---------TTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSK 369
Query: 426 TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 485
+SGQG EFKNEV ++AKLQH+NLVRLLG + G E +L+YEYMPNKSLD LFD +
Sbjct: 370 SSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQN 429
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
QLDW RR +I GIARGILYLH+DSRL IIHRDLKASNILLD DMNPK++DFGLARIFG
Sbjct: 430 QLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGM 489
Query: 546 NQNQANTNII 555
+Q Q NT+ I
Sbjct: 490 DQTQENTSRI 499
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 197/495 (39%), Positives = 277/495 (55%), Gaps = 53/495 (10%)
Query: 84 TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
++++T+++NL L + A S + N G+ PD V GL+LC+ ++S + C NC+
Sbjct: 51 SSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVA 110
Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMK------IFQNTYN 195
+VN L +C +EA +Y+ EC++R+S + S + L M+ QN +
Sbjct: 111 FSVNESLTRCPNQREAVFYYE--ECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRD 168
Query: 196 VTKSLAQS-FNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTI 254
L QS N + SS + +T +T ++++ L QC P L+ DC CL ++I
Sbjct: 169 QFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSI 228
Query: 255 RWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGA-----LAPSSAPG-------G 302
+ F +G R +PSC +ELY + A+G L P S P G
Sbjct: 229 NRMMPLFR---IG-ARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPG 284
Query: 303 KRGRAISIAIGTTLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNH 360
K G + + + + A+ + L G +R + D ++ EV
Sbjct: 285 KSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTA---SASEV------------ 329
Query: 361 YAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAV 420
G A + L R ATN F++ NK+G+GGFG VYKGT ++GK +AV
Sbjct: 330 --------GDDMATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAV 380
Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
KRLS+ S QG EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD
Sbjct: 381 KRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFD 440
Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
T+ QLDW +R +II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+A
Sbjct: 441 PTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMA 500
Query: 541 RIFGGNQNQANTNII 555
RIFG +Q Q NT+ I
Sbjct: 501 RIFGLDQTQDNTSRI 515
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 203/520 (39%), Positives = 277/520 (53%), Gaps = 64/520 (12%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ SNL L + A SL ++ ++G+ D V+GLYLCK ++S +SC+ C++ A
Sbjct: 46 YFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCRECVIFAAKD 105
Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDV 207
+C G KE I Y ECM+ +SD + MDT + + NT VT + FND
Sbjct: 106 TRSRCPGGKEFLIQYD--ECMLGYSDRNI-FMDTVTTTTIITW-NTQKVTADQSDRFNDA 161
Query: 208 I---------AMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
+ + +S + A K+++ S+ L QCIP L+ +DC CL +I+ +
Sbjct: 162 VLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPDLTSEDCVMCLQQSIKELY 221
Query: 259 RCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL--------------APSSAPGGKR 304
F+ G GR L PSC +E+Y + K G + PS PG +
Sbjct: 222 --FNKVG---GRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVSTPSFPPGKGK 276
Query: 305 GRAISIAIGTTL---SALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
+ I S LI V SF +R + D E+ +
Sbjct: 277 NSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDD----------------- 319
Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
I G Q F ++ AT+ FS NKLGQGGFG VYKGTL +G +AVK
Sbjct: 320 ---ITTAGSLQ--------FDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVK 368
Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
RLS+TSGQG +EFKNEV ++AKLQH+NLV+LLG CLE +E +L+YE++ NKSLD LFD+
Sbjct: 369 RLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDS 428
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
QLDW R II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+AR
Sbjct: 429 RMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMAR 488
Query: 542 IFGGNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581
IF +Q +A+T + S ++ Y ++ V F
Sbjct: 489 IFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSF 528
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 301 bits (771), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 184/487 (37%), Positives = 253/487 (51%), Gaps = 73/487 (14%)
Query: 109 LYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY-QVQEC 167
LYYN S G+ P+ VY + +C + + C +CI L+ C EA+ W + C
Sbjct: 61 LYYNGSIGQQPNRVYAIGMCIPGSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLC 120
Query: 168 MVRFSDHS---------------SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPS 212
VR+S+ S + +D++ KI++ S A + + PS
Sbjct: 121 YVRYSNTSFSGSADLNPRNWLTNTGDLDSNLTEFTKIWEGLMGRMISAASTAK---STPS 177
Query: 213 LSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRIL 272
S + ++ ++ + QC P LS DC +CL + Q C G ++
Sbjct: 178 SSDNHYSADSAVLTPLLNIYALMQCTPDLSSGDCENCLRQSAIDYQSCCSQKRGGV--VM 235
Query: 273 FPSCIMGFELYRYSKVPAVGALAPSS-----------------------APGGKRGRAIS 309
PSC + ++LY YS A L +S + G G ++
Sbjct: 236 RPSCFLRWDLYTYSN--AFDNLTVASPPPEPPVTVPQPAGDQDNPTNNDSKGISAGVVVA 293
Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGG 369
I + T ++ LI+++ G L+ RR+ + R + E
Sbjct: 294 ITVPTVIAILILLVLGFVLFRRRKSYQRTKTES--------------------------- 326
Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ 429
+ + + ++ + ATN FS NKLG+GGFG VYKG L++G +AVKRLS+ SGQ
Sbjct: 327 ESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQ 386
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW 489
G +EF+NE L+ KLQH+NLVRLLG CLE +E +LIYE++ NKSLD LFD + QLDW
Sbjct: 387 GTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDW 446
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
RR II GIARGILYLH+DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG Q Q
Sbjct: 447 TRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQ 506
Query: 550 ANTNIIA 556
NTN IA
Sbjct: 507 GNTNRIA 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 186/483 (38%), Positives = 262/483 (54%), Gaps = 74/483 (15%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ NA+ G+ PD V GL+LC+ +VS + C+NC+ +VN L C +EA +Y+ +C++
Sbjct: 68 FQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYE--QCIL 125
Query: 170 RFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQ----------SFNDVIAMPSLSSFRNA 219
R+S H + + I NT ++ + Q + ++ + SS +
Sbjct: 126 RYS-HKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLY 184
Query: 220 TKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRI----LFPS 275
T T ++ L QC P L+ DC CL ++I GM RI +PS
Sbjct: 185 TVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSIN---------GMALSRIGARLYWPS 235
Query: 276 CIMGFELYRYSKVPAVGA---------------------LAPSSAPGGKRGRAISIAIGT 314
C +ELY + A+ ++ SS PG K G + + +
Sbjct: 236 CTARYELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPG-KSGNSTVLVVAV 294
Query: 315 TLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQ 372
+ A+ + L G ++++ D ++ EV G
Sbjct: 295 VVLAVLLFIALVGYCFLAKKKKKTFDTA---SASEV--------------------GDDM 331
Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
A + L R ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG
Sbjct: 332 ATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 390
Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
EFK EV ++AKLQH+NLVRLLG L+G+E +L+YEYMPNKSLD LFD T+ +QLDW +R
Sbjct: 391 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQR 450
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT
Sbjct: 451 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 510
Query: 553 NII 555
+ I
Sbjct: 511 SRI 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 205/541 (37%), Positives = 281/541 (51%), Gaps = 72/541 (13%)
Query: 77 SCAVSNNTAS--NTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVS 133
SC S T S +T+ +NL L + A S + A+ G+ PD V GL+LC+ +VS
Sbjct: 35 SCPSSILTYSRNSTYFTNLKTLLSSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVS 94
Query: 134 FQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNT 193
+ C+NC+ +V L C KE ++Y ECM+R+S +I+ T I N
Sbjct: 95 QEVCRNCVAFSVKETLYWCPYNKEVVLYY--DECMLRYSHR--NILSTVTYDGSAILLNG 150
Query: 194 YNVTKS---LAQSFNDVIAMP-SLSSFR--NATKRTNISNIIR---LETFGQCIPVLSVD 244
N++ S F D+++ +L++ N++K+ +I L QC P L+
Sbjct: 151 ANISSSNQNQVDEFRDLVSSTLNLAAVEAANSSKKFYTRKVITPQPLYLLVQCTPDLTRQ 210
Query: 245 DCRDCLNNTIRWIQRCFDPPGMGF----GRILFPSCIMGFELYRYSKVPAVGA------- 293
DC CL +I+ GM GR +PSC +E Y + A +
Sbjct: 211 DCLRCLQKSIK---------GMSLYRIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLP 261
Query: 294 ----------LAPS---SAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQE 340
LAP S G R ++ I + + AL+ +LF +F R ++ + E
Sbjct: 262 PRSTPQQQLKLAPPPLISERGKGRNSSVIIVVVVPIIALL-LLFVAFFSLRAKKTRTNYE 320
Query: 341 EKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLG 400
+ ++E +I G Q F + ATN F + NKLG
Sbjct: 321 REPLTEESD--------------DITTAGSLQ--------FDFKAIEAATNKFCETNKLG 358
Query: 401 QGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460
QGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKLQH+NLVRLLG CLE
Sbjct: 359 QGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERD 418
Query: 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520
E +L+YE++PNKSLD +FD+T LDW RR II GIARGILYLH+DSRL IIHRDLK
Sbjct: 419 ERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLK 478
Query: 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580
A NILL DDMN KI+DFG+ARIFG +Q +ANT I S ++ Y ++ V
Sbjct: 479 AGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYS 538
Query: 581 F 581
F
Sbjct: 539 F 539
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | ||||||
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.811 | 0.705 | 0.515 | 1e-122 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.849 | 0.607 | 0.493 | 1e-121 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.753 | 0.659 | 0.473 | 1e-106 | |
| 255555021 | 686 | ATP binding protein, putative [Ricinus c | 0.777 | 0.660 | 0.429 | 1e-104 | |
| 356575777 | 671 | PREDICTED: cysteine-rich receptor-like p | 0.775 | 0.673 | 0.439 | 1e-96 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.751 | 0.660 | 0.437 | 1e-95 | |
| 356575779 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.773 | 0.677 | 0.445 | 8e-95 | |
| 356575781 | 659 | PREDICTED: cysteine-rich receptor-like p | 0.770 | 0.681 | 0.425 | 2e-94 | |
| 359496705 | 1453 | PREDICTED: uncharacterized protein LOC10 | 0.828 | 0.332 | 0.406 | 9e-94 | |
| 356575789 | 697 | PREDICTED: cysteine-rich receptor-like p | 0.881 | 0.737 | 0.399 | 1e-93 |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-122, Method: Compositional matrix adjust.
Identities = 252/489 (51%), Positives = 318/489 (65%), Gaps = 16/489 (3%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
C +++ S F SNL L ++ L++E G S + EGE PD VYGL+LC+ +VS C
Sbjct: 35 CNNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHIC 94
Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTYNV 196
Q+CI AA ++Q C KEA IWY EC +R+S+ S S ++ L M QN
Sbjct: 95 QSCIDAATLKIVQVCQHKKEAIIWYN--ECFLRYSNRSFFSNLEMKPTLYMWNTQNASAP 152
Query: 197 TK---SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
K L + F ++ A + S A + +SN + L QC L + CR CL+
Sbjct: 153 DKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEV 212
Query: 254 IRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKV--PAVGALAPSS-APGGKRGRAIS- 309
+ +I + G GR+L PSC + +E+Y ++ V P V A PSS +P G++GR
Sbjct: 213 VGYIPNFME--GKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSSISPRGRKGRKTKW 270
Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEG-RIR-NHYAYNILR 367
IA GT+LS ++VV F + RRR+ A D EEK + ++ L G R+ Y+ L+
Sbjct: 271 IATGTSLSGIVVVAFCVYYVIRRRKGA-DPEEKESKGDLCLLDLGGGRLDAEDYSSETLQ 329
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 427
G A+S+EFP+ + EAT HFS++NKLG+GGFGPVYKGTL+DGK IAVKRLS TS
Sbjct: 330 G-DMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTS 388
Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
GQGLQEFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD LFD+TR ++L
Sbjct: 389 GQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLEL 448
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
DWK R SIINGIARGI YLHEDSRL+IIHRDLK SNILLD DMNPKISDFGLARIF G++
Sbjct: 449 DWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSE 508
Query: 548 NQANTNIIA 556
N NT I
Sbjct: 509 NGTNTAKIV 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 256/519 (49%), Positives = 328/519 (63%), Gaps = 24/519 (4%)
Query: 55 LHLLSIVSSVMSQYFAEEDMVLSCAVSNNTA--------SNTFTSNLNILFNQKLHSEAG 106
+ L+ I ++ +F + + + N+T N SNL L ++ L++E G
Sbjct: 149 IGLVDIAFGWLAYWFEGTEEAVGTKLLNSTTFPRLHAWIQNFKQSNLGALLSRSLNNEGG 208
Query: 107 KSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQE 166
S + EGE PD VYGL+LC+ +VS CQ+CI AA ++Q C KEA IWY E
Sbjct: 209 ISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYN--E 266
Query: 167 CMVRFSDHSS-SIMDTSAPLCMKIFQNTYNVTK---SLAQSFNDVIAMPSLSSFRNATKR 222
C +R+S+ S S ++ L M QN K L + F ++ A + S A +
Sbjct: 267 CFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTAKATSSDGMYAIGQ 326
Query: 223 TNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFEL 282
+SN + L QC L + CR CL+ + +I + G GR+L PSC + +E+
Sbjct: 327 VEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFME--GKEGGRVLAPSCYIRYEI 384
Query: 283 YRYSKV--PAVGALAPSS-APGGKRGRAIS-IAIGTTLSALIVVLFGSFLWYRRRRHARD 338
Y ++ V P V A PSS +P G++GR IA GT+LS ++VV F + RRR+ A D
Sbjct: 385 YPFAAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGA-D 443
Query: 339 QEEKRNSQEVQFLHWEG-RIR-NHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDE 396
EEK + ++ L G R+ Y+ L+G A+S+EFP+ + EAT HFS++
Sbjct: 444 PEEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKSKEFPVIGFDIVYEATQHFSND 502
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
NKLG+GGFGPVYKGTL+DGK IAVKRLSRTSGQGLQEFKNEV LIAKLQH+NLVRLLGCC
Sbjct: 503 NKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCC 562
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
LEG ELLLIYEYMPNKSLD LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIH
Sbjct: 563 LEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIH 622
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
RDLK SNILLD DMNPKISDFGLARIF G++N NT I
Sbjct: 623 RDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKI 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1003), Expect = e-106, Method: Compositional matrix adjust.
Identities = 232/490 (47%), Positives = 294/490 (60%), Gaps = 51/490 (10%)
Query: 89 FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
+ NLN L + + S+ ++NAS G PD VYGL+ C+ ++S CQNC+ A
Sbjct: 52 YKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCRGDLSTDVCQNCVANATKD 111
Query: 148 VLQK-CSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTY-------NVTK 198
++Q+ C K AFIWY EC +R+S+ S M+ + +N +
Sbjct: 112 IVQRRCPTQKVAFIWYD--ECFLRYSNKIMFSTMERDPNYTLWNPENVAVHADFNRELLN 169
Query: 199 SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
++ + N MP+ + ATK N + L QC P LS DC CL ++
Sbjct: 170 TIFTAVNRAANMPAGAKKFRATK-ANYTTEHYLYVLVQCTPDLSSGDCEQCLLAAYSGLE 228
Query: 259 RCFDPPGMGFGRILFPSCIMGFELY-RYSKV-PAVGALAPSSAP-------GGKRG--RA 307
C + G RILFPSCI+ FE Y Y++ ALAPS P G +G +
Sbjct: 229 ICCNEKRGG--RILFPSCIVNFETYINYNETYVESAALAPSPVPQEKHFCYAGDKGSSKK 286
Query: 308 ISIAIGTTLSALI-VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNIL 366
I IG TLS ++ V+L SF + RR RD S E+ +
Sbjct: 287 TWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDD----CSNEIMY---------------- 326
Query: 367 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 426
+ +SQ+ L L + L+ATN +S+ENKLGQGGFGPVYKG + DGK IAVKRLSRT
Sbjct: 327 ----GEVKSQDSFLIQLDIVLKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRT 382
Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
SGQGL+EF NEVNLIA+LQH+NLV+LLGCCLE E LL+YEYMPNKSLDV LFD+ VQ
Sbjct: 383 SGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQ 442
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
LDW+RR SIINGIARG+LYLHEDSRL+IIHRDLKASNILLD +MNPKISDFG+ARIFGGN
Sbjct: 443 LDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGN 502
Query: 547 QNQANTNIIA 556
++ANTN I
Sbjct: 503 HSEANTNRIV 512
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 387 bits (993), Expect = e-104, Method: Compositional matrix adjust.
Identities = 226/526 (42%), Positives = 308/526 (58%), Gaps = 73/526 (13%)
Query: 81 SNNTA---SNTFTSNLN-ILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQS 136
SN+TA ++T+ +NLN +L + + ++ + +Y+ SEGE D VYGL+ C ++S +
Sbjct: 32 SNSTAFTRNSTYQNNLNRLLLSIRTNAINRPNGFYDTSEGEGEDRVYGLFFCTADLSTEV 91
Query: 137 CQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMKIFQNTYN 195
CQ+C+++A ++ +C K A +WY EC++R+S+ + SI+ S L M QN +
Sbjct: 92 CQDCVISATRDIVGRCPIEKTAIVWYD--ECILRYSNQTIYSILALSPGLYMWNAQNVSD 149
Query: 196 -------VTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
+ ++ ++ N A L + + AT N + +L T QC P LS D
Sbjct: 150 QEGFSELLATTMIKTANQAAA--PLGAIKFATLVANFTASQKLYTLAQCTPDLSYSDSAQ 207
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYR-YSKVPAVGALAP----------- 296
CL+ I + C D G GRIL+PSC + +E Y Y++ ++P
Sbjct: 208 CLHTAISNLPLCCD--GKRGGRILYPSCNIRYEFYPFYNETGFHREVSPFNNTTVVEGNP 265
Query: 297 -----------------------SSAPGGKRGRAISIAIGTTLSALIV--VLFGSFLWYR 331
GG+ + + +++A IV +LF SF +
Sbjct: 266 HSPILPPPPPPPIHPPAPMEKLGKVEKGGEGSKPTRTKVIASVTAAIVGILLFSSFFYIT 325
Query: 332 RRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATN 391
RR + EGR R+ Y+ + G + ++Q+FP+ P + EAT
Sbjct: 326 WRRK---------------IQKEGRTRDEYSCENITG---EMDAQDFPMIPFDIIEEATE 367
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
HFSD+ KLG+GGFGPVYKGTL DGK IAVKRLSRTSGQGL EF NEV LI KLQH+NLVR
Sbjct: 368 HFSDDAKLGEGGFGPVYKGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRNLVR 427
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLGCCLE E LLIYEYMPNKSLDV LFD+ V+LDW+RR SII+GIARG+LYLHEDSR
Sbjct: 428 LLGCCLEKSEKLLIYEYMPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHEDSR 487
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAV 557
L+IIHRDLKASNILLD DMNPKISDFG+ARIFGGN +++ I+
Sbjct: 488 LRIIHRDLKASNILLDYDMNPKISDFGMARIFGGNDSKSTNRIVGT 533
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 360 bits (924), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 219/498 (43%), Positives = 291/498 (58%), Gaps = 46/498 (9%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
C C++ A + +CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154
Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGRA 307
L++ I + C + G GRIL PSC + ++LY + + V A A P + G
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGNI 272
Query: 308 IS-----IAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRI 357
IS I+ GT ++ ++ V+LF +W +R A+ KRNS Q E I
Sbjct: 273 ISYGGSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETEI 326
Query: 358 RNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA 417
A LR F AT+ FSD NKLG+GGFG VYKG L G+
Sbjct: 327 S---AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQE 370
Query: 418 IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH 477
+AVKRLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD
Sbjct: 371 VAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYI 430
Query: 478 LFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537
LFD + LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDF
Sbjct: 431 LFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDF 490
Query: 538 GLARIFGGNQNQANTNII 555
G+ARIFG +Q QANTN I
Sbjct: 491 GMARIFGVDQTQANTNRI 508
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 357 bits (915), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 216/494 (43%), Positives = 291/494 (58%), Gaps = 56/494 (11%)
Query: 86 SNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFP-DSVYGLYLCKFNVSFQSCQNCIVAA 144
++++ +NLN + + + +YN + G P D YGL+LC+ +V+ Q CQ+C+ A
Sbjct: 38 NSSYETNLNFALSSLSSNATRDTGFYNVTAGRTPPDVAYGLFLCRGDVTSQVCQDCVATA 97
Query: 145 VN-SVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQS 203
VN +V Q+C G K+A IWY ECM+R+S+ S + +P NT N+T+
Sbjct: 98 VNETVRQRCRGFKQAIIWYD--ECMLRYSNESFFSQVSESPRVS--MWNTQNITE--PDQ 151
Query: 204 FNDVIAMPSLSSFRN-----------ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNN 252
FN V+ +L S R ATK N + R+ + QC P LS D C CL
Sbjct: 152 FNQVLG-DTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTPDLSPDQCDRCLIG 210
Query: 253 TIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK--------VPAVGALAPSSAPGGKR 304
TI + C G R+LFPSC + +ELY + + PA + + GG
Sbjct: 211 TIAILPDCCG--GKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPARPSEPSTEGKGGIS 268
Query: 305 GRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYN 364
+ I I + T + VV+F + RR A+ + + ++ V+F N
Sbjct: 269 SKTIVIIVVPTFVS--VVIFSILCYCFIRRCAKKRYDTLEAENVEF-------------N 313
Query: 365 ILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS 424
I +S +F L ++ ATN+FSD NK+G+GGFG VYKGTL+ G+ IA+KRLS
Sbjct: 314 I-----TTEQSLQFDLATIQ---AATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLS 365
Query: 425 RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF---DA 481
++SGQG EFKNEV L+AKLQH+NLVRLLG CLEG+E +L+YEY+PNKSLD LF
Sbjct: 366 KSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQP 425
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
T+ QLDW RR II GIARGILYLHEDSRL++IHRDLKASN+LLD DMNPKISDFG+AR
Sbjct: 426 TKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMAR 485
Query: 542 IFGGNQNQANTNII 555
IFG +Q Q NTN +
Sbjct: 486 IFGVDQTQGNTNRV 499
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 8e-95, Method: Compositional matrix adjust.
Identities = 220/494 (44%), Positives = 292/494 (59%), Gaps = 43/494 (8%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAA---VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---K 188
C C++ A ++S LQ CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQ-CSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSA 153
Query: 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR
Sbjct: 154 NISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRS 213
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGR 306
CL++ I + C + G GRIL PSC + ++LY + + V A A P + G
Sbjct: 214 CLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGG 271
Query: 307 AISIAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
I+ GT ++ ++ V+LF +W +R A+ KRNS Q E I
Sbjct: 272 GSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETEIS--- 322
Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
A LR F AT+ FSD NKLG+GGFG VYKG L G+ +AVK
Sbjct: 323 AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVK 369
Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
RLS+ SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD LFD
Sbjct: 370 RLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDP 429
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+AR
Sbjct: 430 EKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMAR 489
Query: 542 IFGGNQNQANTNII 555
IFG +Q QANTN I
Sbjct: 490 IFGVDQTQANTNRI 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575781|ref|XP_003556015.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 353 bits (905), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 208/489 (42%), Positives = 283/489 (57%), Gaps = 40/489 (8%)
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
C + TA++TF N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ
Sbjct: 37 CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96
Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
C C++ A + +CS +K+A IWY ECMVR+S+ S S +DT + +
Sbjct: 97 LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154
Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
N N + + + N+ ++ + + ATK+ NIS L QC P LS CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214
Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP---GGKRGR 306
L++ I + C + G GRIL PSC + ++LY + + + P+S P G
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNV--SAPPASVPPTDSSNSGG 270
Query: 307 AISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNIL 366
I I + V+LF +W +R A+ H +++ L
Sbjct: 271 NIIIVAIVVPITVAVLLFIVGIWLLSKRAAK---------------------KHMSFHFL 309
Query: 367 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 426
+ + + E F AT+ FSD NKLG+GGFG VYKG L G+ +AVKRLS+
Sbjct: 310 --AETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVKRLSKN 367
Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
SGQG EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD LFD +
Sbjct: 368 SGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDPEKQKS 427
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
LDW RR I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG +
Sbjct: 428 LDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVD 487
Query: 547 QNQANTNII 555
Q QANTN I
Sbjct: 488 QTQANTNRI 496
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496705|ref|XP_003635307.1| PREDICTED: uncharacterized protein LOC100265431, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 350 bits (899), Expect = 9e-94, Method: Compositional matrix adjust.
Identities = 229/564 (40%), Positives = 309/564 (54%), Gaps = 81/564 (14%)
Query: 49 SQAIRWLHLL-----------SIVSSV--------------------MSQYFAEEDMVLS 77
S+A+RW+H+ ++SSV M ++F + S
Sbjct: 612 SEALRWIHIALLCVQEEPNDRPLMSSVALMLGSKSVNLPQPSAPPFSMGRHFMSDQ---S 668
Query: 78 CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
+T + + +NL L + L S+A +YN S + +Y LYLC+ +V+ +C
Sbjct: 669 STTGTSTDNANYENNLTALLD-SLSSKASLYSFYNDSANQ----IYSLYLCRGDVNATTC 723
Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVT 197
QNC+ A V Q+C + A IWY EC +R+S + + ++P + NT N +
Sbjct: 724 QNCVRTASQEVQQQCQSNRTAIIWYD--ECKLRYSSENFFGIAATSPYFL--LWNTRNNS 779
Query: 198 K-------SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFG--QCIPVLSVDDCRD 248
LA + V P+ + ++N + +G QC +S D+CR
Sbjct: 780 SPDERDVGGLAFIYTLVSKAPNSENMFGTDVAEAVNNASQ-NIYGSVQCTRDISNDECRS 838
Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP-------- 300
CL I I+ C G I+ PSC M +E Y + + P + P+S P
Sbjct: 839 CLLQQIEEIEGCCQ--GKIGWNIMGPSCNMRYEQYLFYQQP-LAPSTPASQPMPDDNPVY 895
Query: 301 ------GGKRGRAISIAIGTTLSALIVVLFGSFLW---YRRRRHARDQEEKRNSQEVQFL 351
GGK I+I +T++ VL G +L+ +RR+R + E+ S+E+ L
Sbjct: 896 NIVAGKGGKNTTDIAIITVSTVTG-AAVLLGFYLYCSIFRRKR----EPEEHVSEEI-LL 949
Query: 352 HWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT 411
H+ + +I + Q S E F L L ATN+FSD NKLG+GGFGPVYKG
Sbjct: 950 HYSTAATHFMEGHI--HARDQDNSGELHCFNLTTILTATNNFSDANKLGEGGFGPVYKGK 1007
Query: 412 LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471
L +GK IAVKRLSR SGQGL+EFKNEV LI KLQHKNLVRLLGCC+E +E LL+YEYM N
Sbjct: 1008 LLNGKEIAVKRLSRKSGQGLEEFKNEVMLIVKLQHKNLVRLLGCCIEREEKLLVYEYMAN 1067
Query: 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531
SLD LFD +S QLDW +R +I+ GIARGILYLHEDSRLKIIHRDLKASN+LLD++MN
Sbjct: 1068 TSLDAFLFDPIKSRQLDWAKRAAIVGGIARGILYLHEDSRLKIIHRDLKASNVLLDEEMN 1127
Query: 532 PKISDFGLARIFGGNQNQANTNII 555
PKISDFG ARIFG NQ ANTN +
Sbjct: 1128 PKISDFGTARIFGSNQIDANTNKV 1151
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575789|ref|XP_003556019.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 350 bits (898), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 214/536 (39%), Positives = 303/536 (56%), Gaps = 22/536 (4%)
Query: 30 FISEVKSYRRTMPTAANLASQAIRWLHL-LSIVSSVMSQYFAEEDMVLSCAVSNNTASNT 88
++S VK + P A +S + +L + +S + ++ + C + TA++T
Sbjct: 11 YVSAVKQLKHINPAMAWNSSFKLLFLFVFVSFLCFATTKAQGPNFLYQDCPSNQTTANST 70
Query: 89 FTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQSCQNCIVAAVN 146
F N+ LF+ + +++YN++ G P D+VYGL++C+ +V FQ C C++ A
Sbjct: 71 FQINIRTLFSSLSSNATTNNVFYNSTVTGTNPSDTVYGLFMCRGDVPFQLCGQCVINATQ 130
Query: 147 SVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KIFQNTYNVTKSL 200
+ +CS +K+A IWY ECMVR+S+HS S +DT + + N N + +
Sbjct: 131 KLSSDLQCSLSKQAVIWYD--ECMVRYSNHSFFSTVDTRPAIGLLNSANISNQANFMRLM 188
Query: 201 AQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRC 260
+ N+ ++ + + ATK+ NIS L QC P LS CR CL++ I + RC
Sbjct: 189 FDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPRC 248
Query: 261 FDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGRAISIAIGTTLSALI 320
+ G GRIL PSC + +ELY + + + +S+P ++S+ T S+
Sbjct: 249 CE--GKQGGRILNPSCNVRYELYPFFRTNTI-----ASSPAPTPTPSVSVPPTPTTSSNS 301
Query: 321 VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQA-ESQEFP 379
G ++ + + H + L G + A ES F
Sbjct: 302 GGSGGISSGTIVAIVVPIAVAVVIFVVGIWILCKRAAKKHMPFLFLAGTEISAVESLRFD 361
Query: 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
+ AT FS+ NKLG+GGFG VYKG L G+ +AVKRLS+ SGQG +EFKNEV
Sbjct: 362 FSTIE---AATQKFSEANKLGEGGFGEVYKGLLPSGQEVAVKRLSKISGQGGEEFKNEVE 418
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++AKLQH+NLVRLLG CLEG+E +L+YE++ NKSLD LFD + LDW RR I+ GI
Sbjct: 419 IVAKLQHRNLVRLLGFCLEGEEKILVYEFVVNKSLDYILFDPEKQKSLDWTRRYKIVEGI 478
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
ARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG +Q QANTN I
Sbjct: 479 ARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRI 534
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | ||||||
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.725 | 0.626 | 0.422 | 2e-79 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.293 | 0.255 | 0.651 | 1.4e-78 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.334 | 0.302 | 0.585 | 1.4e-78 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.288 | 0.251 | 0.660 | 6.9e-74 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.293 | 0.259 | 0.627 | 2.9e-72 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.334 | 0.288 | 0.575 | 4.7e-72 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.718 | 0.619 | 0.396 | 2.3e-71 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.343 | 0.240 | 0.559 | 4e-71 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.301 | 0.263 | 0.625 | 3.7e-68 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.288 | 0.256 | 0.598 | 4.2e-67 |
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 202/478 (42%), Positives = 272/478 (56%)
Query: 108 SLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ 165
SL+ NA+ GE DS VYG++LC+ +VS + C++C+ A N LQ+C K A IWY
Sbjct: 66 SLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYD-- 123
Query: 166 ECMVRFSDHSSSIMDTSAPLCMKIF-QNTYNVTKSLAQSFN--------DVIAMPSLSSF 216
ECMVR+S+ S P +F N N+T++ FN DV +LSS
Sbjct: 124 ECMVRYSNQSIVGQMRIRP---GVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSR 180
Query: 217 RNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSC 276
+ AT++ N + + + QC P L+ DC CL I ++ RC D +G GR++ PSC
Sbjct: 181 KFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAPSC 238
Query: 277 IMGFELYR-YSKVPAVGALAP--SS---APG----GKRGRAISIAIGTTLSAL----IVV 322
+ELY Y++ A +AP SS AP ++G+ ++ + T A+ V+
Sbjct: 239 SFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVL 298
Query: 323 LFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFP 382
L G+ W RR + S E + L +G I + E+ +F
Sbjct: 299 LLGAMCWLLARRR-----NNKLSAETEDLDEDG-ITS-------------TETLQFQFSA 339
Query: 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIA 442
+ A TN FS+ NKLG GGFG VYKG L G+ +A+KRLS+ S QG +EFKNEV+++A
Sbjct: 340 IEAA---TNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVA 396
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
KLQH+NL + +YE++PNKSLD LFD + LDW+RR II GIARG
Sbjct: 397 KLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARG 456
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
ILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT I V T+
Sbjct: 457 ILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRI-VGTY 513
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
Identities = 112/172 (65%), Positives = 132/172 (76%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
AT+ F + NK+GQGGFG VYKGTL+DG +AVKRLS++SGQG EFKNEV L+AKLQH+N
Sbjct: 344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR +YEY+PNKSLD LFD + QLDW RR II G+ARGILYLH+
Sbjct: 404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q + NT+ I V T+
Sbjct: 464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRI-VGTY 514
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
Identities = 116/198 (58%), Positives = 143/198 (72%)
Query: 386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
A+EA TN F NKLGQGGFG VYKGTL+ G +AVKRLS+TSGQG +EF+NEV ++AKL
Sbjct: 318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
QH+NLV+ +YE++PNKSLD LFD+T ++LDW RR II GIARGIL
Sbjct: 378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP-QS 563
YLH+DSRL IIHRDLKA NILLDDDMNPKI+DFG+ARIFG +Q +A T + V T+ S
Sbjct: 438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRV-VGTYGYMS 496
Query: 564 MQWEAYFLLNLMFSVLEF 581
++ Y ++ V F
Sbjct: 497 PEYAMYGQFSMKSDVYSF 514
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 6.9e-74, Sum P(3) = 6.9e-74
Identities = 111/168 (66%), Positives = 125/168 (74%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
ATN FS NKLG+GGFG VYKG L++G +AVKRLS+ SGQG +EF+NE L+ KLQH+N
Sbjct: 346 ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRN 405
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR IYE++ NKSLD LFD + QLDW RR II GIARGILYLH+
Sbjct: 406 LVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQ 465
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG Q Q NTN IA
Sbjct: 466 DSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIA 513
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
Identities = 108/172 (62%), Positives = 128/172 (74%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
ATN FS+ NK+G+GGFG VYKGT ++G +AVKRLS+TS QG EFKNEV ++A L+HKN
Sbjct: 332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LVR +YEY+ NKSLD LFD + QL W +R II GIARGILYLH+
Sbjct: 392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q Q NT+ I V T+
Sbjct: 452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRI-VGTY 502
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 4.7e-72, Sum P(2) = 4.7e-72
Identities = 114/198 (57%), Positives = 137/198 (69%)
Query: 386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
A+EA TN F + NKLGQGGFG VYKG G +AVKRLS+TSGQG +EF NEV ++AKL
Sbjct: 343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
QH+NLVR +YE++PNKSLD +FD+T LDW RR II GIARGIL
Sbjct: 403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP-QS 563
YLH+DSRL IIHRDLKA NILL DDMN KI+DFG+ARIFG +Q +ANT I V T+ S
Sbjct: 463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRI-VGTYGYMS 521
Query: 564 MQWEAYFLLNLMFSVLEF 581
++ Y ++ V F
Sbjct: 522 PEYAMYGQFSMKSDVYSF 539
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
Identities = 188/474 (39%), Positives = 258/474 (54%)
Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
+ N G+ PD V GL+LC+ ++S + C NC+ +VN L +C +EA +Y+ EC++
Sbjct: 78 FQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYE--ECIL 135
Query: 170 RFSDHSS--SIMDTSAPLCMK------IFQNTYNVTKSLAQSFNDVIAMPSLSSFRN-AT 220
R+S H + S + L M+ QN + L QS + A + +S R +T
Sbjct: 136 RYS-HKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFST 194
Query: 221 KRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGF 280
+T ++++ L QC P L+ DC CL ++I + F +G R +PSC +
Sbjct: 195 IKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLFR---IG-ARQFWPSCNSRY 250
Query: 281 ELYRYSKVPAVGA-----LAPSSAPG-------GKRGRAISIAIGTTLSA--LIVVLFGS 326
ELY + A+G L P S P GK G + + + + A L + L G
Sbjct: 251 ELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGY 310
Query: 327 FLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLA 386
+R + D ++ EV G A + L R
Sbjct: 311 CFLAQRTKKTFDTA---SASEV--------------------GDDMATADSLQL-DYRTI 346
Query: 387 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG EFK EV ++AKLQH
Sbjct: 347 QTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQH 406
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+NLVR +YEYMPNKSLD LFD T+ QLDW +R +II GIARGILYL
Sbjct: 407 RNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYL 466
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
H+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT+ I V T+
Sbjct: 467 HQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRI-VGTY 519
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 4.0e-71, Sum P(2) = 4.0e-71
Identities = 113/202 (55%), Positives = 139/202 (68%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
F + + ATN+F NKLGQGGFG VYKGT G +AVKRLS+TSGQG +EF+NEV +
Sbjct: 496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
+AKLQH+NLVR +YE++ NKSLD LFD T QLDW RR II GIA
Sbjct: 556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
RGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIFG +Q +ANT + V T+
Sbjct: 616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRV-VGTY 674
Query: 561 P-QSMQWEAYFLLNLMFSVLEF 581
+ ++ Y ++ V F
Sbjct: 675 GYMAPEYAMYGQFSMKSDVYSF 696
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 3.7e-68, Sum P(2) = 3.7e-68
Identities = 110/176 (62%), Positives = 132/176 (75%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
F + AT+ FSD N +G+GGFG VY+G L+ G +AVKRLS+TSGQG +EFKNE L
Sbjct: 333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
++KLQHKNLVR +YE++PNKSLD LFD + +LDW RR +II GIA
Sbjct: 393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
RGILYLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q+QANT IA
Sbjct: 453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIA 508
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 4.2e-67, Sum P(2) = 4.2e-67
Identities = 106/177 (59%), Positives = 126/177 (71%)
Query: 385 LALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ LEA T+ FS NKLG+GGFG VYKG L + +AVKRLS SGQG QEFKNEV ++AK
Sbjct: 312 MTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQGTQEFKNEVVIVAK 371
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDV--------HLFDATRSVQLDWKRRQSI 495
LQHKNLVR +YE++PNKSL+ HL D T+ QLDWKRR +I
Sbjct: 372 LQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPTKKSQLDWKRRYNI 431
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
I GI RG+LYLH+DSRL IIHRD+KASNILLD DMNPKI+DFG+AR F +Q + NT
Sbjct: 432 IGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNT 488
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00020409001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (654 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 583 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-06 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 63/152 (41%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
KLG+G FG VYKGTL +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C E + L+++ EYMP L +L R +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 3e-40
Identities = 60/152 (39%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
KLG+G FG VYKG L +AVK L S Q ++EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C E + L ++ EYM L +L +L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 62/156 (39%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 397 NKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
KLG+G FG VYKG L +AVK L S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRQSIINGIARGILY 505
LLG C E + L L+ EYM L +L F + L K S IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
L K +HRDL A N L+ +D+ KISDFGL+R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 58/158 (36%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG G FG VYK GK +AVK L + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L+ EY L +L +R L + I I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IHRDLK NILLD++ KI+DFGLA+ + + T
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-39
Identities = 56/159 (35%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
LG+GGFG VY GK +A+K + + S L+E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ L L+ EY SL L + +L I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 517 RDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNI 554
RDLK NILLD D+ K++DFGL+++ +++ T +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 59/150 (39%), Positives = 81/150 (54%), Gaps = 11/150 (7%)
Query: 398 KLGQGGFGPVYKGTLADGKA-----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
KLG+G FG VYKGTL +AVK L S + +EF E +++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLG C +G+ L ++ EYMP L L + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLES--- 120
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N L+ +++ KISDFGL+R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLV 450
+ KLG+G FG VY GK +A+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL + +L L+ EY L L + +L + + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
I+HRDLK NILLD+D + K++DFGLAR +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 56/178 (31%), Positives = 80/178 (44%), Gaps = 37/178 (20%)
Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG VY D G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-------------RQSIING 498
G E L + EY+ SL L K+ RQ
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----------KKFGKLPEPVIRKYTRQ----- 109
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
I G+ YLH I+HRD+K +NIL+D D K++DFG A+ G + T +
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 55/148 (37%), Positives = 79/148 (53%), Gaps = 16/148 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
+G+G FG V G G+ +AVK L S Q F E +++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSV-----QLDWKRRQSIINGIARGILYLHEDSRLK 513
G L ++ EYM SL +L R+V QL + + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D+ K+SDFGLA+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
F K+G+GGFG VYK GK +A+K + S + ++ NE+ ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL---- 504
+ G L+ EL ++ E+ SL D +S + +S I + + +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLK----DLLKS----TNQTLTESQIAYVCKELLKGLE 112
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQ 562
YLH IIHRD+KA+NILL D K+ DFGL+ + +A ++ W P+
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPE 167
Query: 563 SMQWEAY 569
+ + Y
Sbjct: 168 VINGKPY 174
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/154 (35%), Positives = 84/154 (54%), Gaps = 13/154 (8%)
Query: 397 NKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V G+ +AVK L+ + Q +F+ E+ ++ L H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 451 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C + G+ L LI EY+P+ SL +L Q++ KR + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ IHRDL A NIL++ + KISDFGLA++
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 39/179 (21%)
Query: 392 HFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKN 448
++ + +G+G FG VYKG L G +A+K++S + L+ E++L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------- 498
+V+ +G L +I EY N SL + II
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL------------------RQIIKKFGPFPESLVA 102
Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ +G+ YLHE +IHRD+KA+NIL D K++DFG+A +
Sbjct: 103 VYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
F+ E KLG G FG V++G + +A+K L Q+F+ EV + +L+HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
C G+ + +I E M SL L V S+I+ +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
IHRDL A NIL+ +D+ K++DFGLAR+
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
F KLG+G +G VYK G+ +A+K + LQE E++++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 452 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G + +L ++ EY S D + T L + +I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K IHRD+KA NILL+++ K++DFG++ + NT I
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++G+G FG VY +DGK +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIARGILYL 506
E +L ++ EY L + + + LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYL 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H KI+HRD+K NI L + K+ DFG++++ + A T
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 63/185 (34%), Positives = 89/185 (48%), Gaps = 33/185 (17%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG---TLADGK---AIAVKRLSRT-SGQ 429
E PL +R F +E LG+G FG VYKG + ++A+K L +
Sbjct: 1 EIPLSAVR--------FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK 50
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHL 478
QEF+ E L++ LQH N+V LLG C + Q +++EY+ + L DV
Sbjct: 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 479 FDATRSVQ--LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
+V+ LD I IA G+ YL S +HRDL A N L+ + + KISD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167
Query: 537 FGLAR 541
FGL+R
Sbjct: 168 FGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 54/162 (33%), Positives = 88/162 (54%), Gaps = 23/162 (14%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKR---------LSRTSGQGLQEFKNEVNLIA 442
+ KLG+G +G VYK G+ +A+K+ + T+ L+E ++L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
+L+H N+V+LL ++L L++EY +D+ + R L +SI+ + RG
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ Y H S +I+HRDLK NIL++ D K++DFGLAR FG
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 399 LGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVR 451
LG+G FG V+ G + +AVK L T+ ++ F+ E L+ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 452 LLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
G C EG ++++EYM NK L H DA D + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G++YL + +HRDL N L+ D+ KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEF----KNEVNLIAKLQHKNLVR 451
++G+G +G VYK G+ +A+K++ R + F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L + +++EYM + D+ + V+ + + + + G+ YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
I+HRD+K SNIL+++D K++DFGLAR + + TN
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 55/161 (34%), Positives = 89/161 (55%), Gaps = 20/161 (12%)
Query: 399 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG + +G+ +A+K L + + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLF---DATRSVQ-LDWKRRQSIINGIARGILYLHE 508
LG CL ++ LI + MP L ++ D S L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-E 126
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ RL +HRDL A N+L+ + KI+DFGLA++ ++ +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
C E + + ++ EYM SL L R +++ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL----RLPQLVDMAAQIAEGMAYLE---SR 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIF 543
IHRDL A NIL+ +++ KI+DFGLAR+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 377 EFPLFPLRLALEA---TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
E L+ + + + K+G+G G VYK T A GK +A+K++ R Q +
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
NE+ ++ +H N+V L G EL ++ EYM SL D +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT----DIITQNFVRMNEP 116
Query: 493 Q--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
Q + + +G+ YLH +IHRD+K+ NILL D + K++DFG A +++
Sbjct: 117 QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 551 NT 552
N+
Sbjct: 174 NS 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 53/151 (35%), Positives = 82/151 (54%), Gaps = 16/151 (10%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VY+G L DG AVK +S +T + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LG E L + E +P SL L + + + RQ I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+HRD+K +NIL+D + K++DFG+A+
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G FG VYKG L +AVK T L ++F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
++ Q + ++ E +P SL L + +L K+ + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 517 RDLKASNILLDDDMNPKISDFGLAR 541
RDL A N L+ ++ KISDFG++R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/151 (34%), Positives = 87/151 (57%), Gaps = 10/151 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 455 CCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L L++E++ LD+ D++ LD +S + + +GI Y H S +
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L+D + K++DFGLAR FG
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 57/162 (35%), Positives = 92/162 (56%), Gaps = 18/162 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKL 444
+H + + +G G FG V++G L G+ A+A+K L T Q Q+F +E +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQF 63
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIAR 501
H N++RL G + + ++I EYM N +LD +L D S QL ++ GIA
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAA 118
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
G+ YL S + +HRDL A NIL++ ++ K+SDFGL+R+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 61/179 (34%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 397 NKLGQGGFGPVYKGT--LADGK--AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG G FG V KG + GK +AVK L + G +EF E +++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L+G C G+ L+L+ E P L +L D K + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAVDTWPQSMQWEA 568
+HRDL A N+LL + KISDFG++R G + +A T WP ++W A
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA----GRWP--LKWYA 166
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 40/169 (23%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN-----------EVNLIAK 443
KLG+G + VYK G+ +A+K++ L E K E+ L+ +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQE 58
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMP--------NKSLDVHLFDATRSVQLDWKRRQSI 495
L+H N++ LL + L++E+M +KS+ L A D K S
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPA------DIK---SY 107
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ RG+ YLH I+HRDLK +N+L+ D K++DFGLAR FG
Sbjct: 108 MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
KLG G FG V+ G +A+K L + S + F E NL+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I EYM N SL V ++L + + IA G+ ++ R I
Sbjct: 70 VTQ-EPIYIITEYMENGSL-VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
HRDL+A+NIL+ + + KI+DFGLAR+ N+ A
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 398 KLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG+G FG V+ D +AVK L S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 452 LLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
G C EG+ LL+++EYM + L D + V QL + +I + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 7/163 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL 449
F NK+G+G FG V+K AD + A+K+ LS+ + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+R L+ +L ++ EY N L L R L + I G+ +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLH-KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
KI+HRD+K+ N+ LD N KI D G+A++ N N ANT
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 53/157 (33%), Positives = 93/157 (59%), Gaps = 11/157 (7%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNL 449
++ K+G+G +G VYKG G+ +A+K++ S +G+ E++L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLF-DATRSVQ-LDWKRRQSIINGIARGILYLH 507
V L ++ L LI+E++ S+D+ + D+ Q +D + +S + I +GIL+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L+D+ K++DFGLAR FG
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 396 ENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
E +G G FG V +G L +A+K L S + +F E +++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G + + +++I EYM N SLD L + + ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ +HRDL A NIL++ ++ K+SDFGL+R ++ T
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 13/167 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKL 444
+ KLG+G FG VYK + G+ +A+K++ + G + + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 445 QHKNLVRLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
+H N+V L+ +E ++ +Y P D+ SV+L + + + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
GI YLHE+ I+HRD+KA+NIL+D+ KI+DFGLAR + G
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 18/152 (11%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR-----LSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY D G+ +AVK+ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLHED 509
GC + + L + EYMP S+ L + A T +V + R+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 58/165 (35%), Positives = 94/165 (56%), Gaps = 20/165 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG + +G+ + A+K L+ T+G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSL----DVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LG CL + L+ + MP+ L H + + L+W + IA+G++YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+++HRDL A N+L+ + KI+DFGLAR+ G++ + N +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 44/162 (27%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
F+ +G+G FG VYK + +A+K + + +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G L+G +L +I EY S D + +LD I+ + G+ YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IHRD+KA+NILL ++ + K++DFG++ ++ NT
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDS 510
C +I E+M +L +L + R V L + Q I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-----ISSAMEYLEKKN 124
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
IHRDL A N L+ ++ K++DFGL+R+ G+
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LGQG G VYK GK A+K++ + ++ E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
G + E+ ++ EYM SL D + V K + ++ IAR IL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVG---KIPEPVLAYIARQILKGLDYLH-- 116
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++ IIHRD+K SN+L++ KI+DFG++++ +Q NT +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++G+G G V+K G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYLHEDSRL 512
G +L+ EYMP+ L + R + Q S + + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
I+HRDLK +N+L+ D KI+DFGLAR+F
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 57/154 (37%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
KLG G FG V+ G + +AVK L + +Q F E NL+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 458 EGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ + + +I EYM SL D D V L + IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
RDL+A+N+L+ + + KI+DFGLAR+ N+ A
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 61/151 (40%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 399 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
LG+G FG V Y G+ +AVK L R GQ +K E+N++ L H+N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 453 LGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
GCC E G+ L LI EY+P SL +L ++ Q I G+A YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YLHSQ- 126
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N+LLD+D KI DFGLA+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.6 bits (223), Expect = 1e-19
Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH-KNLVRLL 453
KLG+G FG VY D K +A+K L++ + ++ F E+ ++A L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L+ EY+ SL+ L R L I+ I + YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 514 IIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNI 554
IIHRD+K NILLD D K+ DFGLA++ + ++
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 24/157 (15%)
Query: 399 LGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG V L D G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 454 GCCLEG--QELLLIYEYMPNKSL------DVHLFDATRSVQLDWKRRQSIINGIARGILY 505
G C + L L+ EY+P SL D + + + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + +HRDL NIL++ + KI DFGL ++
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+L L++E+M D++ R L +S + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+HRDLK N+L++ + K++DFGLAR FG
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 57/159 (35%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 398 KLGQGGFGPVYKGTL--ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRL 452
KLG G FG V +G + GK I AVK L + +F E ++ L H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 453 LGCCLEGQELLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
G L L+++ E P SL L S D+ + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ IHRDL A NILL D KI DFGL R N
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
KLG G FG V++G + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 458 EGQELLLIYEYMPNKSLDVHL-FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+ + ++ E M SL +L A R+++L + + +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
RDL A N+L+ ++ K++DFGLAR+ + +A
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFK-----NEVNLIAKL 444
+ F +G+G F V K A+K L + Q ++E K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 445 -QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
H +++L + + L + EY PN L ++ + LD K + I +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--NQANTNIIAVDTWP 561
YLH IIHRDLK NILLD DM+ KI+DFG A++ N + +D+
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 562 QSMQ 565
+ +
Sbjct: 173 EKNR 176
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLV 450
LGQG FG VY+G +A+K ++ + + + EF NE +++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLF----DATRSVQLDWKRRQSIIN---GIARGI 503
RLLG GQ L++ E M L +L +A + L Q I IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YL K +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 30/185 (16%)
Query: 396 ENKLGQGGFGPVYKGTLA------DGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKN 448
+GQG FG V++ +AVK L S +F+ E L+A+ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-------------------RSVQLDW 489
+V+LLG C G+ + L++EYM L+ L + + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQN 548
+ I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R I+ +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 549 QANTN 553
+A+ N
Sbjct: 187 KASEN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 60/160 (37%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 399 LGQGGFGPVYKGT----LADGKA---IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLV 450
LG G FG VY+GT L G +AVK L + + Q +EF E +L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRQSIINGIARGILYL 506
+LLG CL + +I E M L +L DA L K I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 507 HEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLAR 541
++ IHRDL A N L+ D D KI DFGLAR
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-18
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 83 NTASNTFTSNLNILFNQKLHSEAGKS---LYYNASEGEFPDSVYGLYLCKFNVSFQSCQN 139
TA++TF SNLN L + L S A S + + G PD+VYGL C+ ++S C++
Sbjct: 13 TTANSTFESNLNALLSS-LSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 140 CIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSD 173
C+ AV+ + + C K IWY C +R+
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWY--DSCFLRYES 103
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 21/183 (11%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKR--LSRTSGQG-------LQEFKNEVNLIAKLQHKN 448
+G G FG VY G A G+ +AVK+ L S L E+ L+ +LQH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+ LG L+ L + EY+P S+ L + ++ + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEA 568
+R IIHRD+K +NIL+D+ KISDFG+++ + +AN+ + S+Q
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISK-----KLEANSLSTKTNGARPSLQGSV 176
Query: 569 YFL 571
+++
Sbjct: 177 FWM 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
++G G FG V+ G + + +A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
E + L++E+M + L +L + + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
DL A N L+ ++ K+SDFG+ R +Q ++T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 45/149 (30%), Positives = 83/149 (55%), Gaps = 14/149 (9%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G +G VYK +A G+ +A+K + G + + E++++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSR 511
L +L ++ EY SL ++ TR +Q+ + R+++ +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
IHRD+K +NILL +D + K++DFG++
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 395 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
DEN LG+G +G VY L+ IA+K + + +Q E+ L + L+H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----Y 505
V+ LG E + E +P SL L RS K + I + IL Y
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGG 545
LH+ +I+HRD+K N+L++ KISDFG ++ G
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 399 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG V +G L+ DG +AVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 503
+G C E L ++I +M + L L +L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 546
YL S IHRDL A N +L +DM ++DFGL++ I+ G+
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 10/146 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCCL 457
LG+G FG V+KGTL D +AVK Q L+ +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI--ARGILYLHEDSRLKII 515
+ Q + ++ E +P L R + + K +Q + + A G+ YL + I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 516 HRDLKASNILLDDDMNPKISDFGLAR 541
HRDL A N L+ ++ KISDFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
E P LRL E KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQ 50
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E ++ KL+H+ LV+L E + + ++ EYM SL + L + +
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMA 108
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IA G+ Y+ R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 109 AQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 12/152 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGC 455
KLG+G + VYKG G+ +A+K + + +G E++L+ +L+H+N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 456 CLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L+L++EYM K +D H LD +S + +GI + HE+
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTH----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ K++DFGLAR FG
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 16/159 (10%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGL-QEFKNEVNLIAKLQ---HKNLV 450
++G+G +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 451 RLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
RLL C +L L++E++ ++ L +L + L + + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
LH +I+HRDLK NIL+ D KI+DFGLARI+
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 55/171 (32%), Positives = 84/171 (49%), Gaps = 31/171 (18%)
Query: 399 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V K T A +AVK L + L++ +E NL+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIING--------- 498
L G C + LLLI EY SL L ++ + + D R S ++
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+RG+ YL E +K++HRDL A N+L+ + KISDFGL+R
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
G + +++ + EY +L + LD + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
I+HRD+K +NI LD + K+ DFG A N
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V K T GK A+K L + + ++ E N+++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L + +E L L+ EY P L HL ++ + +R + I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLH--- 110
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
L II+RDLK NILLD D + K++DFGLA+ ++ NT
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 393 FSDENKLGQGGFGPVYKG---TLADGKAIAVKRL--SRTSGQGL-QEFKNEVNLIAKLQH 446
+ E +G+G +G VYK DGK A+K+ + G+ Q E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 447 KNLVRLLGCCLEGQE--LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGI 503
+N+V L+ LE + + L+++Y + + + V + +S++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIF 543
YLH + ++HRDLK +NIL+ + KI D GLAR+F
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ D +AVK L S ++F E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDA------TRSVQLDWKRRQSIINGI 499
V+ G C+EG L++++EYM NK L H DA R +L + I I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G++YL + +HRDL N L+ +++ KI DFG++R
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 15/153 (9%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
K+G+G +G V+K + +A+KR+ +G+ E+ L+ +L+HKN+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
++L L++EY D L FD+ +D + +S + + +G+ + H
Sbjct: 67 VLHSDKKLTLVFEY-----CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
KLG G FG V+ GT +AVK L + + F E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
E + + ++ EYM SL L D R+++L + +A G+ Y+ R+
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IHRDL+++NIL+ D + KI+DFGLAR+ N+ A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLS------RTSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+G +G VY G G+ IAVK++ + + ++ + EV+L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ LG CL+ + + E++P S+ L F +Q I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ ++HRD+K +N++L + K+ DFG AR
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 57/166 (34%), Positives = 89/166 (53%), Gaps = 18/166 (10%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNL 449
E +G G FG V G L GK +A+K L T Q ++F +E +++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSV-QLDWKRRQSIINGIARGILYL 506
+ L G + + ++++ EYM N SLD L D +V QL ++ GIA G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
S + +HRDL A NIL++ ++ K+SDFGL+R+ + A T
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 31/176 (17%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------EVNLI 441
+ +G G +G V G+ +A+K++S F + E+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSI 495
L+H+N++ LL + ++ ++ E M + L +S Q L Q
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYF 108
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+ I RG+ YLH +IHRDLK SNIL++ + + KI DFGLAR ++++
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 52/154 (33%), Positives = 87/154 (56%), Gaps = 16/154 (10%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G G FG V +G L GK +A+K L S + + ++F +E +++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 507
L G + + +++I E+M N +LD + D +V QL ++ GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
E + +HRDL A NIL++ ++ K+SDFGL+R
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 59/172 (34%), Positives = 85/172 (49%), Gaps = 20/172 (11%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+G+G FG V +G G+ +AVK + Q F E ++ KL HKNLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L ++ E M +L L R+ V + + S+ +A G+ YL K++H
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEA 568
RDL A NIL+ +D K+SDFGLAR+ + VD ++W A
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----------GSMGVDNSKLPVKWTA 165
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 47/143 (32%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
LG G FG V+ G +A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518
+ + ++ EYM N L +L + + +W + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 519 LKASNILLDDDMNPKISDFGLAR 541
L A N L+ +D K+SDFGLAR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 26/167 (15%)
Query: 396 ENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ D +AVK L + ++F+ E L+ LQH+++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQS----------- 494
V+ G C +G L++++EYM NK L H DA + +D + RQ+
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM--ILVDGQPRQAKGELGLSQMLH 127
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I + IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 58/166 (34%), Positives = 90/166 (54%), Gaps = 18/166 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAI----AVKRLSR-TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG VYKG + +G+ + A+K L TS + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGI 503
++ RLLG CL + LI + MP L D R + D Q ++N IA+G+
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAKGM 122
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
YL E+ RL +HRDL A N+L+ + KI+DFGLA++ G ++ +
Sbjct: 123 NYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 63/175 (36%), Positives = 91/175 (52%), Gaps = 29/175 (16%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTL---ADG---KAIAVKRLS-RTSGQGLQEFKNEVNLI 441
+T F +E LG+ FG VYKG L A G +A+A+K L + G +EFK+E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW------KRRQS- 494
++LQH N+V LLG + Q L +I+ Y + D+H F RS D K +S
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 495 --------IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I+ IA G+ +L S ++H+DL N+L+ D +N KISD GL R
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 46/155 (29%), Positives = 87/155 (56%), Gaps = 8/155 (5%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNL 449
F K+G+G +G VYK G+ +A+K++ T +G+ E++L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LL +L L++E++ ++ L + DA+ + +S + + +G+ + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 16/149 (10%)
Query: 398 KLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+LG G FG VYK G LA K I K S + L+++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
LLG +L ++ E+ P ++D + + R + + Q I + + YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS--- 128
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
+KIIHRDLKA N+LL D + K++DFG++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR--LSRTSGQGLQE--------FKNEVNLIAKLQHK 447
+G+G +G VY G+ +AVK+ L T ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 448 NLVRLLGCCLEGQELLLIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N+V+ LG +E L I+ EY+P S+ L + + + + + G+ YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----IFGGNQN 548
H I+HRDLKA N+L+D D KISDFG+++ I+ +QN
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLV 450
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRRQSIIN 497
LLG C + L ++ EY + +L L D R L K S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L S+ K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 29/172 (16%)
Query: 392 HFSDEN-----KLGQGGFGPVY----KGTLADGK--AIAVKRLSRTSGQGLQ-EFKNEVN 439
F N LG+G FG V+ KG +G + VK L +T + LQ EF+ E++
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEY----------MPNKSLDVHLFDATRSVQLDW 489
+ KL HKN+VRLLG C E + +I EY KS D + + L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLST 116
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++ ++ IA G+ +L S + +HRDL A N L+ K+S L++
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 4e-16
Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRLL 453
+LG G FG VY G+ +A+K++ + +E N EV + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
E EL ++EYM +L L + +SII I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
HRDLK N+L+ KI+DFGLAR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 51/181 (28%), Positives = 94/181 (51%), Gaps = 12/181 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
F+ ++G+G FG VYKG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
R G L+G +L +I EY+ S D + L+ +I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEA 568
+ IHRD+KA+N+LL + + K++DFG+A Q + NT + W P+ ++ A
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSA 177
Query: 569 Y 569
Y
Sbjct: 178 Y 178
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
E P LRL + KLGQG FG V+ GT +A+K L + + F
Sbjct: 2 EIPRESLRL----------DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQ 50
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E ++ KL+H LV L E + + ++ E+M SL + L + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMA 108
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IA G+ Y+ R+ IHRDL+A+NIL+ D++ KI+DFGLAR+ N+ A
Sbjct: 109 AQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
+ + + +I E+M SL D +S + + +I+ IA G+ ++ + +
Sbjct: 69 VVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
IHRDL+A+NIL+ + KI+DFGLAR+ N+ A
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
+G+G +G V K A G+ +A+K+ + ++ K EV ++ +L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L++EY+ L+ L +A+ L +S I + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLE--LLEASPG-GLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IIHRD+K NIL+ + K+ DFG AR T+ +A
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 54/148 (36%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG V+KG + +G +I A+K + R+ Q QE + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
LG C G L L+ + P SL H+ LD +R + IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+++HR+L A NILL D +I+DFG+A
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 48/224 (21%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA----------------IAV 420
EFP LRL + KLG+G FG V+ A+G A +AV
Sbjct: 1 EFPRQQLRL----------KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAV 49
Query: 421 KRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF 479
K L + + +F E+ ++++L++ N++RLLG C+ L +I EYM N D++ F
Sbjct: 50 KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG--DLNQF 107
Query: 480 DATRSVQLDWKRRQSIIN-----------GIARGILYLHEDSRLKIIHRDLKASNILLDD 528
+ R ++ + +I + IA G+ YL + L +HRDL N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164
Query: 529 DMNPKISDFGLAR-IFGGNQNQANTNIIAVDTWPQSMQWEAYFL 571
KI+DFG++R ++ G+ + + W M WE+ L
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW---MAWESILL 205
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
+ + K+G+G +G VYK + IA+K RL + E++L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGIL 504
N+VRL + L L++EY LD+ L D++ + + ++ + I RGI
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFG 544
Y H S +++HRDLK N+L+D N K++DFGLAR FG
Sbjct: 117 YCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 51/183 (27%), Positives = 96/183 (52%), Gaps = 16/183 (8%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKN 448
F+ ++G+G FG V+KG D + +A+K + + +++ + E+ ++++
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + G L+G +L +I EY+ S D R+ D + +++ I +G+ YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQW 566
+ K IHRD+KA+N+LL + + K++DFG+A Q + NT + W P+ +Q
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQ 175
Query: 567 EAY 569
AY
Sbjct: 176 SAY 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 21/167 (12%)
Query: 398 KLGQGGFGPVYK-GTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G +G VYK L+D + A+K L S + ++ NE+ ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIARGILYLH 507
L+G +L ++ EY P L + + KR+ I + RG+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
E KI+HRDLK++NILL + KI D G++++ +N A T I
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI 162
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 459 GQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ L ++ EYM SL +L RSV L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
DL A N+L+ +D K+SDFGL + Q+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKN 448
F+D ++G G FG VY + + +A+K++S + Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEI-----AAICHGALQGLAY 130
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + IHRD+KA NILL + K++DFG A +
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYK G A K I ++ S + L++F E++++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L ++ E+ +LD + L + + + + + +LH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALD-SIMLELERG-LTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
K+IHRDLKA NILL D + K++DFG++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 54/159 (33%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 397 NKLGQGGFGPVYKGTLA--DGKA----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VY+G DG A +AVK L S Q +F E +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILY 505
VRL+G E ++ E M L L + R L K +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 506 LHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR 541
L E+ IHRD+ A N LL KI+DFG+AR
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRL 452
+++G G FG V G G + A VK L ++ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
LG C+E LL+ E+ P L +L V ++ Q + +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ IH DL N L D++ KI D+GLA
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+LG G FG VYK + +A ++ T S + L+++ E++++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L ++ E+ ++D + + R L + + + + YLHE+ KIIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLA 540
RDLKA NIL D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 59/152 (38%), Positives = 86/152 (56%), Gaps = 17/152 (11%)
Query: 399 LGQGGFGPVYKGTL--ADGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG VY GTL +DG+ I AVK L+R T + +++F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYLHED 509
G CL EG L+++ YM K D+ F RS + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYM--KHGDLRNF--IRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K +HRDL A N +LD+ K++DFGLAR
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSR-TSGQG 430
E PL +R E LG+ FG +YKG L + +A+K L + Q
Sbjct: 1 ELPLSAVRFMEE----------LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ 50
Query: 431 LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF----------- 479
EF+ E +L+A+L H N+V LLG + Q + +++EY+ D+H F
Sbjct: 51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVG 108
Query: 480 -----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534
D T LD I IA G+ YL S +H+DL A NIL+ + ++ KI
Sbjct: 109 CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKI 165
Query: 535 SDFGLAR-IFGGNQNQANTNIIAVDTW--PQSMQWEAY 569
SD GL+R I+ + + + W P+++ + +
Sbjct: 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 14/160 (8%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK 443
E TN + D +G G FG V G+ +A+K++ + T + ++ E+ L+
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 444 LQHKNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
L+H+N++ L + E + + E + D+H +R ++ + Q + I RG
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFI--QYFLYQILRG 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ Y+H ++HRDLK SNIL++++ + KI DFGLARI
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY AD G+ +AVK++ S + + + + E+ L+ L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + E L + E+MP S+ L + A T +V + R+ I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG V K +DGK + K + + + Q+ +EVN++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-----L 506
+ Q L ++ EY D + +Q K R+ I IL L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGG-------DLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 507 HE-----DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+E D ++HRDLK +NI LD + N K+ DFGLA+I G + + A T
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G VY L + + +A+KR+ + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 455 CCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ G EL L+ Y+ S LD+ R LD +++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGL-ARIF--GGNQNQANTNIIAVDTW--PQSMQ 565
IHRD+KA NILL +D + KI+DFG+ A + G + + W P+ M+
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 47/163 (28%), Positives = 87/163 (53%), Gaps = 20/163 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH---KNLVRLL 453
+G+G +G VY+G + G+ +A+K ++ T + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
G L+G L +I EY S+ R++ + I+ I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+IHRD+KA+NIL+ + N K+ DFG+A + N ++ +T
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 52/149 (34%), Positives = 82/149 (55%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
+KLG+G + VYKG L D +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L L++EY+ +K L +L D S+ + + + + RG+ Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RR 123
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++HRDLK N+L+++ K++DFGLAR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 52/154 (33%), Positives = 84/154 (54%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG VY AD G+ +AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + +E L + EYMP S+ L + A T +V + R+ I +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
++ GC L L+ EY + D L + + L ++ +G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAYLHS 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +IHRD+KA NILL + K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRL 512
L G EL ++ EY+ SL D +D + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRECLQALEFLHSN--- 134
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEAY 569
++IHRD+K+ NILL D + K++DFG Q++ +T ++ W P+ + +AY
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 32/169 (18%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE------VNLIAKLQ------- 445
LG+G FG V + A+ I R +T ++ K+ +LI++++
Sbjct: 20 LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 492
HKN++ LLG C + L +I EY +L L FD T+ QL +K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL +SR + IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ K+G+G G V T + G+ +AVK++ Q + NEV ++ QH N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ L G EL ++ E++ +L D +++ ++ ++ + + + +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+IHRD+K+ +ILL D K+SDFG
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
F+D ++G G FG VY + +A+K++S + S + Q+ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 140
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + +IHRD+KA NILL + K++DFG A I
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
+G+G +G VYK G+ +A+K + +E K E N++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 457 L------EGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQS------IINGIARG 502
+ +L L+ E S T V+ +R I+ RG
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ YLHE+ K+IHRD+K NILL + K+ DFG++
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGC 455
++G+G FG V+ G L AD +AVK T L+ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + Q + ++ E + + D F T +L K ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 516 HRDLKASNILLDDDMNPKISDFGLAR 541
HRDL A N L+ + KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
+LG G G V K GK +AVK + + +Q + E++++ K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
++ + EYM SLD L + + + I + +G+ YLHE KI
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK--HKI 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
IHRD+K SNIL++ K+ DFG++
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 27/163 (16%)
Query: 398 KLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNL 449
+LGQG FG VY+G +A G +A+K ++ + + EF NE +++ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRQSIING 498
VRLLG +GQ L+I E M L +L RS++ + K+ +
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 48/144 (33%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+LG G FG V G +A+K + S EF E ++ KL H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ + + ++ EYM N L +L + + Q + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A N L+DD K+SDFGL+R
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKN 448
F +++G G FG VY T + + +AVK++S + Q Q+ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+ GC L+ L+ EY + L+VH + V++ +I +G +G+ Y
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 136
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
LH + +IHRD+KA NILL + K++DFG A
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V K +AVK L + + L + +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
++ LLG C + L ++ EY +L +L FD + QL +K S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRL 452
+LG G FG V KG K +AVK L + E E N++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+G C E + +L+ E L+ L ++ + K +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAVDTWPQSMQWEAYF 570
+HRDL A N+LL KISDFGL++ G ++N +A T+ WP ++W A
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH----GKWP--VKWYAPE 168
Query: 571 LLN 573
+N
Sbjct: 169 CMN 171
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 49/163 (30%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 399 LGQGGFGPVYKGTLADGKAI---AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G FG V +G L +I AVK +++ + +++F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 454 GCCLEGQEL------LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGIL 504
G CL+ E ++I +M + L L + + Q ++ IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGN 546
YL S IHRDL A N +L+++MN ++DFGL+ +I+ G+
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGLQEFKN---EVN 439
+ E + + + + +G G +G V +A+K+LSR Q K E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELR 66
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
L+ + H+N++ LL L + Y+ + L + + +L Q ++
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ 126
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I RG+ Y+H IIHRDLK SNI +++D KI DFGLAR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 53/154 (34%), Positives = 82/154 (53%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG VY D G+ +A K++ S + + + + E+ L+ LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 453 LGCCLE-GQELLLIY-EYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
GC + ++ L I+ EYMP S+ L + A T SV + R+ I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+HRD+K +NIL D N K+ DFG ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 55/154 (35%), Positives = 82/154 (53%), Gaps = 18/154 (11%)
Query: 399 LGQGGFGPVYKGTLA-DGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G FG VYKG DG+ + A+K L TS + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
LG CL + L+ + MP L D R + D Q ++N IA+G+ YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCL----LDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
++++HRDL A N+L+ + KI+DFGLAR+
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 12/181 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEA 568
+ IHRD+KA+N+LL + K++DFG+A Q + N + W P+ ++ A
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEVIKQSA 177
Query: 569 Y 569
Y
Sbjct: 178 Y 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 47/180 (26%), Positives = 93/180 (51%), Gaps = 11/180 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++ K+GQG G V+ +A G+ +A+K+++ + NE+ ++ +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEAY 569
++IHRD+K+ N+LL D + K++DFG Q++ +T ++ W P+ + +AY
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 40/181 (22%)
Query: 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRL-----SRTSGQG-------LQEFKNEVNLI 441
KLG+G +G V+K D + +A+K++ + T Q LQE +
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD----- 65
Query: 442 AKLQHKNLVRLLGC--CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
H N+V+LL +++ L++EYM D+H R+ L+ ++ I+ +
Sbjct: 66 ----HPNIVKLLNVIKAENDKDIYLVFEYMET---DLH--AVIRANILEDVHKRYIMYQL 116
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF----GGNQNQANTNII 555
+ + Y+H S +IHRDLK SNILL+ D K++DFGLAR +N T+ +
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 556 A 556
A
Sbjct: 174 A 174
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V K + +AVK L + + L + +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
++ LLG C + L +I EY +L +L +D R Q+ +K S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 15/152 (9%)
Query: 399 LGQGGFGPVY------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG V +G G+ +AVK L + G + + K E+ ++ L H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
G C E G + LI E++P+ SL +L + L + + ++ I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
SR + +HRDL A N+L++ + KI DFGL +
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 6/144 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
+LG G FG V+ G +A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ + L ++ E+M N L +L R +L S+ + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A N L+ K+SDFG+ R
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 27/190 (14%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQ 429
+ EFP + + + K+GQG FG V+K + +A+K++ + G
Sbjct: 1 DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54
Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCC---------LEGQELLLIYEYMPNKSLDVHLFD 480
+ + E+ ++ L+H+N+V L+ C +G L++E+ + D+
Sbjct: 55 PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGS-FYLVFEFCEH---DLAGLL 109
Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ ++V+ + ++ + G+ Y+H R KI+HRD+KA+NIL+ D K++DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 541 RIFGGNQNQA 550
R F ++N
Sbjct: 167 RAFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 397 NKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
++LG+G G V K L + I A+K ++ LQ + E+ + + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 455 CCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---------GIARGI 503
L+ + + EY SLD S+ K+R I + +G+
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD--------SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
YLH KIIHRD+K SNILL K+ DFG
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 11/146 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
++G G +G VYK L G+ AVK + G + E+ ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 457 LEGQELLLIYEYMPNKSL-DV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L ++L + EY SL D+ H+ +Q+ + R+++ +G+ YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
HRD+K +NILL D+ + K++DFG+A
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 23/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLV 450
++ +G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----WKRRQSIING------- 498
LLG C L L EY P+ +L + +R ++ D S ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 499 --IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 25/162 (15%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
+LGQG FG VY+G D G+A +AVK ++ + S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-----------SIINGI 499
RLLG +GQ L++ E M + L +L RS++ + + + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
A G+ YL+ K +HRDL A N ++ D KI DFG+ R
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 399 LGQGGFGPVYKGTLADGKA---------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+G+G FG V+ L KA I V+++++ Q NE ++ L H N+
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNI 61
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ LE + L+++ EY P +L ++ S+ LD +I++ + +L LH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHFFVQILLALHHV 117
Query: 510 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFG 544
I+HRDLK NILLD M KI DFG+++I
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 397 NKLGQGGFGPVYK----GTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVR 451
N++G G G VYK T G+ A+K + ++ + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 452 LLGCCLEGQELLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
E+ ++ E+M SL+ H+ D L RQ I++GIA YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLADVARQ-ILSGIA----YLH--- 185
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
R I+HRD+K SN+L++ N KI+DFG++RI + N+++
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
|
Length = 353 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRT-SGQGLQEFKNEVN 439
KLG+G FG V+ K + A +AVK L S ++F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQS 494
++++L N+ RLLG C L +I EYM N L+ L + + +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
++ IA G+ YL L +HRDL N L+ + KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 399 LGQGGFGPVYK--GTLADGKAIAVKRLS----------RTSGQGLQEFKNEVNLIAK-LQ 445
LG G FG VYK +A+K ++ R + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
H N+VR LE L ++ + + L H Q +R +I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YLH++ R I+HRDL +NI+L +D I+DFGLA+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 7e-13
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 11/175 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+K+++ + NE+ ++ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEAY 569
RD+K+ NILL D + K++DFG Q++ +T ++ W P+ + +AY
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSG----QGLQEFKNEVNLIAKLQ 445
F N++G+G +G VY+ G+ +A+K R+ L+E + L+ L+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64
Query: 446 HKNLVRLLGCCLEGQEL---LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
H N+V L + G+ L L+ EY + L L + + + ++ + RG
Sbjct: 65 HPNIVELKEV-VVGKHLDSIFLVMEYC-EQDLASLLDNMPTP--FSESQVKCLMLQLLRG 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ YLHE+ IIHRDLK SN+LL D KI+DFGLAR +G
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
LG G F Y+ + G +AVK+++ TS + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHE 508
+LG E L E+M S+ L +V +++ + + RG+ YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121
Query: 509 DSRLKIIHRDLKASNILLDDD-MNPKISDFGLA 540
+ +IIHRD+K +N+L+D +I+DFG A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
KLG+G + V+KG L + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L L++EY+ +K L ++ D + + + + I RG+ Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM--HNVKIFLYQILRGLAYCH---RR 123
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
K++HRDLK N+L+++ K++DFGLAR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
+G+G +G V K + G+ +A+K+ L + +++ E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L++E++ + LD D + LD R + + I RGI + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IIHRD+K NIL+ K+ DFG AR + T+ +A
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRTSGQGLQ-EFKNEVN 439
KLG+G FG V+ K D +AVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 491
++++L+ N++RLL C+ L +I EYM N L+ L + V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQA 550
+ IA G+ YL S L +HRDL N L+ + KI+DFG++R ++ G+ +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 551 NTNIIAVDTWPQSMQWEAYFL 571
+ W M WE+ L
Sbjct: 189 QGRAVLPIRW---MSWESILL 206
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 399 LGQGGFGP--VYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+G FG +Y+ T D + K L+R S + ++ NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 455 CCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
++ LL+ EY +L LF+ + W Q I + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE---MVLWYLFQ-----IVSAVSYIH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ I+HRD+K NI L K+ DFG+++I G + A T
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
++G G +G VYK + G+ A+K + G+ + E+ ++ +H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 457 LEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L +L + E+ SL H+ Q+ + R+++ +G+ YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
+HRD+K +NILL D+ + K++DFG++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + GK A K+L + +G Q NE ++ K+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+L L+ M L H+++ R I G+ +LH + +I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK N+LLDD N +ISD GLA
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHK 447
HF +G+G FG V D K + A+K +++ ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
LV L + + + L+ + + L HL ++ V+ ++ + I I + YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
IIHRD+K NILLD+ + I+DF +A +
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
+F E K+G+G F VYK L DG+ +A+K++ + Q+ E++L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSVQLDWKRRQSII 496
H N+++ L +E EL ++ E L L R++ WK
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WK----YF 112
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ + ++H +I+HRD+K +N+ + K+ D GL R F
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 4e-12
Identities = 46/175 (26%), Positives = 89/175 (50%), Gaps = 11/175 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ EY+ SL D +D + ++ + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEAY 569
RD+K+ NILL D + K++DFG Q++ + ++ W P+ + +AY
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAY 193
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 25/179 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
+ F ++G+G +G VYK D G+ +A+K++ + G + + E+ ++ +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 447 KNLVRLLGCCLEGQELL----------LIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--S 494
+N+V L + Q+ L L++EYM D L S + + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ + G+ Y H+ + L HRD+K SNILL++ K++DFGLAR++ +++ TN
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 43/153 (28%)
Query: 415 GKAIAVKRLSRTSGQGLQEFKN---------EVNLIAKLQHKNLVRLLGCCLEGQELLLI 465
G+ +A+K+LSR F+N E+ L+ + HKN++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 466 YEYMPNKSLD--------VHLFDAT--RSVQ--LDWKRRQSIINGIARGILYLHEDSRLK 513
+ P KSL+ + L DA + +Q LD +R ++ + GI +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + +GK +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L++EY+ D+ + L + + + + RG+ Y+H+ I
Sbjct: 71 IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ D K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 31/166 (18%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNEVNLI 441
+ + + +G+G +G V T G +A+K++S RT L+E K ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIK----IL 57
Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+ +H+N++ +L ++ ++ E M D++ ++ L Q +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLY--KLIKTQHLSNDHIQYFL 112
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLARI
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 399 LGQGGFGPVYKGT---LADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 450
LG G FG V + T L+ A +AVK L T+ +E +E+ +++ L H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LLG C G +L+I EY L ++ R L + S +A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
IHRDL A N+LL KI DFGLAR
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 42/143 (29%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G G V T+ + GK +AVK++ Q + NEV ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ E++ +L D +++ ++ ++ + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL 539
RD+K+ +ILL D K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ D LG G G V+ +D K +AVK++ T Q ++ E+ +I +L H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 452 L--------------LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
+ +G E + ++ EYM + L + L + + +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
+ RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 41/205 (20%)
Query: 398 KLGQGGFGPV---------------YKGTLADGKA--IAVKRL-SRTSGQGLQEFKNEVN 439
KLG+G FG V + + G+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-----HLFDAT--------RSVQ 486
++++L+ N++RLLG C++ L +I EYM N L+ HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 487 LDWKRRQSIIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-I 542
L S+++ IA G+ YL S L +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 543 FGGNQNQANTNIIAVDTWPQSMQWE 567
+ G+ + + W M WE
Sbjct: 189 YAGDYYRIQGRAVLPIRW---MAWE 210
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 14/175 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
+LG G FG V KG K +A+K L + + ++ E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C E + L+L+ E L + F + + ++ +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEA 568
+HRDL A N+LL + KISDFGL++ G + + + WP ++W A
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR--SAGKWP--LKWYA 166
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFK---NEVNLIAKLQH 446
F ++GQGG+G V+ D I A+KR+ ++ L E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+ LV+LL + + L L EY+P L + + D R +A +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFY-----MAEMFEAV 114
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
L IHRDLK N L+D + K++DFGL+
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V G + K + KRL + SG+ + + E+ + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H+++ L+ +R I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
I++RD+K N+LLDD N ++SD GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A K+L++ +G + E ++AK+ H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 455 CCLEGQ-ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ + +L L+ M L H+++ + R I G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+II+RDLK N+LLD+D N +ISD GLA
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 8/143 (5%)
Query: 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
K+G+G G V T GK +AVK++ Q + NEV ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
L G EL ++ E++ +L D +++ ++ ++ + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 517 RDLKASNILLDDDMNPKISDFGL 539
RD+K+ +ILL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G FG +Y LA K+ I L++ + + K EV L+AK++H N+V
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
E L ++ EY L + + R V + S I+ G+ ++H+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 512 LKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANT 552
KI+HRD+K+ NI L + M K+ DFG+AR + A T
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 24/162 (14%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKN-LVRLL 453
K+G+G +G VYK GK +A+K+ +G+ E++L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 454 GCCLEGQE-------LLLIYEYMPNKSLDVHLF-DATR---SVQLDWKRRQSIINGIARG 502
+E E L L++EY+ D+ F D+ L K +S + + +G
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIF 543
+ + H + ++HRDLK N+L+D KI+D GL R F
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 23/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKNLV 450
E+ +G+G FG V + + DG + A+K L S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD------------WKRRQ--SII 496
LLG C L + EY P +L + +R ++ D +Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +A G+ YL E + IHRDL A N+L+ +++ KI+DFGL+R
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 398 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLL 453
++G G FG V G + G + VK L ++ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL---DWKRRQSIINGIARGILYLHEDS 510
G C E LL+ E+ P L +L + R +L D Q + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
IH DL N LL D+ KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 14/146 (9%)
Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
K+G+G G V +A G+ +AVK + Q + NEV ++ QH+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
L G+EL ++ E++ +L D +L+ ++ ++ + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 514 IIHRDLKASNILLDDDMNPKISDFGL 539
+IHRD+K+ +ILL D K+SDFG
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL 457
+G G +G VYKG +A ++ +G +E K E+N++ K H+N+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 458 EGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L L+ E+ S+ L T+ L + I I RG+ +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K+IHRD+K N+LL ++ K+ DFG++ + NT I
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 32/169 (18%)
Query: 399 LGQGGFGPVYKGTLADG-----------KAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +A+ +AVK L S + + L + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L QL +K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 19/169 (11%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
+ +G +G V+ K T G A+K + + + + E +++++ Q +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L +G++ L L+ EY+P L L + S+ D R I I + YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH--- 110
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT 559
IIHRDLK NIL+D + + K++DFGL++ G + Q N N +
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKED 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 398 KLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
+G+G FG VY+G + A+AVK + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+G E + ++ E P L +L LD ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +HRD+ A N+L+ K+ DFGL+R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 398 KLGQGGFGPVYKG-TLADG-KAIAVKRLS-RTSGQGLQ-EFKNEVNLIAKLQ---HKNLV 450
++G+G +G V+K L +G + +A+KR+ +T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 451 RLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
RL C + +L L++E++ ++ L +L D + + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
LH +++HRDLK NIL+ K++DFGLARI+ Q + V W
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQH-K 447
D ++G+G FG V K G +AVKR+ T + Q +++++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIA----R 501
+V+ G + + E M D+ L + V K + I+ IA +
Sbjct: 64 YIVKFYGALFREGDCWICMELM-----DISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ YL E+ LKIIHRD+K SNILLD + N K+ DFG++
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ---HKNLVR 451
++G G +G VYK G +A+K + + + GL EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 452 LLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L+ C + ++ L++E++ ++ L +L D L + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H + I+HRDLK NIL+ K++DFGLARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG GGFG V + + A+K + + G QE +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLK 513
+ + + ++ EY L + R D + I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
II+RDLK N+LLD + K+ DFG A+ Q
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + G+ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L L++EY+ + L ++ D + + R + + RG+ Y H + ++
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVR--LFLFQLLRGLAYCH---QRRV 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ + K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK--------NEVNLIAKLQHK 447
+ +LG+G FG VY + D KA+A +RL + E E L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIA 500
+V+ LE +I EY + LD L + + + +W +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
G+ Y+H+ +I+HRDLKA NI L +++ KI DFG++R+ G+ + A T
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+KLG+G + V+KG + +A+K RL G + EV+L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ L L++EY+ + D+ + + + + + RG+ Y H + K
Sbjct: 70 DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I+HRDLK N+L+++ K++DFGLAR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 47/160 (29%), Positives = 86/160 (53%), Gaps = 21/160 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
N++ +G +G VY+ G+ +A+K+L G + + E+N++ KLQH N+V +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69
Query: 453 ----LGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+G L+ ++ ++ EY+ + KSL + + + ++ + G+ +L
Sbjct: 70 KEVVVGSNLD--KIYMVMEYVEHDLKSL---METMKQPFLQ--SEVKCLMLQLLSGVAHL 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
H++ I+HRDLK SN+LL++ KI DFGLAR +G
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 34/164 (20%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
LG G FG V +KG+ GK A+K LS+ Q ++ NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------G 502
L G + L L+ EY+P L HL ++ +AR
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLA 113
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ YLH L I++RDLK N+LLD D KI+DFG A+ G
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRTSGQGLQE--FKNEVNLIAKLQHKNL 449
E LG G FG + +G L K +A+ L R Q F E + + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
VRL G G ++++ EYM N +LD L QL + ++ G+A G+ YL E
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFG 538
+ +H+ L A +L++ D+ KIS F
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 23/162 (14%)
Query: 399 LGQGGFGPVYKGTLA-DGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLVRLL 453
+G+G FG V K + DG + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--WKRRQSIINGI------------ 499
G C L L EY P+ +L + +R ++ D + S + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 11/141 (7%)
Query: 395 DENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+EN + +G G YKG ++ +G VK ++ + E + + KLQH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C + LI+EY+ K+L L + L W+RR+ I GIA+ + +LH
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 514 IIHRDLKASNILLDDDMNPKI 534
++ +L I++D P +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 399 LGQGGFGPVYKGTL-------ADGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQHKN 448
LGQG F +YKG L G V + + G + F +L+++L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV+L G C+ E +++ EY+ LDV L +V L WK + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 509 DSRLKIIHRDLKASNILL---DDDMNP----KISDFGLAR 541
K++H ++ NIL+ + K+SD G+
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK--NEVNLIAKLQHKNLVRLLG 454
KLG+G + VYKG + +G+ +A+K +S + +G+ F E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L ++EYM D+ + L + + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/139 (35%), Positives = 71/139 (51%), Gaps = 25/139 (17%)
Query: 415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
G +AVK+LSR F+N+ + AK ++ LV LL C + L+ + P KSL
Sbjct: 46 GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 475 D--------VHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522
+ + L DA ++LD +R ++ + GI +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 523 NILLDDDMNPKISDFGLAR 541
NI++ D KI DFGLAR
Sbjct: 153 NIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 47/151 (31%), Positives = 65/151 (43%), Gaps = 20/151 (13%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRL------SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG+G FG V YK T G+ A+K L +R + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV L C + + EY L +H+ R + G+ YLHE
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+ KI++RDLK N+LLD + KI+DFGL
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 398 KLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
++G G FG V + +A VK L + Q EF + + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR-------QSIINGIARGILYL 506
G C+E LL++EY L +L Q W RR Q + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
+G G +G VYKG + G+ A+K + T + +E K E+N++ K H+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 457 LE----GQ--ELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHE 508
++ G +L L+ E+ S+ L T+ +++ DW I I RG+ +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWI--AYICREILRGLAHLHA 139
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K+IHRD+K N+LL ++ K+ DFG++ + NT I
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
E + + + +G G +G V G +AVK+LSR Q + K E+ L+
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKH 72
Query: 444 LQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
++H+N++ LL + L + Y+ + L + + +L Q +I I RG
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 25/169 (14%)
Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G FG K L DGK +K + S+ S + +E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------LDWKRRQSIINGIARGILY 505
E L ++ +Y L +A R V LDW + I + +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+H+ KI+HRD+K+ NI L D K+ DFG+AR+ A T I
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 457 LE--GQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
L +++ L+++Y + + F + VQL +S++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIF 543
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
F E K+G+G F VY+ T L D K +A+K++ + Q+ E++L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARGI 503
+++ L +E EL ++ E L + F + + + WK + + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H SR +++HRD+K +N+ + K+ D GL R F A++
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLG- 454
+G G +G V G+ +A+K+LSR S + E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 455 --CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ G E Y MP D+ L + Q ++ + G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
IIHRDLK N+ +++D KI DFGLAR
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+G FG V + L + +AVK L S ++EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIAR 501
+G L + ++I +M K D+H F L + + IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 546
G+ YL S IHRDL A N +L+++M ++DFGL++ I+ G+
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 34/166 (20%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+GG+G V+ K T AD GK A+K L + + + K E N++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 501
L+ G +L LI EY+ L +HL R+ I ++ I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISL 111
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGG 545
+ +LH + II+RDLK NILLD + K++DFGL + I G
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E L+ + H +++R+ + G ++ +P+ S D++ + RS L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I G+ YLH +IIHRD+K NI ++D I D G A+
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
K+G+G +G VYK DGK L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 457 L--EGQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
L +++ L+++Y + + F + +QL +S++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIF 543
++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--------------EVNLI 441
LG+G +G V K GK +A+K++ E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIING 498
+++H+N++ L+ +EG + L+ + M + K +D R ++L + + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTESQVKCILLQ 127
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
I G+ LH+ +HRDL +NI ++ KI+DFGLAR +G
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
|
Length = 335 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 384 RLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
+ E + + D ++G G +G V G +A+K+L R L + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
+ ++H+N++ LL L +++ MP D L + +L R Q ++
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVY 125
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 48/141 (34%), Positives = 72/141 (51%), Gaps = 25/141 (17%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
+ +A+K+LSR F+N+ + AK ++ LV L+ C + L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 476 --------VHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523
+ L DA ++LD +R ++ + GI +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 524 ILLDDDMNPKISDFGLARIFG 544
I++ D KI DFGLAR G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
K+G+G +G V+K + G+ +A+K+ + + K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ ++L L++EY + L + + + + II + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVL--NELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
IHRD+K NIL+ K+ DFG ARI G
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 43/175 (24%)
Query: 398 KLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQG------------LQEFKNEVNLI 441
+LGQG +G V T ++ + +A+K+++ + L+ F+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60
Query: 442 AKLQHKNLVRLLGCCLEGQELLL------IYEYMPNKSLDVHLFDATRS-VQLDWKRRQS 494
HKN+ CL +++ +Y Y D+H RS L QS
Sbjct: 61 ----HKNIT-----CLYDMDIVFPGNFNELYLYEELMEADLH--QIIRSGQPLTDAHFQS 109
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
I I G+ Y+H + ++HRDLK N+L++ D KI DFGLAR F N +
Sbjct: 110 FIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 16/189 (8%)
Query: 378 FPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
FP L LE+ +D +G+G +G VYK T DG AVK L S +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63
Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCC-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
E + E N++ L H N+V+ G L G +L L+ E S+ + Q
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 487 -LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
LD I+ G G+ +LH + +IIHRD+K +NILL + K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 546 NQNQANTNI 554
+ + NT++
Sbjct: 181 TRLRRNTSV 189
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 50/148 (33%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVN-LIAKLQHKNLVRLL 453
+G+G FG V ADGK AVK L + + +E K+ E N L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
II+RDLK NILLD + ++DFGL +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V + A GK A K+L + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H+++ D +R I G+ LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RE 121
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+I++RDLK NILLDD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 401 QGGFGPVYKGTLADGK-----AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLG 454
+G FG ++ G L D K + VK + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 455 CCLEGQEL-LLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSIINGIARGILYLHE 508
C+E E ++Y YM +L + L +A L ++ + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +IH+D+ A N ++D+++ KI+D L+R
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 393 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ + +G G G V Y L + +A+K+LSR F+N+ + AK ++ L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIIN 497
V L+ C + L+ + P KSL+ + L DA ++LD +R ++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ GI +LH IIHRDLK SNI++ D KI DFGLAR G
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG+GGFG V G + K + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
L L+ M L H++ + + R I G+ LH++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
+I++RDLK NILLDD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 18/153 (11%)
Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRL 452
K+G+G F V K + GK A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQSIINGIARGILYLHE 508
+ + + L L++E M D++L++ + + L KR +S + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
R I HRD+K NIL+ DD K++DFG R
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHK 447
+F E K+G+G F VY+ T L DG +A+K++ + + E++L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARG 502
N+++ +E EL ++ E L + F + + + WK + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H SR +++HRD+K +N+ + K+ D GL R F A++
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQ-LDWK 490
E+ L+ L H+N++ + ++ ++YE M D L RS Q L
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDD 108
Query: 491 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
Q + + RG+ Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 26/155 (16%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G FG V+ A+K ++ + Q NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GILYL 506
+ + L ++ EY+P L +L + N + YL
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
H +I++RDLK NILLD + + K++DFG A+
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A KRL + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L L+ M L H+++ + +R I G+ LH ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---T 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK NILLDD + +ISD GLA
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 388 EATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLI 441
E + + +G G +G V Y L + +AVK+LSR Q L + E+ L+
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLL 68
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
++H+N++ LL + E Y+ + L + + +L + Q +I +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
RG+ Y+H IIHRDLK SN+ +++D +I DFGLAR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 53/196 (27%), Positives = 80/196 (40%), Gaps = 40/196 (20%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH 446
F +G+G FG V GK A+K L ++ L K E +++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSIINGI 499
+V L + Q L LI E++P L L D TR +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------M 107
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-------------RIFGGN 546
A +L + +L IHRD+K NIL+D + K+SDFGL+ ++ G
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 547 QNQ---ANTNIIAVDT 559
N+ N N +AVD+
Sbjct: 168 SNKNRIDNRNSVAVDS 183
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 11/147 (7%)
Query: 401 QGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRLLGC 455
+G FG VY + G A+K L ++ + N ++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
L L+ EY+ L + DW ++ I + G+ LH+ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---II 119
Query: 516 HRDLKASNILLDDDMNPKISDFGLARI 542
HRD+K N+L+D + K++DFGL+R
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 399 LGQGGFGPVYKGT---LADGKA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
LGQG F ++KG + D + +K L ++ + F +++++L HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G C+ G E +++ EY+ SLD +L + + WK + +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLEDK- 119
Query: 511 RLKIIHRDLKASNILL-----DDDMNP---KISDFGLA 540
+ H ++ A N+LL NP K+SD G++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
LG+G FG V LA+ K A+K L + +Q+ E ++ K LQ K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPF 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
L +L C L + EY+ L H+ + +K Q++ I+ G+ +L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL----------ARIFGGNQNQANTNIIA 556
H II+RDLK N++LD + + KI+DFG+ R F G + IIA
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 557 VDTWPQSMQWEAYFLL 572
+ +S+ W AY +L
Sbjct: 175 YQPYGKSVDWWAYGVL 190
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V L G+ AVK L + LQ+ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L C L + E++ L +F +S + D R + I +++LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGG 545
II+RDLK N+LLD + + K++DFG+ + IF G
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 15/145 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+ K +AVK+ L S + L+ + E+ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 457 LEGQELLLIYEYMPNKS----LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ EL ++ M S L H + + + + I+ + + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120
Query: 513 KIIHRDLKASNILLDDDMNPKISDF 537
IHR +KAS+ILL D +S
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG V+ K T D G+ A+K L + + + K E +++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH---SL 117
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
II+RDLK NILLD++ + K++DFGL++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+GGFG V + A GK A K+L + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L L+ M L H+++ D +R + G+ L R +I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
++RDLK NILLDD + +ISD GLA
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 30/156 (19%)
Query: 399 LGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V+ L G+ A+K L ++ Q + + E +++A +V
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+L + +E L L+ EYMP L +F + R IA +L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IAELVL 112
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
L +L IHRD+K NIL+D D + K++DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 32/160 (20%)
Query: 397 NKLGQGGFGPV----YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNL 449
LG G FG V +KGT G+ A+K L + + +Q E +++ +L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-------- 501
V ++ + + + E++ L HL A R N +A+
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----------FPNDVAKFYHAELVL 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
YLH II+RDLK N+LLD+ + K++DFG A+
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 27/188 (14%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++LG+G +G VYK G +A+K RL + + E++++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G + + EYM SLD + + + I + +G+ +L E+
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLA---------------------RIFGGNQNQANT 552
IIHRD+K +N+L++ + K+ DFG++ RI G NQ T
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 553 NIIAVDTW 560
+ D W
Sbjct: 184 YTVQSDVW 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKN 448
LG+G FG V KGT + AVK L + LQ+ E + K +H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 449 LVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
L +L C + ++ L + EY+ L H+ RS + D R + I G+ +LH
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGL----------ARIFGGNQNQANTNIIAV 557
E II+RDLK N+LLD + + KI+DFG+ F G + I++
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 558 DTWPQSMQWEAYFLLNLMFSVL 579
+ ++ W A + L++ +L
Sbjct: 171 QPYGPAVDWWALGV--LLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAKLQH-KNLVRLL 453
LG+G +G V K + G +AVKR+ T QE K ++++ + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 454 GCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G ++ + E M + SLD ++D ++ D + I I + + YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS-- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+L +IHRD+K SN+L++ + K+ DFG++
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
LG G +G V+ G GK A+K L + + + + + E ++ ++ L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL+ + I I + +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANT 552
L II+RD+K NILLD + + ++DFGL++ F + +A +
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCC 456
LG G G VYK L + +AVK + LQ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA----RGILYLHEDSRL 512
+ + E+M SLDV+ K + ++ IA +G+ YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLAR 541
KI+HRD+K SN+L++ K+ DFG++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 38/160 (23%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH--KNLVRL 452
+G G G VYK G +AVK++ RT + +E K +++++ K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-------- 504
G + ++ + E M S LD K + I I IL
Sbjct: 80 YGYFITDSDVFICMELM--------------STCLD-KLLKRIQGPIPEDILGKMTVAIV 124
Query: 505 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YL E +IHRD+K SNILLD N K+ DFG++
Sbjct: 125 KALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
+G+G FG V +DG AVK L + + +E + E N++ K L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
++L + +Y+ L HL R R + +A I YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
II+RDLK NILLD + ++DFGL +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 13/84 (15%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL----------ARIFGGNQN 548
IA G+ +LH II+RDLK N++LD + + KI+DFG+ R F G +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 549 QANTNIIAVDTWPQSMQWEAYFLL 572
IIA + +S+ W A+ +L
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVL 190
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ RG+ Y+H +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 21/153 (13%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKN 448
LG+G FG V KGT + A+K L + LQ+ + + K +H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPF 57
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
L L C L + EY+ L +F RS + D R + + +++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
R +I+RDLK NILLD + + K++DFG+ +
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 35/196 (17%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
LG+G FG V LA+ K A+K L + +Q+ E ++ K L K
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPF 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
L +L C L + EY+ L + R +K ++ IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL----------ARIFGGNQNQANTNIIA 556
H II+RDLK N++LD + + KI+DFG+ + F G + IIA
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 557 VDTWPQSMQWEAYFLL 572
+ +S+ W A+ +L
Sbjct: 175 YQPYGKSVDWWAFGVL 190
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCC 456
+G+G +G V+K +G AVK L +E + E N++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 457 LE-----GQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ G +L L+ E S+ D+ R +++ I++ G+ +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
K IHRD+K +NILL + K+ DFG++ + + NT++
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 185
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-LVRL 452
LG+G FG V L G+ AVK L + L + E ++ K L +N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 453 LGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L C + +E L + E++ L H+ D R D R I G+ +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANT 552
II+RDLK N++LD D + KI+DFG+ + +FG N+A+T
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
+G+G FG V DGK AVK L + +E K+ E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
++L + +++ L HL R R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 19/136 (13%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI--YEYMPNKS 473
+ + KR+ S +Q +NE+ + +L H+N++++ +E+L YM +
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI-------EEILRSEANTYMITQK 244
Query: 474 LDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527
D L+ DWK R ++I+ + + Y+H+ K+IHRD+K NI L+
Sbjct: 245 YDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 528 DDMNPKISDFGLARIF 543
D + DFG A F
Sbjct: 302 CDGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN----EVNLIAKLQ 445
N F +G+G +G V K + K I A+K+ + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+N+V L +L L++EY+ L++ L + V + + +S I + + I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPE--KVRSYIYQLIKAIHW 115
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS 563
H++ I+HRD+K N+L+ + K+ DFG AR N T +A W +S
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT-RWYRS 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 32/156 (20%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V K T G A+K+L ++ Q + + E +++A+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGI 503
+L + L LI EY+P + D + TR IA I
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETI 111
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
+G G FG V+ T DGK +A+K++ Q L K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSAL- 65
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWK----RRQSI--------INGIARG 502
++L P+ ++ T +Q D Q + + I RG
Sbjct: 66 ------DIL----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ YLH I+HRD+K N+L++ + KI DFGLAR+
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V L A+K L + L++ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L C + +E L + EY+ L H+ + R D R + I G+ +LH+
Sbjct: 61 LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N+LLD D + KI+DFG+ + + +A+T
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
LG+G FG V+ L + A+K L + L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
L C + +E L + EY+ L H+ + D R I G+ +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD D + KI+DFG+ +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-06
Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 2/51 (3%)
Query: 235 GQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285
QC LS DCR CL + ++RC P G GRI + SC + +E Y +
Sbjct: 58 AQCRGDLSASDCRSCLATAVSELRRCC-PNKKG-GRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 22/116 (18%)
Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLF-----DATRSVQ 486
E+ L+ L+H ++V + L E +++ +++E M + D+H D T
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP--- 102
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ Q + + R + Y+H + + HRDLK NIL + D KI DFGLAR+
Sbjct: 103 ---EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 25/43 (58%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 45/147 (30%), Positives = 64/147 (43%), Gaps = 10/147 (6%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A GK A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY+ L HL +R R + I + YLH KI
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
++RDLK N++LD D + KI+DFGL +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNL 449
LG G +G V+ K + D GK A+K L + + + + + E ++ + Q L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL ++ + + Q I + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH-- 122
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+L II+RD+K NILLD + + ++DFGL++ F ++ +
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 5/80 (6%)
Query: 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520
E+ + E+M SLD L A R + + + SI + RG+ YL E + KI+HRD+K
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGR-IPENILGKISI--AVLRGLTYLRE--KHKIMHRDVK 127
Query: 521 ASNILLDDDMNPKISDFGLA 540
SNIL++ K+ DFG++
Sbjct: 128 PSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 40/176 (22%)
Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVR- 451
+G+G +G V +L DGK +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 452 -------------LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
++G C EG +L Y K L + V +W +
Sbjct: 65 RESWEGEDGLLYIVMGFC-EGGDL-----YHKLKEQKGKLLPENQVV--EWFVQ------ 110
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
IA + YLHE I+HRDLK N+ L K+ D G+AR+ + A+T I
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
LG G G V K GT+ K + + S Q L+E + ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
G L + + E+M SLD ++ + ++ + I + G+ YL+ R
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA 540
I+HRD+K SNIL++ K+ DFG++
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
+G+G FG VY+ D + I A+K LS+ +E + E N++ + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 455 CCLEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
Q +L L+ +YM L HL R R + I + + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD + + DFGL++
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
LG G +G V+ K T D GK A+K L + + + ++ + E N++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 451 RLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L + + +L LI +Y+ + HL+ Q D + IL L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSEDEVRFYSGEIILALEHL 121
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+L I++RD+K NILLD + + ++DFGL++ F
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 32/175 (18%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQE-FKNE------VNLIAK 443
F KLG+G FG VYK +L + ++ + L + + G E + NE N A
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEY---------MPNK----SLDVHLFDATRSVQLDWK 490
+ L + + E L++ Y M +K +++ +L + + +
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 491 RRQSIINGIARGILY----LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLA 540
R II I R IL+ LH I+HRD+K NI+ + KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 415 GKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLL--GCCLEGQELLLIYEYM 469
G +A+K L + + + F+ E L A+L H N+V LL G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 470 PNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-- 526
P ++L +V D + +++ +A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114
Query: 527 -DDDMNPKISDFGLARIFGGNQNQANTNIIA 556
+ K+ DFG+ + G ++ +
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 18/141 (12%)
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
LV L C L L+ EY+ L +F R +L + + I + +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----------IFGGNQNQANTNIIAVD 558
II+RDLK N+LLD D + K++D+G+ + F G N I+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 559 TWPQSMQWEAYFLLNLMFSVL 579
+ S+ W A L LMF ++
Sbjct: 172 EYGFSVDWWA--LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 18/144 (12%)
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H LV L C L + EY+ L +F R +L + + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----------IFGGNQNQANTNII 555
LHE II+RDLK N+LLD + + K++D+G+ + F G N I+
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 556 AVDTWPQSMQWEAYFLLNLMFSVL 579
+ + S+ W A L LMF ++
Sbjct: 169 RGEDYGFSVDWWA--LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAK-LQHKNLVRLL 453
+G+G FG V A+ K AVK L + + +E K +E N++ K ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+L + +Y+ L HL R R + IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I++RDLK NILLD + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 399 LGQGGFGP--VYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG + + +D K A+ RL ++S +++ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDS 510
L ++ EY L + L W + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+++HRD+K+ NI L + K+ DFG AR+
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 15/151 (9%)
Query: 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV--R 451
S L G VY D + +K + + EV ++ L K L +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPK 57
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+L L+ E++ ++LD + + Q +A + LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQ-----LAELLAKLHQLPL 107
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + H DL NIL+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 22/152 (14%)
Query: 401 QGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+G FG VY G + K AVK + + + + + + E + +A + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 457 LEGQELLLIYEYMPN---KSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ L+ EY+ KSL +H+ FD +V+ I+ +A + YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAVKY--------ISEVALALDYLH--- 121
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
R IIHRDLK N+L+ ++ + K++DFGL+++
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 39/144 (27%), Positives = 64/144 (44%), Gaps = 18/144 (12%)
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H LV L C L + E++ L H+ R +L + + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARFYSAEISLALNF 111
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----------IFGGNQNQANTNII 555
LHE II+RDLK N+LLD + + K++D+G+ + F G N I+
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 556 AVDTWPQSMQWEAYFLLNLMFSVL 579
+ + S+ W A L LMF ++
Sbjct: 169 RGEDYGFSVDWWA--LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 21/154 (13%)
Query: 399 LGQGGFGPVYKGTLADGK--AIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG G FG V T + +A+KR ++ + + +E ++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI-----ARGILYLHE 508
G + L L+ E++ L +R + N + A+ +L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L I++RDLK N+LLD D K++DFG A++
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L I + M L HL ++ K + I G+ ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+++RDLK +NILLD+ + +ISD GLA F + A+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 25/43 (58%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 24/43 (55%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L SR K IHRDL A NILL ++ KI DFGLAR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V D KA+ A+K L + + K E +++A+ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L + +Y+P + + L D R IA + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGF 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIF 543
IHRD+K NIL+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E +++ + H ++++L G + LI +P D++ + A + + +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ R I YLHE+ IIHRD+KA NI ++ + + DFG A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHK 447
F +G G FG V D A+ A+K L + K E +++A+ ++
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V+L + L + +Y+P + + L + D R I + I +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDM-MSLLIRLGIFEEDLAR--FYIAELTCAIESVH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
++ IHRD+K NIL+D D + K++DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
I + YLH +++RDLK N++LD D + KI+DFGL +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 7/104 (6%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E++++ + H+ ++ L+ + ++ MP D+ + RS L ++ +I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ + YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKN 448
F +G+G FG V D G A+K L + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V++ + L LI E++P + T ++ D + IA +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDM------MTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
E+ ++ + +V G E+ + E+M SLD L +A R + + + SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ RG+ YL E + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKN 448
F +G+G FG V D I ++ R + + + + E +++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V++ + + L LI E++P + T ++ D ++ IA +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDM------MTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K T K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + V W R + A +L L
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ IHRD+K N+LLD + K++DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
+G+GGFG VY AD GK A+K L + QG NE ++L++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L I + M L HL Q + A IL L
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
+++RDLK +NILLD+ + +ISD GLA
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 43/147 (29%), Positives = 63/147 (42%), Gaps = 9/147 (6%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY L HL +R R + I + YLH S +
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
++RDLK N++LD D + KI+DFGL +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
E EFP L+ LG G FG V + T GK +AVK L ++
Sbjct: 31 EKWEFPRDNLQFG----------KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468
+E +E+ +++ L QHKN+V LLG C G +L+I EY
Sbjct: 81 HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K + K A+K LS+ + F E +++A +V+
Sbjct: 51 IGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + V W + + A +L L
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ +IHRD+K N+LLD + K++DFG
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 12/114 (10%)
Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
F +L++++ H +L + G C+ G E +++ E++ + LDV L V + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-----LDDDMNP--KISDFGLA 540
++ +A + YL ED L +H ++ A NIL L + +P K+SD G++
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLV 450
F ++LG G G V+K + I ++L + + E+ ++ + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHED 509
G E+ + E+M SLD L A R Q+ K ++I +G+ YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+ KI+HRD+K SNIL++ K+ DFG++
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRT-SGQGL--QEFKNEVNLIAKLQHKNLVRLL 453
+G+GG G VY + +A+K++ S L + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQS------IINGIARGIL 504
C +G + Y+ +L L + S+ + + S I + I I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
Y+H S+ ++HRDLK NILL I D+G A
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V D A+ A+K L + + + K E +++A+ ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ L + +Y+P + L ++++ IA L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
IHRD+K NIL+D D + K++DFGL F N
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 10/147 (6%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
LG+G FG V A G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
L + EY L HL +R +R + I + YLH +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
++RD+K N++LD D + KI+DFGL +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V +K + + A+K LS+ + F E +++A + +V+
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + + L ++ EYMP L V+L + + W R A +L L
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAIHS 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFG 538
+ IHRD+K N+LLD + K++DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.001
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 57/196 (29%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR------TSGQGLQEFKN-----EVN 439
N + K+G G FG V+ + KR S +GL+E + EVN
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 440 LIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-- 495
++ +L+HKN+VR + L Q+L ++ E+ D +R++Q +K I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNIQKCYKMFGKIEE 117
Query: 496 --INGIARGIL----YLHE----DSRLKIIHRDLKASNILLD-------------DDMN- 531
I I R +L Y H + +++HRDLK NI L +++N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 532 ---PKISDFGLARIFG 544
KI DFGL++ G
Sbjct: 178 RPIAKIGDFGLSKNIG 193
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 17/27 (62%), Positives = 19/27 (70%)
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
IHRD+ A N+LL D KI DFGLAR
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 37/167 (22%), Positives = 55/167 (32%), Gaps = 51/167 (30%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK----------------RLSRTSGQGLQEFKNEVNLI 441
+ QG +Y A+ VK R RT + E ++
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAV-VKERIPKRYRHPELDEKLRRERT--------RREARIL 53
Query: 442 AKLQHKNLVRLLGCC------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 495
AK R G ++ L++ EY+ + L DA + D R
Sbjct: 54 AKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK----DALEEARPDLLRE--- 100
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ R + LH+ I+H DL SNI+L DFGL
Sbjct: 101 ---VGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAK 443
F ++ +G+G FG V K T G A+K + ++ + + + F+ E ++++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+ +L + L L+ EY P L + L + Q D Q + + I
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED-QFDEDMAQFYLAELVLAI 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
+H+ + +HRD+K N+L+D + K++DFG A
Sbjct: 116 HSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 490 KRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
KR ++I G+ R +L L + R+ I+HRD+K N+L+ D KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + IHRDL A NILL KI DFGLAR
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 399 LGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQE----FKNEVNLIAKLQ 445
LG+G +Y G L +K + + ++ F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
HK++V L G C+ E +++ E++ LD+ + + + WK + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASALSY 120
Query: 506 LHEDSRLKIIHRDLKASNILL-----DDDMNP--KISDFGL 539
L ED L +H ++ NILL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLVRLLG 454
N +G G FG VY+ D + +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 455 C----CLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
C + E L ++ E++P A + L + + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQ 547
H I HRDLK N+L+D + + K+ DFG A+ Q
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
|
Length = 440 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G+G FG V + D + I +++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
++L L+ ++ L HL R + D R + + + LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FNV 114
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
I+RDLK NILLD + + DFGL ++ + ++ NT
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 7/120 (5%)
Query: 410 GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
GTL + + L + + L+ +NEV L +H N++ G L +I +M
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529
S + L + +I+ G RG+ YLH++ IHR++KAS+IL+ D
Sbjct: 82 AYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.89 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.89 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.88 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.87 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.84 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.84 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.83 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.81 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.77 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.69 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.65 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.24 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.22 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.07 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.12 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.66 | |
| PLN02236 | 344 | choline kinase | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.49 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.3 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.1 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.89 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.56 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.07 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.94 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.88 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.86 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.82 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.62 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.35 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.82 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.63 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.3 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.80 Aligned_cols=203 Identities=46% Similarity=0.747 Sum_probs=175.0
Q ss_pred CccccChHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEE
Q 007969 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456 (583)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 456 (583)
....|++.++..+|++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56678999999999999999999999999999999999999999998876543145699999999999999999999999
Q ss_pred EeCC-eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 457 LEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 457 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999875544 79999999999999999999999988899999999999999999999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
|||+|+..........+.. .|+.+|..++ .|+|++|+++.+++.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence 9999976654211111111 6676666555 5788899999888654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.41 Aligned_cols=184 Identities=26% Similarity=0.436 Sum_probs=159.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
..+|...++||+|.|+.||+|+++ ++.+||||.+.+. ..+..+.+..|+.+|+.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999975 5899999999866 5566777899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC------CceEEEecCCc
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD------MNPKISDFGLA 540 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~kl~DFGla 540 (583)
|||++|+|.+|++.. +.+++.+...+..|+|.||++||+++ ||||||||.||||+.. -..||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999653 35999999999999999999999996 9999999999999765 46899999999
Q ss_pred eecCCCCCcccceeeeeccCCCcchhH---HHHHHHHHHHhhhhc
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQWE---AYFLLNLMFSVLEFF 582 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~f 582 (583)
|.+.... .-+..+|++.||.+|++ .|..-+|+|++|.++
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 9987443 44568999999999977 445666666666543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=281.91 Aligned_cols=186 Identities=27% Similarity=0.469 Sum_probs=160.6
Q ss_pred cCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (583)
.+.|+..++||+|+||.||||+ ..+|+.||+|++.... .....-..+||.+|++|+||||++|.+...+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567778999999999999998 5679999999997553 33345568999999999999999999999887 68999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+|||+. +|.-++. .....+++.++..+..|++.||.|+|.++ |+|||||.+|||||.+|..||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 6666663 23456999999999999999999999986 9999999999999999999999999999998
Q ss_pred CCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 545 GNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
.+.....|. .+.|.||.++|. ..|+.++|+|++||+|
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl 310 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCIL 310 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHH
Confidence 888776665 456789999984 4899999999999886
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=285.06 Aligned_cols=183 Identities=26% Similarity=0.368 Sum_probs=157.8
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
..|...+.||+|+|..+|+++. ..|+.||+|++.+. .....+...+||++.+.|+|||||+++++|++.+..|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 78999999999864 3445688999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|+|++++|..+++ +++++++.++..+..||+.||.|||+.+ |+|||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 4567999999999999999999999985 999999999999999999999999999999866
Q ss_pred CCcccceeeeeccCCCcchhH---HHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQWE---AYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~ 581 (583)
.....| ++||+.|.+||+- ..++.+|+|++|+.
T Consensus 172 ~Erk~T--lCGTPNYIAPEVl~k~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 172 GERKKT--LCGTPNYIAPEVLNKSGHSFEVDIWSLGCV 207 (592)
T ss_pred ccccce--ecCCCcccChhHhccCCCCCchhhhhhhhH
Confidence 544433 7899988887742 33344444444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=273.36 Aligned_cols=181 Identities=29% Similarity=0.461 Sum_probs=155.2
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhh--CCCCCceeEEEEEEeCC----eEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEGQ----ELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 464 (583)
......+.||+|+||.||||.+. ++.||||++... ..+.|++|-++.+. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455678999999999999995 589999999744 34678888887765 58999999999987665 8999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
|+||.++|+|.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999944 3589999999999999999999986 34679999999999999999999999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcchh----------------HHHHHHHHHHHhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSMQW----------------EAYFLLNLMFSVL 579 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~l~ 579 (583)
||.++.....+..+-.-+||.-||.+|. |+|..|.++||+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999998877776666778877777663 7888999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=275.34 Aligned_cols=184 Identities=36% Similarity=0.522 Sum_probs=152.9
Q ss_pred CCccccccccCceEEEEEEecCCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-eEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~ 469 (583)
+...+.||+|+||+||+|.+.....||||++..... ...++|.+|+.++++++|||||+++|+|.++. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344566999999999999997555599999986532 22569999999999999999999999999987 799999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecCCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 548 (583)
++|+|..+++.. ....+++..+++++.|||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++.......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 999999999774 45679999999999999999999999853 99999999999999997 999999999998765421
Q ss_pred cccceeeeeccCCC------------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~ 581 (583)
..+ ...||+.++ ..+.|+|++|+++|++..+
T Consensus 200 -~~~-~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~ 242 (362)
T KOG0192|consen 200 -SMT-SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG 242 (362)
T ss_pred -ccc-CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence 111 134444433 3445789999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=270.47 Aligned_cols=185 Identities=25% Similarity=0.361 Sum_probs=153.0
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCch-------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
..+.|...+.||+|+||.|-+|.- ++|+.||||.+++.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456678889999999999999974 57999999999865221 1234679999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEec
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDF 537 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DF 537 (583)
..|+||||++||+|.+++-. .+.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999854 344777788889999999999999997 9999999999999665 88999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCcchh------HHHHHHHHHHHhhhhc
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQSMQW------EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~f 582 (583)
|+|+..+... ..+..+||+.|-.||. ..+.-.+|+|+||+.+
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL 371 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL 371 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence 9999886332 3455788888877763 2344567777777653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=252.85 Aligned_cols=184 Identities=30% Similarity=0.519 Sum_probs=159.0
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchh--HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.+|...++||+|.||.||+|+. .+|+.||||+++....++ .....+||..++.++|+||+.+++++.+.+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999984 579999999998663321 2356899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||+ .+|+..+++. ...+...++..++.++.+||+|||.+. |+||||||.|+|++++|.+||+|||+||.+....
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 5898888553 346899999999999999999999997 9999999999999999999999999999997554
Q ss_pred CcccceeeeeccCCCcch----hHHHHHHHHHHHhhhhc
Q 007969 548 NQANTNIIAVDTWPQSMQ----WEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~f 582 (583)
...... +.+.||..+| ...|+.++|+|++||+|
T Consensus 156 ~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~ 192 (318)
T KOG0659|consen 156 RIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIF 192 (318)
T ss_pred cccccc--eeeeeccChHHhccchhcCCcchhhhHHHHH
Confidence 433222 7788999998 46899999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=265.31 Aligned_cols=181 Identities=27% Similarity=0.369 Sum_probs=146.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-eEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~ 468 (583)
+++..+.||+|.-|+|||++++ +++.+|+|++... ++...+++.+|++++++.+||+||+++|.|..++ +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455678999999999999976 5788999999544 4445678999999999999999999999999998 59999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC--
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-- 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~-- 546 (583)
|++|+|++++... +.+++...-+|+.+|++||.|||+.. +||||||||+|||+++.|.|||+|||.++.+..+
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 9999999999543 45899999999999999999999743 5999999999999999999999999999887544
Q ss_pred ------CCcccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 547 ------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 547 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
..+..|+++.|+.+...-+ .|++|+.++|+.
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sD--IWSLGLsllE~a 271 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSD--IWSLGLSLLELA 271 (364)
T ss_pred ccccccccccChhhhcCCcCCcccc--eecccHHHHHHh
Confidence 3344444444444333333 333555555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=261.61 Aligned_cols=185 Identities=27% Similarity=0.388 Sum_probs=159.1
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
..++|+..++||+|+||+|+.++.+ +++.+|+|++++.. ....+....|..++.+++||.||+++-.|++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567999999999999999999865 58899999998762 2346678899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+||+.||.|..+|. +.+.+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999994 3456899999999999999999999996 9999999999999999999999999999765
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... +...+||..|+.+| .|+|++|+.+|+|+.+
T Consensus 177 ~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G 221 (357)
T KOG0598|consen 177 KDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTG 221 (357)
T ss_pred cCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhC
Confidence 44332 33367777777665 3566699999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=260.53 Aligned_cols=186 Identities=25% Similarity=0.395 Sum_probs=154.7
Q ss_pred CCCCccccccccCceEEEEEE-ecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEE-EeCCe-EEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQE-LLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~-~~lV 465 (583)
.+|.+.++||+|.||+|||+. +.+|..||.|.+.-. +.+..++...|+.+|++|+|||||+++++. .++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357778999999999999997 668999999999733 556678999999999999999999999954 44444 8999
Q ss_pred EEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR-LKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
|||+..|+|...++..+ ....+++..+|+++.|+++||.++|...+ .-|+||||||.||+|+.+|.+||+||||+|++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998886543 34458999999999999999999998432 13999999999999999999999999999999
Q ss_pred CCCCCcccceeeeeccCCCcchh----------HHHHHHHHHHHh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSV 578 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l 578 (583)
........ ..+||++|++++. |.|++|+.+|+|
T Consensus 179 ~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 179 SSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred cchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 87766543 4789999999873 455555555554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=273.79 Aligned_cols=183 Identities=32% Similarity=0.518 Sum_probs=153.3
Q ss_pred CCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+...+.||+|.||.||.|.++....||+|.++..+ ...+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34467899999999999999888899999998753 23478999999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|.++|.. .....+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+||||||....+......
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999976 33455888999999999999999999984 999999999999999999999999999965555443322
Q ss_pred eeeeeccC---------CCcchhHHHHHHHHHHHhhh
Q 007969 553 NIIAVDTW---------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 553 ~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~ 580 (583)
..-..-.| -++...|+|++|+.+||+..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT 399 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFT 399 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhc
Confidence 22222223 34556788889999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=258.26 Aligned_cols=183 Identities=23% Similarity=0.393 Sum_probs=154.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|+...++|+|+||.|||++.+ +|+.||||++..... .-.+-..+||+++++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35667788999999999999976 599999999975532 334567899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC-C
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG-N 546 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~-~ 546 (583)
|++..-|+++-+ ....++.+...+++.|++.|+.|+|++. +|||||||+||||+.++.+||+|||+||.+.+ +
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998876665432 2334899999999999999999999985 99999999999999999999999999999984 3
Q ss_pred CCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 547 QNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
..+ |. .+.|.||.++|. -.|+..+|+|.+||.|
T Consensus 156 d~Y--TD-YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~ 192 (396)
T KOG0593|consen 156 DNY--TD-YVATRWYRAPELLVGDTQYGKPVDIWAIGCVF 192 (396)
T ss_pred chh--hh-hhhhhhccChhhhcccCcCCCcccchhhhHHH
Confidence 332 33 567789988884 3788888888888876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.36 Aligned_cols=189 Identities=30% Similarity=0.506 Sum_probs=158.1
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.+.+....++||+|.||+||+|+.. +...||||.|++.... ..++|++|+++++.++|||||+|+|+|..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455666789999999999999843 3457999999977655 78899999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
.++|+|||..|||.+||..... ..+|+..+.+.|+.|||.||.||-+++ +|||||..||+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999974321 234889999999999999999999885 99999999999999999
Q ss_pred ceEEEecCCceecCCCCCcccc-eeeeeccC---------CCcchhHHHHHHHHHHHhhh
Q 007969 531 NPKISDFGLARIFGGNQNQANT-NIIAVDTW---------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 531 ~~kl~DFGla~~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~ 580 (583)
.|||+||||+|..-..+.+..- +....-.| .+..+.|+|++|+++||+..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc
Confidence 9999999999987555544332 22333333 45567889999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=246.14 Aligned_cols=181 Identities=28% Similarity=0.373 Sum_probs=154.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..+.||.|+||+|...+.+ +|..+|+|++++..- +..+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777889999999999999965 588999999987643 33456789999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||++||.|.++|++ .+.+++.....++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999955 345899999999999999999999986 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhhc
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~f 582 (583)
|-.++||+.|.++| .|+|++|+.+|+|+.|+
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 22355555544443 24555999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=262.35 Aligned_cols=188 Identities=27% Similarity=0.438 Sum_probs=156.3
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchh-HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.+.....++||+|.||+|..++...+..||||.++...... ..+|.+||++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345567789999999999999999888999999999776554 4899999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||++|+|..|+.+..... +.-....+|+.||++||+||.+. ++|||||.++|+|+|.++++||+|||++|.+-..+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997653322 45566778999999999999986 59999999999999999999999999999765555
Q ss_pred Ccccceeeee-ccC---------CCcchhHHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAV-DTW---------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~l~~l~~ 580 (583)
.+....+.+. -.| .+....|+|++++.+||+.-
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~ 734 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM 734 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence 5443322222 223 33445688889999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=265.20 Aligned_cols=183 Identities=26% Similarity=0.406 Sum_probs=154.7
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHH--HHHHHHHhhCC-CCCceeEEEEEEeCC-eEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEF--KNEVNLIAKLQ-HKNLVRLLGCCLEGQ-ELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~l 464 (583)
.++|...++||.|+||.||+|+. .+|+.||||++++.-.. +++. ++|+..|++++ ||||++|..++.+++ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45788889999999999999984 56889999999876433 3333 68999999998 999999999999887 9999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||| ..+|..+++++ +..+++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+||+||||||...
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99999 46899888765 567999999999999999999999997 9999999999999999999999999999987
Q ss_pred CCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 545 GNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
....+. ..+-|.||..+|. -.|...+|||.+|+++
T Consensus 162 SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 162 SKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIM 200 (538)
T ss_pred cCCCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHH
Confidence 766553 3577889888884 2555666666666654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=247.98 Aligned_cols=185 Identities=27% Similarity=0.430 Sum_probs=155.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchh--HHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (583)
.++|+..++|++|+||.||+|+.+ +++.||+|+++-...+. --.-++||.++.+++|||||.+-.+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356777889999999999999864 68899999998543221 12348999999999999999999998754 57999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|||||+. +|...+.... .++...+...+..|+++|++|||..+ |+|||||++|+|+.+.|.+||+||||||.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 7888886544 45888899999999999999999997 9999999999999999999999999999997
Q ss_pred CCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 545 GNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
...... | ..+.|.||.+++. ..|+..+|||++||+|
T Consensus 229 sp~k~~-T-~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~ 268 (419)
T KOG0663|consen 229 SPLKPY-T-PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIF 268 (419)
T ss_pred CCcccC-c-ceEEEeeecCHHHhcCCcccCcchhhhhHHHHH
Confidence 764433 3 3677899999984 5888999999999886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.04 Aligned_cols=184 Identities=23% Similarity=0.445 Sum_probs=160.5
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.+|++.+.||+|.||+|-++.- ..|+.||||.+++.. .+++-.+.+||++|+.|+||||+.++.+|.+.+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577788999999999999974 679999999998663 444556789999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC--
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG-- 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~-- 544 (583)
||..+|.|.+|+.+ .+.|++.+...++.||.+|+.|+|.++ ++|||||.+|||||.++++||+||||+-.+.
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999954 456999999999999999999999984 9999999999999999999999999998774
Q ss_pred -------CCCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 -------GNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
++..+..++.+-| ..|..++.++|.+|+.+|.|.-|
T Consensus 207 kfLqTFCGSPLYASPEIvNG-~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNG-TPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred cHHHHhcCCcccCCccccCC-CCCCCCccchhhHHHHHHHHhhc
Confidence 4555667765544 45678888999999999988644
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=246.97 Aligned_cols=186 Identities=27% Similarity=0.446 Sum_probs=153.8
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCch--hHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCC------
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQ------ 460 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------ 460 (583)
..|...++||+|+||+||+|+. .+|+.||+|++.....+ .-....+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466677899999999999985 46899999999865332 2345689999999999999 999999998876
Q ss_pred eEEEEEEcCCCCChhHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
.+++|+||++ -+|..++...... ..++...+..+..||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7899999994 5898888765432 45777899999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
|+.+.-....-.+ .++|.||.++|. ..|+..+|+|++|++|
T Consensus 167 Ara~~ip~~~yt~--evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 167 ARAFSIPMRTYTP--EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HHHhcCCcccccc--cEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 9977633332233 467788988883 3677888999998887
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=255.91 Aligned_cols=189 Identities=28% Similarity=0.377 Sum_probs=158.7
Q ss_pred HHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
....++|...+.||+|+|++|++|+. ..++++|||++.+.. .+..+-...|-++|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34457899999999999999999984 468999999998652 22234567888999999 89999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
+|+|+||.++|+|.+++++ .+.+++.....++.+|+.||+|||+.| ||||||||+|||||++|++||+|||-|+
T Consensus 149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999955 356899999999999999999999986 9999999999999999999999999999
Q ss_pred ecCCCCCc---------ccc--eeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQ---------ANT--NIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~---------~~~--~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
.+.+.... ... ...+||..|.++|. |.|.+||++|.|+.|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 98654322 222 44788888777763 566677777777665
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=247.95 Aligned_cols=193 Identities=23% Similarity=0.335 Sum_probs=161.2
Q ss_pred cccChHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhh--CCCCCceeEEEEE
Q 007969 379 PLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCC 456 (583)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~ 456 (583)
.-.++-..+.........+.||+|.||+||+|+++ |+.||||++...++ +.+.+|.++... |+|+||+.+++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 44566666777778888999999999999999995 88999999986654 456778887765 5999999999886
Q ss_pred EeC----CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEc
Q 007969 457 LEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLD 527 (583)
Q Consensus 457 ~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~ 527 (583)
..+ .++|||.+|.++|||.+||.. ..++-+..++++..+|.||+|||.+ +++.|.|||||++|||+.
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 543 268999999999999999943 4589999999999999999999964 778899999999999999
Q ss_pred CCCceEEEecCCceecCCCCC--cccceeeeeccCCCcchh----------------HHHHHHHHHHHhh
Q 007969 528 DDMNPKISDFGLARIFGGNQN--QANTNIIAVDTWPQSMQW----------------EAYFLLNLMFSVL 579 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~--~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~l~ 579 (583)
+++.+.|+|+|||-.+..+.+ ...++.-+||--|+.||. |.|++|.++||+.
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 999999999999999876533 334555678877777764 6788999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=257.35 Aligned_cols=181 Identities=26% Similarity=0.444 Sum_probs=154.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. ..+.++.+.+|++++++++||||+.++.+|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999865 6789999999765 44567889999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+.+ +|..+|.+ ...++++.+..|+.++..||.|||+.+ |+|||+||+||||+.++++|++|||+||..+.+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 99999944 556999999999999999999999985 9999999999999999999999999999887643
Q ss_pred CcccceeeeeccCCCcchh----------HHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~ 580 (583)
. .-..+.|++.|+.+|. |.|++|+++|++..
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~ 195 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV 195 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc
Confidence 3 3445778888887773 34445555555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=268.87 Aligned_cols=184 Identities=29% Similarity=0.489 Sum_probs=151.4
Q ss_pred CCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
...++++||.|.||+|++|+++- ...||||.|+... .+.+.+|+.|+.+|.+++||||++|.|+....+..+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34567899999999999999763 3479999999774 455779999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|||+||+|+.||++. .+.+++.+...++++||.||.||.+.+ .|||||.++|||++.+..+|++||||+|.+..+
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999653 456999999999999999999999875 999999999999999999999999999988666
Q ss_pred CCccccee--eeeccC---------CCcchhHHHHHHHHHHHhhh
Q 007969 547 QNQANTNI--IAVDTW---------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~l~~l~~ 580 (583)
....-+.. .+.-.| .+....|+|++|.+|||++.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS 829 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 829 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecc
Confidence 53221111 011123 22334567778888888764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=250.11 Aligned_cols=151 Identities=26% Similarity=0.386 Sum_probs=136.1
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
....++|+..++||+|+||.||.++.+ +|..+|+|+|++..- .+....+.|-.+|...++|.||+|+-.|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999865 699999999987633 3356678899999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
||||||++||++..+|. +...|++.....++.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999994 4556999999999999999999999986 99999999999999999999999999974
Q ss_pred c
Q 007969 543 F 543 (583)
Q Consensus 543 ~ 543 (583)
+
T Consensus 291 l 291 (550)
T KOG0605|consen 291 L 291 (550)
T ss_pred h
Confidence 4
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=250.14 Aligned_cols=189 Identities=24% Similarity=0.371 Sum_probs=157.9
Q ss_pred HHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC----Cc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCC
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT----SG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 460 (583)
...+.|...+.||+|+||+|+.|.. .+++.||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456788899999999999999975 46899999977654 22 23456678999999999 999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGL 539 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl 539 (583)
..++||||+.+|+|.+++.+ .+.+.+.....++.|+++|++|+|+.+ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999955 445888999999999999999999986 9999999999999999 9999999999
Q ss_pred ceecC-C---------CCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhhc
Q 007969 540 ARIFG-G---------NQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 540 a~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~f 582 (583)
+.... . ...+..|+.+.+...|.+.+.|.|++|+++|.|++|.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 99873 1 2234444444443336677778888999999998875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=242.84 Aligned_cols=188 Identities=25% Similarity=0.359 Sum_probs=156.9
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--eEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 466 (583)
..++...+.||+|.||.||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3456778899999999999999754 8999999998764444678999999999999999999999855444 689999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 545 (583)
||+++|+|.+++.+... .+++..+..+..||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999965432 5999999999999999999999986 999999999999999 79999999999998875
Q ss_pred CCC-cccceeeeeccCCCcchhHHHH--H--HHHHHHhhhhc
Q 007969 546 NQN-QANTNIIAVDTWPQSMQWEAYF--L--LNLMFSVLEFF 582 (583)
Q Consensus 546 ~~~-~~~~~~~~~~~~~~~~~~~~~~--~--~~~l~~l~~~f 582 (583)
... ........|+..+++||....+ . .+|+|++|+.+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtV 212 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTV 212 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEE
Confidence 222 2233346788888888876522 3 78999998854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=271.30 Aligned_cols=188 Identities=31% Similarity=0.521 Sum_probs=153.8
Q ss_pred cCCCCccccccccCceEEEEEEecC--Cc----EEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD--GK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
..+....+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667889999999999998653 33 4999999876 455678999999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 463 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
+|++|||++|+|..||++.+ ....+...+.+.++.|||+|+.||++++ +|||||.+||+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 2345899999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCccccee-eeeccCC---------CcchhHHHHHHHHHHHhhh
Q 007969 539 LARIFGGNQNQANTNI-IAVDTWP---------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 539 la~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~l~~l~~ 580 (583)
|||.+...+.+..-.. ...-.|. +..+.|+|++|+.+||++.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifs 899 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFS 899 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHh
Confidence 9996554444433322 1111232 2233578889999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=252.98 Aligned_cols=181 Identities=28% Similarity=0.439 Sum_probs=155.8
Q ss_pred cCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
...|..-++||+|.-|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..+...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3557778899999999999997 457889999999877666667889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|++|+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||||..|||++.++.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998843 23899999999999999999999996 99999999999999999999999999999988877
Q ss_pred cccceeeeeccCCCcchh---HHHHHHHHHHHhh
Q 007969 549 QANTNIIAVDTWPQSMQW---EAYFLLNLMFSVL 579 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~ 579 (583)
...+ .+||++++.+|. ..|+..+|+|+||
T Consensus 425 KR~T--mVGTPYWMAPEVvtrk~YG~KVDIWSLG 456 (550)
T KOG0578|consen 425 KRST--MVGTPYWMAPEVVTRKPYGPKVDIWSLG 456 (550)
T ss_pred cccc--ccCCCCccchhhhhhcccCccccchhhh
Confidence 5544 688877666663 2445555555554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=254.57 Aligned_cols=148 Identities=35% Similarity=0.523 Sum_probs=131.3
Q ss_pred CCCccccccccCceEEEEEEecC--C---cEEEEEEecc---CCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD--G---KAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~--g---~~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
+....++||+|.||.||+|+++. + ..||||..+. ......++|.+|+++|++++|||||+++|++....+++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999998653 2 2389999885 34566789999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|||+|+||+|.++|.+... .++..+++.++.+.|.||+|||++. +|||||.+||+|++.++.+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999965433 5899999999999999999999985 999999999999999999999999999866
Q ss_pred C
Q 007969 544 G 544 (583)
Q Consensus 544 ~ 544 (583)
.
T Consensus 313 ~ 313 (474)
T KOG0194|consen 313 S 313 (474)
T ss_pred c
Confidence 4
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=238.89 Aligned_cols=186 Identities=26% Similarity=0.407 Sum_probs=157.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEecc--CCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe-----CCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 461 (583)
...|...+.||+|.+|.|+.+..+ +|+.||||++.. .+....++-.+|+.+++.++|+||+.+..++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345566789999999999999854 689999999983 345557888999999999999999999999865 357
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.|+|+|+| ..+|...++. ...|+......+..||++||.|+|+.+ |+||||||+|+|++.+...||+||||||
T Consensus 101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 6788888843 334899999999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch----hHHHHHHHHHHHhhhhc
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ----WEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~f 582 (583)
..........-...+.|.||..++ |..|..++|+|++||+|
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL 218 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence 987653333323467789999988 55788999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=245.47 Aligned_cols=188 Identities=26% Similarity=0.380 Sum_probs=146.9
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC-C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (583)
.++|...++||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 235689999997543 23356789999999999 899999999998764 4
Q ss_pred eEEEEEEcCCCCChhHHHhccCC---------------------------------------------------------
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (583)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCC
Q 007969 484 --SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP 561 (583)
Q Consensus 484 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 561 (583)
...+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....+..........++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999985 999999999999999999999999999876433222111111222222
Q ss_pred Cc----------chhHHHHHHHHHHHhhh
Q 007969 562 QS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 562 ~~----------~~~~~~~~~~~l~~l~~ 580 (583)
++ ...|.|++|+.+|+++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 22 33578889999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=239.07 Aligned_cols=187 Identities=26% Similarity=0.417 Sum_probs=148.0
Q ss_pred cCCCCccccccccCceEEEEEEecC-----------------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCcee
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 451 (583)
.++|...++||+|+||.||++..++ +..||+|.+.... .....+|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3567888999999999999997532 3369999987653 334568999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEcCCCCChhHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 007969 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDAT----------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515 (583)
Q Consensus 452 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 515 (583)
+++++.+.+..++||||+++|+|.+++.... ....++|...+.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 1134788999999999999999999985 99
Q ss_pred eCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhh
Q 007969 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVL 579 (583)
Q Consensus 516 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~ 579 (583)
||||||+|||+++++.+||+|||+++...............++..|++ ...|.|++|+.+|++.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999987644332211111122222222 3457788888888875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=251.21 Aligned_cols=184 Identities=34% Similarity=0.563 Sum_probs=152.9
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.+.+...+.||+|.||+||+|++- -.||||+|... ....++.|++|+.++++-+|.||+-+.|+|..+.. .||..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 344566788999999999999985 36999999865 34568899999999999999999999999998877 99999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC---
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG--- 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~--- 544 (583)
+|+|.+|..+||..+ ..++..+...|+.|||+||.|||.+. |||||||..||+|.+++.|||+||||+..-.
T Consensus 468 wCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999998755 34888999999999999999999985 9999999999999999999999999997643
Q ss_pred CCCCc---------ccceee-eeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQ---------ANTNII-AVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~---------~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
++... ..++.+ ..+..+++...|+|.+|+++|||+.+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 22111 111111 13334677778999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=245.09 Aligned_cols=185 Identities=22% Similarity=0.286 Sum_probs=152.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..++||+|+||+||+++.. +++.||+|++++.. ....+.+.+|+.++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 58899999997542 233457889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999854 345899999999999999999999985 999999999999999999999999999865321
Q ss_pred CCc---------------------------------ccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 547 QNQ---------------------------------ANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~---------------------------------~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
... .......|+..|+++|. |.|++|+.+|+|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 100 00112456766666663 677788888888765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=246.64 Aligned_cols=186 Identities=26% Similarity=0.352 Sum_probs=152.8
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
....++|...++||+|.||+|+++.++ +++.+|||++++... ...+....|-+++... +||.++.++.+|..+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578899999999999999999976 578899999998743 3355667777777766 59999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
+++||||+.||++..+. ....+++..+..++..|+.||+|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999944332 3345899999999999999999999996 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..-.... .|.+.+||+-|+.+| .|+|++|+.||+|+.|
T Consensus 517 e~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~G 564 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVG 564 (694)
T ss_pred ccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcC
Confidence 7654333 234466776655554 3566689999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=237.08 Aligned_cols=180 Identities=23% Similarity=0.283 Sum_probs=150.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999865 68899999996432 233567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999854 335899999999999999999999985 999999999999999999999999999876432
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ...|+..|.++| .|.|++|+++|+|+.+
T Consensus 155 ~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g 194 (291)
T cd05612 155 TW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194 (291)
T ss_pred cc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 21 123444444443 5778888888888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=233.02 Aligned_cols=187 Identities=22% Similarity=0.322 Sum_probs=157.2
Q ss_pred cCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|+..++||.|.-+.||+|+ .+.++.||||++... .....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678899999999999999998 456899999999754 33447899999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||.+|++.++++..-..+ +++..+..|++++++||.|||.+| -||||||+.||||+++|.|||+|||.+-.+..+.
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997654443 899999999999999999999997 8999999999999999999999999776654333
Q ss_pred Ccccc--eeeeeccCCCcchh-----HHHHHHHHHHHhhh
Q 007969 548 NQANT--NIIAVDTWPQSMQW-----EAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~ 580 (583)
..... +..+|+++++.+|. .-|.+-+|||++|=
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI 220 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence 22211 45678888877776 35666777777663
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=240.76 Aligned_cols=180 Identities=22% Similarity=0.322 Sum_probs=151.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999975 58899999997542 233567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999854 335789999999999999999999985 999999999999999999999999999876443
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ...|+..|+++| .|.|++|+.+|+|+.+
T Consensus 172 ~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 211 (329)
T PTZ00263 172 TF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211 (329)
T ss_pred cc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcC
Confidence 21 123444443333 5777889999998765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=235.00 Aligned_cols=151 Identities=30% Similarity=0.500 Sum_probs=130.3
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch--------------hHHHHHHHHHHHhhCCCCCcee
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--------------GLQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~--------------~~~~~~~Ei~~l~~l~H~niv~ 451 (583)
....+.|.+.+.||+|.||.|-+|+.. +++.||||++.+.... ..++..+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345578999999999999999999854 6899999999754211 1468899999999999999999
Q ss_pred EEEEEEeC--CeEEEEEEcCCCCChhHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 007969 452 LLGCCLEG--QELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 528 (583)
Q Consensus 452 l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 528 (583)
|+.+.-+. +.+|+|+|||..|.+... ....+ +.+.+..+++.++..||.|||.++ ||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99998765 579999999999887532 22334 899999999999999999999996 999999999999999
Q ss_pred CCceEEEecCCceecC
Q 007969 529 DMNPKISDFGLARIFG 544 (583)
Q Consensus 529 ~~~~kl~DFGla~~~~ 544 (583)
+|++||+|||.+..+.
T Consensus 246 ~g~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFP 261 (576)
T ss_pred CCcEEeeccceeeecc
Confidence 9999999999998873
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.65 Aligned_cols=147 Identities=29% Similarity=0.396 Sum_probs=131.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999854 6889999998653 2234567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999854 345889999999999999999999985 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=240.63 Aligned_cols=180 Identities=24% Similarity=0.335 Sum_probs=149.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58899999997542 233567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 99999999999954 335889999999999999999999985 999999999999999999999999999876431
Q ss_pred CCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
. ....|+..|+++ ..|.|++|+++|+|+.+
T Consensus 155 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 194 (333)
T cd05600 155 A-----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194 (333)
T ss_pred c-----CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhC
Confidence 1 112333333333 35677788888888754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=244.46 Aligned_cols=148 Identities=26% Similarity=0.402 Sum_probs=132.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999865 68899999997542 233456889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999854 335899999999999999999999985 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=254.79 Aligned_cols=182 Identities=30% Similarity=0.497 Sum_probs=151.1
Q ss_pred CccccccccCceEEEEEEe-cCC----cEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTL-ADG----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~-~~g----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
...++||+|+||+||||.+ ++| -+||+|++.... .+..+++++|+-+|++++|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4468999999999999974 444 378999987653 445689999999999999999999999998775 889999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||+.|+|.+|++..+ ..+.-...+.+..|||+||.|||++ +++||||.+||||+.+-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999997643 3577888999999999999999988 49999999999999999999999999999998776
Q ss_pred Ccccceeeeec-cC---------CCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVD-TW---------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~-~~---------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.+-........ .| ..-.+.|+|++|+.+||++.+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTF 896 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTF 896 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhc
Confidence 65433322111 11 344567889999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=240.67 Aligned_cols=181 Identities=22% Similarity=0.278 Sum_probs=150.5
Q ss_pred cCCCCccccccccCceEEEEEEecC--CcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|+||.||+|..++ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568888999999999999998543 368999998643 22345678899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999854 335899999999999999999999985 9999999999999999999999999998764
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... ....|+..|+++| .|.|++|+++|+|+.+
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G 224 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence 322 1234555444444 4677788888888765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=219.85 Aligned_cols=184 Identities=27% Similarity=0.400 Sum_probs=149.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
-++|+..+.||+|.||.||.|+.+ ++-.||+|++.+.. .+-.+++.+|+++-+.|+||||+++++++.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999865 57789999997652 22346889999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||.++|++...|.+.. ...+++.....++.|+|.||.|+|.. +||||||||+|+|++..+..||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999997533 44588889999999999999999988 499999999999999999999999998875542
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+. . ...+||.-|-++| .+.|.+|+.-|+++.+
T Consensus 177 ~k--R--~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg 218 (281)
T KOG0580|consen 177 NK--R--KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG 218 (281)
T ss_pred CC--c--eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence 22 2 2356666654444 3444455555555543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=237.88 Aligned_cols=177 Identities=24% Similarity=0.250 Sum_probs=144.8
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.||+|+||.||+++.. +|+.||+|++++.. ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999997542 233467889999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 99988854 345899999999999999999999985 99999999999999999999999999986432221 12
Q ss_pred eeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 553 NIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 553 ~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 191 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence 2344565555555 4666677777777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=230.93 Aligned_cols=182 Identities=26% Similarity=0.331 Sum_probs=148.5
Q ss_pred CCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 478999999987542 22335678999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988875432 335899999999999999999999985 99999999999999999999999999987643322
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....|+..|+++| .|.|++|+.+|++..+
T Consensus 158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 158 V---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred e---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 1 1123344443333 4777889999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=247.48 Aligned_cols=186 Identities=17% Similarity=0.246 Sum_probs=154.1
Q ss_pred CCccccccccCceEEEEEEec-C-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
|...+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999754 3 67888888766555555678899999999999999999999999999999999999
Q ss_pred CCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 471 NKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 471 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
+|+|.+++.+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 23446899999999999999999999985 999999999999999999999999999987654333
Q ss_pred ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.......|+..|+++| .|.|++|+.+|+|+.+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 2333445666665554 4677788888877654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=236.39 Aligned_cols=177 Identities=23% Similarity=0.256 Sum_probs=143.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.||+|+||.||+++.. +|+.||+|+++.. .......+.+|++++++++||||+++++.+..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999999754 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence 99888854 335899999999999999999999985 999999999999999999999999998864322111 1
Q ss_pred eeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 553 NIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 553 ~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
....|+..|+++ ..|.|++|+.+|+++.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g 191 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence 112334333333 35778888888888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=242.82 Aligned_cols=185 Identities=21% Similarity=0.248 Sum_probs=151.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
..++|...++||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567889999999999999999975 5789999998643 22234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 24788899999999999999999985 9999999999999999999999999999775
Q ss_pred CCCCcccceeeeeccCCCcch--------------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ--------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~ 581 (583)
..... ......|+.+|+++| .|.|++|+.+|+|+.+
T Consensus 194 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G 243 (370)
T cd05621 194 ETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243 (370)
T ss_pred cCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhC
Confidence 33221 112234555554444 4566788888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=242.43 Aligned_cols=146 Identities=26% Similarity=0.384 Sum_probs=130.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|...++||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999854 68899999997542 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
|+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999854 335889999999999999999999985 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=252.14 Aligned_cols=153 Identities=31% Similarity=0.452 Sum_probs=135.5
Q ss_pred HcCCCCccccccccCceEEEEEEecCC-cEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEE-EEe----C--
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGC-CLE----G-- 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~----~-- 459 (583)
...++.+++.|.+|||+.||.++...+ .++|+|++-..+...++.+.+||++|++|+ |+|||.+++. ... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345567789999999999999998766 999999998888888999999999999997 9999999993 321 1
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
-+.+|.||||++|.|-+++..+.... |++.++++|+.|+++|+++||.. ++||||||||.+||||+.+++.||||||-
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 37899999999999999997655444 99999999999999999999998 57899999999999999999999999998
Q ss_pred ceec
Q 007969 540 ARIF 543 (583)
Q Consensus 540 a~~~ 543 (583)
|.--
T Consensus 193 att~ 196 (738)
T KOG1989|consen 193 ATTK 196 (738)
T ss_pred cccc
Confidence 8754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=235.72 Aligned_cols=177 Identities=24% Similarity=0.266 Sum_probs=145.1
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999854 6899999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--c
Confidence 99888844 335899999999999999999999985 999999999999999999999999999864322211 1
Q ss_pred eeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 553 NIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 553 ~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....|+..|+++| .|.|++|+.+|+++.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 1233454444444 4677788888888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=240.97 Aligned_cols=188 Identities=29% Similarity=0.389 Sum_probs=148.6
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999963 245689999997543 33456789999999999 89999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC----------------------------------------------------------
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (583)
.++||||+++|+|.+++.+...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 484 --------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 484 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
...++|..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124789999999999999999999985 999999999999999999999999999876543321
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.......++..| .....|.|++|+.+|+++.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt 311 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHh
Confidence 111111111112 2234578889999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=234.04 Aligned_cols=175 Identities=23% Similarity=0.292 Sum_probs=145.8
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||.||+++.. +++.||+|++++. .......+.+|+.++.+++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 5789999999753 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--ccc
Confidence 999854 345899999999999999999999985 999999999999999999999999999865332221 223
Q ss_pred eeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg 189 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC
Confidence 44555555554 4778888888888754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=242.43 Aligned_cols=146 Identities=26% Similarity=0.398 Sum_probs=129.9
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|...++||+|+||.||+|+.. +++.+|+|++.+.. ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 68899999997542 2335678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998542 35788999999999999999999985 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=242.82 Aligned_cols=147 Identities=25% Similarity=0.386 Sum_probs=130.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999864 58899999997542 223467889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
||+++|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999854 335888999999999999999999985 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.28 Aligned_cols=184 Identities=27% Similarity=0.370 Sum_probs=156.6
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.-|..++.||.|+-|.|-.|+. .+|+.+|||.+.+.. ......+.+||.+|+-+.|||+++++++|+++.++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577789999999999999985 479999999997652 223457899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC--
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG-- 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~-- 544 (583)
||+++|.|.+++. +++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.+-.
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 4566999999999999999999999885 9999999999999999999999999998754
Q ss_pred -------CCCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 -------GNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+...+..|+.+.|. .|..-..|+|..|+++|.|+.|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG 208 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTG 208 (786)
T ss_pred ccccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhC
Confidence 33445555544443 3445556788899999999876
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=234.05 Aligned_cols=185 Identities=20% Similarity=0.245 Sum_probs=151.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999965 5889999999753 2233456889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 235889999999999999999999985 999999999999999999999999999876543
Q ss_pred CCcccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
..... ....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 156 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g 204 (331)
T cd05597 156 GTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204 (331)
T ss_pred CCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC
Confidence 32211 1234555554443 4677788888887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=225.42 Aligned_cols=191 Identities=28% Similarity=0.463 Sum_probs=156.5
Q ss_pred HHcCCCCccccccccCceEEEEEEecC-----CcEEEEEEeccCCc-hh-HHHHHHHHHHHhhCCCCCceeEEEEEEe-C
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKNLVRLLGCCLE-G 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~ 459 (583)
+....|+...+||+|++|.||||.-++ ...+|+|+++.... .+ .....+|+.+++.++||||+.|..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 445668888999999999999996432 23789999975522 11 3567899999999999999999999977 7
Q ss_pred CeEEEEEEcCCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC----CceE
Q 007969 460 QELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPK 533 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~k 533 (583)
...++++||.+. +|...++- ..+...++.....+|+.||+.|+.|||+.. |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 789999999976 56666542 233457899999999999999999999998 9999999999999766 9999
Q ss_pred EEecCCceecCCCCCc-ccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 534 ISDFGLARIFGGNQNQ-ANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 534 l~DFGla~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
|+|||++|++...-.. .....++.|.||..+|. .-|..++|+|.+||+|
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 9999999999765433 25566889999999984 3677888999999887
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=233.50 Aligned_cols=177 Identities=28% Similarity=0.361 Sum_probs=144.3
Q ss_pred ccccccCceEEEEEEe----cCCcEEEEEEeccC----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++||+|+||.||+++. .+++.||+|.+++. .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35789999999753 223345678999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.. ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999998854 335788889999999999999999985 99999999999999999999999999986433222
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. .....|+..|.++| .|.|++|+.+|+|+.+
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 156 V--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred c--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 1 11233444444443 5778899999998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=227.05 Aligned_cols=183 Identities=25% Similarity=0.398 Sum_probs=145.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999865 68899999997543 22345778999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++ +|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 888887543 234789999999999999999999985 99999999999999999999999999987543221
Q ss_pred cccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++.+|. ....|.|++|+.+|++..+
T Consensus 159 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 159 TYS--NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred ccc--CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 111 112222322 2335667777777777654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=238.46 Aligned_cols=189 Identities=28% Similarity=0.351 Sum_probs=148.7
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 460 (583)
..++|.+.++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999842 234799999975433 33567999999999996 999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCC---------------------------------------------------------
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (583)
..++||||+++|+|.+++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998865311
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 484 ------------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 484 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
...+++..+..++.||++||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788899999999999999999985 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
+++.+||+|||+++...............++..| .....|.|++|+.+|+++.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999876443222111111111111 2234678888999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=238.55 Aligned_cols=188 Identities=20% Similarity=0.222 Sum_probs=152.7
Q ss_pred HHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 386 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.....++|...+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3345578999999999999999999875 5789999998643 22334567899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998853 23788888999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCcch--------------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ--------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~ 581 (583)
......... .....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 191 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G 243 (371)
T cd05622 191 KMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243 (371)
T ss_pred EcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhC
Confidence 775432211 12234555544443 4667788888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=230.98 Aligned_cols=183 Identities=23% Similarity=0.263 Sum_probs=150.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|+..++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888999999999999999865 58889999987543 3345679999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999998542 35889999999999999999999864 49999999999999999999999999998664322
Q ss_pred CcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
. ....++..|.+ ...|.|++|+.+|+++.+
T Consensus 159 ~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred c----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 1 11223333333 345778888888888654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=236.07 Aligned_cols=179 Identities=25% Similarity=0.348 Sum_probs=144.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999865 689999999975433 3356789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.... ...+.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3567788899999999999999985 99999999999999999999999999987653321
Q ss_pred cccceeeeeccCCCc---------------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....|+..|.+ ...|+|++|+.+|+++.+
T Consensus 224 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g 269 (353)
T PLN00034 224 PC--NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269 (353)
T ss_pred cc--cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhC
Confidence 11 11233333322 246788888888888654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=227.24 Aligned_cols=184 Identities=21% Similarity=0.357 Sum_probs=148.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...+.||+|+||.||+++.+ +++.+|+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 57899999987542 2335678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2345899999999999999999999885 9999999999999999999999999998764332
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... .....++.++.++| .|.|++|+.+|++..+
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 155 NAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred ccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 211 11233444444443 5677788888888654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=238.62 Aligned_cols=188 Identities=29% Similarity=0.414 Sum_probs=147.7
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+++. .++..||+|+++... ....+.+.+|+++++.+ +|+||+++++++..++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 44788899999999999999873 234579999997543 33356788999999999 89999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC----------------------------------------------------------
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (583)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 484 ---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 484 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
...+++...++++.||++||.|||+.+ |+||||||+|||+++++++||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788999999999999999999985 99999999999999999999999999987644322111111
Q ss_pred eeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 555 IAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 555 ~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
..++..|++ ...|.|++|+.+|+++.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 309 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 111222222 33577888999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=237.91 Aligned_cols=185 Identities=21% Similarity=0.250 Sum_probs=150.5
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
..++|...++||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467888999999999999999865 5889999999643 22334567899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998854 23788888899999999999999985 9999999999999999999999999998765
Q ss_pred CCCCcccceeeeeccCCCcch--------------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ--------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~ 581 (583)
...... .....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 194 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG 243 (370)
T cd05596 194 ANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243 (370)
T ss_pred CCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence 432211 11233444444433 4677788898888765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=239.84 Aligned_cols=186 Identities=27% Similarity=0.455 Sum_probs=156.1
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+.....+||-|.||.||.|.++. ...||||.|+... -..++|+.|+.+|+.++|||+|+|+|+|..+...|||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3445667899999999999999875 5689999998653 3478999999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|..|+|.+||++..+. .++.-..+.++.||.+||.||..+. +|||||.++|+|+.++..+||+||||+|++.++..
T Consensus 345 M~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999886643 4777888999999999999999884 99999999999999999999999999999987654
Q ss_pred cccceeee---------eccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIA---------VDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
......-. .-+..++.+.++|.+|+.+|++..
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHh
Confidence 32111111 112356677888889999999854
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.52 Aligned_cols=185 Identities=20% Similarity=0.224 Sum_probs=150.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 5788999998753 2223456888999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999653 235889999999999999999999985 999999999999999999999999999877543
Q ss_pred CCcccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
.... .....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g 204 (331)
T cd05624 156 GTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204 (331)
T ss_pred Ccee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC
Confidence 3221 12234555554444 3667778888877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=244.24 Aligned_cols=184 Identities=26% Similarity=0.374 Sum_probs=149.9
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------CeEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~ 463 (583)
.|...+.||+|+||.||+|+. ..|+.||||..++.. ....+..-+|++++++++|+|||+++++-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345568899999999999995 479999999998653 34467889999999999999999999986543 3679
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCC--ceEEEecCC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--DDDM--NPKISDFGL 539 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~kl~DFGl 539 (583)
+|||||.+|||+..|.+......|++...+.++.++..||.|||+++ |+||||||.||++ ..+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888888999999999999999999999885 9999999999998 2333 579999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~ 581 (583)
||.+..+. .-..++||..|..|+. ..|..-+|+|++|+.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvt 213 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVT 213 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhH
Confidence 99987766 2334677766655552 234455555555543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.18 Aligned_cols=184 Identities=28% Similarity=0.451 Sum_probs=146.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999854 333 48999987543 34467899999999999999999999999865 5679
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
++||+++|+|.+++.+.. ..+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986532 34889999999999999999999985 9999999999999999999999999999875
Q ss_pred CCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
.............+..|++ ...|.|++|+.+|+++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t 206 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 4433211111111122222 33578889999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=226.96 Aligned_cols=184 Identities=26% Similarity=0.394 Sum_probs=146.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999975 688999999975432 223567899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 6777777542 345889999999999999999999985 9999999999999999999999999998654322
Q ss_pred CcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
... ....++..|.++| .|.|++|+.+|+|+.+
T Consensus 158 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 200 (303)
T cd07869 158 HTY--SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200 (303)
T ss_pred ccC--CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 111 1122333333333 4667777777777654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=237.18 Aligned_cols=185 Identities=23% Similarity=0.335 Sum_probs=152.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999965 68999999997542 234567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998653 45899999999999999999999975 999999999999999999999999999876543
Q ss_pred CC---------------------------cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QN---------------------------QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~---------------------------~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ........|+..|.++| .|.|++|+++|+|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 30 01112234555555544 4677788888887654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=230.30 Aligned_cols=177 Identities=27% Similarity=0.420 Sum_probs=136.8
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-----eEEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIY 466 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 466 (583)
|...+++|.|+||.||+|.+. +++.||||+.-..... --+|+++|++++|||||+++-++.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 556789999999999999965 4689999998655332 146899999999999999999987542 246899
Q ss_pred EcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~~ 544 (583)
|||+. +|...++.. ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |..||+|||-|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99976 677776542 22345777888889999999999999975 9999999999999977 999999999999997
Q ss_pred CCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~ 580 (583)
.++... ...-+.+|.+|| +|.|+.|+++-||+.
T Consensus 178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred cCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc
Confidence 665432 233444555555 345556666666654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=230.05 Aligned_cols=185 Identities=22% Similarity=0.272 Sum_probs=149.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|+..++||+|+||.||++... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467889999999999999999876 57889999887542 3335678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.. ...+++.....++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999854 335889999999999999999999753 49999999999999999999999999998653321
Q ss_pred --------CcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 --------NQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.+..++...+. ......|.|++|+.+|+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g 198 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIG 198 (333)
T ss_pred cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHC
Confidence 11222222111 123345777788888888654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=229.62 Aligned_cols=182 Identities=23% Similarity=0.279 Sum_probs=146.8
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCC-CceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 466 (583)
+|...+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999865 5789999999754 233456788899999999765 6888999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988854 335889999999999999999999985 999999999999999999999999999754221
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ......|+..|.++| .|.|++|+++|+|+.+
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhC
Confidence 11 112234555544444 4778888898888765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=229.75 Aligned_cols=177 Identities=25% Similarity=0.348 Sum_probs=142.2
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57889999997542 23345566677777654 899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 999988854 235899999999999999999999985 99999999999999999999999999986543221 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G 192 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC
Confidence 22334555555544 4677788888888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=232.28 Aligned_cols=183 Identities=25% Similarity=0.322 Sum_probs=146.8
Q ss_pred CCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
+|...++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999987532 22345688999999999 599999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998854 335899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+....... +....|+..|+++| .|.|++|+++|+|+.+
T Consensus 155 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 155 FLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred ccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 64332221 11234444444433 4666677777777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=225.95 Aligned_cols=179 Identities=16% Similarity=0.265 Sum_probs=144.6
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchh---HHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEEEEEEcC
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYM 469 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 469 (583)
..|++|++|.||+|.. +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999997653322 4678899999999999999999999977 34689999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN- 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 548 (583)
++|+|.+++.+ ...++|...+.++.|++.||.|||+.. .++||||||+|||+++++.+||+|||+++.......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK 179 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccccc
Confidence 99999999954 345899999999999999999999752 378999999999999999999999999987543221
Q ss_pred ------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+.........|.|++|+.+|++..+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g 218 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence 122222222122344567888899999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.18 Aligned_cols=185 Identities=20% Similarity=0.226 Sum_probs=150.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.+ +++.+|+|.+.+. .....+.+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999975 4778999998643 2223456889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 235899999999999999999999985 999999999999999999999999999876433
Q ss_pred CCcccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
... ......|+..|+++| .|.|++|+.+|+|+.+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g 204 (332)
T cd05623 156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204 (332)
T ss_pred Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC
Confidence 221 112234555544443 4677788888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=236.81 Aligned_cols=148 Identities=26% Similarity=0.399 Sum_probs=131.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999865 58899999997532 233567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||+++|+|.+++.+ ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999854 345899999999999999999999985 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=233.93 Aligned_cols=169 Identities=22% Similarity=0.291 Sum_probs=141.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999865 68899999997542 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998653 235899999999999999999999985 999999999999999999999999999987544
Q ss_pred CCcccceeeeeccCCCcch
Q 007969 547 QNQANTNIIAVDTWPQSMQ 565 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~ 565 (583)
... ......++..|.++|
T Consensus 156 ~~~-~~~~~~gt~~y~aPE 173 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPE 173 (330)
T ss_pred Cce-eeecccCCccccCHH
Confidence 332 122234555555555
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=232.15 Aligned_cols=177 Identities=24% Similarity=0.273 Sum_probs=140.5
Q ss_pred ccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.||+|+||.||+++. .+++.||+|.+++. .......+.+|++++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999999754 2233567788999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|..++.. ...+++..+..++.||+.||.|||+.. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 99988843 335899999999999999999999731 4999999999999999999999999999864332221 1
Q ss_pred eeeeeccCCCcchh----------HHHHHHHHHHHhhh
Q 007969 553 NIIAVDTWPQSMQW----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 553 ~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~ 580 (583)
....|+..|+++|. |.|++|+++|+|+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 191 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 191 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeecc
Confidence 22345666665553 44445555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=222.02 Aligned_cols=182 Identities=35% Similarity=0.551 Sum_probs=144.5
Q ss_pred ccccccccCceEEEEEEec-----CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 395 DENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999976 25689999996543 34478999999999999999999999999988889999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2345899999999999999999999984 99999999999999999999999999998743222
Q ss_pred cccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
............+ ...+.|+|++|+.+|++..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccc
Confidence 2111111122222 2345688889999998875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=230.81 Aligned_cols=183 Identities=22% Similarity=0.388 Sum_probs=143.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----CeEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~ 463 (583)
+|...++||+|+||.||+|+.. +++.||+|++... ......++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999854 6899999998743 223356789999999999999999999998643 2579
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888743 335899999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCCc-ccceeeeeccCCCcch------------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQ-ANTNIIAVDTWPQSMQ------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~-~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~ 581 (583)
...... .......++.+|.++| .|.|++|+++|+++.+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg 204 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcC
Confidence 332211 1111233444444444 4667777777777643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=230.27 Aligned_cols=177 Identities=22% Similarity=0.317 Sum_probs=144.1
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+++.. +++.||+|.+++. .....+.+..|..++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999865 6889999999754 223356688999999998 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 999988843 345899999999999999999999985 99999999999999999999999999975322111 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++| .|.|++|+.+|+++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 192 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC
Confidence 12234455444443 4677788888888754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=222.60 Aligned_cols=184 Identities=26% Similarity=0.358 Sum_probs=146.3
Q ss_pred cCCCCccccccccCceEEEEEEec----CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...+.||+|+||.||+|.++ .+..||+|.++.... .....|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999753 356899999986532 335678999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++... ...++|..++.++.||+.||+|||+.+ ++||||||+||+++.++.+|++|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998643 235899999999999999999999985 9999999999999999999999999877543
Q ss_pred CCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhh
Q 007969 545 GNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~ 579 (583)
...... .....++..+. ....|.|++|+.+|+++
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 159 SEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred ccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 221111 00011111122 23467788888888854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=234.44 Aligned_cols=178 Identities=20% Similarity=0.212 Sum_probs=144.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||++... +++.||+|.... +.+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999854 688999997542 4578999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 688887743 235899999999999999999999985 99999999999999999999999999976432211
Q ss_pred cccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
. ......|+..|.++ ..|.|++|+++|+++.+
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 279 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279 (391)
T ss_pred c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 1 11123344444443 35777788888888754
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=229.79 Aligned_cols=180 Identities=26% Similarity=0.352 Sum_probs=143.5
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHH---hhCCCCCceeEEEEEEeCCeEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
|...++||+|+||.||+++.. +++.||||++++.. ....+.+.+|++++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999865 68999999997542 22345566666554 567899999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888743 35899999999999999999999985 99999999999999999999999999876433
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... .....|+..|+++| .|.|++|+.+|+++.+
T Consensus 154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G 197 (324)
T cd05589 154 FGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197 (324)
T ss_pred CCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhC
Confidence 2221 11234454444444 4777788888888654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=230.02 Aligned_cols=177 Identities=23% Similarity=0.326 Sum_probs=143.2
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+++.. +++.+|+|.+++. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5789999999754 233456678899988877 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 999888743 345899999999999999999999985 999999999999999999999999999864322111
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC
Confidence 11234444444433 5677788888888764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=222.91 Aligned_cols=187 Identities=28% Similarity=0.425 Sum_probs=148.3
Q ss_pred CCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+.|+..++||+|+||.||+|.. .++..|++|.+.... ....+++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999984 246789999997543 3445788999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 465 IYEYMPNKSLDVHLFDATR--------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
||||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 234789999999999999999999985 99999999999999999
Q ss_pred ceEEEecCCceecCCCCCcccceeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 531 NPKISDFGLARIFGGNQNQANTNIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 531 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
.+||+|||+++...............++.. ......|.|++|+.+|++..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 999999999987643322111111111111 22345678889999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=228.87 Aligned_cols=177 Identities=25% Similarity=0.334 Sum_probs=142.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+|+.. +++.||+|++++.. ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999997542 23345678899988876 799999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-- 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence 999988854 335889999999999999999999985 999999999999999999999999999864322211
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg 192 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC
Confidence 11233444444443 4777788888888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=222.34 Aligned_cols=178 Identities=28% Similarity=0.370 Sum_probs=144.2
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||+||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 688999999975422 2345678899999999999999999999999999999999999999
Q ss_pred hHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccce
Q 007969 475 DVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553 (583)
Q Consensus 475 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 553 (583)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98875432 3346899999999999999999999985 999999999999999999999999999876543321 11
Q ss_pred eeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 554 IIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 554 ~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...|+..+.++| .|.|++|+.+|+++.+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 223444444433 5677788888888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-25 Score=247.43 Aligned_cols=188 Identities=22% Similarity=0.297 Sum_probs=153.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.. +++.||+|++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999865 58999999997542 223567999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 467 EYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
||+++++|.+++..... ...+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 223567888999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCC----------------cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQN----------------QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~----------------~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+++....... ...+....|+..|++|| .|.|++|+++|+|+.+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence 9997732111 01122345777776666 3788888888888765
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=228.18 Aligned_cols=177 Identities=25% Similarity=0.365 Sum_probs=143.8
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+++.+ +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5889999999753 223356678888888877 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 9999888543 35899999999999999999999985 99999999999999999999999999986432221 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC
Confidence 12234555555444 4777788888888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=236.11 Aligned_cols=183 Identities=23% Similarity=0.388 Sum_probs=155.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe-EEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-LLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 466 (583)
++|...+++|+|+||.++..+.+ ++..+++|.+... +....+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999998865 5778999988644 34445678999999999999999999999999888 99999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
+|++||++.+.+.+.+ ...++++.++.++.|++.|+.|||+. +|+|||||+.||+++.+..|||.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999987644 56799999999999999999999977 4999999999999999999999999999999877
Q ss_pred CCcccceeeeeccCCCcchh----------HHHHHHHHHHHhh
Q 007969 547 QNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVL 579 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~ 579 (583)
... ...++||+.|+.+|. +.|.+|+.+|++.
T Consensus 160 ~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 160 DSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred hhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 643 334788888877774 4455555555553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=204.26 Aligned_cols=183 Identities=27% Similarity=0.424 Sum_probs=152.0
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...++||+|.+|+|+||+.. +++.||+|+++..+. .-.....+||-+++.++|+|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555689999999999999965 578899999875432 2245679999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|. .+|..+... -++.++.+....+..|+++||.|+|++. +.||||||.|.||+.+|+.|++|||++|-++-.-.
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 467777643 3456899999999999999999999985 99999999999999999999999999998865432
Q ss_pred cccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 549 QANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
--+ ..+.+.||.+++. .-|....|+|+.|++|
T Consensus 157 cys--aevvtlwyrppdvlfgakly~tsidmwsagcif 192 (292)
T KOG0662|consen 157 CYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192 (292)
T ss_pred eee--ceeeeeeccCcceeeeeehhccchHhhhcchHH
Confidence 222 2356789988884 4677888888888876
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=228.23 Aligned_cols=182 Identities=23% Similarity=0.274 Sum_probs=146.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (583)
+|...+.||+|+||.||+++.. +++.||+|.+++.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999865 57899999997542 22344567788888777 5899999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988854 235889999999999999999999985 999999999999999999999999999864322
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ......|+..|+++| .|.|++|+.+|+|+.+
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 11 111233444444444 4777889999988765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=241.57 Aligned_cols=191 Identities=18% Similarity=0.274 Sum_probs=153.4
Q ss_pred HHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 460 (583)
...++|...++||+|+||.||+++. .+++.||||++... +......+.+|+..+..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 47899999998754 3344567889999999999999999988775432
Q ss_pred ----eEEEEEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 461 ----ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 461 ----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999986533 2346899999999999999999999985 9999999999999999999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
|||+++.+.............|+..|+++| .|.|++|+++|+|+.+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999875443322233345555555544 5677788888887654
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-25 Score=220.20 Aligned_cols=181 Identities=27% Similarity=0.353 Sum_probs=139.7
Q ss_pred ccccccCceEEEEEEecC---CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
++||+|+||.||+|...+ ...+++|.+..... .....+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 34688888765432 33467889999999999999999999999999999999999999
Q ss_pred ChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 473 SLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 473 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233578888999999999999999985 9999999999999999999999999997643322111
Q ss_pred cceeeeeccCCC-----------------cchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQ-----------------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~l~~ 580 (583)
......++..+. ....|.|++|+.+|+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 111111111122 234667788888888764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=222.09 Aligned_cols=189 Identities=26% Similarity=0.393 Sum_probs=148.5
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.+++|+..++||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999753 24679999986543 2345678999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
.++||||+++++|.+++.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234688899999999999999999975 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
+|||+++...............++..|++ ...|.|++|+.+|++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence 99999986643322211111112222333 33577788888888764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=221.31 Aligned_cols=187 Identities=29% Similarity=0.469 Sum_probs=149.5
Q ss_pred CCCCccccccccCceEEEEEEecC------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...+.||+|+||.||+|.... ...|++|.+.... ....++|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998543 2579999987543 334567899999999999999999999999989999
Q ss_pred EEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 464 LIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
++|||+++++|.+++..... ...+++...+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145889999999999999999999985 99999999999999999
Q ss_pred ceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 531 NPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 531 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
.+||+|||+++...............++..+.+ ...|.|++|+.+|+++.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence 999999999987643332211212222233333 34688889999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=228.83 Aligned_cols=183 Identities=23% Similarity=0.374 Sum_probs=154.2
Q ss_pred HcCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCch---hHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 463 (583)
....|+..+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45668888999999999999999764 999999999876443 3468999999999998 999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC----CceEEEecCC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGL 539 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGl 539 (583)
+|||++.||.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998654 3899999999999999999999985 9999999999999543 5799999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++...... ....++|++.|..++ .+.|++|++.|.|++|
T Consensus 186 a~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G 234 (382)
T KOG0032|consen 186 AKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSG 234 (382)
T ss_pred ceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhC
Confidence 99987722 234467777766655 3556677777776665
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=222.50 Aligned_cols=183 Identities=27% Similarity=0.325 Sum_probs=147.9
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999864 688999999975422 223457889999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998885432 345899999999999999999999985 9999999999999999999999999998764332
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... ...|+..++++| .|.|++|+.+|+++.+
T Consensus 157 ~~~---~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 157 TIR---GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred ccc---cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 211 112333333332 4677788888888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=221.23 Aligned_cols=187 Identities=26% Similarity=0.449 Sum_probs=149.8
Q ss_pred CCCCccccccccCceEEEEEEecC------CcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...+.||+|+||.||+|...+ ++.|++|.++..... ..+.+.+|++++++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999999866444 4578999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 464 LIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345889999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
||+|||+++...............++..| .....|.|++|+.+|+++.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence 99999999865433221111111112222 2334677888888888874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=218.15 Aligned_cols=184 Identities=26% Similarity=0.404 Sum_probs=151.2
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...+.||+|++|.||+|...+++.|++|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999987543 33567999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986533 345899999999999999999999985 999999999999999999999999999987532211
Q ss_pred -----------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 -----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+ .......|.|++|+.+|++..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred ccCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHh
Confidence 11111111 112334678888999988864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=224.84 Aligned_cols=177 Identities=25% Similarity=0.340 Sum_probs=141.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999997542 23345567788888764 899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 999998854 235889999999999999999999985 99999999999999999999999999986432211 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|++..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence 12234555544444 4677788888887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=228.15 Aligned_cols=177 Identities=27% Similarity=0.335 Sum_probs=140.0
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHH-HHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||+||+++.. +|+.||+|++.+.. ....+++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 68999999997542 222345555554 56789999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 999988854 345889999999999999999999985 99999999999999999999999999986432221 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 192 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC
Confidence 11233444444433 5677788888888754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-25 Score=235.48 Aligned_cols=179 Identities=21% Similarity=0.223 Sum_probs=148.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
...|.+.++||+|+||.||++... .++.|+||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999975 478899996432 3467899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+. ++|..++... ...++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888887542 235899999999999999999999985 99999999999999999999999999998755433
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
........|+..|++++ .|.|++|+++|++..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~ 357 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV 357 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH
Confidence 22223345666665555 478888999998764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=220.98 Aligned_cols=183 Identities=25% Similarity=0.449 Sum_probs=142.3
Q ss_pred CCCCccccccccCceEEEEEEec--CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhC---CCCCceeEEEEEEe-----
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE----- 458 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 458 (583)
++|...++||+|+||.||+++.. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 468899999875422 2234566777776665 69999999999863
Q ss_pred CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
....++|+||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 68988886433 335899999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+++....... .....++.+|.++| .|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 205 (290)
T cd07862 156 LARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 205 (290)
T ss_pred ceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcC
Confidence 9987654321 12234455544444 4778888888888643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=227.03 Aligned_cols=182 Identities=23% Similarity=0.284 Sum_probs=145.5
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 466 (583)
+|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 68899999997542 233456788999988885 577888999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998854 345899999999999999999999985 999999999999999999999999999864322
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... .....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 155 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 155 GVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred Ccc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 211 11233444444433 5777788888888764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=230.16 Aligned_cols=175 Identities=26% Similarity=0.328 Sum_probs=140.3
Q ss_pred ccccccCceEEEEEEe----cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++||+|+||.||+++. .+|+.+|+|++.+.. ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 9999998844 345899999999999999999999985 999999999999999999999999999876443221
Q ss_pred cceeeeeccCCCcch----------hHHHHHHHHHHHhh
Q 007969 551 NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVL 579 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~ 579 (583)
.....|+..|.++| .|.|++|+.+|+|+
T Consensus 155 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 192 (318)
T cd05582 155 -AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192 (318)
T ss_pred -eecccCChhhcCHHHHcCCCCCCccceeccceEeeeec
Confidence 12234555555544 34444555555554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=221.29 Aligned_cols=188 Identities=27% Similarity=0.478 Sum_probs=150.1
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.++|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356788899999999999999742 34568999998766666778999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceE
Q 007969 464 LIYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 533 (583)
+|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2235899999999999999999999985 99999999999999999999
Q ss_pred EEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
|+|||+++...............++..| .....|.|++|+.+|+|+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999866433221111111111122 2334677778888888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=233.31 Aligned_cols=186 Identities=26% Similarity=0.410 Sum_probs=156.7
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
....|...++||+|.|++|..++.. ++.+||||.+++. +...++.+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467888999999999999999854 6899999999876 334456799999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||..+|.+.+++.+.. .+.+.....++.|+.++++|||.+. |+|||||++||||+.++++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999996543 3556888889999999999999996 99999999999999999999999999998863
Q ss_pred C---------CCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 546 N---------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. ..+..++...|- .|..++.+.|.+++++|.+.++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~G 251 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEG 251 (596)
T ss_pred cccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeec
Confidence 3 223333333332 2677788888899999988765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=218.19 Aligned_cols=185 Identities=29% Similarity=0.450 Sum_probs=148.2
Q ss_pred CCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...+.||+|+||.||+|.+.. ...|++|.++... ....++|.+|+.++++++||||+++++.+..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998742 3579999987543 33456899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999985532 36899999999999999999999975 99999999999999999999999999998753
Q ss_pred CCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 546 NQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
......+....++..|. ....|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence 22211111111111222 223567778888888653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=228.76 Aligned_cols=177 Identities=26% Similarity=0.334 Sum_probs=139.7
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHH-HHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+++.. +|+.+|+|++.+. .....+++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 6899999999754 2233345566655 46779999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-- 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--
Confidence 999888843 345899999999999999999999985 999999999999999999999999999864322211
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC
Confidence 12234444444444 4667778888777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=230.65 Aligned_cols=182 Identities=24% Similarity=0.400 Sum_probs=144.5
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-----eEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 463 (583)
+|+..++||+|+||.||++.. .+++.||+|++... .....+++.+|+++++.++|+||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998754 2234567899999999999999999999998776 789
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|+||+. ++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 577777633 345899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
........+. ..++.+|.+ ...|.|++|+++|+|+.+
T Consensus 154 ~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 154 EPDESKHMTQ-EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred ccCccccCCC-CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence 5433222111 123333333 334677778888777643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=217.18 Aligned_cols=182 Identities=27% Similarity=0.423 Sum_probs=148.5
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...+.||+|+||.||++.++++..+++|.+.... ...+++.+|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888899999886443 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc-
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ- 549 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 549 (583)
+|+|.++++... ..++|..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999886432 35899999999999999999999885 999999999999999999999999999865432221
Q ss_pred ----------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+. ......+.|++|+.+|++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~ 196 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFT 196 (256)
T ss_pred cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHc
Confidence 111111111 12334678888999988864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=216.02 Aligned_cols=177 Identities=27% Similarity=0.427 Sum_probs=142.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
++||+|+||.||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++..++..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 68899999886543 33456799999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC------
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------ 548 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~------ 548 (583)
.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 235899999999999999999999885 99999999999999999999999999986542211
Q ss_pred ------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 ------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+..|+...+ .......|.|++|+.+|+++.
T Consensus 156 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 156 KQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred CCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHh
Confidence 111111111 112234588889999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=227.30 Aligned_cols=177 Identities=27% Similarity=0.325 Sum_probs=139.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHH-HHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+++.. +++.||+|++.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999997542 222345555654 57889999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
++|...+.. ...+++.....++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 999888743 345788889999999999999999885 99999999999999999999999999986422221 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC
Confidence 22234444444443 5677788888888754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=218.00 Aligned_cols=185 Identities=29% Similarity=0.447 Sum_probs=151.0
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678889999999999999998888899999987543 23578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986532 345889999999999999999999875 999999999999999999999999999877543221
Q ss_pred ccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
... ...++..+. ....|.|++|+.+|+++.
T Consensus 160 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t 199 (261)
T cd05072 160 ARE-GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199 (261)
T ss_pred ccC-CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence 111 111122222 234678888999988864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=221.80 Aligned_cols=187 Identities=25% Similarity=0.440 Sum_probs=150.4
Q ss_pred CCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.+|...+.||+|+||.||+++.. ++..+++|.++.......+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34677889999999999999742 345789999887666666789999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 007969 465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 531 (583)
||||+++++|.+++.... ....++|..++.++.||+.||.|||+.+ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1235899999999999999999999985 999999999999999999
Q ss_pred eEEEecCCceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 532 PKISDFGLARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
+||+|||+++...............++..|. ....|.|++|+++|+|+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998664432211111112222222 234778888998888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=216.82 Aligned_cols=184 Identities=23% Similarity=0.359 Sum_probs=150.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|+. .+++.|++|++........+.+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45688899999999999999986 46889999999766555566788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998854 235899999999999999999999885 99999999999999999999999999987643221
Q ss_pred cccceeeeeccCC-------------CcchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWP-------------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..+ .....+.|++|+.+|++..+
T Consensus 162 ~~~--~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 162 KRK--SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ccC--ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 110 11122222 22345777788888888653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=224.62 Aligned_cols=177 Identities=28% Similarity=0.353 Sum_probs=143.5
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+++.. +++.||+|++++.. ....+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997542 23456678899999888 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.+ ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 999988854 235899999999999999999999985 999999999999999999999999999764222211
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+....|+..|+++| .|.|++|+++|+|+.+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G 192 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence 12233444444444 4777788888888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=225.19 Aligned_cols=177 Identities=25% Similarity=0.339 Sum_probs=141.9
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+++.+ +|+.||+|.+++.. ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 58899999997542 23345667788887764 899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.+ ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 999988854 345889999999999999999999985 99999999999999999999999999985422111 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++| .|.|++|+.+|+|..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 192 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC
Confidence 12234455444444 4677788888888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=226.25 Aligned_cols=177 Identities=24% Similarity=0.330 Sum_probs=143.4
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+++.. +++.+|+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999998542 23456688999999888 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-- 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--
Confidence 999988843 235899999999999999999999985 999999999999999999999999999864322111
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g 192 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC
Confidence 11233444444433 4677788888888754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=222.14 Aligned_cols=188 Identities=24% Similarity=0.377 Sum_probs=147.5
Q ss_pred cCCCCccccccccCceEEEEEEecC---------------CcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD---------------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLL 453 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~ 453 (583)
.++|...++||+|+||.||+++..+ ...|++|.++.. .....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3568888999999999999987532 225899998754 333456799999999999999999999
Q ss_pred EEEEeCCeEEEEEEcCCCCChhHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 007969 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (583)
Q Consensus 454 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 524 (583)
+++...+..++||||+++++|.+++.+... ...+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999864321 124789999999999999999999985 99999999999
Q ss_pred EEcCCCceEEEecCCceecCCCCCcccceeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 525 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 525 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
++++++.+||+|||+++...............++.. ......|.|++|+.+|++..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 999999999999999987643322111111111111 22345778888999888854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=219.89 Aligned_cols=183 Identities=27% Similarity=0.510 Sum_probs=148.1
Q ss_pred CCCCccccccccCceEEEEEEec-----CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (583)
++|...+.||+|+||.||++..+ +++.|++|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999742 5789999999877666678899999999999999999999987543 4689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|+||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235899999999999999999999985 999999999999999999999999999976
Q ss_pred CCCCCc-------------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 544 GGNQNQ-------------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
...... ..|+...+ .......|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~ 206 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFT 206 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhh
Confidence 543221 11111111 122334677788888888865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=216.82 Aligned_cols=183 Identities=28% Similarity=0.407 Sum_probs=148.3
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++++++||||+++++++..+...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3467778999999999999998777789999987543 234679999999999999999999999998889999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999986532 25899999999999999999999985 9999999999999999999999999998764432211
Q ss_pred cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.. ...++..+ .....+.|++|+.+|++..
T Consensus 158 ~~-~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~ 196 (256)
T cd05113 158 SV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196 (256)
T ss_pred cC-CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence 10 01111212 2334678888888888764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=219.25 Aligned_cols=184 Identities=29% Similarity=0.423 Sum_probs=144.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...+.||+|+||.||+|.+. +++ .+++|.+..... ...+++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777889999999999999864 344 477888764432 334678889999999999999999998754 45788
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
++||+++|+|.+++... ...++|.....++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999643 235899999999999999999999985 9999999999999999999999999999775
Q ss_pred CCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
............++..++++ ..|.|++|+.+|+++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t 206 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 43322222222233333333 3588889999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=217.09 Aligned_cols=181 Identities=28% Similarity=0.374 Sum_probs=141.7
Q ss_pred ccccccCceEEEEEEecC---CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.||+|+||.||+|...+ +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799999875532 33457899999999999999999999999988999999999999
Q ss_pred ChhHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 473 SLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 473 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986533 2234678888899999999999999985 9999999999999999999999999997654332211
Q ss_pred cceeeeeccCCC-----------------cchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQ-----------------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~l~~ 580 (583)
......++..+. ....|.|++|+.+|+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 111112222222 234577888888888763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=219.81 Aligned_cols=186 Identities=29% Similarity=0.421 Sum_probs=147.0
Q ss_pred CCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+|...+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23578999887553 3345689999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 007969 465 IYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 523 (583)
++||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1235889999999999999999999885 9999999999
Q ss_pred EEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
||+++++.+||+|||+++...............++..+.+ ...|.|++|+.+|+|..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 9999999999999999987643332211111122222333 23578888888888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=232.52 Aligned_cols=169 Identities=29% Similarity=0.424 Sum_probs=144.2
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChh
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 475 (583)
.+-||.|+.|.||+|++. ++.||||+++... ..+|.-|++|+|+||+.|.|+|....-++||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 567999999999999995 7889999886442 46788899999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceee
Q 007969 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555 (583)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 555 (583)
..|+. ...++......+..+||.||.|||.+ +|||||||+-||||..+-.|||+|||-++.+..-.+.. ..
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM---SF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM---SF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh---hh
Confidence 99954 44588888999999999999999998 59999999999999999999999999999886654332 23
Q ss_pred eeccC----------CCcchhHHHHHHHHHHHhhhh
Q 007969 556 AVDTW----------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 556 ~~~~~----------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+||.. +-+.+.+.|.+|+++|+|+.+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~ 307 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG 307 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc
Confidence 45433 344557888999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=220.28 Aligned_cols=189 Identities=24% Similarity=0.358 Sum_probs=147.1
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
..++|.+.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999999743 24579999887543 2334578899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
.++||||+++|+|.+++.+... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234577888999999999999999885 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
+|||+++...............++..+ .....+.|++|+.+|++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence 999999865432221111111111112 2334577888888888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=218.49 Aligned_cols=187 Identities=28% Similarity=0.446 Sum_probs=150.5
Q ss_pred CCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++...++||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999632 356899999887766667889999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
++||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134889999999999999999999885 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
||+|||+++.......+.......++..| ...+.|.|++|+.+|+++.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 219 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 99999999866433221111111111222 2334688888999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=225.76 Aligned_cols=177 Identities=25% Similarity=0.293 Sum_probs=139.6
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHH-HHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEV-NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+++.. +++.+|+|++.+.. .....++..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57889999997542 12223444444 456788999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
++|.+++.. ...+.+.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 999998854 334788888899999999999999985 99999999999999999999999999986432221 1
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++| .|.|++|+.+|+|+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC
Confidence 22234555554444 4677788888888754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=218.42 Aligned_cols=185 Identities=30% Similarity=0.458 Sum_probs=153.9
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
..+|...++||+|+||.||+|...+++.+++|.+........+++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999998889999999998776656778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996533 345899999999999999999999985 999999999999999999999999999876432211
Q ss_pred ----------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+ .......+.|++|+.+|++..
T Consensus 161 ~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHc
Confidence 11111111 122334678888999988864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=216.20 Aligned_cols=185 Identities=25% Similarity=0.427 Sum_probs=144.8
Q ss_pred CCccccccccCceEEEEEEecC----CcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe-----
Q 007969 393 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (583)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998754 23345689999999999999999999999876554
Q ss_pred -EEEEEEcCCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 462 -LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 462 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
.++++||+++++|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2345899999999999999999999985 999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeecc----------CCCcchhHHHHHHHHHHHhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDT----------WPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~l~~ 580 (583)
|+++................+. .......|.|++|+.+|+++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence 9999765433221111111111 122334677889999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.76 Aligned_cols=188 Identities=26% Similarity=0.379 Sum_probs=148.0
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC-C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (583)
.++|.+.++||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888999999999999999632 34789999987543 23356788999999999 899999999988754 5
Q ss_pred eEEEEEEcCCCCChhHHHhccCC---------------------------------------------------------
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (583)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999998854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCC
Q 007969 484 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQ 562 (583)
Q Consensus 484 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 562 (583)
...++|..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125899999999999999999999885 9999999999999999999999999999864433222222223333344
Q ss_pred cch----------hHHHHHHHHHHHhhh
Q 007969 563 SMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 563 ~~~----------~~~~~~~~~l~~l~~ 580 (583)
++| .|.|++|+++|++..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t 270 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFS 270 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHH
Confidence 444 578889999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=229.86 Aligned_cols=188 Identities=27% Similarity=0.375 Sum_probs=147.0
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++..++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777899999999999999853 346899999986533 23457899999999997 9999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC----------------------------------------------------------
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------- 483 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 483 (583)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999865321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 484 -------------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 484 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
...+++...+.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 123678888999999999999999875 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
++++.+||+|||+++.+.............++..| .....+.|++|+.+|+++.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 99999999999999876432221111111112222 2334678888999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=220.60 Aligned_cols=183 Identities=26% Similarity=0.418 Sum_probs=145.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 578899999975432 2335678999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++ +|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 7877775432 34789999999999999999999985 99999999999999999999999999986543222
Q ss_pred cccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ..++.++. ....|.|++|+.+|+|+.+
T Consensus 160 ~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg 201 (309)
T cd07872 160 TYSN--EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201 (309)
T ss_pred cccc--ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1111 12222222 2345677788888887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=219.31 Aligned_cols=188 Identities=26% Similarity=0.394 Sum_probs=149.7
Q ss_pred cCCCCccccccccCceEEEEEEecC-----------------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCcee
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 451 (583)
.++|...++||+|+||.||++...+ +..|++|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987542 2468999987653 344678999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEcCCCCChhHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 007969 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDAT--------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 452 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 523 (583)
+++++..++..++++||+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1225899999999999999999999885 9999999999
Q ss_pred EEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
|++++++.+||+|||+++...............++..|+ ....|.|++|+.+|++..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 999999999999999998764332221111112222222 334677888888888764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=219.71 Aligned_cols=188 Identities=24% Similarity=0.404 Sum_probs=148.3
Q ss_pred cCCCCccccccccCceEEEEEEec-----------------CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCcee
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-----------------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~ 451 (583)
.++|+..++||+|+||.||++... ++..+|+|++... .....+++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 2346899999754 3344578999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEcCCCCChhHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 007969 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 452 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 523 (583)
+++++..++..++||||+++++|.+++.+... ...+++...+.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134788899999999999999999985 9999999999
Q ss_pred EEEcCCCceEEEecCCceecCCCCCcccceeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
||+++++.+||+|||+++.+.............++.. ......|.|++|+.+|++..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 9999999999999999987643322111111111111 22335678888999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.60 Aligned_cols=149 Identities=26% Similarity=0.336 Sum_probs=133.0
Q ss_pred CCCCccccccccCceEEEEEEecC-CcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||.|.-|+||.+++++ +..+|+|++.+.. .+...+.+.|-++|+.++||.+++|++.+..++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356667899999999999999875 5889999998763 344567788999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
|||+||+|..+++++ ..+.+++..+..++.+|+-||+|||..| ||.|||||+||||-++|++-|+||.|+...
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999888654 4456999999999999999999999987 999999999999999999999999988654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=214.26 Aligned_cols=181 Identities=29% Similarity=0.432 Sum_probs=147.4
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+|...+.||+|+||.||++..+++..+++|.+.+... ..+++.+|++++++++||||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777889999999999999987778899999865432 245788999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc--
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-- 549 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-- 549 (583)
++|.+++.... ..++|...+.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999986432 35899999999999999999999985 999999999999999999999999999876432211
Q ss_pred ---------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 ---------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+. ......|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~ 196 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred CCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhc
Confidence 111111111 12234678888999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=221.32 Aligned_cols=189 Identities=28% Similarity=0.412 Sum_probs=149.5
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
..++|...+.||+|+||.||++... ....+++|.+... ..+...++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999864 2367999998754 334456789999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 22346899999999999999999999885 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
+++.+||+|||+++...............++..|.++ ..|.|++|+++|+++.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhc
Confidence 9999999999999876543221111111111222233 3477888999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=216.53 Aligned_cols=183 Identities=22% Similarity=0.370 Sum_probs=149.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|...++||+|+||.||+++.. +++.|++|.++.........+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 68899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.. ...+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999998854 335899999999999999999999985 999999999999999999999999999876432211
Q ss_pred ccceeeeeccCCCc-------------chhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQS-------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~ 581 (583)
.....++..|.+ ...|.|++|+.+|++..+
T Consensus 163 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 163 --RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred --cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 111223333333 335677788888877543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=225.36 Aligned_cols=188 Identities=26% Similarity=0.373 Sum_probs=145.2
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC-C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (583)
.++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999973 356789999997543 23356788999999999 689999999988754 4
Q ss_pred eEEEEEEcCCCCChhHHHhccCC---------------------------------------------------------
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------------- 483 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 483 (583)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67999999999999999864210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeee
Q 007969 484 -------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556 (583)
Q Consensus 484 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 556 (583)
...+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123688889999999999999999985 9999999999999999999999999998764332211111111
Q ss_pred eccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 557 VDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 557 ~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
++..|. ....+.|++|+.+|+++.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 111122 233577888888888763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=217.06 Aligned_cols=182 Identities=27% Similarity=0.329 Sum_probs=147.5
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
|+..++||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 68899999987542 22235678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886432 335899999999999999999999885 99999999999999999999999999987643221
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....|+..+.+++ .+.|++|+.+|+++.+
T Consensus 158 ~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 158 I---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred c---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 1 1123444444443 3777788888888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=229.70 Aligned_cols=179 Identities=20% Similarity=0.265 Sum_probs=146.8
Q ss_pred cCCCCccccccccCceEEEEEEec---CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
..+|...++||+|+||.||++... .+..|++|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988654 24568999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 67888873 2346899999999999999999999985 999999999999999999999999999877554
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
..........|+..|.++| .|.|++|+++|+|+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~ 282 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 3332223344555554444 577888888888864
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=213.40 Aligned_cols=185 Identities=26% Similarity=0.419 Sum_probs=149.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-----chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999854 68999999986432 1234678999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988542 35889999999999999999999985 9999999999999999999999999998764
Q ss_pred CCCCccc-ceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQAN-TNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... .....+..++.+ ...|.|++|+++|+++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 3211110 011122223333 346888899999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-24 Score=216.34 Aligned_cols=187 Identities=26% Similarity=0.411 Sum_probs=152.4
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.+.|...++||+|+||.||+|+.. +++.+++|.+...+....+.+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 356888899999999999999875 4889999999877766778899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|..++.+. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998877543 235899999999999999999999885 99999999999999999999999999876533211
Q ss_pred ----------cccceeeeec---cCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------QANTNIIAVD---TWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+. ........|.|++|+.+|++..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g 211 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC
Confidence 1222222110 01122346788899999988754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=211.91 Aligned_cols=184 Identities=28% Similarity=0.383 Sum_probs=151.9
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...+.||+|++|.||++..+ +++.|++|.+... .....+++.+|++++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999865 6889999998643 344567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987542 346899999999999999999999885 99999999999999999999999999997754432
Q ss_pred cccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++.++.+ ...|.|++|+.+|++..+
T Consensus 157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 197 (256)
T cd08529 157 FA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197 (256)
T ss_pred hh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 21 11223333333 346788899999988754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=213.51 Aligned_cols=177 Identities=23% Similarity=0.382 Sum_probs=141.3
Q ss_pred ccccccCceEEEEEEecCCc-----------EEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 397 NKLGQGGFGPVYKGTLADGK-----------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++||+|+||.||+|...+.. .+++|.+...... .+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 5788877655433 5789999999999999999999999988 778999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-------ceEEEecC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-------NPKISDFG 538 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DFG 538 (583)
+||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865332 5899999999999999999999875 99999999999999888 79999999
Q ss_pred CceecCCCC------CcccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 539 LARIFGGNQ------NQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 539 la~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+++...... .+..++...+.........|.|++|+.+|+++.
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 998754321 122333322221234445678888888888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=220.13 Aligned_cols=188 Identities=28% Similarity=0.419 Sum_probs=147.8
Q ss_pred cCCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (583)
.++|.+.+.||+|+||.||+++.. ++..|++|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778899999999999999731 24579999987542 34467899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
...++||||+++|+|.+++.+... ...+++..+..++.||++||.|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999875321 235789999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
++++.+||+|||+++..........+....++..| .....|.|++|+.+|++..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999999877432221111111111111 2234678888888888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=215.36 Aligned_cols=187 Identities=25% Similarity=0.407 Sum_probs=149.3
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC------
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------ 459 (583)
.+++.|+..++||+|+||.||+|... +++.|++|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888899999999999999865 57889999986543 3346788999999998 799999999998753
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++||||+++++|.+++... ....++|..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998653 2345899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCc---------------chhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~ 581 (583)
++......... ....|+..|.+ ...|.|++|+.+|+++.+
T Consensus 158 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 158 SAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred ceecccccccC--CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 98764322111 11223332222 246778889999988765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=215.68 Aligned_cols=143 Identities=27% Similarity=0.437 Sum_probs=121.8
Q ss_pred ccccccCceEEEEEEecCC---cEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 397 NKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
++||+|+||.||+++..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677766443 334578999999999999999999999999999999999999999
Q ss_pred ChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 473 SLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 473 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
+|.+++.+... ...+++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 99999865322 234677788899999999999999875 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=215.85 Aligned_cols=185 Identities=26% Similarity=0.423 Sum_probs=145.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCc----EEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.++|...++||+|+||.||+|+. .+++ .||+|.++... ....+++.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35678889999999999999985 3444 48999987543 33456889999999999999999999998754 577
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+++||+++|+|.+++.+. ...+++...+.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998643 235899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.............++..+++++ .|.|++|+.+|++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t 206 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 5433221111111122223333 478888888888754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-24 Score=211.87 Aligned_cols=186 Identities=23% Similarity=0.402 Sum_probs=152.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|... +|+.|++|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7899999988643 2333578999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+++++|..++.+.. ....+++..++.++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2345899999999999999999999985 99999999999999999999999999987644
Q ss_pred CCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..+.++ ..|.|++|+.+|+++.+
T Consensus 159 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g 202 (267)
T cd08224 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred CCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHC
Confidence 32211 112233333333 34788889999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=218.63 Aligned_cols=184 Identities=23% Similarity=0.261 Sum_probs=148.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||++... ++..+++|.+.... ....+++.+|++++++++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 57889999887543 23356789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC-
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ- 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~- 547 (583)
+++++|.+++... ..+++.....++.||++||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence 9999999998543 45889999999999999999999742 49999999999999999999999999987653221
Q ss_pred -------CcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 -------NQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
....++...+. ......+.|.+|+.+|++..+
T Consensus 156 ~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 156 NSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred ccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhC
Confidence 11122211111 122345777889999888764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=216.37 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=149.8
Q ss_pred HcCCCCccccccccCceEEEEEEecC-----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 461 (583)
..++|...+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678888999999999999999765 6889999987543 3446778999999999999999999999876 467
Q ss_pred EEEEEEcCCCCChhHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEe
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 536 (583)
.++++||+++++|.+++...... ..+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999885 99999999999999999999999
Q ss_pred cCCceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 537 FGLARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
||+++.+.............++..+. ....|.|++|+.+|++..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhc
Confidence 99998764433221111111122222 234677778888888764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=213.50 Aligned_cols=191 Identities=24% Similarity=0.325 Sum_probs=150.9
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 45566667789999999999999854 57889999998776666778999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 545 (583)
||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999865322212378888999999999999999885 999999999999976 67999999999987643
Q ss_pred CCCc----------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ..++...+.........+.|++|+.+|+++.+
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g 207 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence 2211 11111111111123456788888888888654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=212.73 Aligned_cols=179 Identities=30% Similarity=0.429 Sum_probs=146.0
Q ss_pred ccccccCceEEEEEEecC--C--cEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|++|.||+|.+.+ + ..|++|.+..... ...+++.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999987765 567789999999999999999999999988 889999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc-c
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-A 550 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 550 (583)
++|.+++.+... ..++|...+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999866432 46899999999999999999999985 999999999999999999999999999987543221 1
Q ss_pred cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
......++..|.+++ .|.|++|+.+|+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t 195 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHh
Confidence 111122333333333 678888888888864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=219.67 Aligned_cols=180 Identities=27% Similarity=0.414 Sum_probs=155.1
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
-|.+.++||+|+||.|||+.++ .|..||||++... .+++++.+||.++.+.+.|++|+++|.+.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3566789999999999999865 5999999998754 357899999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
.|+..+.++. ++++|.+.++..++.+.++||+|||.. +-||||||+.||||+-+|.+||+|||.|-.+...-...
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999854 445799999999999999999999987 48999999999999999999999999998876544333
Q ss_pred cceeeeeccCCCcchhH---HHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQSMQWE---AYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~ 580 (583)
+.+.|++..+.++.- -|....|+|+||-
T Consensus 187 --NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGI 217 (502)
T KOG0574|consen 187 --NTVIGTPFWMAPEVIEEIGYDTKADIWSLGI 217 (502)
T ss_pred --CccccCcccccHHHHHHhccchhhhHhhhcc
Confidence 347788777766643 4667889999873
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-24 Score=215.34 Aligned_cols=181 Identities=25% Similarity=0.402 Sum_probs=147.9
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
|+..++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556788999999999999875 4778899999776666678899999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
++|..++.+. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~- 160 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR- 160 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc-
Confidence 9999887542 345899999999999999999999985 9999999999999999999999999997654322111
Q ss_pred ceeeeeccCCCc---------------chhHHHHHHHHHHHhhh
Q 007969 552 TNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 552 ~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~ 580 (583)
....++..|.+ ...|.|++|+.+|++..
T Consensus 161 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 161 -DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred -ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 11122222222 24677778888888764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=219.90 Aligned_cols=185 Identities=29% Similarity=0.417 Sum_probs=147.5
Q ss_pred CCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
++|.+.++||+|+||.||+++.. +...+|+|.++... ....+++.+|++++.++ +||||+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999742 23469999997542 34456788999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
..++||||+++|+|.+++..... ...++|..++.++.||+.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975321 235899999999999999999999875 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCc------------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQ------------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
.++.+||+|||+++........ ..|+...+ .......|.|++|+.+|++..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~ 237 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFT 237 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHc
Confidence 9999999999999866432111 11111111 112334678889999988864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=227.40 Aligned_cols=185 Identities=24% Similarity=0.446 Sum_probs=153.8
Q ss_pred cCCCCccccccccCceEEEEEEecC---C--cEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD---G--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~---g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.+.....++||+|-||.||+|...+ | -.||||.-+.. +....+.|+.|..+|++++||||++++|+|.+. ..|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3445667899999999999998532 2 36899998874 556678999999999999999999999999875 689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|||.++.|.|..||...+ ..|+..+...++.||+.+|.|||+. ++|||||.++|||+.+.--+||+||||+|.+
T Consensus 467 ivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999996543 3488888999999999999999998 5999999999999999999999999999999
Q ss_pred CCCCCcccceeeeeccCC---------CcchhHHHHHHHHHHHhhh
Q 007969 544 GGNQNQANTNIIAVDTWP---------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~l~~ 580 (583)
..+..+..+.....--|. +....++|++|+=||+++-
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~ 587 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS 587 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHH
Confidence 888777665333333332 2344688889999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=217.44 Aligned_cols=186 Identities=28% Similarity=0.392 Sum_probs=146.5
Q ss_pred CCCccccccccCceEEEEEEec------CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+|...++||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999853 2478999999855432 34678899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 007969 465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 531 (583)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235889999999999999999999985 999999999999999999
Q ss_pred eEEEecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 532 PKISDFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
+||+|||+++...............+++.| .....|.|++|+.+|+++.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 999999999876433322111111122222 2334678888999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=219.02 Aligned_cols=187 Identities=29% Similarity=0.386 Sum_probs=149.5
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||++.. ..+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688899999999999999974 134579999987653 33456789999999999 79999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 234899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
...............++..+.+++ .|.|++|+.+|+++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 765433211111112222233333 588889999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=217.16 Aligned_cols=188 Identities=27% Similarity=0.468 Sum_probs=149.1
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...++||+|+||.||++... ++..|++|.+.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46789999987553 33456799999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 007969 463 LLIYEYMPNKSLDVHLFDAT-------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 523 (583)
++|+||+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1134788999999999999999999985 9999999999
Q ss_pred EEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
|++++++.+||+|||+++................+..|.+ ...+.|++|+.+|+|..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999999987543322111111111122222 23577888888888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=207.70 Aligned_cols=186 Identities=28% Similarity=0.392 Sum_probs=153.0
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC----ch----hHHHHHHHHHHHhhC-CCCCceeEEEEE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQ----GLQEFKNEVNLIAKL-QHKNLVRLLGCC 456 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~----~~----~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 456 (583)
...-+.|...+.||+|..+.|-++..+ +|.+.|+|++.... .. -++.-..|+.+++++ -||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567788899999999999888754 68899999986431 11 134557899999998 599999999999
Q ss_pred EeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEe
Q 007969 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (583)
Q Consensus 457 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 536 (583)
..+...++|+|.|+.|.|.++| .....++++...+|..|+.+|+.|||... |+||||||+|||+|+++++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999 44567999999999999999999999985 99999999999999999999999
Q ss_pred cCCceecCCCCCcccceeeeeccCC----------------CcchhHHHHHHHHHHHhhhh
Q 007969 537 FGLARIFGGNQNQANTNIIAVDTWP----------------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~l~~~ 581 (583)
||+|..+.+...-. .++||++| .+.+.+.|..|++||.|+.|
T Consensus 167 FGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 167 FGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred cceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 99999987654321 23444443 34566788888888888765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-24 Score=213.25 Aligned_cols=183 Identities=27% Similarity=0.455 Sum_probs=149.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.+|...++||+|+||.||+|..+ .++.|++|.+... ....+++.+|++++.+++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999865 5889999998754 334578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999985533 345899999999999999999999885 999999999999999999999999999876543211
Q ss_pred -----------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 -----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+ .......|.|++|+.+|+|..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred ccCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHc
Confidence 11111111 112234678888999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=213.03 Aligned_cols=186 Identities=22% Similarity=0.395 Sum_probs=149.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.. +++.|+||.++.. .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999864 6899999988643 2333567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+++++|.+++.... ....+++...+.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 2345889999999999999999999985 99999999999999999999999999987653
Q ss_pred CCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..+.+ ...|.|++|+.+|++..+
T Consensus 159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g 202 (267)
T cd08228 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred hhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcC
Confidence 32211 11122222222 235788888888888643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-24 Score=213.82 Aligned_cols=185 Identities=28% Similarity=0.436 Sum_probs=147.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...++||+|++|.||+|+.. ++..|++|+++... ....+.+.+|+.++.+++||||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999865 68899999986442 22346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
++ ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865444456899999999999999999999985 99999999999999999999999999986643221
Q ss_pred ----------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+. .......|.|++|+.+|+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHC
Confidence 1112211111 1123346778888888888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=216.78 Aligned_cols=180 Identities=28% Similarity=0.374 Sum_probs=150.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999865 58999999987542 234567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 45899999999999999999999985 999999999999999999999999999887544
Q ss_pred CCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ...++..+.+ ...|.|++|+.+|+++.+
T Consensus 155 ~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 194 (290)
T cd05580 155 TY-----TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194 (290)
T ss_pred CC-----CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 21 1122222222 335788889999988765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-24 Score=212.88 Aligned_cols=184 Identities=26% Similarity=0.440 Sum_probs=141.5
Q ss_pred CccccccccCceEEEEEEecCC-c--EEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------CeE
Q 007969 394 SDENKLGQGGFGPVYKGTLADG-K--AIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QEL 462 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g-~--~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 462 (583)
.+.++||+|+||.||+|+..+. . .+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999987543 2 5899988754 334467889999999999999999999987542 246
Q ss_pred EEEEEcCCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 463 LLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
++++||+++|+|..++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 2345899999999999999999999975 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeecc----------CCCcchhHHHHHHHHHHHhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDT----------WPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~l~~ 580 (583)
++...............++. .......|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 99765432211111011111 112345677888999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-24 Score=213.70 Aligned_cols=176 Identities=26% Similarity=0.338 Sum_probs=141.5
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||.||+++.+ +|+.+|+|++.... ....+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999996432 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.......... .
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~---~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT---Q 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceee---c
Confidence 98875433 334889999999999999999999985 9999999999999999999999999998765432211 1
Q ss_pred eeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..++..+.++ ..|.|++|+.+|+++.+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 2233333333 35777888888888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-24 Score=210.61 Aligned_cols=181 Identities=33% Similarity=0.491 Sum_probs=148.1
Q ss_pred ccccccCceEEEEEEecC----CcEEEEEEeccCCchh-HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||++.... +..+++|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 7889999998664433 67899999999999999999999999999999999999999
Q ss_pred CChhHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 472 KSLDVHLFDATR------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 472 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
++|.+++.+... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999966421 256899999999999999999999985 99999999999999999999999999998765
Q ss_pred CCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 546 NQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
...........++..+.+ ...|.|++|+++|+++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHh
Confidence 432111111222222222 33577888888888764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=209.08 Aligned_cols=177 Identities=28% Similarity=0.427 Sum_probs=144.1
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChh
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 475 (583)
++||+|+||.||+|...++..+++|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999876543 33457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc------
Q 007969 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ------ 549 (583)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~------ 549 (583)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988543 235889999999999999999999885 999999999999999999999999999865332211
Q ss_pred -----ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 -----ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+ .......|.|++|+.+|+++.
T Consensus 156 ~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 156 IPIKWTAPEALNY--GRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred CcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhc
Confidence 11111111 122334688888999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=215.28 Aligned_cols=185 Identities=23% Similarity=0.379 Sum_probs=152.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|++.++||+|+||.||++... ++..+++|.++.......+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999875 5889999999877666678899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999885432 35899999999999999999999985 99999999999999999999999999876543221
Q ss_pred cccceeeeeccCCCc---------------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~ 581 (583)
. .....++..+.+ ...|.|++|+.+|++..+
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g 204 (280)
T cd06611 159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM 204 (280)
T ss_pred c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC
Confidence 1 111223332222 235777888888888764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=217.99 Aligned_cols=180 Identities=28% Similarity=0.453 Sum_probs=136.2
Q ss_pred cccccccCceEEEEEEec---CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEEEEEcCC
Q 007969 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 470 (583)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+.++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 467899999875432 3467899999999999999999999864 456899999986
Q ss_pred CCChhHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCceEEEecCCc
Q 007969 471 NKSLDVHLFDAT------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (583)
Q Consensus 471 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 540 (583)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47777764321 2235899999999999999999999985 9999999999999 46679999999999
Q ss_pred eecCCCCCc-ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQ-ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+.+...... .......++.+|+++| .|.|++|+++|+++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 987543221 1122234454444444 3555666666666543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=215.31 Aligned_cols=188 Identities=24% Similarity=0.358 Sum_probs=148.8
Q ss_pred cCCCCccccccccCceEEEEEEecC------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...+.||+|+||.||+|.... +..|++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998642 4689999987553 23456789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 463 LLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
++||||+++++|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865321 234789999999999999999999885 9999999999999999999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
|||+++...............++..+ .....|.|++|+.+|++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 216 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence 99999876443321111111122222 2233577888888888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=214.78 Aligned_cols=176 Identities=20% Similarity=0.299 Sum_probs=137.7
Q ss_pred cccccCceEEEEEEecC-------------------------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeE
Q 007969 398 KLGQGGFGPVYKGTLAD-------------------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 452 (583)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555555688999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC--
Q 007969 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-- 530 (583)
Q Consensus 453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-- 530 (583)
++++..+...++||||+++|+|..++.+. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888542 345889999999999999999999885 99999999999997654
Q ss_pred -----ceEEEecCCceecCCCCC------cccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 531 -----NPKISDFGLARIFGGNQN------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 531 -----~~kl~DFGla~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
.+||+|||+++....... ...++...+. .......+.|++|+.+|++.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHH
Confidence 379999999875532221 1122211111 22344567888888888873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=230.46 Aligned_cols=182 Identities=21% Similarity=0.330 Sum_probs=139.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------- 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 459 (583)
...+|...++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999864 68899999886442 2345799999999999999999987532
Q ss_pred CeEEEEEEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEec
Q 007969 460 QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDF 537 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DF 537 (583)
...++||||+++ +|.+++... .....+++.....++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 666665432 23456899999999999999999999985 99999999999998664 7999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
|+++.+....... ...++.+|++ ...|.|++|+++|+|+.+
T Consensus 216 Gla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 267 (440)
T PTZ00036 216 GSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267 (440)
T ss_pred ccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999765432211 1122333333 345677788888887655
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=213.21 Aligned_cols=186 Identities=22% Similarity=0.385 Sum_probs=151.2
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++. .+++.++||.+... .....+++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577889999999999999985 47899999988653 2234568899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+++++|.+++.... ....+++...+.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2346899999999999999999999985 99999999999999999999999999987644
Q ss_pred CCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..+.++ ..|.|.+|+.+|+++.+
T Consensus 159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 32211 112233333333 35788889999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=212.42 Aligned_cols=183 Identities=28% Similarity=0.409 Sum_probs=145.7
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||.||+|+..+...|++|+++.... ..+++.+|++++++++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888999999999999999987777899999975432 3467899999999999999999999874 456799999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|.+++.+. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999643 2335799999999999999999999985 9999999999999999999999999998765432211
Q ss_pred cceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
.....++..|. ....|.|++|+.+|+++.
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt 198 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHc
Confidence 11111222222 234677778888888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=215.58 Aligned_cols=189 Identities=21% Similarity=0.325 Sum_probs=150.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..+.||+|+||.||++... ++..|++|.++.. .....+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999975 6899999988754 333456889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|..++........+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999998865433446899999999999999999999742 499999999999999999999999999987643221
Q ss_pred c--------ccceeeeecc----CCCcchhHHHHHHHHHHHhhhh
Q 007969 549 Q--------ANTNIIAVDT----WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~--------~~~~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. ..|+...+.. .......+.|++|+.+|++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g 203 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhC
Confidence 1 1122111100 0113345777889999888754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=248.52 Aligned_cols=178 Identities=25% Similarity=0.437 Sum_probs=142.8
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
..+...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|++.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567788999999999999986 57899999998754322 235688999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC---
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN--- 546 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~--- 546 (583)
++|+|.++++ .++|..+.+|+.||++||+|||.....+|+||||||+||+++.++.+++. ||.......+
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~ 838 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC 838 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCc
Confidence 9999999994 28999999999999999999997655679999999999999999998886 7766544322
Q ss_pred ---CCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 547 ---QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
..+..|+...+. ....+.|+|++|+.+|++..+
T Consensus 839 ~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 839 FISSAYVAPETRETK--DITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred cccccccCcccccCC--CCCcccchhhHHHHHHHHHhC
Confidence 122233322211 223457888899999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-25 Score=223.00 Aligned_cols=178 Identities=26% Similarity=0.398 Sum_probs=147.7
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
++.||.|.||+||-|..+ +|+.||||++.+. ..+..+.+.+|+.++.+++||.||.+.--|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999864 7999999999765 4455578999999999999999999999999999999999999665
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEecCCceecCCCCCc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~~~~~~~ 549 (583)
-|+-+|. .+.+.|++.....++.||+.||.|||.++ |+|.||||+||||.+. -++||+|||+||+++...-.
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5655553 34456899999999999999999999985 9999999999999643 47999999999999765533
Q ss_pred ccceeeeeccCCCcchh---HHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQW---EAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~ 581 (583)
+.++||+.|.++|. .-|--..|||++|.+
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVI 755 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVI 755 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEE
Confidence 35788888887774 345556677776654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=214.16 Aligned_cols=182 Identities=27% Similarity=0.329 Sum_probs=147.1
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999865 688999999875422 2234678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998885433 235899999999999999999999875 99999999999999999999999999987643322
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ...|+..++++| .|.|++|+.+|+++.+
T Consensus 158 ~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 158 IK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred cc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 11 112333333333 4677788888888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=212.67 Aligned_cols=178 Identities=21% Similarity=0.298 Sum_probs=144.7
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+|+..++||+|+||.||+|.. .+++.|++|.+... .....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999985 46889999998754 3334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN- 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 548 (583)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence 999996542 3688889999999999999999985 99999999999999999999999999987643221
Q ss_pred -------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 -------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+.. .....|.|++|+.+|++..+
T Consensus 152 ~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g 189 (279)
T cd06619 152 TYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALG 189 (279)
T ss_pred CCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhC
Confidence 11222222211 22335778889999988754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=218.24 Aligned_cols=187 Identities=30% Similarity=0.421 Sum_probs=146.9
Q ss_pred CCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
++|...++||+|+||.||+++.. ....+++|.++... ....+++.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 24578999987543 34467789999999999 6999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
..++++||+++|+|.+++.+... ...++|.....++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999865321 235899999999999999999999985 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
+++.+||+|||+++...............++..|+ ....|.|++|+.+|+++.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHh
Confidence 99999999999998764322111111111111122 233577888999988865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=211.86 Aligned_cols=177 Identities=20% Similarity=0.328 Sum_probs=139.9
Q ss_pred ccccccCceEEEEEEecC-------------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 397 NKLGQGGFGPVYKGTLAD-------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
+.||+|+||.||+|...+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887665555668899999999999999999999999998999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-------eEEEe
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-------PKISD 536 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~kl~D 536 (583)
+||||+++++|..++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888542 345899999999999999999999985 999999999999987664 89999
Q ss_pred cCCceecCCCCC------cccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 537 FGLARIFGGNQN------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 537 FGla~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
||++........ +..|+... .........+.|++|+.+|+++
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~ 203 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEIC 203 (262)
T ss_pred CCCCccccCcccccccccccChhhhc-CCCCCCchhHHHHHHHHHHHHH
Confidence 999986643322 12222111 1122233457788889998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=220.87 Aligned_cols=186 Identities=27% Similarity=0.340 Sum_probs=159.1
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
..+.|..-++||+|+||.||-++.+ +|+-+|.|++.+. ..++....++|-.++.+++.+.||.+--.+..++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466788899999999999999865 6889999988654 23344567899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+..|.||+|..+|.+... ..+++.+...++.+|+.||.+||... ||.|||||+|||||++|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999977554 45999999999999999999999984 9999999999999999999999999999987
Q ss_pred CCCCcccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
..+.... .+||.+||.++. |+|++|+.+|+|..+
T Consensus 339 ~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 339 EGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred CCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence 7665432 277777777663 567799999998765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=211.38 Aligned_cols=184 Identities=25% Similarity=0.416 Sum_probs=147.2
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCc------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
+|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3677889999999999999988899999999864321 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998542 35789999999999999999999885 99999999999999999999999999986532
Q ss_pred CCCc----ccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQ----ANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~----~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... .......++..+.+ ...+.|++|+.+|++..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 1110 01111223333222 346777888888887654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=221.46 Aligned_cols=178 Identities=21% Similarity=0.237 Sum_probs=142.7
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
....+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++..+...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44567999999999999999999875 4678999975433 2356999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+. ++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 6888887542 345899999999999999999999985 999999999999999999999999999854322
Q ss_pred CCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 547 QNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
... ....|+..|.+ ...+.|++|+++|+++.
T Consensus 211 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 211 PAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 111 11223333322 33577888999988864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=213.93 Aligned_cols=186 Identities=27% Similarity=0.389 Sum_probs=146.8
Q ss_pred cCCCCccccccccCceEEEEEEecC------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
+++|...+.||+|+||.||+|...+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4668888999999999999998753 5678999887543 33346799999999999999999999999998899
Q ss_pred EEEEEcCCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---ceEEE
Q 007969 463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 535 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 535 (583)
++||||+++++|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 235899999999999999999999985 99999999999998754 69999
Q ss_pred ecCCceecCCCCCc------------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 536 DFGLARIFGGNQNQ------------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 536 DFGla~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
|||+++........ ..|+...+ .......|.|++|+++|+++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHc
Confidence 99999876432211 11111111 112334677788888888763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=215.62 Aligned_cols=183 Identities=23% Similarity=0.388 Sum_probs=150.9
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+|...++||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35688889999999999999985 46889999999876655567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998843 24789999999999999999999985 99999999999999999999999999886543321
Q ss_pred cccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..| .....|.|++|+.+|++..+
T Consensus 172 ~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g 212 (296)
T cd06654 172 KRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (296)
T ss_pred ccC--cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 111 01122222 22446788889999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.54 Aligned_cols=183 Identities=28% Similarity=0.421 Sum_probs=147.5
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|+..++||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999988888999999876433 3467999999999999999999999875 456899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999986532 345899999999999999999999985 9999999999999999999999999998765432211
Q ss_pred cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.. ...++..+ .....+.|++|+.+|+++.
T Consensus 160 ~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 198 (260)
T cd05070 160 RQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred cc-CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHh
Confidence 10 01111222 2234678888999988865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=209.66 Aligned_cols=181 Identities=28% Similarity=0.405 Sum_probs=148.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-----chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
+|...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999986543 23457899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||+++++|.+++.+. ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998542 35889999999999999999999985 99999999999999999999999999987644
Q ss_pred CCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++..+ .....|.|++|+.+|+++.+
T Consensus 155 ~~~~---~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 155 FSFA---KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred cccc---cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 3311 111122221 23446778888888888754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=214.80 Aligned_cols=183 Identities=24% Similarity=0.386 Sum_probs=151.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+|...++||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35688889999999999999985 47899999999866555567789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998843 24789999999999999999999985 99999999999999999999999999987654332
Q ss_pred cccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..+. ....|.|++|+.+|++..+
T Consensus 171 ~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg 211 (297)
T cd06656 171 KRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (297)
T ss_pred CcC--cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 211 112222222 2346777888888887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=210.01 Aligned_cols=184 Identities=30% Similarity=0.442 Sum_probs=148.3
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.+.|...++||+|+||.||+|..++++.|++|.+..... ..+++.+|+.++++++|+||+++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456788899999999999999988899999999875543 3468999999999999999999999864 45789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885533 346899999999999999999999875 999999999999999999999999999877532221
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
... ...++..| .....|.|++|+.+|+++.
T Consensus 159 ~~~-~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 159 ARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred ccc-CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHh
Confidence 110 01111122 2334677888999988864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=211.80 Aligned_cols=185 Identities=28% Similarity=0.454 Sum_probs=146.4
Q ss_pred CCCCccccccccCceEEEEEEec-C---CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-D---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.+|...+.||+|+||.||+|... + +..+++|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999863 2 3379999987543 33456899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++... ...+++.+.+.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235899999999999999999999985 99999999999999999999999999987754
Q ss_pred CCCcccc-eeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 546 NQNQANT-NIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
......+ ....++.. ......+.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 3221110 00000111 12334677788888888653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=222.76 Aligned_cols=175 Identities=25% Similarity=0.294 Sum_probs=135.6
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC---CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
||+|+||.||+|+.. +++.||+|++.+.. ......+..|..++.+. +||||+++++.+..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58999999996532 12233455666676655 699999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|..++.+ ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 999988853 345899999999999999999999985 999999999999999999999999999864332221
Q ss_pred ceeeeeccCCCcchhH----HHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSMQWE----AYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~ 581 (583)
.....|+..|+++|.. .+...+|+|++|..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvi 186 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccE
Confidence 2234456666665532 13344555555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=210.68 Aligned_cols=185 Identities=26% Similarity=0.382 Sum_probs=145.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-----chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
++|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999864 58999999886321 22356788999999999999999999998764 467
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++++||+++++|.+++.+. ..+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988542 34788889999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCCc-ccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... .......++..|.+ ...|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 205 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE 205 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhC
Confidence 5422110 01111223333322 235777888888888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=207.42 Aligned_cols=177 Identities=29% Similarity=0.453 Sum_probs=145.0
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChh
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 475 (583)
++||+|+||.||++...+++.|++|.++..... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765443 5678999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-------
Q 007969 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------- 548 (583)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~------- 548 (583)
+++.+. ...+++...+.++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998543 235789999999999999999999885 99999999999999999999999999986542211
Q ss_pred -----cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 -----QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+..|+...+ .......|.|++|+.+|+++.
T Consensus 156 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 156 QIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred cceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHh
Confidence 111221111 112234577888999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=209.34 Aligned_cols=185 Identities=29% Similarity=0.456 Sum_probs=151.7
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..++|.+.++||+|+||.||++..++++.|++|.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3467888999999999999999988888999999875433 357899999999999999999999999988899999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999996532 345899999999999999999999985 99999999999999999999999999987653211
Q ss_pred -----------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 -----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+..|+...+ .......|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t 199 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVT 199 (261)
T ss_pred hhhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHh
Confidence 111211111 123345678888888888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=227.34 Aligned_cols=182 Identities=25% Similarity=0.336 Sum_probs=150.7
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-C-----CCceeEEEEEEeCCeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H-----KNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 464 (583)
+|.+.+.||+|.||.|-||.. ++++.||||+++.... ...+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999984 5699999999986633 3456688999999997 5 389999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC--ceEEEecCCcee
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARI 542 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGla~~ 542 (583)
|+|.+ .-+|.++++... -..++...+..|+.||+.||.+||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 569999997644 345899999999999999999999885 99999999999996543 799999999987
Q ss_pred cC-------CCCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 543 FG-------GNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. .++.+..|+.+.|.++..+.+.|+ +|+++-||..|
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWS--LGCIlAEL~tG 384 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWS--LGCILAELFTG 384 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceee--hhhhHHhHhcC
Confidence 64 345567788777766655555555 77777777654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=214.14 Aligned_cols=181 Identities=29% Similarity=0.460 Sum_probs=145.5
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhH--HHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
|+..++||+|+||+||+++.. +++.+|+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 466899999987754432 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 9999999996 2345899999999999999999999985 99999999999999999999999999986421111
Q ss_pred ccceeeeeccC-----------CCcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTW-----------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
......++.+ ......|.|++|+.+|+|+.+
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 154 -NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp -EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHS
T ss_pred -cccccccccccccccccccccccccccccccccccccccccc
Confidence 1111222222 333445677788888887654
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=208.21 Aligned_cols=184 Identities=23% Similarity=0.374 Sum_probs=150.3
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..+.||+|+||.||.++. .+++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999885 45889999998654 344567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+.. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986532 345899999999999999999999885 99999999999999999999999999987754432
Q ss_pred cccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++..+.+ ...|.|++|+.+|++..+
T Consensus 157 ~~--~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 157 MA--ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred cc--cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence 11 11222322222 235788889999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=211.15 Aligned_cols=186 Identities=29% Similarity=0.498 Sum_probs=148.3
Q ss_pred cCCCCccccccccCceEEEEEEecC-C---cEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|+..+.||+|+||.||+|+.+. + ..+++|.++... ....+++.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467788999999999999998752 3 379999987553 3446789999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 245899999999999999999999885 9999999999999999999999999998775
Q ss_pred CCCCccccee-eeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNI-IAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
.......... ...+..+. ....|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~ 205 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHh
Confidence 4322111100 00011122 234678888999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=219.30 Aligned_cols=187 Identities=28% Similarity=0.412 Sum_probs=146.8
Q ss_pred CCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
.+|.+.++||+|+||.||+++.. .+..|++|.++... ....+++.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999742 12368999887542 34467899999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
..++++||+++|+|.+++.+.. ....++|..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235889999999999999999999985 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
+++.+||+|||+++...............++..|+ ....|.|++|+.+|+|+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999998764432211111111111122 234678888888888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=213.98 Aligned_cols=185 Identities=26% Similarity=0.460 Sum_probs=146.2
Q ss_pred CCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
..|...++||+|+||.||+++. .++..|++|.++... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 357889999987553 33456899999999999999999999998875 568
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.+. ...++|..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998543 235899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCCc-ccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
+...... .......++..+ .....|.|++|+.+|+++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt 207 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc
Confidence 6543221 111111122112 2234677778888888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=208.66 Aligned_cols=183 Identities=30% Similarity=0.481 Sum_probs=150.2
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...+.||+|+||.||++... ++.|++|.++.... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999874 78999999986654 5678999999999999999999999999989999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence 9999999986533 235899999999999999999999985 999999999999999999999999999877432221
Q ss_pred -------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 -------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..++...+ .......+.|++|+.+|++..
T Consensus 159 ~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred CCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHh
Confidence 11211111 112234678888888888763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=210.01 Aligned_cols=184 Identities=30% Similarity=0.485 Sum_probs=147.4
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch---------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
+|...+.||+|++|.||+|... +++.+++|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988654221 23568899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999954 245889999999999999999999885 9999999999999999999999999998
Q ss_pred ecCCCCCcccc----eeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANT----NIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
....+...... ....++..+.+ ...|.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence 77532211100 11122222222 236788899999988754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=211.90 Aligned_cols=184 Identities=27% Similarity=0.446 Sum_probs=145.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.+|...++||+|+||.||+|..+ +|+ .+++|.+..... ....++.+|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777899999999999999864 233 689998876543 345788999999999999999999999987 78899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+||+++|+|.+++.+.. ..+++...+.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986532 34899999999999999999999975 9999999999999999999999999998775
Q ss_pred CCCCcccceeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
............++.. ......|.|++|+.+|++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~ 206 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence 4332111110001111 22234667778888888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=208.60 Aligned_cols=176 Identities=25% Similarity=0.404 Sum_probs=138.1
Q ss_pred cccccCceEEEEEEec---CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999976543 33567999999999999999999999875 457899999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccce
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 553 (583)
|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998542 345899999999999999999999985 9999999999999999999999999998764432211110
Q ss_pred e-eeeccCCC----------cchhHHHHHHHHHHHhh
Q 007969 554 I-IAVDTWPQ----------SMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 554 ~-~~~~~~~~----------~~~~~~~~~~~~l~~l~ 579 (583)
. ..++..+. ....|.|++|+.+|+++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 0 00111122 22457778888888875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=216.23 Aligned_cols=185 Identities=26% Similarity=0.443 Sum_probs=146.0
Q ss_pred CCCCccccccccCceEEEEEEecC-C--cEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD-G--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~-g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
++|+..+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998753 3 34788888743 334457899999999999 799999999999999999999
Q ss_pred EEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1134889999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCC---------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQN---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
||+|||+++....... +..++...+ .......|.|++|+.+|+|..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t 213 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVS 213 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHc
Confidence 9999999874321111 111221111 122345778889999998863
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=223.91 Aligned_cols=181 Identities=25% Similarity=0.396 Sum_probs=156.0
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..|...+.||+|.||.||||.. ..++.||+|++... .....+++++|+.+++.++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999985 46889999999865 344568899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|.+|++.+.|. ....+++....-|..++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999983 3344578888889999999999999985 99999999999999999999999999999887766
Q ss_pred cccceeeeeccCCCcchh---HHHHHHHHHHHhh
Q 007969 549 QANTNIIAVDTWPQSMQW---EAYFLLNLMFSVL 579 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~ 579 (583)
.. ...+||+++|.+|. ..|...+|||+||
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLG 198 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLG 198 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhh
Confidence 55 45788888887774 3667777888776
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=214.53 Aligned_cols=180 Identities=28% Similarity=0.452 Sum_probs=136.7
Q ss_pred cccccccCceEEEEEEec---CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEEEEEcCC
Q 007969 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 470 (583)
..+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999865 357899999875432 2467899999999999999999999864 457899999987
Q ss_pred CCChhHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCceEEEecCCc
Q 007969 471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (583)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 540 (583)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++++||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676665421 12235889999999999999999999985 9999999999999 56789999999999
Q ss_pred eecCCCCCc-ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQ-ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+........ .......++.+|.++| .|.|++|+.+|+++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 987543221 1112234444444433 4667777777777653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=211.10 Aligned_cols=186 Identities=27% Similarity=0.377 Sum_probs=147.2
Q ss_pred CCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999854 2457999988765443 4678999999999999999999999999988999
Q ss_pred EEEEcCCCCChhHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 464 LIYEYMPNKSLDVHLFDATRS------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654321 25899999999999999999999885 999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
|+++........... ...++..+ .....+.|++|+.+|++..
T Consensus 162 ~~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 162 SLSKDVYNSEYYKLR-NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred ccccccCcccccccC-CceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 998765332211111 11111111 1233567778888887753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=211.58 Aligned_cols=184 Identities=23% Similarity=0.372 Sum_probs=147.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|+..+.||+|+||.||+++.+ +++.|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999976 58999999986442 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877633 335899999999999999999999975 9999999999999999999999999999875433
Q ss_pred Cc----------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ..|+...+. .......+.|++|+.+|++..+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g 197 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTG 197 (286)
T ss_pred ccccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhC
Confidence 11 112211111 1123346777788888888653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=238.93 Aligned_cols=190 Identities=23% Similarity=0.323 Sum_probs=148.5
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (583)
..++|.+.++||+|+||.||+++.. ++..+++|.+... .....+.|..|+.++++++||||+++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4567889999999999999999865 5778899988743 333457889999999999999999999998653 5689
Q ss_pred EEEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCcEEEcC----------
Q 007969 464 LIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR----LKIIHRDLKASNILLDD---------- 528 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlk~~NILl~~---------- 528 (583)
+||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986532 23469999999999999999999998531 24999999999999964
Q ss_pred -------CCceEEEecCCceecCCCCCcccceeeeeccCCCc------------chhHHHHHHHHHHHhhhh
Q 007969 529 -------DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 529 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~ 581 (583)
...+||+|||+++.+...... ....|++.|.+ ...|+|++|+++|+|+.+
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 335899999999876433211 12234444433 345777788888887764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=221.01 Aligned_cols=181 Identities=28% Similarity=0.371 Sum_probs=142.4
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-----
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 460 (583)
..++|...++||+|+||.||+++.. +|+.||+|++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578899999999999999999864 5889999999754 2334567889999999999999999999986543
Q ss_pred -eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 461 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999975 4555552 23788899999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
++....+... ....++..|.++ ..|.|++|+.+|+|+.+
T Consensus 170 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 170 ARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred ccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence 9865432211 111233333333 35777788888888754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=214.44 Aligned_cols=183 Identities=25% Similarity=0.395 Sum_probs=147.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|+..++||+|+||.||++..+ +++.|++|++..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999976 588999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|..+... ...++|..++.++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877643 234899999999999999999999985 9999999999999999999999999998764432
Q ss_pred CcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ....++.++. ....|.|++|+.+|++..+
T Consensus 155 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g 197 (286)
T cd07846 155 EVY--TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197 (286)
T ss_pred ccc--CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence 211 0111222222 2346777888888887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=214.21 Aligned_cols=182 Identities=24% Similarity=0.412 Sum_probs=150.8
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.+|+..++||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999985 468999999997665555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|..++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998843 24899999999999999999999985 999999999999999999999999998876543321
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..++..| .....|.|++|+.+|+++.+
T Consensus 172 ~~~--~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 172 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred CCC--cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 111 1122222 22346788889999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=213.44 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=147.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch-----hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
+|...+.||+|+||.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999865 6899999999765332 234677899999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985432 35899999999999999999999985 99999999999999999999999999988754
Q ss_pred CCCccc----------ceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQAN----------TNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... ++...+ ........|.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g 199 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLR 199 (298)
T ss_pred CCccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcC
Confidence 322111 111100 01223457788889999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=208.27 Aligned_cols=176 Identities=28% Similarity=0.439 Sum_probs=139.8
Q ss_pred cccccCceEEEEEEe---cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 398 KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+||+|+||.||+|.+ .++..+++|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999974 357889999987543 234578999999999999999999999875 45678999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999854 235899999999999999999999985 999999999999999999999999999877544321111
Q ss_pred -eeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 553 -NIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 553 -~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
....+++.++ ....|.|++|+.+|+++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 0111111222 234678888999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=229.72 Aligned_cols=176 Identities=30% Similarity=0.412 Sum_probs=145.8
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|++.+.||.|+||.||.++. .+.+.||||+++-. +...++++++|+..|.+++|||++.+-|++......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466778899999999999985 46789999999733 44568899999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||- |+..+++.-. .+++.+.++..|..+.+.||.|||+.. .||||||+.||||.+.|.|||+|||-|.+..+..
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 994 5666666432 346889999999999999999999985 8999999999999999999999999998776554
Q ss_pred CcccceeeeeccCCCcchhH------HHHHHHHHHHhh
Q 007969 548 NQANTNIIAVDTWPQSMQWE------AYFLLNLMFSVL 579 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~ 579 (583)
..+||++.+.+++. .|.=-+|+|+||
T Consensus 181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLG 212 (948)
T KOG0577|consen 181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 212 (948)
T ss_pred ------cccCCccccchhHheeccccccCCccceeecc
Confidence 35677666665532 455556777766
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=214.04 Aligned_cols=146 Identities=22% Similarity=0.369 Sum_probs=130.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999865 57899999987653 233567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998542 35899999999999999999999885 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=208.12 Aligned_cols=183 Identities=28% Similarity=0.412 Sum_probs=145.8
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|++|.||++....+..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999998777789999886543 23467899999999999999999999875 456889999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.+.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999986532 345899999999999999999999885 9999999999999999999999999998764332111
Q ss_pred cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.. ...++..+ .....+.|++|+.+|++..
T Consensus 160 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 160 RQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred cC-CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence 00 01111222 2334678888888888864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.64 Aligned_cols=180 Identities=26% Similarity=0.401 Sum_probs=143.4
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (583)
..++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456788999999999999999985 468899999997542 23345678999999999999999999987543
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 788887773 235899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcc-----------hhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~ 581 (583)
++....... ...++.+|.++ ..|.|++|+.+|+|..+
T Consensus 165 ~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 165 ARQADDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred ceecCCCcC-----CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 987654321 12334333333 35677778888777654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=206.85 Aligned_cols=183 Identities=25% Similarity=0.407 Sum_probs=152.1
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||++...+ ++.+++|.++.... .+++.+|++++++++|+||+++++.+..++..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999765 78999999875533 67899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++... ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999998542 345899999999999999999999885 99999999999999999999999999987654321
Q ss_pred cccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
. .....++..+.++ ..+.|.+|+++|+++.+
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 155 K--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred c--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 1 1112233333333 36788888888888654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=211.78 Aligned_cols=186 Identities=30% Similarity=0.471 Sum_probs=147.4
Q ss_pred CCCCccccccccCceEEEEEEec-----CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 462 (583)
.+|...+.||+|+||.||++++. +++.+|+|.++..... ..++|.+|++.+++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999854 3678999999866443 46789999999999999999999999887 5578
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996533 25899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCc-ccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
....... .......++..+ .....+.|++|+.+|+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence 7633221 111001111111 22235677788888887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-23 Score=212.73 Aligned_cols=183 Identities=26% Similarity=0.420 Sum_probs=146.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 57899999987543 22345678999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
++ ++|..++.+. ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887543 235789999999999999999999985 99999999999999999999999999986543221
Q ss_pred cccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ..++..+.+ ...|.|++|+.+|+|..+
T Consensus 160 ~~~~--~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg 201 (301)
T cd07873 160 TYSN--EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201 (301)
T ss_pred cccc--cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC
Confidence 1111 112222222 345788888888888654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=211.11 Aligned_cols=183 Identities=28% Similarity=0.470 Sum_probs=145.6
Q ss_pred CCCccccccccCceEEEEEEecC-C---cEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.|...+.||+|+||.||+|.... + ..|++|.++.. .....++|.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998653 3 36999998765 3444678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 345899999999999999999999985 999999999999999999999999999876443
Q ss_pred CCccc-ceeeee--ccCCC----------cchhHHHHHHHHHHHhh
Q 007969 547 QNQAN-TNIIAV--DTWPQ----------SMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 547 ~~~~~-~~~~~~--~~~~~----------~~~~~~~~~~~~l~~l~ 579 (583)
..... .....+ +..+. ....+.|++|+.+|+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l 205 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHh
Confidence 22110 000000 11111 23357778888888865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=213.39 Aligned_cols=150 Identities=28% Similarity=0.353 Sum_probs=133.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch---hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||++... +++.+++|.+...... ..+.+.+|++++++++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999875 4899999999765322 4567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||+++++|.+++... ....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988643 2346899999999999999999999985 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=226.37 Aligned_cols=177 Identities=28% Similarity=0.379 Sum_probs=156.0
Q ss_pred cccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhH
Q 007969 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 476 (583)
+||+|.||+||-|+.. +...+|||.+...+.+..+.+..||.+.+.++|+|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 456799999998888888899999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceecCCCCCcccce
Q 007969 477 HLFDATRSVQL--DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTN 553 (583)
Q Consensus 477 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 553 (583)
+|.. +-+++ .+.+.-.+..||++||.|||+.. |||||||-.|||++ -.|.+||+|||-++++.+=.. .|+
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 9953 34455 77888889999999999999985 99999999999995 689999999999998865433 466
Q ss_pred eeeeccCCCcchh-----HHHHHHHHHHHhhhh
Q 007969 554 IIAVDTWPQSMQW-----EAYFLLNLMFSVLEF 581 (583)
Q Consensus 554 ~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~ 581 (583)
...||..|+.++. --|+..+|||++||-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT 767 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCT 767 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccce
Confidence 7889999998884 378899999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=226.42 Aligned_cols=183 Identities=31% Similarity=0.467 Sum_probs=153.3
Q ss_pred CccccccccCceEEEEEEecC--Cc--EEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 394 SDENKLGQGGFGPVYKGTLAD--GK--AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
...++||+|.||.|++|.|+. |+ .||||.++..... ..++|++|+.+|.+|+|+|+++|||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345789999999999998753 44 6899999866443 67899999999999999999999999988 678999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
++.|+|.+.|++ .....|--.....++.|||.||.||..++ +|||||.++|+||.....|||+||||.|-+..++.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 44556788888999999999999999985 99999999999999999999999999999976654
Q ss_pred c-c-cceeeeeccC---------CCcchhHHHHHHHHHHHhhhh
Q 007969 549 Q-A-NTNIIAVDTW---------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~-~-~~~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+ . .+.+.+...| .++-..|+|++|+.||||..+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhcc
Confidence 3 2 2223333333 455667899999999999653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-23 Score=207.66 Aligned_cols=185 Identities=26% Similarity=0.404 Sum_probs=146.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-----chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
.+|...+.||+|+||.||++... ++..|++|++.... .+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999886432 22345788999999999999999999998753 578
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998542 34889999999999999999999875 99999999999999999999999999986
Q ss_pred cCCCCCc-ccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
....... .......++..|.++ ..|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g 205 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTE 205 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHC
Confidence 6432111 111112233333333 35777788888888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=217.72 Aligned_cols=186 Identities=28% Similarity=0.448 Sum_probs=145.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCc--EEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (583)
.++|+..+.||+|+||.||+|..+ ++. .+++|.++... ....+.+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999864 444 46888776542 33456789999999999 89999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 007969 465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 531 (583)
|+||+++++|.+++.+.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986532 1235889999999999999999999885 999999999999999999
Q ss_pred eEEEecCCceecCCCCC---------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 532 PKISDFGLARIFGGNQN---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+||+|||+++....... +..++...+ .......|.|++|+.+|+++.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHh
Confidence 99999999974321111 111111111 112344678889999998863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=214.82 Aligned_cols=183 Identities=15% Similarity=0.191 Sum_probs=141.5
Q ss_pred cccccccc--CceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 395 DENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 395 ~~~~LG~G--~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
..++||+| +|++||+++.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999864 68999999997542 233456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN- 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 548 (583)
++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234899999999999999999999985 99999999999999999999999986544321110
Q ss_pred ----------------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+.........|.|++|+++|++..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 111222111111223446777788888887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.24 Aligned_cols=185 Identities=23% Similarity=0.300 Sum_probs=154.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.-|..++.||+|-|..|-.+++- +|..||||++.+..- .....+..|++-|+.++|||||+||.+.-....+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999743 799999999986633 334568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-cCCCceEEEecCCceecCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGla~~~~~~ 546 (583)
.=++|+|.+|+.+..+ .+.+....+++.||..|+.|+|+.+ +|||||||+||.. ..-|-|||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976543 4899999999999999999999886 9999999999865 67789999999999988765
Q ss_pred CC---------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QN---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+. +..|+.+.|+ .|-.+..+.|.+|+++|.|.+|
T Consensus 173 ~kL~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCG 215 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCG 215 (864)
T ss_pred chhhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhC
Confidence 43 3445544444 3455566777789999888775
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=213.57 Aligned_cols=184 Identities=30% Similarity=0.513 Sum_probs=143.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...+.||+|+||.||+|... ++. .|++|.+..... ....++.+|+.++++++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999853 444 578888875533 3345789999999999999999999998754 4678
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
++||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998543 235889999999999999999999985 9999999999999999999999999999775
Q ss_pred CCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
............++..+++ ...+.|++|+.+|+++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 4332211111122222222 33577888888888753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=208.67 Aligned_cols=184 Identities=24% Similarity=0.399 Sum_probs=146.0
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc----------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG----------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 688999998863211 11346788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccC------------CCcchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTW------------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+...............++.. ......|.|++|+++|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence 86543211111111112211 123345778889999888765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=210.66 Aligned_cols=185 Identities=25% Similarity=0.258 Sum_probs=155.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchh---HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
..++|...++||+|.||+|-.++-+ .++.+|+|+|++.-.-. ...-+.|-+++...+||.+..|--.+..++.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4578889999999999999999854 68999999998764332 3344678899999999999999989999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||..||.|..+|. +...+++.....+...|..||.|||+++ ||.||||.+|.|||.+|++||+||||++.-.
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999998883 3445888888899999999999999975 9999999999999999999999999998654
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... .+...+|++.|..++ .++|++|++||+|+||
T Consensus 320 ~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCG 364 (516)
T KOG0690|consen 320 KYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCG 364 (516)
T ss_pred cccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhc
Confidence 4333 234467777655544 4678899999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=219.26 Aligned_cols=181 Identities=28% Similarity=0.379 Sum_probs=143.7
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (583)
..++|...++||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3467899999999999999999854 5889999999754 233456788999999999999999999987543
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6666662 23788999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++........ ....++..|.++| .|.|++|+.+|+|+.+
T Consensus 173 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 221 (364)
T cd07875 173 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221 (364)
T ss_pred ccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhC
Confidence 9876433211 1123444444443 5777888888888654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=206.04 Aligned_cols=188 Identities=22% Similarity=0.347 Sum_probs=153.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999854 67899999987542 33567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++........+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865443356899999999999999999999885 99999999999999999999999999987754332
Q ss_pred cc--cceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 549 QA--NTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.. ......++..+.+++ .|.|++|+.+|++..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g 203 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence 21 112223333333332 4777788888888754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=208.06 Aligned_cols=182 Identities=24% Similarity=0.387 Sum_probs=150.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..+.||.|++|.||+|+.. +++.|++|.+.... ....+.+.+|++++++++|+||+++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999865 58899999987553 34456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998542 6899999999999999999999985 99999999999999999999999999988764321
Q ss_pred cccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++..+.+ ...|.|++|+.+|++..+
T Consensus 154 ~~--~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg 194 (274)
T cd06609 154 KR--NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194 (274)
T ss_pred cc--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 11 11122222222 336788889999888765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=211.14 Aligned_cols=191 Identities=23% Similarity=0.306 Sum_probs=149.8
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEE-----
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL----- 457 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~----- 457 (583)
......++|+..+.||+|+||.||++... +++.+++|.++.... ...++.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 33456788999999999999999999864 578999998865322 235688899999999 6999999999985
Q ss_pred eCCeEEEEEEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEe
Q 007969 458 EGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (583)
Q Consensus 458 ~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 536 (583)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 335689999999999999887542 22345889999999999999999999885 99999999999999999999999
Q ss_pred cCCceecCCCCCcccceeeeeccCCCcc---------------hhHHHHHHHHHHHhhhh
Q 007969 537 FGLARIFGGNQNQANTNIIAVDTWPQSM---------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~l~~~ 581 (583)
||+++......... ....++..|.++ ..+.|++|+.+|+++.+
T Consensus 168 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 168 FGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred CCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 99998764332211 112333333333 35777888888887654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=208.65 Aligned_cols=184 Identities=29% Similarity=0.478 Sum_probs=147.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+|+..++||+|++|.||+|+.. +|+.|++|+++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 588999999976533 23467789999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++ +|.+++........+++..+..++.||++||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 88888765444456899999999999999999999885 999999999999999999999999999866432211
Q ss_pred ccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..++.++. ....+.|.+|+.+|++..+
T Consensus 157 ~~~--~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 157 FSN--EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred ccc--ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 111 11222222 2345677788888887654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=219.23 Aligned_cols=181 Identities=28% Similarity=0.390 Sum_probs=142.8
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (583)
..++|...+.||+|+||.||++... .++.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568899999999999999999854 5889999999754 233356788999999999999999999998643
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5655552 23788999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++........ ....++..|.++| .|.|++|+++|+|..+
T Consensus 166 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 214 (355)
T cd07874 166 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_pred cccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9876433211 1123344444433 5777788888887653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=212.74 Aligned_cols=185 Identities=28% Similarity=0.456 Sum_probs=144.3
Q ss_pred CCCccccccccCceEEEEEEec---CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 463 (583)
.|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677789999999999999965 47899999998643 33346788999999999999999999999988 7899
Q ss_pred EEEEcCCCCChhHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----CCceEEEec
Q 007969 464 LIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD----DMNPKISDF 537 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DF 537 (583)
+||||+++ +|.+++.... ....+++...+.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666554322 2236889999999999999999999985 999999999999999 999999999
Q ss_pred CCceecCCCCC-cccceeeeeccCCCcch-----------hHHHHHHHHHHHhhh
Q 007969 538 GLARIFGGNQN-QANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~ 580 (583)
|+++....... ........++.++.+++ .+.|++|+.+|++..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99997654332 11122233444444433 466777777777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=213.39 Aligned_cols=178 Identities=24% Similarity=0.379 Sum_probs=146.9
Q ss_pred ccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
...+||+|+||.||++... +++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 688999999976555556778999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccce
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 553 (583)
|..++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..+.... .
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--K 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--c
Confidence 9987733 34899999999999999999999885 9999999999999999999999999997654332211 1
Q ss_pred eeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 554 IIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 554 ~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...++..|.++| .|.|++|+.+|+|+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 123344443333 5788889999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=210.55 Aligned_cols=186 Identities=25% Similarity=0.360 Sum_probs=145.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++++|...++||+|+||.||+|... +++.|++|++...... ....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4577889999999999999999864 6889999999755332 2346789999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6776666432 234788889999999999999999985 999999999999999999999999999865322
Q ss_pred CC----------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QN----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. +..|+...+. .......|.|++|+.+|+++.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g 200 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQG 200 (291)
T ss_pred CCCCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhC
Confidence 11 1112211111 0122345788888888888754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=206.67 Aligned_cols=184 Identities=28% Similarity=0.423 Sum_probs=148.1
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45688899999999999999998778889999887543 335688999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999986532 345889999999999999999999875 999999999999999999999999999876543221
Q ss_pred ccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
. .....++..+. ....|.|++|+.+|+++.
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t 198 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHh
Confidence 1 11111122222 223577788888888764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=204.57 Aligned_cols=183 Identities=25% Similarity=0.338 Sum_probs=153.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46788899999999999999876 489999999986644 4467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 458999999999999999999998 75 9999999999999999999999999999875443
Q ss_pred CcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++..|.+ ...|.|++|+.+|+++.+
T Consensus 155 ~~~~--~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 155 DQCN--TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred Cccc--ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 3221 1222222222 346888899999988764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=206.19 Aligned_cols=187 Identities=24% Similarity=0.400 Sum_probs=152.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+..++..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999864 5788999999876666678899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999988543 245899999999999999999999885 99999999999999999999999999987643221
Q ss_pred ----------cccceeeeec-cCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------QANTNIIAVD-TWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..++...+. ........|.|++|+.+|+|+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg 200 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhC
Confidence 1222222221 01222345777888888888654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=208.54 Aligned_cols=183 Identities=26% Similarity=0.436 Sum_probs=148.8
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...+.||+|+||.||+|... +|+.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999864 68999999997653 33356899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+ +++|.+++.... ..+++..+..++.||+++|.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886533 45899999999999999999999985 99999999999999999999999999987754331
Q ss_pred cccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++.++ .....|.|++|+.+|++..+
T Consensus 155 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 155 RLYS-HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred Cccc-cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 1000 11122221 23456777888888887643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=208.38 Aligned_cols=182 Identities=22% Similarity=0.343 Sum_probs=144.6
Q ss_pred CCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...++||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999887654 4456789999999999999999999998875 457899
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999995432 34899999999999999999999885 99999999999999999999999999987654
Q ss_pred CCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhh
Q 007969 546 NQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~ 579 (583)
......+ ...+...| .....|.|++|+.+|+++
T Consensus 160 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 202 (270)
T cd05056 160 ESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202 (270)
T ss_pred ccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 4222111 01111112 223357888888888865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=207.64 Aligned_cols=185 Identities=24% Similarity=0.410 Sum_probs=142.8
Q ss_pred CCccccccccCceEEEEEEec----CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 393 FSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
|...+.||+|+||.||+|.+. +++.|++|++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999998754 3344678899999999999999999999986542
Q ss_pred eEEEEEEcCCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
..++++||+++|+|..++.... ....+++...+.++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 2235789999999999999999999885 999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeeccC----------CCcchhHHHHHHHHHHHhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTW----------PQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~l~~ 580 (583)
|+++....+..........+... ......|.|++|+.+|++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 99997654332211111111111 12234678888999998864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=205.02 Aligned_cols=184 Identities=20% Similarity=0.314 Sum_probs=147.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+|+..++||+|+||.||++... +++.+++|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999865 6889999998643 3344578889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++... ....+++...+.++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||+++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999888542 2345789999999999999999999985 999999999999999999999999999877543221
Q ss_pred ccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
. ....++..+.++ ..|.|++|+.+|+++.+
T Consensus 157 ~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g 196 (255)
T cd08219 157 A--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196 (255)
T ss_pred c--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence 1 112333333333 34666677777776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=205.68 Aligned_cols=181 Identities=27% Similarity=0.415 Sum_probs=144.6
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~ 469 (583)
++|...+.||+|+||.||++..+ +..+++|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999874 7789999986543 34678999999999999999999998654 45789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCC
Confidence 9999999986533 335899999999999999999999885 999999999999999999999999999876432211
Q ss_pred -------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 -------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..|+...+ .......|.|++|+.+|++..
T Consensus 159 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred CccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHh
Confidence 11111111 112234678888888888863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=209.14 Aligned_cols=180 Identities=33% Similarity=0.506 Sum_probs=143.5
Q ss_pred CCccccccccCceEEEEEEe-----cCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (583)
|...+.||+|+||+||++.. .++..||+|.++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37778999999999988652 3577899999976532 3457789999999999999999999998754 46899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999854 24899999999999999999999985 9999999999999999999999999998765
Q ss_pred CCCCc-------------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQ-------------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
..... ..|+...+ .......|.|++|+.+|++..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhC
Confidence 33221 11111111 1123346788899999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=213.15 Aligned_cols=179 Identities=24% Similarity=0.384 Sum_probs=146.7
Q ss_pred CccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
....+||+|+||.||++... ++..|+||++........+.+.+|+..+++++|+||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999864 58899999997665556678999999999999999999999999999999999999999
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccc
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
+|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..........
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~-- 175 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-- 175 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--
Confidence 99988743 24889999999999999999999985 9999999999999999999999999998654332211
Q ss_pred eeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 553 NIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 553 ~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
....++..+.++ ..|.|++|+.+|++..+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g 214 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 122344443333 36777788888887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=205.70 Aligned_cols=179 Identities=28% Similarity=0.420 Sum_probs=137.8
Q ss_pred ccccccCceEEEEEEec----CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeEEEEEEcCC
Q 007969 397 NKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYMP 470 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 470 (583)
+.||+|+||.||+|... ++..+++|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998654 33446788999999999999999999998764 556899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.+.. ..+.+.....++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999986432 34678888999999999999999875 9999999999999999999999999998654321100
Q ss_pred --cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 551 --NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 --~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
......++..+ ...+.|.|++|+.+|++..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 197 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHc
Confidence 00011111112 2234677888888888765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=209.72 Aligned_cols=184 Identities=24% Similarity=0.392 Sum_probs=145.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..++||+|++|.||+|..+ +++.|++|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 688999999875432 2234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++ +|.+++.+.. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8988885433 35889999999999999999999885 99999999999999999999999999876432111
Q ss_pred ----------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+. .......+.|++|+.+|+|+.+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g 200 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATG 200 (291)
T ss_pred cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhC
Confidence 1111111111 1122345777788888888754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=206.97 Aligned_cols=181 Identities=24% Similarity=0.443 Sum_probs=148.3
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 466 (583)
.|+..++||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 46899999998754 3344567889999999996 999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 25899999999999999999999985 999999999999999999999999999887544
Q ss_pred CCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
..... ...++..+ .....+.|.+|+.+|+++.+
T Consensus 155 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g 198 (277)
T cd06917 155 SSKRS--TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198 (277)
T ss_pred ccccc--cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC
Confidence 32111 11222221 23346778888888888754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-23 Score=203.30 Aligned_cols=183 Identities=33% Similarity=0.498 Sum_probs=147.2
Q ss_pred CCccccccccCceEEEEEEecC-----CcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++..+.||+|+||.||+++..+ +..|++|.+...... ..+.+..|++.+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999998754 378999999765443 5678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999865322 22899999999999999999999985 999999999999999999999999999877644
Q ss_pred CCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 547 QNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
...... ...++..+ .....+.|.+|+.+|++..
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~ 199 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence 222111 00112222 2234567778888888754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=207.42 Aligned_cols=184 Identities=24% Similarity=0.396 Sum_probs=147.7
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+|+..+.||+|++|.||++.. .+++.|++|++..... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 5689999999874321 235678999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceec
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~ 543 (583)
|+||+++++|.+++.+ ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++..
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999854 235889999999999999999999985 99999999999998776 6999999999877
Q ss_pred CCCCCcc--cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQA--NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~--~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....... ......++..+.+++ .|.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 204 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhC
Confidence 5432111 011123333333333 4677788888888654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=209.21 Aligned_cols=183 Identities=25% Similarity=0.306 Sum_probs=146.7
Q ss_pred CCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
+|+..+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 368899999997542 22346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 235889999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCCcccceeeeeccCCC------------cchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQ------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~ 581 (583)
......... ....++..+. ....+.|.+|+.+|+++.+
T Consensus 155 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 155 FHEDEVERA-YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred ccccccccc-ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 644322111 1112222222 2346778888888888754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=209.89 Aligned_cols=181 Identities=25% Similarity=0.421 Sum_probs=147.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999864 57889999987543 344568999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999988842 35889999999999999999999885 999999999999999999999999999876543221
Q ss_pred ccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
. ....++..+. ....|.|++|+.+|++..+
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06642 158 R--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197 (277)
T ss_pred h--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC
Confidence 1 1112233322 3346788889999888765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=204.20 Aligned_cols=182 Identities=25% Similarity=0.463 Sum_probs=147.1
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
.+|+..+.||+|+||.||++...++..+++|.+..... ..++|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999987788999999875432 24678999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc-
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ- 549 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 549 (583)
+++|.+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988542 235789999999999999999999885 999999999999999999999999999876433211
Q ss_pred ----------ccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 550 ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
..++...+. ......|.|++|+.+|+++.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHc
Confidence 111111111 12223677788888888764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=209.43 Aligned_cols=193 Identities=26% Similarity=0.337 Sum_probs=151.9
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC-
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG- 459 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~- 459 (583)
...+..+.++|...+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3444456788999999999999999999864 688999999875432 235678899999999 899999999998754
Q ss_pred ----CeEEEEEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 460 ----QELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 460 ----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
+..++|+||+++++|.++++... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 35899999999999999886422 2345899999999999999999999885 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCC---------------cchhHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQ---------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~l~~~ 581 (583)
+|||+++.......... ...++..+. ....|.|++|+.+|+++.+
T Consensus 170 ~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 170 VDFGVSAQLTSTRLRRN--TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred eecccchhccccccccc--CccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 99999987643221110 111222222 2346788899999998765
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=218.73 Aligned_cols=188 Identities=28% Similarity=0.332 Sum_probs=150.2
Q ss_pred CCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCch-------hHHHHHHHHHHHhhCCCCCceeEEEEEE-eCCe
Q 007969 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~ 461 (583)
++|.....||+|+|+.|||+. +...+-||||+-...... ..+...+|.++.+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456667889999999999997 556788999976433211 1234578999999999999999999996 4567
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 538 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 538 (583)
.+-|+|||+|.+|+.||.+ ...++++++..|+.||..||.||.+. ++||||-||||.||||-+ -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 8999999999999999954 44589999999999999999999998 468999999999999954 4689999999
Q ss_pred CceecCCCCCc-----ccceeeeeccCCCcchhHH-------HHHHHHHHHhhhhc
Q 007969 539 LARIFGGNQNQ-----ANTNIIAVDTWPQSMQWEA-------YFLLNLMFSVLEFF 582 (583)
Q Consensus 539 la~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~f 582 (583)
|+++..++... .-|...+|++||.+++--+ ..--+|+|++|.+|
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 99998765432 3456678999988776322 22456677777665
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=208.28 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=140.5
Q ss_pred ccccccCceEEEEEEecC-Cc--EEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+|+.++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 5788888754 334456889999999999 899999999999999999999999999
Q ss_pred CChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 472 KSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 472 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
|+|.+++.+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999975 9999999999999999999999999
Q ss_pred CceecCCCCC---------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 539 LARIFGGNQN---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 539 la~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+++....... +..++...+ .....+.|.|++|+.+|+++.
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~ 206 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHc
Confidence 9864321110 111111111 122345678889999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=208.15 Aligned_cols=188 Identities=21% Similarity=0.315 Sum_probs=143.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHH-HhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|+..+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999865 68999999987543 2334456666665 666789999999999999999999999
Q ss_pred cCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 468 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 468 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|++ |+|.+++... .....+++..++.++.||+.||.|||++. +++||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6887777542 23356899999999999999999999862 4999999999999999999999999999876432
Q ss_pred CC---------cccceeeeeccC--CCcchhHHHHHHHHHHHhhhh
Q 007969 547 QN---------QANTNIIAVDTW--PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~---------~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. +..++...+... ......+.|.+|+.+|++..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhC
Confidence 21 111221111000 112234677788888888754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=208.72 Aligned_cols=179 Identities=21% Similarity=0.345 Sum_probs=141.0
Q ss_pred ccccccCceEEEEEEecC--------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+.||+|+||.||+|.... ..+|++|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 235888888766555567889999999999999999999999998999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--------eEEEecCCc
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PKISDFGLA 540 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DFGla 540 (583)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986533 25899999999999999999999985 999999999999987765 699999998
Q ss_pred eecCCCCC------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQN------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
........ +..|+...+ ........+.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g 201 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSG 201 (258)
T ss_pred cccCCchhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcC
Confidence 76643322 111221111 11123345777788888888664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=203.54 Aligned_cols=177 Identities=30% Similarity=0.460 Sum_probs=140.2
Q ss_pred ccccccCceEEEEEEecC----CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+|.... +..+++|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999986544 34568999999999999999999999876 4568999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996432 5899999999999999999999885 99999999999999999999999999987744332111
Q ss_pred -ceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 552 -TNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 552 -~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
.....++..+. ....|.|++|+.+|+++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 11011111122 224678889999998874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-25 Score=206.04 Aligned_cols=184 Identities=24% Similarity=0.328 Sum_probs=149.6
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
..+.|++.+.||+|.|+.|+++.. .+|+.+++|.+... +..+.+++.+|+++...|+||||++|.......+..++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345677888999999999999875 46888888877532 444678899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCcee
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARI 542 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~ 542 (583)
+|+|.|++|..-+-++ ...++...-...+||+++|.|+|.++ |||||+||+|+||.+ .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997655332 34677888899999999999999985 999999999999954 33589999999999
Q ss_pred cCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+++.. ..-..+|+++++++| .+.|+.|+++|.|+.|
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G 208 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 208 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence 87322 233345666655554 4677788888888876
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=207.76 Aligned_cols=181 Identities=34% Similarity=0.460 Sum_probs=142.2
Q ss_pred ccccccCceEEEEEEecC-------CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+.||+|+||.||+|+..+ +..+++|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578999886543 23456889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-----ceEEEecCC
Q 007969 469 MPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGL 539 (583)
Q Consensus 469 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGl 539 (583)
+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++++. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999875 99999999999999887 899999999
Q ss_pred ceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
++...............++..+ .....|.|++|+.+|+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 208 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence 9866433221111111111122 2334688889999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=205.02 Aligned_cols=181 Identities=24% Similarity=0.372 Sum_probs=147.9
Q ss_pred cccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.+.||+|+++.|-.+. +.+|.++|||++.+.....+.+..+|++++...+ |+||+.|+.+++++...|+|||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4689999999999887 6789999999999998888899999999999995 9999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEecCCceecC--CCCC
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFG--GNQN 548 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~~~--~~~~ 548 (583)
|..++++ ...+++.+..++..+|+.||.|||.++ |.||||||+|||-.+... +||+||.|+.-.. .+-+
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999965 345899999999999999999999997 999999999999865543 7999998876542 2222
Q ss_pred cccceee---eeccCCCcchh---------------HHHHHHHHHHHhhhhc
Q 007969 549 QANTNII---AVDTWPQSMQW---------------EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 549 ~~~~~~~---~~~~~~~~~~~---------------~~~~~~~~l~~l~~~f 582 (583)
...++.+ +|...+|.++. +-|++|+++|.|+.|+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 2222222 33333444442 4566888888887764
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=205.21 Aligned_cols=181 Identities=24% Similarity=0.404 Sum_probs=148.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.|+..++||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999865 58899999987543 345678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998843 34788999999999999999999875 999999999999999999999999999877543321
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
. ....++.++ .....+.|++|+.+|++..+
T Consensus 158 ~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06640 158 R--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred c--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC
Confidence 1 111222222 23346788888888888765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=203.76 Aligned_cols=184 Identities=26% Similarity=0.409 Sum_probs=150.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...++||+|+||.||++... +++.|++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999864 688999999976544 3567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999854 234789999999999999999999985 99999999999999999999999999988754322
Q ss_pred cc--------------cceeeeecc-CCCcchhHHHHHHHHHHHhhhh
Q 007969 549 QA--------------NTNIIAVDT-WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~--------------~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. .++...+.. .....+.+.|.+|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 11 111111111 1133446788899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=205.11 Aligned_cols=177 Identities=24% Similarity=0.358 Sum_probs=144.8
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999975533 3456889999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc-----
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ----- 549 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~----- 549 (583)
.+++.+.. .+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986432 5899999999999999999999985 999999999999999999999999998865433211
Q ss_pred -ccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 550 -ANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 -~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
.......++..+.++ ..|.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g 197 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 011112233333333 46788899999988764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=207.96 Aligned_cols=184 Identities=25% Similarity=0.388 Sum_probs=148.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|+..++||+|+||.||+|..+ +++.|++|+++.. .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999875 5889999998754 23335788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|++++.+..+..+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777766532 334899999999999999999999985 9999999999999999999999999998876543
Q ss_pred CcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
..... ...++.++. ....|.|++|+.+|++..+
T Consensus 155 ~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 198 (288)
T cd07833 155 ASPLT-DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198 (288)
T ss_pred ccccc-CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 21111 112222222 2346778888888888654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=208.00 Aligned_cols=182 Identities=26% Similarity=0.458 Sum_probs=139.8
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhC---CCCCceeEEEEEEeC-----C
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG-----Q 460 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 460 (583)
+|+..+.||+|+||.||+++.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999865 688999999875422 1234556777777665 699999999998642 4
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++|+||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999974 8888875433 345899999999999999999999986 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
+......... ...++..|.++ ..|.|++|+.+|+|..+
T Consensus 156 ~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 203 (288)
T cd07863 156 RIYSCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 203 (288)
T ss_pred ccccCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhC
Confidence 8775332211 12233333333 35777788888887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=208.63 Aligned_cols=182 Identities=20% Similarity=0.258 Sum_probs=146.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..++||+|+||.||++... +++.|++|++.... ....+.+.+|+++++.++||||+++++.+......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999864 68899999887543 34457899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.+ ...+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 999999988854 335899999999999999999999743 499999999999999999999999999876532211
Q ss_pred cccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
....++..+. ....+.|++|+.+|++..+
T Consensus 160 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 198 (284)
T cd06620 160 ----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198 (284)
T ss_pred ----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence 1122232222 2235677788888887643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=199.14 Aligned_cols=182 Identities=30% Similarity=0.462 Sum_probs=152.5
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999987665566889999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999975 99999999999999999999999999988765431
Q ss_pred cceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.....++..+. ....|.|++|+.+|+++.+
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g 193 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 11122332222 3346788899999888754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=203.99 Aligned_cols=185 Identities=26% Similarity=0.411 Sum_probs=146.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
.+|...+.||+|+||.||++... +++.+++|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 6899999987532 223456889999999999999999999998764 468
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++++||+++++|.+++... ..+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988532 34789999999999999999999885 99999999999999999999999999987
Q ss_pred cCCCCCc-ccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
....... .......++..+.++ ..|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE 205 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 6431110 001112233333232 34778889999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=202.67 Aligned_cols=184 Identities=22% Similarity=0.370 Sum_probs=148.8
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..++||+|+||.||++... +++.+++|++... .....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999854 6889999998743 233456889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.... ...+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999885422 235789999999999999999999985 99999999999999999999999999987654322
Q ss_pred cccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++..+.+ ...|.|++|+.+|++..+
T Consensus 157 ~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08218 157 LA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197 (256)
T ss_pred hh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC
Confidence 11 11122222222 235788889999888654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=201.71 Aligned_cols=184 Identities=22% Similarity=0.335 Sum_probs=146.9
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 467 (583)
.|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999865 57889999986542 3345678999999999999999999998764 446799999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.+. ....+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988653 2345899999999999999999999985 9999999999999999999999999998774332
Q ss_pred CcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
... ....++..+.+ ...|.|++|+.+|+++.+
T Consensus 157 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 157 DMA--STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred Ccc--ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 211 11223333322 335778888888888654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=207.15 Aligned_cols=184 Identities=24% Similarity=0.411 Sum_probs=148.1
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..+.||+|++|.||+|+.. +++.|+||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999865 68899999987542 22346789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+. ++|..++.... ...+++..+..++.||+.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888875533 345899999999999999999999885 99999999999999999999999999986643221
Q ss_pred ----------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..++...+. .......+.|++|+.+|+++.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHC
Confidence 1223322221 1123457888899999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-23 Score=208.23 Aligned_cols=182 Identities=25% Similarity=0.403 Sum_probs=149.9
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++.+..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999985 467899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998843 24789999999999999999999985 999999999999999999999999998866543321
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..++..+ .....|.|++|+.+|++..+
T Consensus 172 ~~~--~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g 211 (293)
T cd06647 172 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (293)
T ss_pred ccc--ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 111 1122222 22346788889999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=206.30 Aligned_cols=186 Identities=24% Similarity=0.354 Sum_probs=144.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCe-----
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE----- 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 461 (583)
++|+..+.||+|+||.||+|... +++.|++|+++.... .....+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999865 689999998865432 23467889999999995 6999999999987655
Q ss_pred EEEEEEcCCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG 538 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 538 (583)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78887754332 346899999999999999999999985 999999999999998 8999999999
Q ss_pred CceecCCCCCc----------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQ----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+++.+...... ..++...+. .......|.|++|+.+|+|..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcC
Confidence 99876432211 111111110 1123346778888888887654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=203.01 Aligned_cols=185 Identities=23% Similarity=0.417 Sum_probs=146.4
Q ss_pred CCCccccccccCceEEEEEEecC--CcEEEEEEeccC----------CchhHHHHHHHHHHHhh-CCCCCceeEEEEEEe
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT----------SGQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE 458 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 458 (583)
+|+..+.||+|+||.||++.... ++.+++|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 678999988632 12234567888888875 799999999999999
Q ss_pred CCeEEEEEEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23345899999999999999999999643 4999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
|++......... ....++..+ .....+.|++|+.+|++..+
T Consensus 159 g~~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g 209 (269)
T cd08528 159 GLAKQKQPESKL---TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209 (269)
T ss_pred cceeeccccccc---ccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence 999876544311 111222222 23456888889999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-22 Score=204.00 Aligned_cols=181 Identities=25% Similarity=0.403 Sum_probs=147.1
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
-|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999864 68899999986543 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.. ..+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999988843 34899999999999999999999985 999999999999999999999999999876443211
Q ss_pred ccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ...++.++. ....+.|++|+.+|++..+
T Consensus 158 ~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 158 RN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred hc--cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 11 112222222 2345778888888888765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=205.37 Aligned_cols=184 Identities=25% Similarity=0.327 Sum_probs=149.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..++||+|++|.||++..+ +++.+++|++.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999876 58899999987653 34456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++.... ..+++.....++.|++.||.|||+ . +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986533 468899999999999999999998 6 49999999999999999999999999987664322
Q ss_pred C--------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 N--------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. +..++...+. ......|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred hhcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhC
Confidence 1 1112211111 222346788889999888753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=205.18 Aligned_cols=176 Identities=28% Similarity=0.361 Sum_probs=141.3
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||+||++... +|+.+++|.+.... ....+.+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986532 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....+... ..
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---cc
Confidence 999865432 35899999999999999999999985 999999999999999999999999999876432211 11
Q ss_pred eeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..+...+.+++ .+.|++|+.+|+++.+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 12222233333 4677788888887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=224.93 Aligned_cols=186 Identities=20% Similarity=0.310 Sum_probs=138.0
Q ss_pred HcCCCCccccccccCceEEEEEEecC--CcEEEEE------------------EeccCCchhHHHHHHHHHHHhhCCCCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVK------------------RLSRTSGQGLQEFKNEVNLIAKLQHKN 448 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n 448 (583)
..++|.+.++||+|+||+||++..+. +...++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 111 11223456889999999999999
Q ss_pred ceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 449 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
|+++++++...+..++|+|++. ++|..++..... ...........|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 566666643221 112335567789999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++.+........ ....|+..|+++| .|.|++|+++|+|+.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 363 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363 (501)
T ss_pred CCCCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999998754332211 1234555554444 477888888888864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=206.45 Aligned_cols=183 Identities=25% Similarity=0.418 Sum_probs=145.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 465 (583)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999975 588999999975432 2234577899999999999999999999877 889999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||++ ++|.+++.... ..+++.....++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48988875432 35899999999999999999999985 99999999999999999999999999997755
Q ss_pred CCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
....... ..++..+ .....|.|++|+.+|++..+
T Consensus 159 ~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 159 PLKPYTQ--LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred Ccccccc--ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 4211110 1112211 12345677788888887654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=197.04 Aligned_cols=155 Identities=28% Similarity=0.344 Sum_probs=138.4
Q ss_pred HHcCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----Ce
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (583)
...++|.+.++||+|+|..||.++ +.++..+|+|++.-...++.+...+|++..++++||||++++.+...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 668899999999888778888999999999999999999999987543 35
Q ss_pred EEEEEEcCCCCChhHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
.|++++|...|+|.+.+......+ .+++.+.+.|+.+|++||.+||+.. ++.+||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999987655444 6999999999999999999999985 47999999999999999999999999988
Q ss_pred eec
Q 007969 541 RIF 543 (583)
Q Consensus 541 ~~~ 543 (583)
+..
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=208.21 Aligned_cols=181 Identities=25% Similarity=0.438 Sum_probs=143.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...++||+|+||.||+++.. +|+.+++|+++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999865 68899999987542 22235678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5777776442 245899999999999999999999985 99999999999999999999999999987643221
Q ss_pred cccceeeeeccCCC-----------cchhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~ 580 (583)
.... ..++..+. ....|.|++|+.+|+|..
T Consensus 155 ~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 155 CYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred CcCC--CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh
Confidence 1111 11222222 334677778888888864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=199.80 Aligned_cols=184 Identities=27% Similarity=0.420 Sum_probs=152.0
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (583)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999976 688999999876543 4567899999999999999999999999988 8899999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.+.. .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985433 6899999999999999999999975 999999999999999999999999999988655
Q ss_pred CCcccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
..........++..+ .....|.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g 199 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 431111111222222 33446788899999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=203.35 Aligned_cols=187 Identities=25% Similarity=0.393 Sum_probs=149.9
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------ 460 (583)
.+++|+..+.||+|++|.||+|..+ +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 578899999876543 346799999999999 7999999999997644
Q ss_pred eEEEEEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886432 2356899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCc---------------chhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~ 581 (583)
+........... ...++..+.+ ...|.|++|+.+|+++.+
T Consensus 160 ~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 160 SAQLDSTLGRRN--TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred ceecccchhhhc--CccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 987643322111 1122222222 235788889999888754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=204.86 Aligned_cols=180 Identities=23% Similarity=0.385 Sum_probs=148.1
Q ss_pred CCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999998766555567789999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~- 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR- 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCccc-
Confidence 999998854 34889999999999999999999985 9999999999999999999999999987654332211
Q ss_pred ceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
....++.++.+ ...|.|++|+.+|+++.+
T Consensus 173 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g 211 (285)
T cd06648 173 -KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211 (285)
T ss_pred -ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC
Confidence 11223333333 335788899999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=234.78 Aligned_cols=192 Identities=21% Similarity=0.235 Sum_probs=156.9
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 458 (583)
...++...++|.+.+.||+|+||.|...+++ +++.+|+|++++- ......-|..|-++|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455566788999999999999999999976 5788999999863 22334568889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
+.++|+|||||+||+|..++.+.. .+++.-+..++..|.-||.-||+.| .|||||||.|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999995433 5888888899999999999999886 9999999999999999999999999
Q ss_pred CceecCCCCCcccceeeeeccC---------------CCcchhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTW---------------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
-+-.+..+..-.. ...+||+- .++.+-|+|++|+.+|+|+.|
T Consensus 221 sClkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG 277 (1317)
T KOG0612|consen 221 SCLKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYG 277 (1317)
T ss_pred hHHhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcC
Confidence 8877764433221 12344443 344444677799999999865
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=206.24 Aligned_cols=181 Identities=25% Similarity=0.327 Sum_probs=149.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
+|...++||+|+||.||++... +++.+++|.+.+.. ....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 58899999997542 2346789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|..++... ..+++.....++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 46899999999999999999999885 9999999999999999999999999998765432
Q ss_pred CcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..+. ....+.|++|+.+|++..+
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 155 LTT---STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred ccc---ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 111 111222222 3335777788888888754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=204.49 Aligned_cols=185 Identities=26% Similarity=0.424 Sum_probs=152.6
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++.|+..+.||+|++|.||++..+ ++..+++|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999976 688999999986544 45788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996533 36899999999999999999999975 9999999999999999999999999987654332
Q ss_pred C----------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 N----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. +..++...+. ......|.|.+|+++|++..+
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred hhhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhC
Confidence 1 1112211111 123346788899999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=221.90 Aligned_cols=182 Identities=18% Similarity=0.226 Sum_probs=139.0
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC------CCceeEEEEEEeC-
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH------KNLVRLLGCCLEG- 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~~~- 459 (583)
...++|.+.++||+|+||+||+|... .++.||||+++... ...+++..|++++++++| .+++++++++..+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34678999999999999999999864 57889999997542 223456677777777654 4588899988765
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---------
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM--------- 530 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~--------- 530 (583)
+..++|||++ +++|.+++.+ ...+++..+..|+.||+.||.|||++. +||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 5788999988 6788888754 245899999999999999999999741 499999999999998765
Q ss_pred -------ceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 531 -------NPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 531 -------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.+||+|||++...... .....|+.+|+++| .|.|++|+++|+|+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred ccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 4999999988643221 11245566665555 3677788888887654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=198.75 Aligned_cols=182 Identities=27% Similarity=0.426 Sum_probs=150.8
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..++||+|.+|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 578999999986644 4567899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 46899999999999999999999885 99999999999999999999999999998754433
Q ss_pred cccceeeeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++..+ .....+.|.+|+.+|++..+
T Consensus 155 ~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 155 DD--ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred cc--cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 11 111222222 23446788899999988754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=211.73 Aligned_cols=185 Identities=25% Similarity=0.430 Sum_probs=146.0
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC--CeE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 462 (583)
..++|...+.||+|+||.||+|... +++.+++|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999865 5889999998643 233456778899999999 999999999998654 368
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++|+||++ ++|..++... .++|..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888887432 5889999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCCc---ccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ---ANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~---~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... .......++.++.+ ...|.|++|+.+|++..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg 209 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence 6543221 11112233333322 335788889988888754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=204.23 Aligned_cols=186 Identities=25% Similarity=0.345 Sum_probs=147.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (583)
++|...++||.|++|.||++... +++.+++|.+..... ....++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999975 578999999875433 3457799999999999999999999998654 4689999
Q ss_pred EcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875422 3345889999999999999999999985 99999999999999999999999999876532
Q ss_pred CCC--------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 546 NQN--------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
... +..++...+ .......+.|++|+++|+++.+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g 199 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQN 199 (287)
T ss_pred cccccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhC
Confidence 211 111221111 1223346788899999998764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=201.08 Aligned_cols=180 Identities=30% Similarity=0.444 Sum_probs=144.3
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...+.||+|+||.||++.. +++.|++|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 67889999986543 246789999999999999999999998765 4799999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC--
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-- 548 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-- 548 (583)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 999999986533 335899999999999999999999875 99999999999999999999999999986543211
Q ss_pred -----cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 -----QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+..++...+ .......|.|++|+.+|+++.
T Consensus 158 ~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~ 192 (254)
T cd05083 158 KLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFS 192 (254)
T ss_pred CCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHh
Confidence 111221111 123345688889999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=232.72 Aligned_cols=189 Identities=29% Similarity=0.420 Sum_probs=142.7
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (583)
+..++|+..+.||+|+||.|||++.+ ||+.+|||++.... .+....+.+|+.++++|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678888999999999999999966 89999999998653 33456789999999999999999987665210
Q ss_pred --------------------------------------------------------------------------------
Q 007969 460 -------------------------------------------------------------------------------- 459 (583)
Q Consensus 460 -------------------------------------------------------------------------------- 459 (583)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007969 460 ---------------------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506 (583)
Q Consensus 460 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 506 (583)
..+||-||||+...|.+++.+.... -.....++++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0146778888877777777432211 14567889999999999999
Q ss_pred HhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC----------------CCCCcccceeeeeccCCCcc------
Q 007969 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG----------------GNQNQANTNIIAVDTWPQSM------ 564 (583)
Q Consensus 507 H~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~~~~~~~~~------ 564 (583)
|+++ ||||||||.||+||++..|||+|||+|+... ...........+||.-|.+|
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9997 9999999999999999999999999999821 00111111234555554444
Q ss_pred -------hhHHHHHHHHHHHhhhh
Q 007969 565 -------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 565 -------~~~~~~~~~~l~~l~~~ 581 (583)
+.|.|++|+++|||..=
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yP 814 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYP 814 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhcc
Confidence 45778888888887643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=206.11 Aligned_cols=185 Identities=27% Similarity=0.398 Sum_probs=147.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
..|...++||+|+||.||+|... +++.|++|++.... ....+++.+|+++++.++||||+++++++..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999865 68899999986432 233467899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||++ |++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666666432 235899999999999999999999885 999999999999999999999999999876433
Q ss_pred CC------cccceeeeec-cCCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QN------QANTNIIAVD-TWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. +..|+...+. ........+.|++|+.+|+++.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 22 1222222110 11233457788899999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=201.26 Aligned_cols=174 Identities=25% Similarity=0.308 Sum_probs=142.7
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||.|++|.||+++.. +++.+++|++.+... ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 488999999875432 3356799999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++.+. ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 9998542 34889999999999999999999975 99999999999999999999999999987754321 111
Q ss_pred eeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
..++..+.+ ...|.|.+|+.+|++..+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 122222322 235778888888888654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=200.14 Aligned_cols=188 Identities=26% Similarity=0.412 Sum_probs=148.2
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIY 466 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 466 (583)
+|+..+.||.|+||.||++... ++..+++|.+... .....+++.+|++++++++|+||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999854 6789999998743 33445678999999999999999999998864 35689999
Q ss_pred EcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
||+++++|.+++... .....+++...+.++.||+.||.|||..+ ..+++|+||||+||++++++.+||+|||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456899999999999999999999332 235999999999999999999999999999987
Q ss_pred CCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
........ ...++..+.+ ...|.|.+|+.+|+++.+
T Consensus 161 ~~~~~~~~--~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g 206 (265)
T cd08217 161 GHDSSFAK--TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206 (265)
T ss_pred cCCccccc--ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHC
Confidence 54432111 1123333333 336788889888888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=219.42 Aligned_cols=178 Identities=25% Similarity=0.392 Sum_probs=143.7
Q ss_pred CccccccccCceEEEEEEec-CCcEEEEEEecc----CCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--eEEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY 466 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~----~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 466 (583)
....+||+|.|-+||||... +|.+||--.++. .++..+++|..|+++|+.|+||||++++..|.+.. ..-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999864 477776544431 24556789999999999999999999999998764 488999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~ 545 (583)
|.+..|+|..|+.+.+ .++.+....+++||++||.|||++. +||||||||..||+|+ ..|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999996543 4788899999999999999999986 6899999999999996 458999999999998865
Q ss_pred CCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVL 579 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~ 579 (583)
.... .++||+.-|.++ .|+|++|.=|.+|.
T Consensus 199 s~ak----svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 199 SHAK----SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred cccc----eeccCccccChHHHhhhcchhhhhhhhhHHHHHHH
Confidence 4432 366777655554 45666666666654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.17 Aligned_cols=153 Identities=25% Similarity=0.392 Sum_probs=121.8
Q ss_pred HcCCCCccccccccCceEEEEEEe-----------------cCCcEEEEEEeccCCchhHHHH--------------HHH
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-----------------ADGKAIAVKRLSRTSGQGLQEF--------------KNE 437 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~E 437 (583)
..++|.+.++||+|+||.||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999975443333333 346
Q ss_pred HHHHhhCCCCCc-----eeEEEEEEe--------CCeEEEEEEcCCCCChhHHHhccCC---------------------
Q 007969 438 VNLIAKLQHKNL-----VRLLGCCLE--------GQELLLIYEYMPNKSLDVHLFDATR--------------------- 483 (583)
Q Consensus 438 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 483 (583)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 678888753 3568999999999999998864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 484 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123578889999999999999999885 9999999999999999999999999997654
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=198.83 Aligned_cols=184 Identities=23% Similarity=0.381 Sum_probs=147.1
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..+.||+|+||.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999999864 6889999998754 234467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++.+.. ...+++..+..++.+++.+|.|||+.+ ++|+||||+||+++++ +.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345899999999999999999999985 9999999999999855 468999999998775432
Q ss_pred C---------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 N---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. +..++...+.. .....|.|++|+.+|++..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASL 197 (256)
T ss_pred cccccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhC
Confidence 1 11122211111 12235777788888888653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=202.45 Aligned_cols=182 Identities=25% Similarity=0.421 Sum_probs=146.6
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIYE 467 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 467 (583)
|...++||+|+||.||+|+.. +++.+++|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999865 58899999998663 33346788999999999999999999999988 88999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++ +|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888875432 46899999999999999999999985 9999999999999999999999999999876543
Q ss_pred Cc-----------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQ-----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ..|+...+. .......+.|++|+.+|+++.+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred cccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhC
Confidence 21 122222211 1123457788889998888654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=204.50 Aligned_cols=150 Identities=32% Similarity=0.479 Sum_probs=133.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 465 (583)
++|...+.||+|+||.||++... +++.|++|++... .....+.+.+|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999865 6899999998753 2233467889999999998 99999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 36999999999999999999999985 99999999999999999999999999987754
Q ss_pred C
Q 007969 546 N 546 (583)
Q Consensus 546 ~ 546 (583)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=203.29 Aligned_cols=192 Identities=24% Similarity=0.377 Sum_probs=150.4
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe--
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE-- 458 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 458 (583)
+..+..+.+.|+..++||+|+||.||+|+.. +++.+++|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344456678888999999999999999864 58899999886543 3346788999999998 69999999999863
Q ss_pred ----CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 459 ----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 459 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
....+++|||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999886532 345888889999999999999999985 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCcc---------------hhHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQSM---------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~l~~~ 581 (583)
+|||+++........ .....++..|.++ ..|.|++|+.+|++..+
T Consensus 163 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 163 VDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred eeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 999998865432211 1112233222222 35788889999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=203.87 Aligned_cols=177 Identities=24% Similarity=0.374 Sum_probs=145.0
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
..+||+|+||.||++... +++.|++|++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999864 6889999998765555567899999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++.. ..+++.....++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||++.......... ..
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccc--cc
Confidence 987733 24789999999999999999999985 9999999999999999999999999988664332211 11
Q ss_pred eeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
..++..+. ....|.|++|+.+|++..+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 22332222 3345777788888887753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=204.31 Aligned_cols=187 Identities=24% Similarity=0.413 Sum_probs=146.5
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ---- 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 460 (583)
...++|+..++||+|+||.||+|..+ +++.|++|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567889999999999999999975 588999999975432 22356788999999999999999999987654
Q ss_pred ------eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 461 ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 461 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
..++|+||+++ ++..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 666666432 345899999999999999999999985 999999999999999999999
Q ss_pred EecCCceecCCCCCc-----------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQ-----------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+|||+++........ ..++...+. .......+.|++|+.+|++..+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhC
Confidence 999999876543311 112211111 1123446788889999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-22 Score=201.38 Aligned_cols=184 Identities=27% Similarity=0.457 Sum_probs=142.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...++||+|.+|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999865 688999999865422 234678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN 546 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~ 546 (583)
|++ ++|.+++.... ...+++.....++.||+.||.|||+.+ ++||||+|+||++++ ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57777764322 234678888899999999999999985 999999999999985 567999999999876432
Q ss_pred CCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... ..++..+ .....+.|++|+.+|++..+
T Consensus 157 ~~~~~~--~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 157 VRTFTH--EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred cccccc--CceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 211110 1112222 22345677788888887654
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=178.35 Aligned_cols=99 Identities=32% Similarity=0.646 Sum_probs=76.5
Q ss_pred cccCC---CCcc-CCCChHHHHHHHHHhhhhhhhcc-C--CCceeeccCCCCCeEEEEEecCCCCChhchHHHHHHHHHH
Q 007969 75 VLSCA---VSNN-TASNTFTSNLNILFNQKLHSEAG-K--SLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147 (583)
Q Consensus 75 ~~~C~---~~~~-~~~s~f~~nl~~l~~~~l~~~~~-~--~~~~~~~~g~~~~~vyg~~~C~~Dl~~~~C~~Cl~~a~~~ 147 (583)
|..|+ +++| +++++|++||+.||+. |.+.++ . .+|++++.|.+++++||++||++|+++.+|..||+.|+..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~-l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSS-LVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHH-HHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHH-HHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 56798 3367 6788899999999999 888876 3 5899998899999999999999999999999999999999
Q ss_pred HHhcCCCCccEEEEeecCceEEEEccCCC
Q 007969 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS 176 (583)
Q Consensus 148 ~~~~C~~~~~a~i~~~~~~C~lRy~~~~f 176 (583)
+...|+.++||+||++ +|+||||+++|
T Consensus 80 ~~~~C~~~~g~~v~~~--~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYD--SCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEES--SEEEEEESS--
T ss_pred HHHhCCCCceEEEECC--CEEEEEECCCC
Confidence 9999999999999999 99999999986
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-24 Score=221.31 Aligned_cols=183 Identities=24% Similarity=0.377 Sum_probs=149.4
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.+.|.+...||.|+||+|||+..++ +..-|.|++...+...+++|.-||++|+..+||+||+|++.|...+.+|++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3456667789999999999999765 344578888888888899999999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|.||-.+..+-+- ...|++..+.-++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+-.......
T Consensus 111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999998876443 34689999999999999999999998 599999999999999999999999998765443322
Q ss_pred cccceeeeeccCCCcchhH--------HHHHHHHHHHhh
Q 007969 549 QANTNIIAVDTWPQSMQWE--------AYFLLNLMFSVL 579 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~ 579 (583)
. -...+|+++.+.++.. -|....|+|++|
T Consensus 186 k--RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlG 222 (1187)
T KOG0579|consen 186 K--RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLG 222 (1187)
T ss_pred h--hccccCCcccccchheeeccccCCCchhhhhHHhhh
Confidence 2 2335677665555532 344566666665
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=204.13 Aligned_cols=185 Identities=25% Similarity=0.445 Sum_probs=142.3
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
.++|...++||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 456888999999999999999865 688999999864422 22345678999999999999999999987654
Q ss_pred --eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 461 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
..++||||+.+ +|.+.+... ...+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999964 777777432 235899999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCcc--cceeeeeccCCC-----------cchhHHHHHHHHHHHhhh
Q 007969 539 LARIFGGNQNQA--NTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 539 la~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~ 580 (583)
+++.+....... ......++..+. ....+.|++|+.+|+|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 998764332211 001111222222 234577778888888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=195.90 Aligned_cols=185 Identities=21% Similarity=0.386 Sum_probs=151.0
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...+.||+|+||.||++... +++.+++|++..... ...+++.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999965 588999999976533 4567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++.+.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2356899999999999999999999985 9999999999999999999999999998775543
Q ss_pred CcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++..+. ....|.|.+|+.+|++..+
T Consensus 158 ~~~~--~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 199 (258)
T cd08215 158 DLAK--TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199 (258)
T ss_pred ceec--ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC
Confidence 1111 112222222 2336677788888887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=200.17 Aligned_cols=174 Identities=27% Similarity=0.301 Sum_probs=133.3
Q ss_pred cccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHH---hhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..++ ...+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 588999998865421 1123344454433 34479999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 153 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 153 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc-
Confidence 9999988854 345899999999999999999999985 999999999999999999999999999866432211
Q ss_pred cceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
...++..+. ....|.|++|+.+|++..+
T Consensus 154 ---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 192 (279)
T cd05633 154 ---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192 (279)
T ss_pred ---CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 112222222 2334666777777777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-23 Score=213.59 Aligned_cols=161 Identities=25% Similarity=0.358 Sum_probs=136.7
Q ss_pred CccccChHHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch---hHHHHHHHHHHHhhCCCCCceeE
Q 007969 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRL 452 (583)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l 452 (583)
+.....++........|...+.||-|+||+|.+++.- +...+|.|.|++.+.- .....+.|-++|+.-+.+-||+|
T Consensus 615 ESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 615 ESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred hhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence 3344445555555677888999999999999999744 4667899999876432 33456789999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
+-.|.+++.+|+||||++||++..+|.+ .+-+.+..+..++.+++.|+++.|..| +|||||||.|||||.+|++
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCce
Confidence 9999999999999999999999999854 345788888889999999999999886 9999999999999999999
Q ss_pred EEEecCCceec
Q 007969 533 KISDFGLARIF 543 (583)
Q Consensus 533 kl~DFGla~~~ 543 (583)
||.||||+.-+
T Consensus 769 KLTDFGLCTGf 779 (1034)
T KOG0608|consen 769 KLTDFGLCTGF 779 (1034)
T ss_pred eeeeccccccc
Confidence 99999999754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=207.86 Aligned_cols=184 Identities=24% Similarity=0.416 Sum_probs=143.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----CeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (583)
+++|...++||+|+||.||+|.. .+|+.|++|+++... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999985 468999999997532 23456788999999999999999999987654 357
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++|+||+++ +|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 77766632 35899999999999999999999985 99999999999999999999999999987
Q ss_pred cCCCCCcc-cceeeeeccCCCcc-----------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA-NTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~-~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~ 581 (583)
........ ......++.+++++ ..|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G 206 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 64432211 11112233333333 35677777777777653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=228.93 Aligned_cols=150 Identities=26% Similarity=0.398 Sum_probs=133.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|.+.++||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999975 68899999997542 233467899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ..+++...+.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 999999999998542 35789999999999999999999985 999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-24 Score=206.46 Aligned_cols=182 Identities=26% Similarity=0.413 Sum_probs=147.4
Q ss_pred CCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----CeEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELLL 464 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 464 (583)
.+.++.||.|.||.||.... ++|+.|+.|++...- -...+++.+|+.++..++|.|++..++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34578999999999999885 479999999986442 22357899999999999999999999887644 35788
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+.|.| ..+|..++- ....++...+.-+..||++||.|||+.+ |.||||||.|.|+++|...||+|||+||...
T Consensus 135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88988 457777663 3456888888889999999999999985 9999999999999999999999999999998
Q ss_pred CCCCcccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 545 GNQNQANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
.++...+|..++..+ |..+|. .-|+-.+|+|++|++|
T Consensus 208 ~d~~~hMTqEVVTQY-YRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQY-YRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred hhhhhhhHHHHHHHH-hccHHHhhcchhhcCccceehhhHHH
Confidence 888877777555444 444442 3566777888888776
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=202.77 Aligned_cols=185 Identities=27% Similarity=0.447 Sum_probs=144.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch--hHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (583)
.++|...++||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999865 5899999998744322 233567899999999999999999998765 56899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++ +|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 788877543 245899999999999999999999986 9999999999999999999999999999875
Q ss_pred CCCCcc----------cceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQA----------NTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... .++...+ ........|.|++|+.+|++..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred CccCCCCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhC
Confidence 432111 1111111 01123346777788888887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=208.79 Aligned_cols=183 Identities=20% Similarity=0.395 Sum_probs=144.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 463 (583)
++|+..+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999864 68999999997542 2345678899999999999999999998753 34689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 688888743 344899999999999999999999985 999999999999999999999999999876
Q ss_pred CCCCCcc--cceeeeeccCCCcc-----------hhHHHHHHHHHHHhhh
Q 007969 544 GGNQNQA--NTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~ 580 (583)
....... ......++.++.++ ..+.|++|+.+|++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~ 207 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG 207 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc
Confidence 4332211 01112333333333 3567778888888764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=197.58 Aligned_cols=184 Identities=24% Similarity=0.389 Sum_probs=147.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...+.||+|+||.||++... +|..+++|.+.... ....+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999875 58899999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886532 235799999999999999999999885 99999999999998885 56999999998775432
Q ss_pred CcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++..+. ....+.|++|+.+|++..+
T Consensus 157 ~~~~--~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 157 ELAY--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred cccc--ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 2111 112232222 2346788888888888654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=198.73 Aligned_cols=174 Identities=27% Similarity=0.293 Sum_probs=134.5
Q ss_pred cccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHH---HHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVN---LIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
.||+|+||.||++... +++.||+|.+.+... .....+..|.. .++...||||+++++++..++..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999875422 11223344443 4444579999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~- 153 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 153 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc-
Confidence 9999988843 345899999999999999999999985 999999999999999999999999999866432211
Q ss_pred cceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
...++..++ ....|.|++|+.+|+++.+
T Consensus 154 ---~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g 192 (278)
T cd05606 154 ---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192 (278)
T ss_pred ---CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC
Confidence 112222222 2334677788888888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=207.42 Aligned_cols=181 Identities=28% Similarity=0.380 Sum_probs=143.1
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------ 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 459 (583)
..++|...+.||+|+||.||++... +++.||+|.+.+. .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577889999999999999999854 6899999998653 233456788999999999999999999998643
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++|+||+. ++|.+.+.. .+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 477777632 2788999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
++........ ....++..+.++ ..|.|++|+.+|+|..+
T Consensus 165 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 213 (353)
T cd07850 165 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213 (353)
T ss_pred ceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence 9876543221 111222333332 35777788888887653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=198.82 Aligned_cols=183 Identities=27% Similarity=0.438 Sum_probs=146.4
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
|+..++||+|++|.||+|... +|..|++|++.... ....+.+.+|++.+++++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 68999999987543 222457889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN- 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 548 (583)
+ ++|.+++.... ...+++..++.++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68988885433 235899999999999999999999875 99999999999999999999999999986642211
Q ss_pred ---------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ---------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...|+...+. .......|.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhC
Confidence 1122222211 1224457788889999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=203.64 Aligned_cols=181 Identities=18% Similarity=0.162 Sum_probs=139.7
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.+.+|.|+++.||++.. +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 6899999999754 34556789999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-----
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----- 548 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~----- 548 (583)
|.+++.+.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986532 235889999999999999999999985 99999999999999999999999998876532211
Q ss_pred ------------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ------------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+.........+.|++|+.+|++..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g 206 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhC
Confidence 111111111111122345777788888887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=196.09 Aligned_cols=177 Identities=23% Similarity=0.294 Sum_probs=137.4
Q ss_pred ccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHH-HhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+|+||.||+|... +++.||+|.+.+... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 588999999875432 222344555544 4455899999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC---
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--- 548 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~--- 548 (583)
++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG 155 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence 9999998542 35889999999999999999999985 99999999999999999999999999986543211
Q ss_pred ---cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ---QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..++...+. ......+.|.+|+.+|++..+
T Consensus 156 ~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g 189 (260)
T cd05611 156 TPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFG 189 (260)
T ss_pred CcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHC
Confidence 1122222111 123446788889999888754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=201.27 Aligned_cols=184 Identities=28% Similarity=0.422 Sum_probs=144.2
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|...+.||+|+||.||+++.. ++..|++|++.... ....+++.+|++++++++|+|++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999864 68899999987442 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|++ |+|.+++... ...++|..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 997 4777666432 345899999999999999999999985 9999999999999999999999999988654322
Q ss_pred Cc------ccceeeee-ccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQ------ANTNIIAV-DTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ..++...+ .........+.|++|+++|+++.+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g 220 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence 21 11221110 011223345778889999888754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=201.38 Aligned_cols=183 Identities=25% Similarity=0.314 Sum_probs=146.1
Q ss_pred CCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
+|...+.||+|++|.||+++. .+++.|+||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999974 357889999987532 22346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998853 235889999999999999999999875 99999999999999999999999999987
Q ss_pred cCCCCCcccceeeeeccCC------------CcchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWP------------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~ 581 (583)
+........ ....++..+ .....+.|++|+.+|++..+
T Consensus 155 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 155 FLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred ccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 654322111 111222222 23346788889999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=197.80 Aligned_cols=178 Identities=24% Similarity=0.371 Sum_probs=138.6
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCC-CCCceeEEEEEEeC--CeEEEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIYE 467 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e 467 (583)
|...++||+|+||.||++... +++.+++|+++... ........+|+..+.++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999854 68899999987542 222234567899999885 99999999999987 88999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|++ ++|.+++... ...++|..+..++.||+.||.|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777777542 245899999999999999999999985 999999999999999 999999999998764432
Q ss_pred CcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.... ..++.++ .....|.|++|+.+|++..
T Consensus 154 ~~~~---~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 154 PYTE---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred CcCC---CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 2110 1122222 2334567778888887764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=198.15 Aligned_cols=182 Identities=23% Similarity=0.305 Sum_probs=143.8
Q ss_pred HcCCCCcc-ccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe----CCe
Q 007969 389 ATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQE 461 (583)
Q Consensus 389 ~~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~ 461 (583)
.+++|++. ++||-|-.|+|-.+..+ +++.+|+|+|... ....+|+++.-.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555554 58999999999999765 6889999998755 4557888876666 59999999999864 356
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 538 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 538 (583)
+++|||.|+||.|...+.+.. ...+++.++-.|..||+.|+.|||+. +|.||||||+|+|... |-..||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987644 45699999999999999999999987 5999999999999954 5579999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhhc
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~f 582 (583)
+|+.-..+..-.. ..-|++|..++ -+.|+++++||.|++||
T Consensus 210 FAK~t~~~~~L~T---Pc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGy 260 (400)
T KOG0604|consen 210 FAKETQEPGDLMT---PCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_pred cccccCCCccccC---CcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCC
Confidence 9998765433222 23444444433 24666889999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=203.83 Aligned_cols=181 Identities=22% Similarity=0.273 Sum_probs=141.4
Q ss_pred cccccc--CceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G--~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
+.||+| +||+||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 89999999864 78999999987542 23357789999999999999999999999999999999999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC---
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--- 548 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~--- 548 (583)
++|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+|++||+.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886533 234899999999999999999999885 99999999999999999999999985543321110
Q ss_pred --------------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 --------------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+...+.........|.|++|+.+|++..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g 206 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 111222212112223456788889999988765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=195.83 Aligned_cols=183 Identities=27% Similarity=0.421 Sum_probs=148.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|+..++||+|+||.||++... +++.+++|.+.... .....++.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999754 68899999987542 33456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886532 2345899999999999999999999885 9999999999999999999999999998875442
Q ss_pred CcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ...++..+.+ ...+.|++|+.+|++..+
T Consensus 158 ~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 197 (256)
T cd08530 158 AK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197 (256)
T ss_pred cc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC
Confidence 11 1122222222 245677788888888654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=205.65 Aligned_cols=183 Identities=23% Similarity=0.416 Sum_probs=143.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----Ce
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (583)
.++|...++||+|+||.||+++.. +++.|+||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999854 6899999998753 233356778899999999999999999988654 35
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++|+||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688888743 345899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.......... ...++.++ .....+.|++|+.+|++..+
T Consensus 157 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 205 (337)
T cd07858 157 TTSEKGDFMT--EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205 (337)
T ss_pred ccCCCccccc--ccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence 7654321111 11222222 22335677788888887644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.11 Aligned_cols=147 Identities=27% Similarity=0.452 Sum_probs=126.3
Q ss_pred CCCC-ccccccccCceEEEEEEec-CCcEEEEEEeccCCchh--------------HHHHHHHHHHHhhCCCCCceeEEE
Q 007969 391 NHFS-DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--------------LQEFKNEVNLIAKLQHKNLVRLLG 454 (583)
Q Consensus 391 ~~~~-~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 454 (583)
++|. ..+.||+|+||.||+++.. +++.||+|+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3567999999999999865 68999999987543221 125789999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
++..++..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888843 345889999999999999999999885 999999999999999999999
Q ss_pred EecCCceecC
Q 007969 535 SDFGLARIFG 544 (583)
Q Consensus 535 ~DFGla~~~~ 544 (583)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.87 Aligned_cols=180 Identities=26% Similarity=0.432 Sum_probs=143.0
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-----
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----- 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 460 (583)
..++|...+.||+|+||.||++.. .++..||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788899999999999999985 468999999986432 223457889999999999999999999987543
Q ss_pred -eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 461 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
..++|+||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 468999998 7788887742 35899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
++........ ..++.++ .....+.|++|+.+|++..+
T Consensus 165 ~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 212 (343)
T cd07880 165 ARQTDSEMTG-----YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212 (343)
T ss_pred ccccccCccc-----cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9876433211 1122222 23345677788888777653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.65 Aligned_cols=185 Identities=27% Similarity=0.401 Sum_probs=145.4
Q ss_pred HHHHHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-
Q 007969 384 RLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG- 459 (583)
Q Consensus 384 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~- 459 (583)
..+...+++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556778999999999999999999985 468899999997542 23346788999999999999999999988643
Q ss_pred -----CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 460 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 460 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2467788876 7889887732 24899999999999999999999985 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+|||+++....... ...++.++. ....+.|++|+.+|++..+
T Consensus 162 ~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 214 (345)
T cd07877 162 LDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214 (345)
T ss_pred eccccccccccccc-----ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhC
Confidence 99999986543221 112222222 2345777788888887654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=198.81 Aligned_cols=185 Identities=18% Similarity=0.222 Sum_probs=130.8
Q ss_pred cCCCCccccccccCceEEEEEEecC----CcEEEEEEeccCCchhH-----------HHHHHHHHHHhhCCCCCceeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGL-----------QEFKNEVNLIAKLQHKNLVRLLG 454 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g 454 (583)
.+.|.+.++||+|+||.||+|...+ +..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4678899999999999999998654 34566665432221110 11223444566778999999999
Q ss_pred EEEeCC----eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 455 CCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 455 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
++.... ..++++|++. .++.+.+.. ....++..+..|+.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 3477888764 356555532 123578888999999999999999985 99999999999999999
Q ss_pred ceEEEecCCceecCCCCCc-----ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 531 NPKISDFGLARIFGGNQNQ-----ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 531 ~~kl~DFGla~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.+||+|||+++.+..+... .......|+..|++++ .|.|++|+.+|++..+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999987532211 1122235666666555 4677778888777543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=198.60 Aligned_cols=183 Identities=28% Similarity=0.416 Sum_probs=142.6
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
|...++||+|+||.||+|+.. +++.|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 68899999987442 23346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+. +++.+++... ...+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 96 5777766432 345899999999999999999999985 99999999999999999999999999875432221
Q ss_pred ------cccceeeee-ccCCCcchhHHHHHHHHHHHhhhh
Q 007969 549 ------QANTNIIAV-DTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ------~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+..|+.... .........+.|++|+.+|+++.+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 111221110 011223345788889999888654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-21 Score=193.27 Aligned_cols=181 Identities=20% Similarity=0.241 Sum_probs=138.5
Q ss_pred HHcCCCCccccc--cccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEE
Q 007969 388 EATNHFSDENKL--GQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 388 ~~~~~~~~~~~L--G~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (583)
...++|...+++ |+|+||.||++..+ ++..+++|.+........ |+.....+ +||||+++++.+..++..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 344566666665 99999999999864 678899999875432211 22222222 7999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCcee
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARI 542 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 542 (583)
+||||+++++|.+++... ..++|..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999998543 36899999999999999999999985 99999999999999998 999999999987
Q ss_pred cCCCCCc------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
....... ..|+...+. ......+.|++|+.+|++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g 202 (267)
T PHA03390 160 IGTPSCYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTG 202 (267)
T ss_pred cCCCccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHC
Confidence 6543321 122222221 123346778889999988765
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=231.63 Aligned_cols=186 Identities=26% Similarity=0.332 Sum_probs=152.7
Q ss_pred cCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
+-+|+...+||.|.||.||.+. ..+|+..|+|-++-.+ .+..+...+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778899999999999998 5678999999887543 344567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|||++|+|.+.+... .-.++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|+.|||-|+.+.++
T Consensus 1314 EyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999998543 23566666778899999999999997 999999999999999999999999999988766
Q ss_pred CC--cccceeeeeccCCCcchhH------HHHHHHHHHHhhhh
Q 007969 547 QN--QANTNIIAVDTWPQSMQWE------AYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~ 581 (583)
.. ...-+...||+.||.+|.- -.+-+.|+|+|||.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence 31 1223456788888888752 33345677777764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=196.97 Aligned_cols=183 Identities=28% Similarity=0.385 Sum_probs=145.4
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
|...+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999975 478899999875532 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
+|+|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||+++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889988885533 245899999999999999999999985 999999999999999999999999999877543221
Q ss_pred ---------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 550 ---------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
..++..... .......+.|++|+.+|++..+
T Consensus 156 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 156 TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhC
Confidence 122211111 1123446788899999988754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=192.12 Aligned_cols=175 Identities=30% Similarity=0.387 Sum_probs=143.1
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 588999999876532 2456889999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccccee
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 554 (583)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--ccC
Confidence 9998543 35899999999999999999999975 999999999999999999999999999887543211 111
Q ss_pred eeeccCC----------CcchhHHHHHHHHHHHhhhh
Q 007969 555 IAVDTWP----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 555 ~~~~~~~----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
..++..+ .....|.|.+|+.+|+++.+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 189 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 1222222 23346778888888888754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=202.86 Aligned_cols=183 Identities=26% Similarity=0.418 Sum_probs=146.2
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-----eEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL 463 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 463 (583)
+|...++||+|+||.||+++.. +++.+++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777899999999999999975 48899999997653 344578999999999999999999999998765 789
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
++|||++ ++|.+++.+ ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 578888743 236899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCc-ccceeeeeccC-----------CCcchhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQ-ANTNIIAVDTW-----------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... .......++.+ ......+.|++|+.+|++..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 554310 00111122222 233346777788888887654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=198.20 Aligned_cols=187 Identities=24% Similarity=0.317 Sum_probs=141.7
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+|...++||+|+||.||++... +++.+++|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999864 58999999987543 334567899999999996 99999999999999999999999
Q ss_pred CCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 469 MPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 469 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
+.. ++.++... ......+++.....++.|++.||.|||+.. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443221 122346899999999999999999999752 4999999999999999999999999999866432
Q ss_pred CC---------cccceeeeecc-CCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QN---------QANTNIIAVDT-WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~---------~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.. +..|+...+.. .......|.|++|+.+|++..+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 206 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhC
Confidence 21 11122111110 1223346777788888888643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=198.24 Aligned_cols=187 Identities=23% Similarity=0.347 Sum_probs=143.5
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||++...+ ++.|+||.++.... ....++..|+.++.+.. |+||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999864 88999999975432 33456777887777775 999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||++ +++.+++... ...+++..+..++.||++||.|||+.. +|+||||+|+||++++++.+||+|||+++.+...
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 4676666432 236899999999999999999999742 4999999999999999999999999999876433
Q ss_pred CCcc---------cceeeeecc--CCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQA---------NTNIIAVDT--WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~---------~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.... .++...+.. .......|.|++|+.+|++..+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g 214 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhC
Confidence 2211 111111110 1122346778889999888754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=195.68 Aligned_cols=181 Identities=27% Similarity=0.449 Sum_probs=145.2
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999865 688999999875532 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++ +|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8887775432 46899999999999999999999985 999999999999999999999999999887654311
Q ss_pred ccceeeeeccC-----------CCcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTW-----------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
. . ...++.+ ....+.|.|++|+.+|++..+
T Consensus 155 ~-~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 155 Y-T-HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred c-c-CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 0 0 0112222 223446777888888887654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=200.03 Aligned_cols=182 Identities=27% Similarity=0.387 Sum_probs=139.0
Q ss_pred CCCccccccccCceEEEEEEec-C--CcEEEEEEeccCC--chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC----Ce
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-D--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG----QE 461 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~--g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 461 (583)
+|...+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999965 3 6789999987532 22356788999999999 599999999976433 35
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 688888743 345899999999999999999999986 9999999999999999999999999998
Q ss_pred ecCCCCCcc--cceeeeeccCCCcch-----------hHHHHHHHHHHHhhh
Q 007969 542 IFGGNQNQA--NTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 542 ~~~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~ 580 (583)
.+....... ......++..|.+++ .|.|++|+.+|++..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~ 205 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 765432211 111233444444444 356666766666653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=217.81 Aligned_cols=188 Identities=29% Similarity=0.398 Sum_probs=149.0
Q ss_pred HcCCCCccccccccCceEEEEEEec--------CCcEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE 458 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 458 (583)
..+++...+.||+|.||.|++|.+. ....||||.++.. .....+.+..|+++|..+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444456669999999999999843 1357999999865 335578899999999999 69999999999999
Q ss_pred CCeEEEEEEcCCCCChhHHHhccC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDAT-----------RS--VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 525 (583)
++..++|+||++.|+|.++|++.+ .. ..++..+.+.++.|||.||+||++. ++|||||.+||||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999997654 00 1388899999999999999999987 4999999999999
Q ss_pred EcCCCceEEEecCCceecCCCCCcccceee--eeccC---------CCcchhHHHHHHHHHHHhh
Q 007969 526 LDDDMNPKISDFGLARIFGGNQNQANTNII--AVDTW---------PQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 526 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~~l~~l~ 579 (583)
+.++..+||+|||+||.......+...... ..-.| .+..+.++|++|+.+||+.
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 999999999999999977665554322111 11113 2233346677777888764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-21 Score=199.19 Aligned_cols=186 Identities=26% Similarity=0.416 Sum_probs=147.1
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL 462 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 462 (583)
...+++|+..++||+|+||.||++... +++.|++|++.+. .....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999854 7899999988643 22335678899999999999999999999876 4578
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++++||+ +++|..++.. ..+++.....++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 5688887742 34788888999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCC-------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQN-------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... ...++...+ ........+.|++|+.+|++..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg 202 (328)
T cd07856 158 QDPQMTGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEG 202 (328)
T ss_pred cCCCcCCCcccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhC
Confidence 543211 122222211 12234557888889999888754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=202.05 Aligned_cols=142 Identities=23% Similarity=0.276 Sum_probs=114.7
Q ss_pred HHcCCCCccccccccCceEEEEEEec--CCcEEEEEEeccC-----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
...+.|...++||+|+||+||+|..+ +++.+|||++... .....+.|.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45677999999999999999999864 5778899987633 12235679999999999999999853322 24
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEcCCCceEEEecCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DFGl 539 (583)
..++||||+++++|.. + . . .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~-~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A-R--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHH-h-C--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 6799999999999962 2 1 1 11 1457889999999999985 999999 99999999999999999999
Q ss_pred ceecCC
Q 007969 540 ARIFGG 545 (583)
Q Consensus 540 a~~~~~ 545 (583)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 998754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=199.17 Aligned_cols=186 Identities=29% Similarity=0.471 Sum_probs=143.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch--hHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
.++|...++||+|+||.||+++.. +++.+++|++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999865 6889999998654322 2346789999999999999999999875433
Q ss_pred --eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 461 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
..++|+||+.+ +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999965 666666432 345899999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCccc---------ceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQAN---------TNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~---------~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+++.......... .....++..+. ....|.|++|+++|+|..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g 223 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhC
Confidence 9987653322111 01112222222 2335777788888888654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=195.29 Aligned_cols=181 Identities=30% Similarity=0.453 Sum_probs=146.3
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
|+..++||+|.+|.||+|+.. +++.+++|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999975 58999999998653 333467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
+ ++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999886532 35899999999999999999999985 999999999999999999999999999876543221
Q ss_pred ccceeeeeccC-----------CCcchhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTW-----------PQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..++.+ ......+.|++|+.+|+++.+
T Consensus 155 ~~~--~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 155 YTH--EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred cCc--cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC
Confidence 111 111111 223346788889999888654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=193.20 Aligned_cols=181 Identities=28% Similarity=0.478 Sum_probs=141.1
Q ss_pred CCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhC---CCCCceeEEEEEEeCCe-----
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQE----- 461 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 461 (583)
|.+.++||+|+||.||+++.+ +++.+++|+++.... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999976 489999999974422 2234566788777665 69999999999988776
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.+++|||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999974 7888875433 235899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.+....... ...++..+.+ ...|.|++|+.+|+|..+
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~ 202 (287)
T cd07838 156 IYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR 202 (287)
T ss_pred eccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhC
Confidence 875432211 1112222222 336788889999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=202.51 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=141.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC---------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------- 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------- 459 (583)
..+|...++||+|+||.||+|... +++.|++|++........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367888999999999999999864 5889999999776666667889999999999999999999876543
Q ss_pred -----CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceE
Q 007969 460 -----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 533 (583)
Q Consensus 460 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 533 (583)
...++|+||++ ++|.+++.+ ..+++.....++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588877732 34889999999999999999999985 99999999999997 456789
Q ss_pred EEecCCceecCCCCCcc-cceeeeeccCCCc-----------chhHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQA-NTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~-~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~ 580 (583)
|+|||+++......... ......++.++.+ ...+.|++|+.+|++..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 99999998764321111 0111122223222 23567777788777754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-23 Score=196.91 Aligned_cols=186 Identities=25% Similarity=0.347 Sum_probs=140.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++++....||.|.||+|+|-.++ .|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44555678999999999998865 699999999986643 5678899999876655 78999999999999999999999
Q ss_pred cCCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 468 YMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 468 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
.| ..+|+.+-.. ..+...+++...-.|...+.+||.||.+.. +|||||+||+|||||..|.+||+|||++-.+..
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 4566544321 123345888888889999999999999875 799999999999999999999999999987643
Q ss_pred C---------CCcccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 546 N---------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 546 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
+ +.+..|+++....--.....++|++|..+||+.
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee
Confidence 3 233444444322222233345555555555543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=181.28 Aligned_cols=188 Identities=23% Similarity=0.344 Sum_probs=145.5
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
..+.+...+.||+|++|.|-+-++ .+|..+|+|++... ..+..++.+.|+.+..+- ..|.+|.++|.....+..++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 344555567899999999998885 47999999999855 445567888999886665 799999999999999999999
Q ss_pred EEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||.| ..+|+.+-.+. .+...+++...-+|+..|.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 45777665432 3456688999999999999999999986 479999999999999999999999999998775
Q ss_pred CC---------CCcccceeeeeccC--CCcchhHHHHHHHHHHHhh
Q 007969 545 GN---------QNQANTNIIAVDTW--PQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 545 ~~---------~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~ 579 (583)
.+ +.+..|+++.+... -.+...+.|++|..++||.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 33 33444444433322 2344555666666666553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=210.46 Aligned_cols=190 Identities=26% Similarity=0.420 Sum_probs=153.6
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe--
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE-- 458 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 458 (583)
++.+...++.|++.+.||.|.+|.||+++. ++++..|+|++..... ..++...|..+++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445677899999999999999999984 5788889998865432 336778888898888 69999999999964
Q ss_pred ---CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 459 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
++++|||||||.+|+..++++... ...+.|..+..|+..++.||.+||.. +++|||||-.||||+.++.|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999997655 66799999999999999999999988 49999999999999999999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcchh--------HHHHHHHHHHHhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSMQW--------EAYFLLNLMFSVL 579 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~l~ 579 (583)
|||.+..+........| .+|++..|.++. -.|..-+|+|+||
T Consensus 166 DFGvSaQldsT~grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred eeeeeeeeecccccccC--cCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 99999998776665554 466655444442 1334555555554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-24 Score=198.38 Aligned_cols=182 Identities=27% Similarity=0.514 Sum_probs=139.3
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-h-hHHHHHHHHHHHhhCCCCCceeEEEEEEeC--------C
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-Q-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------Q 460 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~ 460 (583)
.|....+||+|.||+||+|+.+ +|+.||+|++.-... . --....+|++++..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999965 477788887653221 1 124558999999999999999999888532 3
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++|+++|+. +|.-+|.+ ....++..++.++..++.+||.|+|.. +|+|||+||.|+||+.++..||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999975 67777743 234588899999999999999999976 5999999999999999999999999999
Q ss_pred eecCCCCCcccce--eeeeccCCCcch-----------hHHHHHHHHHHHhh
Q 007969 541 RIFGGNQNQANTN--IIAVDTWPQSMQ-----------WEAYFLLNLMFSVL 579 (583)
Q Consensus 541 ~~~~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~l~~l~ 579 (583)
|.+........+. ..+.|.||.++| .+.|+.++++-+|+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence 9886554433222 234567777765 35556666665554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=196.02 Aligned_cols=184 Identities=29% Similarity=0.432 Sum_probs=143.2
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|...+.||+|+||.||+|+.. +++.+++|.+... .....+++.+|+++++.++|+|++++++++..+...++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 5788999998642 22335678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+. |++.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 996 5777766432 234889999999999999999999885 9999999999999999999999999998765432
Q ss_pred Ccc------cceeeee-ccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQA------NTNIIAV-DTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~------~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
... .|+...+ .........+.|++|+.+|++..+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 210 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence 211 1111110 001122335777788888888654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=199.15 Aligned_cols=186 Identities=26% Similarity=0.366 Sum_probs=147.9
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch---hHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
....+|....+||+|+||+|..+.-+ +.+.+|||+|++.-.- +.+--..|-++|+.. +-|.++.+..++...+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888899999999999999865 4567899999876322 122234566677666 578999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
|+||||+.+|+|..++++-. .+.+..+..++..||-||-|||+++ ||.||||..||+||.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998886543 4777888999999999999999997 99999999999999999999999999985
Q ss_pred c----------CCCCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 543 F----------GGNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
- -+...+..++.+...++..+.+||+ +|+.+|+|+.+
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa--~GVLLyEmlaG 546 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA--FGVLLYEMLAG 546 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHH--HHHHHHHHHcC
Confidence 3 2344555666666555556666766 66777887764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=191.59 Aligned_cols=184 Identities=26% Similarity=0.398 Sum_probs=141.0
Q ss_pred CCCccccccccCceEEEEEEecC-CcEEEEEEeccC-----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
+|...++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+++..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998643 444555555432 122344677899999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+||+++++|.+++.+. .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888643 23346899999999999999999999985 999999999999976 569999999998775
Q ss_pred CCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.......+ ..++..+. ....+.|++|+.+|++..+
T Consensus 157 ~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 157 GSCDLATT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred CCcccccC--CCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 43221111 11222222 2346788889999887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-22 Score=191.62 Aligned_cols=184 Identities=24% Similarity=0.370 Sum_probs=150.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|++.+|..++++ +.+.+|+|++++. +.++.+-.+.|-.+..+. +||.+|.+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457888899999999999999975 5678899999865 334456677788887776 79999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|.||+++|+|..++++ ...|+++.+..+...|.-||.|||+.+ ||.||||..|||||..|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999887744 345999999999999999999999997 9999999999999999999999999998653
Q ss_pred CC----------CCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 GN----------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.+ .++..|+...|+-+-++.+||+ +|+.||+|+.+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwa--lgvlmfemmag 447 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA--LGVLMFEMMAG 447 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHH--HHHHHHHHHcC
Confidence 32 3333444444544455566665 88888888765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=197.83 Aligned_cols=182 Identities=26% Similarity=0.411 Sum_probs=140.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (583)
.++|...+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 467888899999999999999854 68999999987542 22345688999999999999999999998754 3
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 666554 224889999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCC-------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQN-------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+....... +..++...+ ........|.|++|+.+|++..+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g 211 (342)
T cd07879 165 RHADAEMTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTG 211 (342)
T ss_pred cCCCCCCCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhC
Confidence 87543221 111221111 01123346777888888888654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=200.37 Aligned_cols=184 Identities=27% Similarity=0.398 Sum_probs=144.7
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe----
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE---- 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 461 (583)
..++|...++||+|++|.||+|+.. +++.|++|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999975 5789999998753 22334677889999999999999999998866554
Q ss_pred --EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 462 --LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 462 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6789888843 35899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCC-------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQN-------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
++....... +..++...+ ........+.|++|+.+|+++.+
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg 212 (343)
T cd07851 165 ARHTDDEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTG 212 (343)
T ss_pred cccccccccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhC
Confidence 987643311 111111111 01223446778888888887654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=211.70 Aligned_cols=184 Identities=21% Similarity=0.280 Sum_probs=126.2
Q ss_pred HcCCCCccccccccCceEEEEEEec-C----CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEE------EE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC------CL 457 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 457 (583)
..++|...++||+|+||.||+|+.. + +..||+|++...... +.+.+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567899999999999999999975 4 689999998654321 111111 1222222233222221 23
Q ss_pred eCCeEEEEEEcCCCCChhHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 458 EGQELLLIYEYMPNKSLDVHLFDATRS-----------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 458 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
.+.+.++|+||+++++|.+++...... ....+..+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456899999999999999988643210 01123345679999999999999985 9999999
Q ss_pred CCcEEEcC-CCceEEEecCCceecCCCCCcccceeeeeccCCCcch--------------------------------hH
Q 007969 521 ASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ--------------------------------WE 567 (583)
Q Consensus 521 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~ 567 (583)
|+|||+++ ++.+||+|||+|+.+........ ....++..|+++| .|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 68999999999987644332221 2234444444444 28
Q ss_pred HHHHHHHHHHhhh
Q 007969 568 AYFLLNLMFSVLE 580 (583)
Q Consensus 568 ~~~~~~~l~~l~~ 580 (583)
.|++|+++|+|..
T Consensus 362 VwSlGviL~el~~ 374 (566)
T PLN03225 362 IYSAGLIFLQMAF 374 (566)
T ss_pred cHHHHHHHHHHHh
Confidence 8889999998863
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=181.84 Aligned_cols=139 Identities=17% Similarity=0.213 Sum_probs=108.5
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCch--h-------HHHH-----------------HHHHHHHhhCCCCCc
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--G-------LQEF-----------------KNEVNLIAKLQHKNL 449 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~H~ni 449 (583)
...||+|+||.||+|...+|+.||||+++..... . ...| .+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 1122 349999999988876
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCcEEEcC
Q 007969 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDD 528 (583)
Q Consensus 450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlk~~NILl~~ 528 (583)
.....+... ..++||||++++++...... ...+++.....++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 544433222 23899999999877654321 24588999999999999999999 6764 99999999999998
Q ss_pred CCceEEEecCCceec
Q 007969 529 DMNPKISDFGLARIF 543 (583)
Q Consensus 529 ~~~~kl~DFGla~~~ 543 (583)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-20 Score=177.56 Aligned_cols=183 Identities=30% Similarity=0.423 Sum_probs=148.8
Q ss_pred CCccccccccCceEEEEEEecC-CcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++.+......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999865 889999999876554 67889999999999999999999999999899999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++..... .+++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999854322 1789999999999999999999985 9999999999999999999999999999876543000
Q ss_pred cceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.....+...+ .....|.|++|+.+|++..+
T Consensus 156 -~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 156 -LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred -ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 0111122221 22246788888888887653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=184.25 Aligned_cols=167 Identities=18% Similarity=0.193 Sum_probs=132.3
Q ss_pred cCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhc
Q 007969 402 GGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480 (583)
Q Consensus 402 G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 480 (583)
|.+|.||+++.. +++.+++|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 68899999997653 234555566667799999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-------cccce
Q 007969 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-------QANTN 553 (583)
Q Consensus 481 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-------~~~~~ 553 (583)
. ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.++++|||+++....... +..++
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 3 34899999999999999999999985 99999999999999999999999998876543211 12222
Q ss_pred eeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 554 IIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
...+ .......|.|++|+.+|++..+
T Consensus 153 ~~~~--~~~~~~~DvwslG~il~el~~g 178 (237)
T cd05576 153 VGGI--SEETEACDWWSLGAILFELLTG 178 (237)
T ss_pred ccCC--CCCCchhhHHHHHHHHHHHHHC
Confidence 1111 1123346777888888888765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=186.44 Aligned_cols=188 Identities=20% Similarity=0.276 Sum_probs=150.1
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEecC------CcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEE
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 457 (583)
++.....++.....+.+|.||.||.|.+.+ .+.|.+|.++.. ++-+...++.|.-++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 334445668888889999999999997643 356888888765 4445678899999999999999999999997
Q ss_pred eC-CeEEEEEEcCCCCChhHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 007969 458 EG-QELLLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 458 ~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 531 (583)
+. ...+++|.++..|+|..||. +.+....++..+...++.|++.||+|||.++ |||.||.++|++||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 65 56799999999999999998 4444456778888899999999999999986 999999999999999999
Q ss_pred eEEEecCCceecCCCCCcccceeeeeccCC---------------CcchhHHHHHHHHHHHhhh
Q 007969 532 PKISDFGLARIFGGNQNQANTNIIAVDTWP---------------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~l~~ 580 (583)
+||+|=.|+|.+-+...+ ..|+..+ ++...|+|.+|+.+|||..
T Consensus 435 VkltDsaLSRDLFP~DYh-----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt 493 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYH-----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT 493 (563)
T ss_pred EEeccchhccccCccccc-----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence 999999999987654432 1222222 2233467778888998864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=199.46 Aligned_cols=150 Identities=23% Similarity=0.358 Sum_probs=127.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch--------hHHHHHHHHHHHhhCC---CCCceeEEEEEEe
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQ---HKNLVRLLGCCLE 458 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 458 (583)
..|+..++||+|+||.|+.+..+ +..+|+||.+.+...- .+-..--||.+|+.++ |+||++++.+|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999976 4668999998765211 1123456999999997 9999999999999
Q ss_pred CCeEEEEEEcCC-CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 459 GQELLLIYEYMP-NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 459 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
++..|+++|-.. +-+|.+++. ....+++.+...|+.||+-|+++||+++ |||||||-+||++|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 568888883 3445899999999999999999999997 999999999999999999999999
Q ss_pred CCceecCCC
Q 007969 538 GLARIFGGN 546 (583)
Q Consensus 538 Gla~~~~~~ 546 (583)
|-|......
T Consensus 715 gsaa~~ksg 723 (772)
T KOG1152|consen 715 GSAAYTKSG 723 (772)
T ss_pred cchhhhcCC
Confidence 988765433
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=193.37 Aligned_cols=185 Identities=21% Similarity=0.319 Sum_probs=152.6
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEecc--CCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 465 (583)
....|+..++||.||-+.||++...+.+.+|+|++.. .+.+.++.|.+|+.+|.+|+ |.+|++|++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4466888999999999999999998888899988763 46677899999999999995 99999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||= ..+|..+|.+.... ...| .+..+-.||+.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9974 67899999664432 2345 56778899999999999996 999999999999865 6899999999999887
Q ss_pred CCCcccceeeeeccCCCcch---------------------hHHHHHHHHHHHhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ---------------------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~l~~ 580 (583)
+.+....+.-+||..|+++| .|+|++|+++|.|.-
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 76655555556777766654 366777777777653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-21 Score=183.84 Aligned_cols=153 Identities=25% Similarity=0.428 Sum_probs=127.1
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
+......||.|+.|.|++.+.+ .|..+|||.+.+... +..++++..++++.+-+ .|.||+-+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3444567999999999999965 588999999987644 45678888888877664 89999999999999999999998
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
|. ..++.+|... .+++++...-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++-++..+..
T Consensus 173 Ms-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 84 3455565432 345888888899999999999999987 699999999999999999999999999998865544
Q ss_pred c
Q 007969 549 Q 549 (583)
Q Consensus 549 ~ 549 (583)
+
T Consensus 248 h 248 (391)
T KOG0983|consen 248 H 248 (391)
T ss_pred c
Confidence 3
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=180.30 Aligned_cols=179 Identities=20% Similarity=0.394 Sum_probs=140.3
Q ss_pred HcCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeC--CeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~l 464 (583)
..++|++.+++|+|.+++|+.|. ..+.+.++||.|+... .+.+.+|+.++..+. ||||++++++..++ ....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34678889999999999999998 5678899999998553 367899999999997 99999999999876 35689
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCceec
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF 543 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~ 543 (583)
|+||+++.+...+- ..|+..++...+.++++||.|+|+.| |+|||+||.|++||.. ...+|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 24777888899999999999999986 9999999999999865 46899999999999
Q ss_pred CCCCCcccceeeeeccCCCc----chhHHHHHHHHHHHhhhhc
Q 007969 544 GGNQNQANTNIIAVDTWPQS----MQWEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~f 582 (583)
.+...+..- +...+.-. .+.-.|....|+|++|+-|
T Consensus 184 Hp~~eYnVR---VASRyfKGPELLVdy~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 184 HPGKEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCML 223 (338)
T ss_pred CCCceeeee---eehhhcCCchheeechhccccHHHHHHHHHH
Confidence 877654321 11111111 2234555556666666543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=175.74 Aligned_cols=142 Identities=19% Similarity=0.249 Sum_probs=112.5
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCch---------------------h-----HHHHHHHHHHHhhCCCCCc
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---------------------G-----LQEFKNEVNLIAKLQHKNL 449 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~H~ni 449 (583)
...||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999999764211 0 1123678999999999988
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcC
Q 007969 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD 528 (583)
Q Consensus 450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~ 528 (583)
.....+.... .++||||++++++...... ...++......++.|++.+|.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 6555544332 4899999998865433211 2347788899999999999999999 75 99999999999999
Q ss_pred CCceEEEecCCceecCCC
Q 007969 529 DMNPKISDFGLARIFGGN 546 (583)
Q Consensus 529 ~~~~kl~DFGla~~~~~~ 546 (583)
++.++|+|||+++.....
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=198.53 Aligned_cols=181 Identities=24% Similarity=0.298 Sum_probs=151.8
Q ss_pred CCCccccccccCceEEEEEEecCCc-EEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++.....||-|+||.|-........ .+|+|.+++. +.+..+....|-.+|...+.|.||+++..+.+.+..|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3444556999999999998875433 4788888765 33445678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
-|-||.|+..|.+ ++.++..+...++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.+..+.
T Consensus 501 aClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999954 456888999999999999999999986 9999999999999999999999999999987665
Q ss_pred CcccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
.|-..+||+.|..+++ +.|.+|..+|+|+.|
T Consensus 575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 3556778887776663 556677888887764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=175.50 Aligned_cols=170 Identities=29% Similarity=0.401 Sum_probs=140.4
Q ss_pred CceEEEEEEec-CCcEEEEEEeccCCchh-HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhc
Q 007969 403 GFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480 (583)
Q Consensus 403 ~fG~Vy~a~~~-~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 480 (583)
+||.||++... +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998665544 68999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccC
Q 007969 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560 (583)
Q Consensus 481 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 560 (583)
.. .+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++......... ....+...
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL---TTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccccc---ccccCCcC
Confidence 32 2889999999999999999999985 999999999999999999999999999987654211 11122222
Q ss_pred CC----------cchhHHHHHHHHHHHhhhh
Q 007969 561 PQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 561 ~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+. ....+.|.+|+.+|++..+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~ 182 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTG 182 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 22 2346778888888887653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-20 Score=193.13 Aligned_cols=181 Identities=22% Similarity=0.375 Sum_probs=142.7
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++.|.....+|.|+|+.|-++... +++..++|++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567788888999999999999854 67889999998762 2335677666665 7999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-cCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGla~~~~~ 545 (583)
|.+.++-+.+.+.... ... ..+..|+.+|+.++.|||+++ ||||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988776663321 122 667789999999999999986 9999999999999 6999999999999998876
Q ss_pred C-------CCcccceeeeeccCCCcchhHHHHHHHHHHHhhhhc
Q 007969 546 N-------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 546 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~f 582 (583)
+ ..+..|+......+.+..+||+ +|+.+|+|+.|.
T Consensus 469 ~~~tp~~t~~y~APEvl~~~~yt~acD~WS--LGvlLy~ML~G~ 510 (612)
T KOG0603|consen 469 SCDTPALTLQYVAPEVLAIQEYTEACDWWS--LGVLLYEMLTGR 510 (612)
T ss_pred hhcccchhhcccChhhhccCCCCcchhhHH--HHHHHHHHHhCC
Confidence 5 1234455444333444445554 899999998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-18 Score=166.72 Aligned_cols=143 Identities=37% Similarity=0.622 Sum_probs=127.7
Q ss_pred ccccCceEEEEEEecC-CcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhH
Q 007969 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 476 (583)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999866443 35789999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCCC
Q 007969 477 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN 546 (583)
Q Consensus 477 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~ 546 (583)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 985432 35889999999999999999999985 999999999999999 899999999999877554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=196.13 Aligned_cols=183 Identities=29% Similarity=0.358 Sum_probs=140.5
Q ss_pred CCCccccccccCceE-EEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 392 HFSDENKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~-Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
-|...+.+|.|.-|+ ||+|.. +|++||||++-... .+-..+|+..+..- +||||+++++.-.++...||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355667889999865 699998 58899999987543 23557899998887 6999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCceEEEecCCceec
Q 007969 470 PNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIF 543 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~~ 543 (583)
..+|.+++........ ..-.....+..|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5699999965311111 11134567889999999999986 5999999999999965 257999999999999
Q ss_pred CCCCCcc-cceeeeeccCCCcchhH---HHHHHHHHHHhhhhc
Q 007969 544 GGNQNQA-NTNIIAVDTWPQSMQWE---AYFLLNLMFSVLEFF 582 (583)
Q Consensus 544 ~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~f 582 (583)
..++..- ......|+.+.+.+|.- .-.-.+|||++||.|
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvf 704 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVF 704 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceE
Confidence 7765532 23445677776666632 222477888888876
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=165.51 Aligned_cols=139 Identities=19% Similarity=0.306 Sum_probs=107.6
Q ss_pred CCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-----CCCCceeEEEEEEeCC---e-EE
Q 007969 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-----QHKNLVRLLGCCLEGQ---E-LL 463 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 463 (583)
+...++||+|+||.||. ...++.. +||++........+++.+|+.+++.+ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44567899999999996 3234444 79988765455567899999999999 5799999999998863 4 33
Q ss_pred EEEEc--CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCcEEEcC----CCceEEEe
Q 007969 464 LIYEY--MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI-LYLHEDSRLKIIHRDLKASNILLDD----DMNPKISD 536 (583)
Q Consensus 464 lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~D 536 (583)
+|+|| +++++|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5579999999542 25554 35677888787 9999986 999999999999974 34899999
Q ss_pred cCCcee
Q 007969 537 FGLARI 542 (583)
Q Consensus 537 FGla~~ 542 (583)
|+-++.
T Consensus 153 g~G~~~ 158 (210)
T PRK10345 153 NIGEST 158 (210)
T ss_pred CCCCcc
Confidence 544433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-20 Score=194.54 Aligned_cols=184 Identities=24% Similarity=0.384 Sum_probs=156.5
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
...++|.....+|.|++|.|||++.. .++..|+|.++.......+-.+.|+-+++..+|||||.++|.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34567888899999999999999954 68899999999887777778899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|||.+|+|.+.-+- ...+.+.++....+...+||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.++..
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999987643 345888888999999999999999997 799999999999999999999999999887665
Q ss_pred CCcccceeeeeccCCCcchhHH------HHHHHHHHHhh
Q 007969 547 QNQANTNIIAVDTWPQSMQWEA------YFLLNLMFSVL 579 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~l~ 579 (583)
-.+. +...|+++.+.+|... |.-.+|+|.+|
T Consensus 166 i~Kr--ksfiGtpywmapEvaaverkggynqlcdiwa~g 202 (829)
T KOG0576|consen 166 IAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG 202 (829)
T ss_pred hhhh--hcccCCccccchhHHHHHhcccccccccccccc
Confidence 4433 3357777777777543 44567777765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=173.12 Aligned_cols=182 Identities=19% Similarity=0.254 Sum_probs=144.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-C-C----CceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H-K----NLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-~----niv~l~g~~~~~~~~ 462 (583)
+++|.+..++|+|.||.|-++... .+..||||+++... ...+.-..|++++.++. + | -+|.+.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678899999999999999999754 47899999987553 23456688999999994 2 2 277888888889999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--------------
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------------- 528 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-------------- 528 (583)
++|+|.+ |-++.++|.+ +...+++-..+..|+.|+++++.|||+. +++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 6689999955 3445688999999999999999999998 4999999999999832
Q ss_pred ------CCceEEEecCCceecCCC-------CCcccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 529 ------DMNPKISDFGLARIFGGN-------QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 529 ------~~~~kl~DFGla~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
+..+||+|||-|+..... +.+..|+.+.|-.|..+.+.|+ .|++++|+-
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWS--iGCIL~Ely 303 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWS--IGCILVELY 303 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCcee--eeeEEEEee
Confidence 235899999999976543 4456677777777777777776 445554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-17 Score=159.49 Aligned_cols=136 Identities=19% Similarity=0.291 Sum_probs=114.9
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCch--------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++||+|++|.||+|.. +|..+++|+....... ....+.+|++++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 124678899999999999998888888788888999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988431 22 78899999999999999985 99999999999999 7899999999998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=158.28 Aligned_cols=146 Identities=21% Similarity=0.190 Sum_probs=112.9
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCch----------------------hHHHHHHHHHHHh
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLQEFKNEVNLIA 442 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~ 442 (583)
.+......|...++||+|+||.||++..++|+.|+||++...... ....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333444447778999999999999999888999999987643210 0123677899999
Q ss_pred hCCCC--CceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 443 KLQHK--NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 443 ~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
++.|+ .++..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 99887 4444444 2456899999999998765410 234578899999999999975 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCC
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
|+||++++++.++|+|||++......
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCc
Confidence 99999999999999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=162.37 Aligned_cols=147 Identities=17% Similarity=0.172 Sum_probs=113.2
Q ss_pred cCCCCccccccccCceEEEEEE--ecCCcEEEEEEeccCCch------------------------hHHHHHHHHHHHhh
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQ------------------------GLQEFKNEVNLIAK 443 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~ 443 (583)
...|...+.||+|+||.||+|. ..+|+.||+|.++..... ....+.+|++.+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457788999999999999998 568999999998754210 01235689999999
Q ss_pred CCCC--CceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 007969 444 LQHK--NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (583)
Q Consensus 444 l~H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 521 (583)
+.+. .+++++++ ...++||||+++.+|...... ...+.......++.||+.+|.+||+.+ +|+||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 9753 34455543 235899999999888655421 223555667889999999999999984 399999999
Q ss_pred CcEEEcCCCceEEEecCCceecCCC
Q 007969 522 SNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 522 ~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
+||+++ ++.++|+|||+++.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCc
Confidence 999999 889999999999866543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.7e-18 Score=162.30 Aligned_cols=140 Identities=14% Similarity=0.134 Sum_probs=115.0
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhH---HH------HHHHHHHHhhCCCCCceeEEEEEEeC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL---QE------FKNEVNLIAKLQHKNLVRLLGCCLEG 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~---~~------~~~Ei~~l~~l~H~niv~l~g~~~~~ 459 (583)
-.++|...+.||+|+||.||.... ++..+++|.+........ +. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999765 577899999975533222 22 67999999999999999999886643
Q ss_pred --------CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 007969 460 --------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 460 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 531 (583)
+..++||||++|.+|.++.. ++. ....+|+.+|..+|+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35899999999999977631 222 24568999999999986 99999999999999988
Q ss_pred eEEEecCCceecC
Q 007969 532 PKISDFGLARIFG 544 (583)
Q Consensus 532 ~kl~DFGla~~~~ 544 (583)
++|+|||..+...
T Consensus 173 i~liDfg~~~~~~ 185 (232)
T PRK10359 173 LRIIDLSGKRCTA 185 (232)
T ss_pred EEEEECCCccccc
Confidence 9999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.2e-18 Score=164.42 Aligned_cols=146 Identities=33% Similarity=0.482 Sum_probs=118.9
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------Ce
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 461 (583)
.+|...+.+|.|.- .|..+.. -.+++|++|++... .....++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 5555542 25889999998644 234467789999999999999999999998643 36
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.|+|||+| ..+|...++ -.++-++...|..|++.|+.|||+.+ |+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 79999999 457776664 23677888999999999999999986 9999999999999999999999999999
Q ss_pred ecCCC
Q 007969 542 IFGGN 546 (583)
Q Consensus 542 ~~~~~ 546 (583)
.-..+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 76554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=180.86 Aligned_cols=141 Identities=19% Similarity=0.294 Sum_probs=113.8
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC-c------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-G------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~-~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
...|...++||+|+||.||+|.+.+...++.+++.+.. . ...+++.+|++++++++|++++....++..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456678999999999999987654433322232211 1 1235688999999999999999988888887788
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 34678999999999999985 9999999999999 678999999999987
Q ss_pred cCC
Q 007969 543 FGG 545 (583)
Q Consensus 543 ~~~ 545 (583)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-18 Score=161.82 Aligned_cols=148 Identities=24% Similarity=0.444 Sum_probs=120.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEE-EEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGC-CLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 466 (583)
.+.|.+.+.||+|.||.+-.++++ ..+.+++|.+.+.. ....+|.+|..---.| .|.||+.-+.+ +...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356788899999999999999976 46788999886543 3357899998765555 58999987765 45567888999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-c-CCCceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-D-DDMNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-~-~~~~~kl~DFGla~~~~ 544 (583)
||++.|+|.+-+.. ..+.+.-..+++.|+++||.|+|++. +||||||.+|||| + +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999876632 34778888899999999999999984 9999999999999 3 34489999999998765
Q ss_pred C
Q 007969 545 G 545 (583)
Q Consensus 545 ~ 545 (583)
.
T Consensus 175 ~ 175 (378)
T KOG1345|consen 175 T 175 (378)
T ss_pred c
Confidence 3
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-17 Score=153.00 Aligned_cols=151 Identities=23% Similarity=0.366 Sum_probs=127.0
Q ss_pred HcCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC-CCceeEEEEEEeCCeEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 466 (583)
..++|...++||.|+||.+|.|. ..+|++||||.-+..... ..+..|..+...++| ..|+.+..+..++..-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34678889999999999999998 668999999987655433 457789999999975 67888888888888889999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~ 543 (583)
|.+ |.+|+++..-+.+ .++.++.+-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||||+.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 8899988865544 3788999999999999999999986 9999999999999644 46899999999998
Q ss_pred CCCC
Q 007969 544 GGNQ 547 (583)
Q Consensus 544 ~~~~ 547 (583)
-...
T Consensus 165 ~d~~ 168 (341)
T KOG1163|consen 165 RDIR 168 (341)
T ss_pred cccc
Confidence 6443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=154.94 Aligned_cols=133 Identities=22% Similarity=0.341 Sum_probs=108.7
Q ss_pred cccccCceEEEEEEecCCcEEEEEEeccCCc---h-----hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSG---Q-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~---~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.||+|+||.||+|.+ ++..+++|+...... . ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 578899998654321 1 1356788999999999887766666666677789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++....
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 9999998874311 078999999999999985 99999999999999 88999999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=150.14 Aligned_cols=134 Identities=20% Similarity=0.171 Sum_probs=106.9
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCchh----HHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEc
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG----LQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.....|++|+||+||.+.- .+.+++.+.+....... ...+.+|++++++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997665 67788888776553311 235889999999995 5889999886 346999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEcCCCceEEEecCCceecCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
++|.+|...+.. ....++.|++.+|.++|+++ |+|||| ||.|||+++++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999988643310 11357789999999999986 999999 79999999999999999999996554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-17 Score=169.11 Aligned_cols=191 Identities=20% Similarity=0.264 Sum_probs=156.2
Q ss_pred ChHHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC------CCceeEEE
Q 007969 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH------KNLVRLLG 454 (583)
Q Consensus 382 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g 454 (583)
.+...+.-.+.|.+.-..|+|-|++|.+|... .|..||||+|..+. ...+.=+.|+++|++|+. -|.++|+.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33444445567888888999999999999854 47899999998653 233455789999999952 48999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceE
Q 007969 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPK 533 (583)
Q Consensus 455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~k 533 (583)
.|....++++|+|-+ .-+|.+.|.+......|....+..++.|+.-||..|...+ |+|.||||.|||+++.. ..|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999988 5689999998888888999999999999999999998875 99999999999998765 579
Q ss_pred EEecCCceecCCCCC--------cccceeeeeccCCCcchhHHHHHHHHHHHhh
Q 007969 534 ISDFGLARIFGGNQN--------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 534 l~DFGla~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 579 (583)
|||||-|...+.++. +..|+.+.|-++..+.+.|+ +||.+|+|-
T Consensus 578 LCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WS--vgctLYElY 629 (752)
T KOG0670|consen 578 LCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWS--VGCTLYELY 629 (752)
T ss_pred eccCccccccccccccHHHHHHhccCcceeecCcccCCcccee--eceeeEEee
Confidence 999999988776543 56777778877777777666 677777664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-16 Score=161.54 Aligned_cols=146 Identities=25% Similarity=0.330 Sum_probs=122.1
Q ss_pred CCCccccccccCceEEEEEEecCC--cEEEEEEeccCCchhHHHHHHHHHHHhhCCC----CCceeEEEEE-EeCCeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADG--KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH----KNLVRLLGCC-LEGQELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 464 (583)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..++... ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999996543 4788888766543333377889999988873 5888999888 47778899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-----CceEEEecCC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-----MNPKISDFGL 539 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGl 539 (583)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 889998775544 566999999999999999999999987 9999999999999755 4699999999
Q ss_pred cee
Q 007969 540 ARI 542 (583)
Q Consensus 540 a~~ 542 (583)
++.
T Consensus 174 ar~ 176 (322)
T KOG1164|consen 174 ARR 176 (322)
T ss_pred Ccc
Confidence 993
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=153.30 Aligned_cols=166 Identities=23% Similarity=0.357 Sum_probs=132.6
Q ss_pred cCCCCccccccccCceEEEEEE-ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 467 (583)
.-+|.+.++||+|.||.++.|+ +-++++||||.-...+. .-++..|.+..+.|. .++|...+-+...+.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3478899999999999999998 55899999997654432 245677888888874 6889988888888888899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCceEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~ 542 (583)
.+ |-+|+++..-+.+ .++.+++.-++.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||||+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88 8899988765544 4888999999999999999999996 999999999999964 34689999999999
Q ss_pred cCCCCCc-----ccceeeeeccCCCc
Q 007969 543 FGGNQNQ-----ANTNIIAVDTWPQS 563 (583)
Q Consensus 543 ~~~~~~~-----~~~~~~~~~~~~~~ 563 (583)
+....+. ..-+.+.||.-||+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hcCccccccCccccccccccceeeeE
Confidence 8755443 22233445554444
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-17 Score=138.77 Aligned_cols=68 Identities=32% Similarity=0.520 Sum_probs=55.8
Q ss_pred ccceecccccccCcceEEEEEeeccCCChhhHHHHHHHHHHHHhhhcCCCCCCcceEeccccccccccccc
Q 007969 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285 (583)
Q Consensus 215 ~~~~a~~~~~~~~~~~~y~laQC~~Dls~~~C~~CL~~~~~~~~~~~~~~~~~~g~v~~~~C~lrye~~~f 285 (583)
..+|++++. ..+..+||||+||++||+++||+.||+.++..++.+|+ ++.||+|+.++|++||+.++|
T Consensus 39 ~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~--~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 39 SKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCP--GSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp -TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTT--SBSSEEEEESSEEEEEESS--
T ss_pred ccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCC--CCceEEEECCCEEEEEECCCC
Confidence 479999975 45778999999999999999999999999999999999 899999999999999999876
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=137.68 Aligned_cols=136 Identities=22% Similarity=0.210 Sum_probs=115.5
Q ss_pred ccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC--CCceeEEEEEEeCCeEEEEEEcCCCC
Q 007969 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 472 (583)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999854 7899999865543 4678999999999976 58999999888888899999999988
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
.+..+ ++.....++.+++++|.+||......++|+|++|+||++++++.+++.|||+++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 76533 55667788999999999999865446999999999999999999999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-15 Score=150.71 Aligned_cols=182 Identities=29% Similarity=0.380 Sum_probs=143.8
Q ss_pred CCccccccccCceEEEEEEecCCcEEEEEEeccCCch---hHHHHHHHHHHHhhCCCC-CceeEEEEEEeCCeEEEEEEc
Q 007969 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~ 468 (583)
|...+.||.|.||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999976 78899999765432 367899999999999988 799999999777778999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ 547 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 547 (583)
+.++++.+++........+.......+..|++.++.|+|..+ ++|||+||+||+++... .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976643221125888999999999999999999986 99999999999999998 79999999999765544
Q ss_pred Ccc----cceeeeeccCCCcchhH------HHHHHHHHHHhh
Q 007969 548 NQA----NTNIIAVDTWPQSMQWE------AYFLLNLMFSVL 579 (583)
Q Consensus 548 ~~~----~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~ 579 (583)
... ......++.++..++.. .+....|+|.+|
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g 198 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG 198 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHH
Confidence 322 23345566666665532 344555666554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.4e-16 Score=156.16 Aligned_cols=145 Identities=27% Similarity=0.499 Sum_probs=126.3
Q ss_pred HHcCCCCccccccccCceEEEEEEec----CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 462 (583)
...+.|...++||+|.|+.||++.+. ..+.||+|.+...+.. .++.+|++.|..+. +.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567888999999999999999854 3678999999766543 57899999999995 89999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCce
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLAR 541 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~ 541 (583)
.+|+||++.....++... ++...+..++..+..||.++|..| ||||||||.|+|.+. .+.-.|.|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999998888843 567888889999999999999997 999999999999975 4678999999998
Q ss_pred ec
Q 007969 542 IF 543 (583)
Q Consensus 542 ~~ 543 (583)
..
T Consensus 182 ~~ 183 (418)
T KOG1167|consen 182 RY 183 (418)
T ss_pred HH
Confidence 43
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=142.74 Aligned_cols=137 Identities=21% Similarity=0.277 Sum_probs=99.6
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCch--hHHHH----------------------HHHHHHHhhCCCC--Cc
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQEF----------------------KNEVNLIAKLQHK--NL 449 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~--ni 449 (583)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754221 11111 3566666666443 34
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCChhHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEc
Q 007969 450 VRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~ 527 (583)
.+.++. ...++||||++++.+... +.+.. .. .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 555543 245899999999654321 21111 11 5567899999999999998 6 499999999999999
Q ss_pred CCCceEEEecCCceecCC
Q 007969 528 DDMNPKISDFGLARIFGG 545 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~ 545 (583)
++.++|+|||.++....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999986655
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-14 Score=141.35 Aligned_cols=137 Identities=23% Similarity=0.273 Sum_probs=106.4
Q ss_pred ccccc-ccCceEEEEEEecCCcEEEEEEeccCC-------------chhHHHHHHHHHHHhhCCCCCc--eeEEEEEEeC
Q 007969 396 ENKLG-QGGFGPVYKGTLADGKAIAVKRLSRTS-------------GQGLQEFKNEVNLIAKLQHKNL--VRLLGCCLEG 459 (583)
Q Consensus 396 ~~~LG-~G~fG~Vy~a~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 459 (583)
...|| .|+.|+||+.... +..++||...... ......+.+|++++.+++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8889999998874 7788998775321 1223567899999999998775 6777775443
Q ss_pred C----eEEEEEEcCCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 460 Q----ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 460 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
. ..++|+|++++ .+|.+++.+ ..++.. ...+|+.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888743 234443 3568999999999986 999999999999999999999
Q ss_pred EecCCceecC
Q 007969 535 SDFGLARIFG 544 (583)
Q Consensus 535 ~DFGla~~~~ 544 (583)
+|||.++...
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=149.03 Aligned_cols=134 Identities=25% Similarity=0.377 Sum_probs=112.1
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-----C---CCceeEEEEEEe---
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----H---KNLVRLLGCCLE--- 458 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~--- 458 (583)
.+|.+.++||-|-|++||++.. .+.+-||+|+.+.. ....+....||.+|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6788999999999999999985 45778999988744 233466789999999984 3 369999999975
Q ss_pred -CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC
Q 007969 459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (583)
Q Consensus 459 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 529 (583)
+.+.++|+|++ |.+|..++.... .+.++...+.+|+.||+.||.|||.++ .|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 35899999999 678888876544 445899999999999999999999987 79999999999999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.6e-14 Score=161.41 Aligned_cols=182 Identities=21% Similarity=0.266 Sum_probs=133.3
Q ss_pred HHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 464 (583)
.....|.+.+.||+|+||+||+|...+|+.||+|+-+..... +|.-=.+++.+|+ -+-|..+.....-.+.-++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 344667778899999999999999888999999987766543 3433344555555 2334455555566677899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-------CCCceEEEec
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------DDMNPKISDF 537 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-------~~~~~kl~DF 537 (583)
|+||.+.|+|.+++. ..+.++|.....++.|+++-+.+||..+ |||+||||+|+||. +..-++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999994 4556999999999999999999999985 99999999999993 2345899999
Q ss_pred CCceecC--CCCC----------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 538 GLARIFG--GNQN----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~--~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
|-+-.+. .+.. ..-.+...|-.|.+. .|-|+++..++.|+-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq--~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ--IDYFGLAATVHVMLF 898 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchh--hhhHHHHHHHHHHHH
Confidence 9876542 1111 111223345455443 456778888877763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=148.67 Aligned_cols=142 Identities=23% Similarity=0.290 Sum_probs=101.7
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhH----------------------------------------HHHH
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL----------------------------------------QEFK 435 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 435 (583)
.+.||.|++|.||+|++++|+.||||+.+....+.. -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999865421110 0245
Q ss_pred HHHHHHhhCC----CCCceeEEEEEE-eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 007969 436 NEVNLIAKLQ----HKNLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-GILYLHED 509 (583)
Q Consensus 436 ~Ei~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 509 (583)
+|++.+.++. |.+-+.+-.++. .....++||||++|++|.++...... ..+ +..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence 5666666552 333333333332 23467999999999999887643211 122 3456666665 46788887
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 510 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+ ++|+|++|.||+++++++++++|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 5 99999999999999999999999999998864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.5e-14 Score=164.39 Aligned_cols=133 Identities=19% Similarity=0.224 Sum_probs=92.4
Q ss_pred hCCC-CCceeEEEEE-------EeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007969 443 KLQH-KNLVRLLGCC-------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514 (583)
Q Consensus 443 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 514 (583)
.++| +||+++++++ .+.+..+.++||+ +++|.++|.+. ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5788888877 2234567788887 66999999543 345899999999999999999999985 9
Q ss_pred eeCCCCCCcEEEcC-------------------CCceEEEecCCceecCCCCC---------cc-----cceeeeeccCC
Q 007969 515 IHRDLKASNILLDD-------------------DMNPKISDFGLARIFGGNQN---------QA-----NTNIIAVDTWP 561 (583)
Q Consensus 515 iHrDlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~---------~~-----~~~~~~~~~~~ 561 (583)
+||||||+||||+. ++.+||+|||+++....... .. ......|+.+|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566777777664321000 00 00012345555
Q ss_pred Ccch----------hHHHHHHHHHHHhhhh
Q 007969 562 QSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 562 ~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++|| .|+|++|+++|+|+.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 5554 4778888888888754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.4e-13 Score=145.73 Aligned_cols=181 Identities=24% Similarity=0.260 Sum_probs=126.4
Q ss_pred ccccccccCceEEEEEEec-CCcEEEEEEec----cC-Cch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLS----RT-SGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~----~~-~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
..+.+|.|.+|.|+..... ..+....|... .. ... ....+..|..+-..++|+|++..+....+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977776532 23333333222 11 111 11236667788888999999888877777766666699
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++ +|..++... ..+...++..++.|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+...-
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999988442 35788889999999999999999997 9999999999999999999999999999875433
Q ss_pred Cc--ccceeeeeccCCCcchh----HHHHHHHHHHHhhhhc
Q 007969 548 NQ--ANTNIIAVDTWPQSMQW----EAYFLLNLMFSVLEFF 582 (583)
Q Consensus 548 ~~--~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~f 582 (583)
.. .....+.|.-.|..+|. +.-...+|+|+.+..|
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~ 515 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIY 515 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceE
Confidence 32 23333444444444331 1122556666665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.1e-12 Score=116.11 Aligned_cols=132 Identities=22% Similarity=0.182 Sum_probs=97.6
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
.+.|+.|.++.||+.+.. +..+++|....... ....+.+|+..+..+.+.++ ++++... ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357889999999999875 77899998765432 12356889999998865554 4555443 3345799999999887
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
.... . ....+..+++++|..||..+ +..++|+|++|.||+++ ++.++++|||.+...
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5320 1 11235678999999999875 22369999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.1e-13 Score=142.49 Aligned_cols=172 Identities=24% Similarity=0.235 Sum_probs=134.3
Q ss_pred cccccCceEEEEEE----ecCCcEEEEEEeccCCchh--HHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 398 KLGQGGFGPVYKGT----LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~----~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
.+|+|.||.|+..+ .+.|..++.|++++..... ......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 3346778888887653321 224566778888887 9999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|...+. +...+++.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988773 3445677777788889999999999986 999999999999999999999999999987554433
Q ss_pred cceeeeeccCCCcchh--------HHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWPQSMQW--------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~~--------~~~~~~~~l~~l~~~ 581 (583)
+|++-|+.+++ ++|++++.+|+++.+
T Consensus 154 -----cgt~eymApEI~~gh~~a~D~ws~gvl~felltg 187 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTG 187 (612)
T ss_pred -----ccchhhhhhHhhhccCCcccchhhhhhHHHHhhC
Confidence 44444444442 345577777777654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=134.62 Aligned_cols=144 Identities=17% Similarity=0.206 Sum_probs=96.0
Q ss_pred CCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchh----------------------------------H-----
Q 007969 392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQG----------------------------------L----- 431 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~----------------------------------~----- 431 (583)
.|+. +.||.|++|+||+|++++ |++||||++++.-.+. .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 789999999999999987 9999999997542110 0
Q ss_pred -HHHHHHHHHHhhCC----CCCceeEEEEEEe-CCeEEEEEEcCCCCChhHHH--hccC-CCCCCCHHHHHHHHHHHHHH
Q 007969 432 -QEFKNEVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHL--FDAT-RSVQLDWKRRQSIINGIARG 502 (583)
Q Consensus 432 -~~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~ia~g 502 (583)
-+|.+|+..+.+++ +.+.+.+-.++.+ ..+.++||||++|+.+.++- .... ....+.......++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 12445555555552 4444444444433 45678999999999997642 1111 00112233333333343
Q ss_pred HHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecCCceecCCC
Q 007969 503 ILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGLARIFGGN 546 (583)
Q Consensus 503 L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGla~~~~~~ 546 (583)
... +++|+|+||.||+++.++ ++++.|||++..++..
T Consensus 277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334 499999999999999988 9999999999988643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.9e-12 Score=121.75 Aligned_cols=137 Identities=28% Similarity=0.470 Sum_probs=115.4
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.-+|.+...|+.|+|+++ |..+++|++... +.....+|..|.-.++-+.||||..++|.|..+..+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888999999999995 667778887643 33334689999999999999999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
|...|++.. ....+..+..+++.+||+||+|||+..+ -|.---|.++.|++|++.+++|+
T Consensus 274 lynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 999998754 3447778899999999999999999863 13445688999999999998885
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.2e-11 Score=118.03 Aligned_cols=184 Identities=21% Similarity=0.240 Sum_probs=114.8
Q ss_pred CccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCC----------CCceeEEEEEE--
Q 007969 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH----------KNLVRLLGCCL-- 457 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~-- 457 (583)
...+.||.|+++.||.++.. +++++++|+.... .....+++++|......+.+ -.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34678999999999999976 4899999988533 23346788888877766543 12222222221
Q ss_pred -------eC---C-----eEEEEEEcCCCCChhHHHh---ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 007969 458 -------EG---Q-----ELLLIYEYMPNKSLDVHLF---DATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518 (583)
Q Consensus 458 -------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 518 (583)
.. . ..+++|+-+ .++|.+++. .... ...+...-++.+..|+.+.+++||..+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 235677766 578877643 2222 122445556777899999999999997 99999
Q ss_pred CCCCcEEEcCCCceEEEecCCceecCCCCCc-c-----cceeeeec-------cCCCcchhHHHHHHHHHHHhhhh
Q 007969 519 LKASNILLDDDMNPKISDFGLARIFGGNQNQ-A-----NTNIIAVD-------TWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 519 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~-----~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
|||+|++++.+|.++|+||+.....+..... . .++..... .-......|+|.+|+.+|.++|+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999887766432221 0 01000000 01233456899999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.3e-12 Score=142.23 Aligned_cols=142 Identities=19% Similarity=0.245 Sum_probs=116.1
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCC-chhHHHHHHHHHH--HhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-GQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++...+.||.+.|=+|.+++.++|. |+||++-+.+ .-.++.|.++++- ...++|||.+++.-+....+..|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677889999999999999998887 8999987665 3445666655544 4455899999998887777778888888
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
+ ..+|.+.+ ..+..+...+..-|+.|++.||.-+|..+ |+|||||.+||||++.+-+.|+||.--|
T Consensus 103 v-khnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 V-KHNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred H-hhhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 8 44777777 33445677778889999999999999986 9999999999999999999999997544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-10 Score=110.49 Aligned_cols=142 Identities=18% Similarity=0.302 Sum_probs=110.6
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCC--CCceeEEEEEEeCC---eEEEEEEcCC
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ---ELLLIYEYMP 470 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~ 470 (583)
+.|+.|..+.||+.+..+|+.+++|....... ....++..|.++++.+.+ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765432 134678999999999975 45677888776542 5689999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS---------------------------------------- 510 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 510 (583)
+.++.+.+.. ..++......++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 24677777788888888888888531
Q ss_pred -------------CCCeeeCCCCCCcEEEcC--CCceEEEecCCcee
Q 007969 511 -------------RLKIIHRDLKASNILLDD--DMNPKISDFGLARI 542 (583)
Q Consensus 511 -------------~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~ 542 (583)
+..++|+|+.|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.2e-10 Score=105.22 Aligned_cols=136 Identities=15% Similarity=0.159 Sum_probs=99.0
Q ss_pred ccccccCceEEEEEEecC-------CcEEEEEEeccCCc----------------------hhHHHHH----HHHHHHhh
Q 007969 397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSG----------------------QGLQEFK----NEVNLIAK 443 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~-------g~~vavK~l~~~~~----------------------~~~~~~~----~Ei~~l~~ 443 (583)
..||.|.=+.||.|.-.+ +..+|||..+.... ...+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899997653210 0122233 79999999
Q ss_pred CC--CCCceeEEEEEEeCCeEEEEEEcCCCCChhH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCC
Q 007969 444 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDL 519 (583)
Q Consensus 444 l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDl 519 (583)
+. .-++++++++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 85 4677788865 45689999998754422 2321 2345556677889999999999 7664 999999
Q ss_pred CCCcEEEcCCCceEEEecCCceecC
Q 007969 520 KASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 520 k~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
++.|||++ ++.++|+|||.+-...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-09 Score=100.32 Aligned_cols=135 Identities=23% Similarity=0.337 Sum_probs=101.5
Q ss_pred ccccccCceEEEEEEecCCcEEEEEE-eccCCc-h------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKR-LSRTSG-Q------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~-l~~~~~-~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+++|+-..+|.+.+. |.++++|. +.+.-. . ..++-.+|+.++++++--.|....=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 44455553 333211 1 134567899999999766666556666777788999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
+++..|.+.+... ...++..|-.-+.-||..+ |+|+||.++||++..+. +.++||||++.-...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999999888543 2456667777788899986 99999999999998775 999999999865443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-10 Score=121.16 Aligned_cols=135 Identities=27% Similarity=0.482 Sum_probs=107.5
Q ss_pred HhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 441 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....++|.....+..+|+.||.|||.-. . ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4578999999999999999999999999999999999965 4456999999999999999999999852 2 2999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCCCC------------cccceeeeecc-----CCCcchhHHHHHHHHHHHhh
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGNQN------------QANTNIIAVDT-----WPQSMQWEAYFLLNLMFSVL 579 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~ 579 (583)
++|+++|....+||+|||+..+...... ...|+...+.. .......+.|+++.+++++.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999988742100 01122111110 11345578899999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=9.7e-10 Score=102.97 Aligned_cols=90 Identities=23% Similarity=0.175 Sum_probs=70.7
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.+. ...++|..++.|+.||++||.|||+++ ||+|||++.++.+|+ ||+++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~--- 64 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQS--- 64 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccC---
Confidence 6888988643 345999999999999999999999874 999999999999999 999987754332
Q ss_pred ceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 552 TNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 552 ~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
.|+..|+++ ..|+|++|+++|+++.+
T Consensus 65 ----~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 100 (176)
T smart00750 65 ----RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDY 100 (176)
T ss_pred ----CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 223333333 46788889999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=115.36 Aligned_cols=162 Identities=19% Similarity=0.226 Sum_probs=122.2
Q ss_pred ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHH
Q 007969 412 LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491 (583)
Q Consensus 412 ~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 491 (583)
..++.+|.|...+.......+...+-++.++.++||||++++..+...+..|+|+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44688899998887766445567788889999999999999999999999999999874 45566643 23455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccC------CCcch
Q 007969 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW------PQSMQ 565 (583)
Q Consensus 492 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~------~~~~~ 565 (583)
..-.+.||+.||.|||+.+ +++|++|.-.-|++++.|..||.+|-++....+.............+. +....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccc
Confidence 5667889999999999877 699999999999999999999999998876644332111111111111 11123
Q ss_pred hHHHHHHHHHHHhhhhcC
Q 007969 566 WEAYFLLNLMFSVLEFFC 583 (583)
Q Consensus 566 ~~~~~~~~~l~~l~~~f~ 583 (583)
.|.|+++..+|++..+.|
T Consensus 184 ~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhhhhHHHHHHHHhCccc
Confidence 589999999999988754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.3e-09 Score=94.92 Aligned_cols=149 Identities=23% Similarity=0.310 Sum_probs=107.4
Q ss_pred ccccccccCceEEEEEEecCCcEEEEE-EeccCCc-------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 395 DENKLGQGGFGPVYKGTLADGKAIAVK-RLSRTSG-------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~g~~vavK-~l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
....|-||+-+.|+++.++ |+...|| +..+.-. -..++..+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999985 6665555 3333311 12456788999999987555554455566666678999
Q ss_pred EcCCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---ceEEEecCCcee
Q 007969 467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARI 542 (583)
Q Consensus 467 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~ 542 (583)
||+++ .++.+++...-.... .......++..|-+.+.-||..+ |||+||..+||+|.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 577888765443332 22333678888999999999986 99999999999996655 358999999976
Q ss_pred cCCCCC
Q 007969 543 FGGNQN 548 (583)
Q Consensus 543 ~~~~~~ 548 (583)
-...+.
T Consensus 166 s~~~ED 171 (229)
T KOG3087|consen 166 SRLPED 171 (229)
T ss_pred ccCccc
Confidence 544443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.9e-08 Score=98.49 Aligned_cols=140 Identities=19% Similarity=0.139 Sum_probs=101.2
Q ss_pred cccccCceEEEEEEecCCcEEEEEEeccCCch-----------hHHHHHHHHHHHhhCC--CCCceeEEEEEEe-----C
Q 007969 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQ--HKNLVRLLGCCLE-----G 459 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~-----~ 459 (583)
.+-+..-..|.+..+ +|+.+.||+.....-. ....+.+|...+.++. .-.++.++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333334445667766 5778999976433211 1124789999999885 3445556666643 2
Q ss_pred CeEEEEEEcCCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-------CCc
Q 007969 460 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMN 531 (583)
Q Consensus 460 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-------~~~ 531 (583)
...++|+|++++. +|.+++.+.. ....+...+..++.+++..+.-||+.+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 8988874322 223456677789999999999999996 999999999999975 568
Q ss_pred eEEEecCCcee
Q 007969 532 PKISDFGLARI 542 (583)
Q Consensus 532 ~kl~DFGla~~ 542 (583)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.9e-08 Score=93.85 Aligned_cols=126 Identities=25% Similarity=0.336 Sum_probs=81.8
Q ss_pred EEEEEEecCCcEEEEEEeccCCc-------------h--------h-----HHHHHHHHHHHhhCCCC--CceeEEEEEE
Q 007969 406 PVYKGTLADGKAIAVKRLSRTSG-------------Q--------G-----LQEFKNEVNLIAKLQHK--NLVRLLGCCL 457 (583)
Q Consensus 406 ~Vy~a~~~~g~~vavK~l~~~~~-------------~--------~-----~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 457 (583)
.||.|...+|..+|+|.-+.... . . .....+|.+.|.++... ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999997753210 0 0 23457899999999755 677777552
Q ss_pred eCCeEEEEEEcCC--CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 458 EGQELLLIYEYMP--NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 458 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
...+||||++ +..+..+. +.. ++......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999998 55554433 211 11233456677777766664 6664 9999999999999988 9999
Q ss_pred EecCCceecC
Q 007969 535 SDFGLARIFG 544 (583)
Q Consensus 535 ~DFGla~~~~ 544 (583)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.5e-08 Score=100.76 Aligned_cols=141 Identities=24% Similarity=0.354 Sum_probs=111.3
Q ss_pred ceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEEEEEEcCCC-CChhHH
Q 007969 404 FGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYMPN-KSLDVH 477 (583)
Q Consensus 404 fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~ 477 (583)
-.+.||+.. .+|..+++|++.....+..-....-++.++++.|.|||++..++.. ...+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 367889874 4899999999943222222223455778999999999999999863 3578999999997 677665
Q ss_pred Hhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 478 LFDA------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 478 l~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
-... ......++...|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4432 12234788999999999999999999986 78899999999999999999999999988876
Q ss_pred CC
Q 007969 546 NQ 547 (583)
Q Consensus 546 ~~ 547 (583)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 65
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-09 Score=113.13 Aligned_cols=114 Identities=25% Similarity=0.285 Sum_probs=90.7
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++.|++|...+|.++|.........++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999765555668899999999999999999 43 899999999999999999999999999
Q ss_pred eecCCCC----CcccceeeeeccCCCcchh----------HHHHHHHHHHHhhh
Q 007969 541 RIFGGNQ----NQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 541 ~~~~~~~----~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~ 580 (583)
....... ....-..-+|+.||+.+|. +.|.+|+++++++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8876555 1222223578999998873 44555555555554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-08 Score=101.78 Aligned_cols=89 Identities=29% Similarity=0.529 Sum_probs=69.0
Q ss_pred CCCCceeEEEEEEe---------------------------CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHH
Q 007969 445 QHKNLVRLLGCCLE---------------------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497 (583)
Q Consensus 445 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 497 (583)
+|||||++.+.|.+ +..+|+||.-++ .+|..++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999988743 224788888774 5788888542 234455666889
Q ss_pred HHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCC--ceEEEecCCce
Q 007969 498 GIARGILYLHEDSRLKIIHRDLKASNILL--DDDM--NPKISDFGLAR 541 (583)
Q Consensus 498 ~ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~kl~DFGla~ 541 (583)
|+++|+.|||.++ |.|||+|+.|||| |++. ...|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999996 9999999999998 5555 45789999654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.2e-09 Score=119.11 Aligned_cols=172 Identities=23% Similarity=0.320 Sum_probs=128.8
Q ss_pred cCCCCccccccccCceEEEEEEecC--CcEEEEEEeccCC--chhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 464 (583)
...|.+.+.||+|.|+.|-...... ...+++|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3446666779999999998877533 4456777665443 222344556777777776 9999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCcee
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARI 542 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 542 (583)
+.||..++++.+.+.. ......+......++.|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999877631 11113566677888999999999999 665 99999999999999999 999999999998
Q ss_pred cCC-CCCcccceeeee-ccCCCcch
Q 007969 543 FGG-NQNQANTNIIAV-DTWPQSMQ 565 (583)
Q Consensus 543 ~~~-~~~~~~~~~~~~-~~~~~~~~ 565 (583)
+.. +.....-....| ++.|..+|
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E 199 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPE 199 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcc
Confidence 876 444333334445 44444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.5e-08 Score=109.82 Aligned_cols=148 Identities=19% Similarity=0.278 Sum_probs=92.7
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...+.|-.|++|.||..+++. .+.+|+| +.+.. .-+.+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc---cccccCCccee------------------
Confidence 3578888999999999999998764 5677884 33221 00111 22222233322
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC--
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-- 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~-- 546 (583)
|+-...+.. .++++-. ++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+.+.....
T Consensus 136 ---gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 444444422 2233322 277899999986 999999999999999999999999999865211
Q ss_pred -----------CCcccceeeeeccCCCcchh----------HHHHHHHHHHHhhh
Q 007969 547 -----------QNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 547 -----------~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~ 580 (583)
..+...+.+.|++.|.++++ |||.+|.++|+.+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV 253 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 253 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe
Confidence 11223345567766655442 23445566655543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.7e-07 Score=86.88 Aligned_cols=108 Identities=27% Similarity=0.279 Sum_probs=86.9
Q ss_pred HHHHHHHHHHHhhCC--CCCceeEEEEEEeCC----eEEEEEEcCCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 007969 431 LQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQ----ELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGI 503 (583)
Q Consensus 431 ~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 503 (583)
.....+|...+.++. .-.+++.+++..... ..++|+|++++. +|.+++.+... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 356788888888885 445667777776532 468999999984 89988854222 55667788999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCcEEEcCCC---ceEEEecCCceecC
Q 007969 504 LYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFG 544 (583)
Q Consensus 504 ~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~~~ 544 (583)
.-||+.+ |+|+|++++|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999996 99999999999999887 89999999888754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.8e-07 Score=89.03 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=93.6
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCch----------------------hHHHHHHHHHHHhhCCCC--
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLQEFKNEVNLIAKLQHK-- 447 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~H~-- 447 (583)
-..+.++||.|.-+.||.|..++|.+++||.-+..... ......+|.+.|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34556899999999999999999999999954322000 123457899999999654
Q ss_pred CceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 448 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
.+++.+++ +...+||||+++-.|...- ++.+..-.|+..|+.-+.-+-..| |||+|+.+-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 77777765 4568999999986664321 111222223333333333333443 99999999999999
Q ss_pred CCCceEEEecCCce
Q 007969 528 DDMNPKISDFGLAR 541 (583)
Q Consensus 528 ~~~~~kl~DFGla~ 541 (583)
++|.+.++||=-+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999995443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.9e-07 Score=99.74 Aligned_cols=143 Identities=15% Similarity=0.192 Sum_probs=94.8
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchh------------------------------HH----------HHHH
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG------------------------------LQ----------EFKN 436 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~------------------------------~~----------~~~~ 436 (583)
+.|+.++-|+||+|++++|+.||||+....-.+. .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999887642210 01 2344
Q ss_pred HHHHHhhCC-----CCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007969 437 EVNLIAKLQ-----HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511 (583)
Q Consensus 437 Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 511 (583)
|...+.+++ .+++.-..=++.-.+...++|||++|-.+.+...-.. ...+.+.......++.--.-+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~~--d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLLR--D-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHHh--c--
Confidence 555555552 3443333333334567899999999988887742211 2244333332222222112222 3
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
+++|.|..|.||+++.++++-+.|||+...+.+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3999999999999999999999999999887643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.6e-06 Score=81.26 Aligned_cols=140 Identities=18% Similarity=0.139 Sum_probs=104.2
Q ss_pred ccccCceEEEEEEecCCcEEEEEEeccC------CchhHHHHHHHHHHHhhCC--CCCceeEEEEEEeC----CeEEEEE
Q 007969 399 LGQGGFGPVYKGTLADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEG----QELLLIY 466 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~~g~~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~----~~~~lV~ 466 (583)
-|+|+-+.|++-.+. |..+-+|+-... .+.....|.+|+..+.++. .-++++++...... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888889987774 446888876522 1335678999999999995 33455555222221 2468999
Q ss_pred EcCCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--eEEEecCCceec
Q 007969 467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~~ 543 (583)
|-+++ .+|.+++.+.. ..+.+...+..+..+|+..+.-||+.+ +.|+|+.++||+++.++. ++++||.-++.-
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 98865 68888874432 224577778899999999999999986 999999999999986667 999999876653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-07 Score=101.65 Aligned_cols=150 Identities=23% Similarity=0.252 Sum_probs=118.7
Q ss_pred CCCccccccc--cCceEEEEEEe---cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEE
Q 007969 392 HFSDENKLGQ--GGFGPVYKGTL---ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 392 ~~~~~~~LG~--G~fG~Vy~a~~---~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 463 (583)
.|.....+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+...++++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555677899 99999999986 35778999984432 2232233356777777774 999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR----GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFG 538 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFG 538 (583)
+-+|++. .+|..+-+. ....++....+.+..+... ||.++|... ++|-|+||.||++.++ ...++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 677776643 2334677778888888888 999999884 9999999999999988 899999999
Q ss_pred CceecCCCC
Q 007969 539 LARIFGGNQ 547 (583)
Q Consensus 539 la~~~~~~~ 547 (583)
+...+....
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999886554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-07 Score=100.10 Aligned_cols=149 Identities=24% Similarity=0.246 Sum_probs=119.1
Q ss_pred HHcCCCCccccccccCceEEEEEEec--CCcEEEEEEeccCCchhHHHH--HHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLQEF--KNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
....+|....+||.|.|+.|++...+ ++..+++|.+.+......++. ..|+.+...+ .|.++++....|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999988644 567889998876644333322 4566665555 488999988888888888
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCce
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLAR 541 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 541 (583)
++-.||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887655 22335788889999999999999999875 9999999999999886 888999999987
Q ss_pred e
Q 007969 542 I 542 (583)
Q Consensus 542 ~ 542 (583)
.
T Consensus 416 ~ 416 (524)
T KOG0601|consen 416 R 416 (524)
T ss_pred c
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.1e-06 Score=80.39 Aligned_cols=140 Identities=17% Similarity=0.199 Sum_probs=86.6
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC--CceeEEEEEEeCCeEEEEEEcCCCCC-
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCCLEGQELLLIYEYMPNKS- 473 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gs- 473 (583)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567788776433 235578899999998643 35778888877778889999999863
Q ss_pred hhHH---------------------HhccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCCeeeCCC
Q 007969 474 LDVH---------------------LFDATRSVQLDWKRRQ-SIIN----------GIAR-GILYLHE-DSRLKIIHRDL 519 (583)
Q Consensus 474 L~~~---------------------l~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~-~~~~~iiHrDl 519 (583)
+... +|..... ........ .+-. .+.+ ...+|.. ..+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 1110000 01101000 0000 0111 1222221 12335789999
Q ss_pred CCCcEEEcCCCceEEEecCCceec
Q 007969 520 KASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 520 k~~NILl~~~~~~kl~DFGla~~~ 543 (583)
.|.||++++++ +.|+||+.+..-
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999988 999999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.1e-06 Score=91.55 Aligned_cols=141 Identities=15% Similarity=0.158 Sum_probs=92.6
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchh-------------------------------------HHHHHHHH
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------------------------LQEFKNEV 438 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei 438 (583)
.+.||.-+.|.||+|++++|+.||||+-+..-.+. .-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46899999999999999999999999876542211 01345566
Q ss_pred HHHhhC----CCCC------ceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007969 439 NLIAKL----QHKN------LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508 (583)
Q Consensus 439 ~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 508 (583)
+...++ +|-+ |++++..+ .....|+||||+|..+.+.-.- ....++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc-
Confidence 554444 4555 33333222 3467999999999877654321 1122454444443333322232222
Q ss_pred CCCCCeeeCCCCCCcEEEcC----CCceEEEecCCceecCC
Q 007969 509 DSRLKIIHRDLKASNILLDD----DMNPKISDFGLARIFGG 545 (583)
Q Consensus 509 ~~~~~iiHrDlk~~NILl~~----~~~~kl~DFGla~~~~~ 545 (583)
+++|.|-.|.||++.. ++.+.+-|||+.+.+..
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3999999999999984 67899999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.4e-07 Score=88.85 Aligned_cols=96 Identities=26% Similarity=0.351 Sum_probs=80.8
Q ss_pred HHHhhCCCCCceeEEEEEEeCC-----eEEEEEEcCCCCChhHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 007969 439 NLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRL 512 (583)
Q Consensus 439 ~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 512 (583)
+.+-.+.|.|||+++.+|.+.+ +..++.|||+.|+|..+|++.++. ..+......+++.||.+||.|||+-. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455667999999999997643 578999999999999999865433 34677777889999999999999974 6
Q ss_pred CeeeCCCCCCcEEEcCCCceEEE
Q 007969 513 KIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 513 ~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
+|+|+++..+-|++..++.+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999999985
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.4e-05 Score=77.49 Aligned_cols=141 Identities=15% Similarity=0.153 Sum_probs=87.6
Q ss_pred ccccCc-eEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcCCCCChhH
Q 007969 399 LGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDV 476 (583)
Q Consensus 399 LG~G~f-G~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 476 (583)
|..|.. ..||+...+ +..+.+|...... ..++.+|+++++.+. +--+++++++...++..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788998764 4678888876543 345678888888884 4557788888877777899999999987764
Q ss_pred HH-------------------hccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 007969 477 HL-------------------FDATR-SVQLD--WKRRQSIIN--------------------GIARGILYLHE----DS 510 (583)
Q Consensus 477 ~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~ 510 (583)
.. |.... ..... ......-.. .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 00111 000000000 01111222211 12
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 511 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
++.++|+|+.|.|||++++..+.|+||+.+...
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 345899999999999999888899999988644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.4e-05 Score=73.30 Aligned_cols=138 Identities=18% Similarity=0.187 Sum_probs=90.3
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHH---------HHHHHHHhhCCC---CCceeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEF---------KNEVNLIAKLQH---KNLVRLLGCCL 457 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~H---~niv~l~g~~~ 457 (583)
.++|...+.+-......|.+-.. +|..+++|..+.......+.| .+++..+.+++. ...+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45666667777666666666555 578889998776543332222 334444444432 23333333332
Q ss_pred e-----CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 458 E-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 458 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
. ....+++|||++|..|.++.. +++ .+...+.+.|.-||+.| +.|+|+.|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 2 235678999999988765431 222 24456778899999997 99999999999998655 8
Q ss_pred EEEecCCceec
Q 007969 533 KISDFGLARIF 543 (583)
Q Consensus 533 kl~DFGla~~~ 543 (583)
+++||+..+..
T Consensus 174 ~iID~~~k~~~ 184 (229)
T PF06176_consen 174 RIIDTQGKRMS 184 (229)
T ss_pred EEEECcccccc
Confidence 99999877654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-05 Score=75.41 Aligned_cols=144 Identities=23% Similarity=0.239 Sum_probs=86.7
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC--CceeEEEEEEe---CCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCCLE---GQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~e~~~~ 471 (583)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+++++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578899999999999877 68999987654 3456778888888888533 46777775543 3457999999999
Q ss_pred CChhH----------------HH---hcc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 007969 472 KSLDV----------------HL---FDA-TRSVQLDWKR---------RQSI------------INGIAR-GILYLHE- 508 (583)
Q Consensus 472 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 508 (583)
..+.. .+ ++. .......+.. .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88776 11 111 0111111111 0000 112222 3333332
Q ss_pred ---CCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceec
Q 007969 509 ---DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543 (583)
Q Consensus 509 ---~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~ 543 (583)
..+..++|+|+.|.|||++ +++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1334699999999999999 6666689999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.4e-05 Score=75.92 Aligned_cols=106 Identities=23% Similarity=0.233 Sum_probs=82.6
Q ss_pred HHHHHHHhhCCC-CCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007969 435 KNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513 (583)
Q Consensus 435 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 513 (583)
.+|..++..+++ +++++++|.|-+ ++|.||...+++...-..-..-..-+|..+.+|+.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 699999999953 678999987766421100011123689999999999999999999864445
Q ss_pred eeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 514 IIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 514 iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+.-.|++++|+-+++++++|+.|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 7779999999999999999999998766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.5e-05 Score=72.94 Aligned_cols=136 Identities=20% Similarity=0.288 Sum_probs=92.4
Q ss_pred cccccCceEEEEEEecCCcEEEEEEeccCCchh-------------------HH-----HHHHHHHHHhhCC--CCCcee
Q 007969 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------LQ-----EFKNEVNLIAKLQ--HKNLVR 451 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~-------------------~~-----~~~~Ei~~l~~l~--H~niv~ 451 (583)
.|..|.-..||+|.-.++..+|||+.+...... .. -..+|...|.++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 466788899999998889999999886442211 00 1134666677663 455555
Q ss_pred EEEEEEeCCeEEEEEEcCCCCCh-hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 452 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 452 l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
.+++.. -.+||||+..... .-.| +...+...+...+..++.+.+.-|-... ++||+||..-|||+. ++
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 555533 4799999965421 1111 1122333356667778888888776633 599999999999999 88
Q ss_pred ceEEEecCCceecC
Q 007969 531 NPKISDFGLARIFG 544 (583)
Q Consensus 531 ~~kl~DFGla~~~~ 544 (583)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999886554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00018 Score=73.59 Aligned_cols=78 Identities=12% Similarity=0.060 Sum_probs=58.0
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC---CCceeEEEEEEeC---CeEEEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEG---QELLLIYE 467 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e 467 (583)
...+.||.|..+.||+-...+++ +.+|..+... ....+..|.+.++.+.- ..++++++++..+ +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 33567999999999998876664 5666643311 23578999999999853 4788999888643 66899999
Q ss_pred cCCCCCh
Q 007969 468 YMPNKSL 474 (583)
Q Consensus 468 ~~~~gsL 474 (583)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=84.40 Aligned_cols=148 Identities=18% Similarity=0.310 Sum_probs=92.1
Q ss_pred cccccccCceEEEEEEecCC---cEEEEEEeccCC-chhHHHHHHHHHHHhhCC-CCCc--eeEEEEEEeC---CeEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNL--VRLLGCCLEG---QELLLI 465 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 465 (583)
.++++.|.+..+|+-...++ ..+++|+..... ......+.+|.++++.+. |.++ +++++++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999877654 367777654332 123457889999999995 6654 7888888764 467899
Q ss_pred EEcCCCCChhH-----------------------HHhccCCC--------CCCC--------HHHHHHH---------HH
Q 007969 466 YEYMPNKSLDV-----------------------HLFDATRS--------VQLD--------WKRRQSI---------IN 497 (583)
Q Consensus 466 ~e~~~~gsL~~-----------------------~l~~~~~~--------~~l~--------~~~~~~i---------~~ 497 (583)
|||+++..+.+ .||..... .+.. |...+.- ..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999864321 01111000 0011 1111100 11
Q ss_pred HHHHHHHHHHhCCC--------CCeeeCCCCCCcEEEcCC--CceEEEecCCceec
Q 007969 498 GIARGILYLHEDSR--------LKIIHRDLKASNILLDDD--MNPKISDFGLARIF 543 (583)
Q Consensus 498 ~ia~gL~yLH~~~~--------~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~ 543 (583)
.+...+.+|..+-+ ..++|+|+++.|||++.+ ..+-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754321 349999999999999853 34679999988754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00024 Score=67.90 Aligned_cols=134 Identities=20% Similarity=0.293 Sum_probs=90.3
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCC----------------chhHHHHHHHHHHHhhCC------CCCcee
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------GQGLQEFKNEVNLIAKLQ------HKNLVR 451 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~ 451 (583)
+....||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456899999999985 3445567888887654 112456667776655555 889999
Q ss_pred EEEEEEeCCeEEEEEEcCCC------CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 007969 452 LLGCCLEGQELLLIYEYMPN------KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (583)
Q Consensus 452 l~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 525 (583)
++|+..++.-.-+|+|.+.+ -+|.+++.+ ..++. ...+.+.+ -..||-+.+ |+.+|++|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEE
Confidence 99999999888899988753 345666632 23554 33333333 345565553 999999999999
Q ss_pred EcCC---C-ceEEEe-cCCc
Q 007969 526 LDDD---M-NPKISD-FGLA 540 (583)
Q Consensus 526 l~~~---~-~~kl~D-FGla 540 (583)
+... . .+.|+| ||-.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 9533 2 567777 4533
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0003 Score=69.35 Aligned_cols=141 Identities=19% Similarity=0.215 Sum_probs=77.8
Q ss_pred ccccccCce-EEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC---CceeEEEEEEeC---CeEEEEEEcC
Q 007969 397 NKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCLEG---QELLLIYEYM 469 (583)
Q Consensus 397 ~~LG~G~fG-~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~ 469 (583)
+.|+.|+.. .||+. +..+++|..... ....++.+|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58874 235667764432 2345788999999888532 455555544332 2348899999
Q ss_pred CCCChhHH------------------HhccCCCC-C------------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 007969 470 PNKSLDVH------------------LFDATRSV-Q------------L-DWKRRQ--SII-------NGIARG-ILY-L 506 (583)
Q Consensus 470 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~g-L~y-L 506 (583)
+|.++... ||...... . + .|.... .+. .+.... +.. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776321 11110000 0 0 121110 000 011111 111 1
Q ss_pred Hh--CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 507 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 507 H~--~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+. ..+..++|+|+.+.||+++++...-|+||+.+..-
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 11 12334899999999999998776789999988644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0006 Score=62.90 Aligned_cols=132 Identities=21% Similarity=0.218 Sum_probs=87.2
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCce-eEEEEEEeCCeEEEEEEcCCCC
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g 472 (583)
...+.|++|++|.||+|.+. |.++|+|+=+..++ ...+..|++++..++..++. +++.+.. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34568999999999999996 55888887665544 36889999999999866654 4444433 34559999998
Q ss_pred ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCcEEEcCCCceEEEecCCceecCC
Q 007969 473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK-ASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk-~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
.|.+.-.. .+.++... +++.---|... .|-|+.|. |...+|-.++.+.|+||.-|+.-..
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 88765421 12233333 33332223333 37777764 4455555555999999998885433
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.001 Score=65.31 Aligned_cols=142 Identities=20% Similarity=0.287 Sum_probs=81.7
Q ss_pred ccccccCceEEEEEEecC--CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
+.|..|-...+|+....+ +..+++|........ .-+..+|+.+++.+...+ .+++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457777788999988764 678888876543222 123357888888885333 445554332 237999999876
Q ss_pred hhHH-----------------HhccCCCC--------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 007969 474 LDVH-----------------LFDATRSV--------QL-DWKRRQSIIN----------------------GIARGILY 505 (583)
Q Consensus 474 L~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~----------------------~ia~gL~y 505 (583)
+... +|+..... .. .|.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 11111111 11 1222111111 11111111
Q ss_pred H----HhC-CCCCeeeCCCCCCcEEEcC-CCceEEEecCCceec
Q 007969 506 L----HED-SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIF 543 (583)
Q Consensus 506 L----H~~-~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~ 543 (583)
| ... .+..++|+|+.+.|||+++ ++.+.|+||..|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 1 111 2345999999999999998 578999999888643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=69.23 Aligned_cols=75 Identities=13% Similarity=0.235 Sum_probs=55.0
Q ss_pred ccccccCceEEEEEEecCC-cEEEEEEeccC-----C--chhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEEE
Q 007969 397 NKLGQGGFGPVYKGTLADG-KAIAVKRLSRT-----S--GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 465 (583)
+.||.|.+..||+....+| +.|+||.-... . +...+++..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998877 58999985421 1 123567778888888763 3467778777 44557899
Q ss_pred EEcCCCCC
Q 007969 466 YEYMPNKS 473 (583)
Q Consensus 466 ~e~~~~gs 473 (583)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00079 Score=67.23 Aligned_cols=139 Identities=17% Similarity=0.126 Sum_probs=78.6
Q ss_pred ccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcCCCCChhHH
Q 007969 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDVH 477 (583)
Q Consensus 399 LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~ 477 (583)
+..|-...+|+... +++.+++|..........-+..+|.++++.+....+ +++++... -++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 566788887654322211235778888888864333 44454432 3689999998665321
Q ss_pred -----------------HhccCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeeeCCCCCCcE
Q 007969 478 -----------------LFDATR-SVQLDWKRR-QSIING---------IARGILYLHED-----SRLKIIHRDLKASNI 524 (583)
Q Consensus 478 -----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDlk~~NI 524 (583)
+|.... ...++.... .....+ +...+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111111 111222111 111111 11112222111 123489999999999
Q ss_pred EEcCCCceEEEecCCceec
Q 007969 525 LLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 525 Ll~~~~~~kl~DFGla~~~ 543 (583)
++++++ ++|+||..+..-
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999877 789999888754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0014 Score=62.32 Aligned_cols=125 Identities=26% Similarity=0.379 Sum_probs=89.3
Q ss_pred CCCCccccccccCc-eEEEEEEecCCcEEEEEEecc---CCc------------------hhHHHHHHHHHHHhhCC---
Q 007969 391 NHFSDENKLGQGGF-GPVYKGTLADGKAIAVKRLSR---TSG------------------QGLQEFKNEVNLIAKLQ--- 445 (583)
Q Consensus 391 ~~~~~~~~LG~G~f-G~Vy~a~~~~g~~vavK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 445 (583)
.+++..+.||.|.- |.|||.++ +|+.+|+|..+. ... ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788899999999 99999999 577999999321 000 11346888999988885
Q ss_pred CCCc--eeEEEEEEeC------------------CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 007969 446 HKNL--VRLLGCCLEG------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505 (583)
Q Consensus 446 H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 505 (583)
+.++ |+.+||..-. ...-||.||.+... .+. .+=+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4466 8999997422 12456777765432 122 2234567777888
Q ss_pred HHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 506 LH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99886 999999999985 4589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.015 Score=60.02 Aligned_cols=142 Identities=17% Similarity=0.199 Sum_probs=78.4
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC--CCCceeEEEE------EEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLGC------CLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~------~~~~~~~~lV~e~ 468 (583)
+.|..|....+|+....+| .+++|+....+. +....|+.++..|. .-.+++++.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999886655 688888752222 33344555555553 2224444431 2235567999999
Q ss_pred CCCCChhH-----------H---HhccCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 007969 469 MPNKSLDV-----------H---LFDATR--------SVQLDW-KRRQS------------II-NGIARGILYLHED--- 509 (583)
Q Consensus 469 ~~~gsL~~-----------~---l~~~~~--------~~~l~~-~~~~~------------i~-~~ia~gL~yLH~~--- 509 (583)
++|..+.. . +|.... ...+.| ..... .. ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 111111 011112 21111 11 1111222333211
Q ss_pred -CCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 510 -SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 510 -~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
-+..++|+|+.|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 233599999999999999776678999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.011 Score=60.30 Aligned_cols=143 Identities=19% Similarity=0.176 Sum_probs=86.7
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC--CceeEEEE------EEeCCeEEEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYE 467 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e 467 (583)
.+.|..|....+|+....+ ..+++|+.... ..++...|++++..+.+. .+++++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999887644 46888887642 235567788888777433 35555442 123456789999
Q ss_pred cCCCCChhH----H----------HhccCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 007969 468 YMPNKSLDV----H----------LFDATR--------SVQLDWKRRQ----------SIINGIARGILYLHED----SR 511 (583)
Q Consensus 468 ~~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~~----~~ 511 (583)
|++|..+.. . +|.... .....|.... .....+...+.++... .+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876531 1 111100 0112232211 1112233445555431 22
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999988889999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.012 Score=60.32 Aligned_cols=143 Identities=17% Similarity=0.172 Sum_probs=83.2
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC--CCceeEEEEE------EeCCeEEEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCC------LEGQELLLIYE 467 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~------~~~~~~~lV~e 467 (583)
.+.++.|.-..+|+....+| .+++|....... .++...|++++..|.. -++++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777788998876555 567787654321 2445566777777642 2345554421 22456789999
Q ss_pred cCCCCChhH--------------HHhccCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 007969 468 YMPNKSLDV--------------HLFDATRS---------VQLDWKRRQ------------SIINGIARGILYLHE---- 508 (583)
Q Consensus 468 ~~~~gsL~~--------------~l~~~~~~---------~~l~~~~~~------------~i~~~ia~gL~yLH~---- 508 (583)
|++|..+.. .+|..... ..-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999855421 11111110 001222111 011223344555542
Q ss_pred CCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 509 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.-+..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999998878999999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00017 Score=81.87 Aligned_cols=149 Identities=19% Similarity=0.236 Sum_probs=99.1
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
+..-+.+.+.+.+..|.++.+..+.-. .|...++|...... ....+....+-.+.-..+||-+++..--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345566777778889999999877633 23333333332221 11112222222233334456666555555556788
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
+|+++|+.+++|...|+... ..+.+-....+..+..+++|||.. ++.|||++|.|.++..++..+++|||+.+
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 99999999999999887644 233333444556678899999986 48999999999999999999999998444
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.011 Score=59.62 Aligned_cols=33 Identities=27% Similarity=0.497 Sum_probs=27.2
Q ss_pred CCeeeCCCCCCcEEEcCCCc-eEEEecCCceecC
Q 007969 512 LKIIHRDLKASNILLDDDMN-PKISDFGLARIFG 544 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~~~ 544 (583)
..++|+|+.+.|||+++++. .-|.||+.+..-.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 34899999999999998554 5699999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.02 Score=58.48 Aligned_cols=142 Identities=25% Similarity=0.349 Sum_probs=83.3
Q ss_pred ccccccCceEEEEEEecC-------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~ 468 (583)
+.|..|---.+|+....+ ++.+++|....... ...+..+|.+++..+.... .+++++.... .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345556667888887654 47888888655432 2245577888888775322 3455655532 358999
Q ss_pred CCCCChhHH-----------------HhccCCCC--------CCCHHHHHH--------------------------HHH
Q 007969 469 MPNKSLDVH-----------------LFDATRSV--------QLDWKRRQS--------------------------IIN 497 (583)
Q Consensus 469 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~ 497 (583)
++|..+... +|+..... ..-|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766421 11111110 011111100 112
Q ss_pred HHHHHHHHHHh------CCCCCeeeCCCCCCcEEEcCC----CceEEEecCCceec
Q 007969 498 GIARGILYLHE------DSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF 543 (583)
Q Consensus 498 ~ia~gL~yLH~------~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~~ 543 (583)
.+..-+.+|-. ..+..++|+|+.+.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233444432 234568999999999999985 88999999988754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.018 Score=60.27 Aligned_cols=141 Identities=19% Similarity=0.289 Sum_probs=81.0
Q ss_pred cccccCceEEEEEEecC-----CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcCCC
Q 007969 398 KLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~ 471 (583)
.|-.|-.-.+|+....+ ++.+++|..........++ .+|..+++.+...++ +++++.+..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44446677888876532 3678888776554333333 678888888854333 3556665332 57999987
Q ss_pred CChhHH-----------------HhccCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 007969 472 KSLDVH-----------------LFDATR---SVQLDWKRRQSIINGI-----------------ARGILYL----HE-D 509 (583)
Q Consensus 472 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~ 509 (583)
.++... +|+... .....|.+...+..++ ..-+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 111110 1112233332322111 1112222 21 2
Q ss_pred CCCCeeeCCCCCCcEEEcC-CCceEEEecCCceec
Q 007969 510 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIF 543 (583)
Q Consensus 510 ~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~ 543 (583)
.+..++|+|+++.|||+++ ++.++|+||..+..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2345899999999999986 478999999888754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.03 Score=57.39 Aligned_cols=130 Identities=19% Similarity=0.287 Sum_probs=76.9
Q ss_pred CcEEEEEEecc--CCchhHHHHHHHHHHHhhCCC--CCceeEEEEEEeCC--eEEEEEEcCCCCChhHHH----------
Q 007969 415 GKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ--ELLLIYEYMPNKSLDVHL---------- 478 (583)
Q Consensus 415 g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l---------- 478 (583)
++++++. ... .......+..+|.++++.+.- .-+.+.++.|.++. ..+.||+|++|..+.+.+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6667776 321 223345566788888888753 34566777777665 679999999884332111
Q ss_pred --------h---cc--------CC------CCCCCHHHHHHH--------HHHHHHHHHHHHhC-----CCCCeeeCCCC
Q 007969 479 --------F---DA--------TR------SVQLDWKRRQSI--------INGIARGILYLHED-----SRLKIIHRDLK 520 (583)
Q Consensus 479 --------~---~~--------~~------~~~l~~~~~~~i--------~~~ia~gL~yLH~~-----~~~~iiHrDlk 520 (583)
. +- .+ .+.-.|...+.. .-....-..||+.+ ++..++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 1 00 00 000112222210 01112224455443 23569999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCC
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+.|++++++.-+=|.||+++..-.+
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCCc
Confidence 9999999998899999999986543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0097 Score=60.12 Aligned_cols=133 Identities=17% Similarity=0.152 Sum_probs=90.4
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccC-----------------Cchh-----HHHHHHHHHHHhhCCC-
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----------------SGQG-----LQEFKNEVNLIAKLQH- 446 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~-----------------~~~~-----~~~~~~Ei~~l~~l~H- 446 (583)
..-++..++||-|.-+.||.+-..+|++.++|.-+.. .... +-...+|...|+.|.-
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred chhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3346778999999999999999999999888843211 0000 1133568888888842
Q ss_pred -CCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 007969 447 -KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (583)
Q Consensus 447 -~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 525 (583)
-.+++.+++ ...++|||++.+-.|...- ...+..++..- +..-+.-|..+| +||+|..-=||+
T Consensus 171 gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 171 GFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC---ceecccchheeE
Confidence 234444433 4568999999887765322 11233444333 333355566665 999999999999
Q ss_pred EcCCCceEEEecC
Q 007969 526 LDDDMNPKISDFG 538 (583)
Q Consensus 526 l~~~~~~kl~DFG 538 (583)
++++..++++||=
T Consensus 235 v~dd~~i~vIDFP 247 (465)
T KOG2268|consen 235 VKDDDKIVVIDFP 247 (465)
T ss_pred EecCCCEEEeech
Confidence 9999999999995
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.026 Score=57.31 Aligned_cols=75 Identities=17% Similarity=0.274 Sum_probs=49.2
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
+..+.++-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++++++....+..++|+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678888899999877 5788899998762 23357888888888883 4568899999888777899999998
Q ss_pred CC
Q 007969 471 NK 472 (583)
Q Consensus 471 ~g 472 (583)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.023 Score=58.43 Aligned_cols=140 Identities=17% Similarity=0.222 Sum_probs=96.4
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccC-----Cch-----------------hHH----HHHHHHHHHhhCCCCCc
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----SGQ-----------------GLQ----EFKNEVNLIAKLQHKNL 449 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~-----~~~-----------------~~~----~~~~Ei~~l~~l~H~ni 449 (583)
...|..|.-..||.+.-.+|..+|||+.+.. +.. .++ -...|++.|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3467789999999999999999999977532 000 011 12468888888876555
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC
Q 007969 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (583)
Q Consensus 450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 529 (583)
+-.--.... ...|||+|+...... ...-+...+....+..+-.+++.-|.-|-..+ ++||.||.--|+|+- +
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 433333222 347999999642221 11123345777778888889999998888777 699999999999885 4
Q ss_pred CceEEEecCCceec
Q 007969 530 MNPKISDFGLARIF 543 (583)
Q Consensus 530 ~~~kl~DFGla~~~ 543 (583)
|.+.|+|.+-+-..
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68899998766543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.13 Score=52.77 Aligned_cols=30 Identities=33% Similarity=0.437 Sum_probs=25.7
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 46899999999999988 5789999996653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.073 Score=55.41 Aligned_cols=79 Identities=15% Similarity=0.172 Sum_probs=51.3
Q ss_pred cccccCceEEEEEEecCC-cEEEEEEeccC-------CchhHHHHHHHHHHHhhCC--CC-CceeEEEEEEeCCeEEEEE
Q 007969 398 KLGQGGFGPVYKGTLADG-KAIAVKRLSRT-------SGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~g-~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 466 (583)
.||.|..-.||++..++| +.|+||.-... -+-..++...|.+.|.... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 68999965421 1223456667777776653 23 45555443 455667999
Q ss_pred EcCCCC-ChhHHH
Q 007969 467 EYMPNK-SLDVHL 478 (583)
Q Consensus 467 e~~~~g-sL~~~l 478 (583)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.11 Score=55.08 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=49.7
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCc-------hhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 465 (583)
.+.||.|..-.||+.... +..++||+-..... ...++-..|.+.|+.+. ..++++++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 467899999999998764 55788997652111 12334445566665553 3578888888773 46788
Q ss_pred EEcCCC
Q 007969 466 YEYMPN 471 (583)
Q Consensus 466 ~e~~~~ 471 (583)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.018 Score=59.10 Aligned_cols=73 Identities=22% Similarity=0.261 Sum_probs=57.0
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...|+++++. |+++.. ...-.|++.+.|+.+.+.-+.-+..+ .+.=|||+.-.||||+ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 3456777764 555531 22357899999999988877777765 4789999999999999 99999999999
Q ss_pred ceec
Q 007969 540 ARIF 543 (583)
Q Consensus 540 a~~~ 543 (583)
+|.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9954
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.002 Score=69.97 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=93.0
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCCeEEEEEEcCCCC-Ch
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPNK-SL 474 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL 474 (583)
+-++++..++++|.+-...+.+..+.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457889999999988544444446655433 34567899999999999 777777777778899999999877 22
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
..... .....+.......+...-++++++||+.- -+||| ||+..+ ...|..||+....+...
T Consensus 323 ~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 323 ALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 11110 01111333344455666788899999752 58999 776655 68899999988877654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.16 Score=53.06 Aligned_cols=180 Identities=14% Similarity=0.139 Sum_probs=104.6
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEE------EeCC-eEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC------LEGQ-ELLLI 465 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~------~~~~-~~~lV 465 (583)
...+.||+|+-+.+|.--- -..-+.|+.......... +.++.|.+. .||-+..-+.|= -+++ ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567899999999985321 111244555544332211 223334444 566443312221 1122 25567
Q ss_pred EEcCCCC-ChhHHHhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 466 YEYMPNK-SLDVHLFD---ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 466 ~e~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
|..+.+. -+..++.. +......+|...++.+..+|.+-+-||+.| -+-+|+.++|+|+.+++.+.|.|=.--.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7766653 22333321 223345789999999999999999999997 7789999999999999998887732111
Q ss_pred ecCCCC---------Ccccceee---eeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQ---------NQANTNII---AVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+...+. ....++.- .-.......+.|.|++++.||.++-+
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 111111 11111100 01112455668999999999998743
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.11 Score=53.84 Aligned_cols=140 Identities=15% Similarity=0.250 Sum_probs=77.4
Q ss_pred cccccCceEEEEEEecC----CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcCCCC
Q 007969 398 KLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNK 472 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g 472 (583)
.|..|=.-.+|+....+ +..+++|.......... +-.+|..+++.+...++ +++++++. ++ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34445567788876543 23788887765433222 23678888888865444 35666653 22 589999876
Q ss_pred ChhH-----------------HHhccCC---CCCCCHHHHHHHHHHH----------------------HHHHHH----H
Q 007969 473 SLDV-----------------HLFDATR---SVQLDWKRRQSIINGI----------------------ARGILY----L 506 (583)
Q Consensus 473 sL~~-----------------~l~~~~~---~~~l~~~~~~~i~~~i----------------------a~gL~y----L 506 (583)
.|.. .+|+... ...--|....++..++ ..-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6521 1111110 1111233322222211 111111 1
Q ss_pred Hh-CCCCCeeeCCCCCCcEEEcC-CCceEEEecCCcee
Q 007969 507 HE-DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI 542 (583)
Q Consensus 507 H~-~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~ 542 (583)
.. ..+.-+.|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12234789999999999975 57899999987764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.33 Score=49.82 Aligned_cols=33 Identities=24% Similarity=0.337 Sum_probs=29.0
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 511 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+..++|+|+.+.|||+++++.+.|+||..+..-
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 345999999999999999999999999888754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.049 Score=52.54 Aligned_cols=30 Identities=37% Similarity=0.535 Sum_probs=21.4
Q ss_pred CeeeCCCCCCcEEE-cCCCceEEEecCCcee
Q 007969 513 KIIHRDLKASNILL-DDDMNPKISDFGLARI 542 (583)
Q Consensus 513 ~iiHrDlk~~NILl-~~~~~~kl~DFGla~~ 542 (583)
-+.|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999988864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.24 Score=51.28 Aligned_cols=137 Identities=25% Similarity=0.342 Sum_probs=81.5
Q ss_pred CceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC------ceeEEEEEE--eCC--eEEEEEEcCCCC
Q 007969 403 GFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCL--EGQ--ELLLIYEYMPNK 472 (583)
Q Consensus 403 ~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~--~~~--~~~lV~e~~~~g 472 (583)
.--.+|+....+|+. ++|..... ....+...|+..+..+.-.. +..+-|-.. -.+ ..+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888777776 88877665 33456666777776663111 333333321 123 778999999998
Q ss_pred ChhH-----H----------HhccC------C---CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 007969 473 SLDV-----H----------LFDAT------R---SVQLDWKR-------------RQSIINGIARGILYLHEDS----R 511 (583)
Q Consensus 473 sL~~-----~----------l~~~~------~---~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~----~ 511 (583)
.+.. . +|... . .....|.. ......++...+..+.+.- +
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 1 11110 1 11233431 1123344455555555431 1
Q ss_pred ---CCeeeCCCCCCcEEEcCCCc-eEEEecCCcee
Q 007969 512 ---LKIIHRDLKASNILLDDDMN-PKISDFGLARI 542 (583)
Q Consensus 512 ---~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~ 542 (583)
..+||+|+.|.||+++.+.. +-+.||+.+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 22999999999999999884 99999998863
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.48 Score=45.95 Aligned_cols=59 Identities=20% Similarity=0.308 Sum_probs=44.7
Q ss_pred CCcEEEEEEeccCCchhHHHHHHHHHHHhhC---CCCCceeEEEEEEeCCeEEEEEEcCCCCChh
Q 007969 414 DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (583)
Q Consensus 414 ~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 475 (583)
+..++-||+-. ...+..|..|+.-|..+ +.-++.+++.+-....+.|+|+||++-+.++
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 35678888643 33456788888776666 3466888898888999999999999987665
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.041 Score=37.40 Aligned_cols=25 Identities=20% Similarity=0.325 Sum_probs=14.1
Q ss_pred CCCcEEEEEeehhhHHHHHHHHhhh
Q 007969 304 RGRAISIAIGTTLSALIVVLFGSFL 328 (583)
Q Consensus 304 ~~~~i~i~i~~~~~~~~~~~~~~~~ 328 (583)
...++++.+++++++++++++++++
T Consensus 9 ~~vaIa~~VvVPV~vI~~vl~~~l~ 33 (40)
T PF08693_consen 9 NTVAIAVGVVVPVGVIIIVLGAFLF 33 (40)
T ss_pred ceEEEEEEEEechHHHHHHHHHHhh
Confidence 3445666666666666555544444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=1.2 Score=46.09 Aligned_cols=72 Identities=14% Similarity=0.059 Sum_probs=44.4
Q ss_pred cCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC--CCceeEE---E--EEEeCCeEEEEEEcCCCCCh
Q 007969 402 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLL---G--CCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 402 G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~---g--~~~~~~~~~lV~e~~~~gsL 474 (583)
+.--.||+....++..+++|..+.. .....++..|++.+..+.. -.++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3446789988877888999987532 2234566777777776632 1223221 2 12234567889999987643
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.17 Score=53.46 Aligned_cols=74 Identities=11% Similarity=0.139 Sum_probs=50.3
Q ss_pred cccccccCceEEEEEEecC-CcEEEEEEeccC-----C-chhHHHHHHHHHHHhhCC--CC-CceeEEEEEEeCCeEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----S-GQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~-----~-~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV 465 (583)
.+.||.|.-..||++..++ ++.|+||.-... + +-..++...|.+.|+... -| .+++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 568999965321 1 223566777777777663 23 45556544 44556889
Q ss_pred EEcCCC
Q 007969 466 YEYMPN 471 (583)
Q Consensus 466 ~e~~~~ 471 (583)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999965
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.47 Score=56.80 Aligned_cols=142 Identities=22% Similarity=0.288 Sum_probs=77.2
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC----CCCceeEEEE--------EEe-CC--e
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ----HKNLVRLLGC--------CLE-GQ--E 461 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~----H~niv~l~g~--------~~~-~~--~ 461 (583)
+.|+ |..-.+|+....+|..+++|+....... .....|.+.+..|. ...+.+++-. ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 4457788888778889999998754322 23334444554442 1223333321 111 22 4
Q ss_pred EEEEEEcCCCCChhHH-------Hh----------c----c---CCCCCCCHHH-----------------HHHHHHHHH
Q 007969 462 LLLIYEYMPNKSLDVH-------LF----------D----A---TRSVQLDWKR-----------------RQSIINGIA 500 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~-------l~----------~----~---~~~~~l~~~~-----------------~~~i~~~ia 500 (583)
.+.+++|++|..+.+. +. . . .....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6778999999776541 10 0 0 0011233321 112222232
Q ss_pred HHHH-----HHHhCCCCCeeeCCCCCCcEEEcCCC--ceE-EEecCCcee
Q 007969 501 RGIL-----YLHEDSRLKIIHRDLKASNILLDDDM--NPK-ISDFGLARI 542 (583)
Q Consensus 501 ~gL~-----yLH~~~~~~iiHrDlk~~NILl~~~~--~~k-l~DFGla~~ 542 (583)
+... .|.+ -+..+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 1222 233599999999999999875 555 999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.63 Score=49.29 Aligned_cols=74 Identities=22% Similarity=0.387 Sum_probs=43.7
Q ss_pred ccccccCceEEEEEEecCC--cE-----EEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADG--KA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g--~~-----vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 468 (583)
+.|..|-...+|+....++ .. |.++.......... +-.+|+++++.+...++ +++++.+.. .+++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3454577788999876543 22 33333222211112 22678888988865544 455555542 599999
Q ss_pred CCCCChh
Q 007969 469 MPNKSLD 475 (583)
Q Consensus 469 ~~~gsL~ 475 (583)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.48 Score=47.07 Aligned_cols=77 Identities=21% Similarity=0.203 Sum_probs=55.0
Q ss_pred ccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHH---HHHhhCCCCCceeEEEEEEeCCeEEEEEEcC-C
Q 007969 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV---NLIAKLQHKNLVRLLGCCLEGQELLLIYEYM-P 470 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei---~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~-~ 470 (583)
....+..|..+.|++++..+|.+.++|....... +..|. ..|+..+-...|+++..-. +.-.+++|.+ +
T Consensus 6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~ 78 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAADP--ERGALLLERLDP 78 (253)
T ss_pred cCCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeecccc--ccchhhhhhccC
Confidence 3445677999999999999999999998875432 23333 5577778788889987753 3456788888 4
Q ss_pred CCChhHHH
Q 007969 471 NKSLDVHL 478 (583)
Q Consensus 471 ~gsL~~~l 478 (583)
+.+|.+..
T Consensus 79 g~~L~~~~ 86 (253)
T PF04655_consen 79 GRSLASLP 86 (253)
T ss_pred CCchhhcc
Confidence 45775544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.27 Score=51.49 Aligned_cols=62 Identities=16% Similarity=0.128 Sum_probs=43.0
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 528 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 528 (583)
...++-+|+.+-++..++...+ .+++...+++.-.++++.-+-... +++|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3467778888888888884322 455556666666666655443332 5999999999999953
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.071 Score=46.53 Aligned_cols=45 Identities=18% Similarity=0.361 Sum_probs=35.0
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhh
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~ 443 (583)
.+.|+.|+.|.||+|++++|+.||||+.+..-. +.+..++.++..
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHHH
Confidence 468999999999999999999999999875532 345555555544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 583 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 9e-95
Identities = 77/195 (39%), Positives = 105/195 (53%), Gaps = 14/195 (7%)
Query: 372 QAESQEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLS- 424
+ F F TN+F + NK+G+GGFG VYKG + + +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 425 ---RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
T+ + Q+F E+ ++AK QH+NLV LLG +G +L L+Y YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ L W R I G A GI +LHE+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 542 IFGGNQNQANTNIIA 556
T+ I
Sbjct: 182 ASEKFAQTVMTSRIV 196
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-93
Identities = 80/169 (47%), Positives = 108/169 (63%), Gaps = 2/169 (1%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVN 439
F LR A+++FS++N LG+GGFG VYKG LADG +AVKRL QG + +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIING 498
+I+ H+NL+RL G C+ E LL+Y YM N S+ L + S LDW +RQ I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
ARG+ YLH+ KIIHRD+KA+NILLD++ + DFGLA++
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 5e-87
Identities = 71/164 (43%), Positives = 105/164 (64%), Gaps = 4/164 (2%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
PL EATN+F + +G G FG VYKG L DG +A+KR + S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGI 499
++ +H +LV L+G C E E++LIY+YM N +L HL+ + + W++R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
ARG+ YLH + IIHRD+K+ NILLD++ PKI+DFG+++
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
+ +G FG V+K L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 441 IAKLQHKNLVRLLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+ ++H+N+++ +G G +L LI + SL L ++ + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 497 NGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ARG+ YLHED + I HRD+K+ N+LL +++ I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 550 ANTN 553
+T+
Sbjct: 188 GDTH 191
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-53
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
++ +G+G +G VYKG+L D + +AVK S + Q K + + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 449 LVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+ R + E LL+ EY PN SL +L T DW + + + RG+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 504 LYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAV 557
YLH + + I HRDL + N+L+ +D ISDFGL+ GN+
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 558 DT 559
Sbjct: 185 AI 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 51/149 (34%), Positives = 82/149 (55%), Gaps = 4/149 (2%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+ K+G G FG V++ G +AVK L + + EF EV ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G + L ++ EY+ SL L + QLD +RR S+ +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARI 542
I+HR+LK+ N+L+D K+ DFGL+R+
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 6/170 (3%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG+G FG K T G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + L I EY+ +L + Q W +R S IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM 564
IHRDL + N L+ ++ N ++DFGLAR+ + Q +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G+G FG V K K +A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G CL + L+ EY SL L A S ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 511 RLKIIHRDLKASNILLDDDMN-PKISDFGLARI 542
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 7/157 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKN 448
+ KL + G ++KG G I VK L S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ +LG C LI +MP SL L + T V +D + +ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H I L + ++++D+DM +IS + F
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL----SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
E +G GGFG VY+ G +AVK Q ++ + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L G CL+ L L+ E+ L ++ + IARG+ YLH+++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 512 LKIIHRDLKASNILLDDDMNP--------KISDFGLARI 542
+ IIHRDLK+SNIL+ + KI+DFGLAR
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 18/165 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIA 442
N E ++G+GGFG V+KG + D +A+K L +G QEF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
L H N+V+L G ++ E++P L L D ++ + W + ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLARI 542
I Y+ + I+HRDL++ NI L + K++DFGL++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 53/147 (36%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
Q L ++ ++ SL HL + + K+ I ARG+ YLH II
Sbjct: 89 STAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 516 HRDLKASNILLDDDMNPKISDFGLARI 542
HRDLK++NI L +D KI DFGLA
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATE 169
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
+G+G FG VY G G+ +A++ + R + L+ FK EV + +H+N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C+ L +I ++L + D + LD + + I I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT-WPQSM 564
I+H+DLK+ N+ D+ I+DFGL I G Q + + + W +
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
+G+G +G V++G+ G+ +AVK S + + + E + L+H+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ + +L LI Y SL +L + LD I+ IA G+ +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ I HRDLK+ NIL+ + I+D GLA + + NQ +
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
++G+G +G V+ G G+ +AVK + E + ++H+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
++G +L LI +Y N SL +L +S LD K + G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ I HRDLK+ NIL+ + I+D GLA F + N+ +
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 19/168 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
+ +G+G FG V++G G+ +AVK S + + + E + L+H+N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ +L L+ +Y + SL FD + + + A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ I HRDLK+ NIL+ + I+D GLA + +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ + +AVK L S Q+F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL------------FDATRSVQLDWKRRQSIIN 497
VR G C EG+ LL+++EYM + L+ L + L + ++ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A G++YL + L +HRDL N L+ + KI DFG++R
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +LG+G FG V+ + +AVK L + ++F+ E L+ LQH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSII 496
V+ G C +G L++++EYM + L+ L +L + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 7/149 (4%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
++G+G FG V+ G L AD +AVK +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
G C + Q + ++ E + L T +L K ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARI 542
IHRDL A N L+ + KISDFG++R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 396 ENKLGQGGFGPVYKGTL---ADGKAI--AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V DG AVK L +G Q +K E++++ L H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
++ GCC + L L+ EY+P SL +L + + I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
IHRDL A N+LLD+D KI DFGLA+
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 56/166 (33%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
+LG+ FG VYKG L A+A+K L + G +EF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSI 495
+V LLG + Q L +I+ Y + L L D T L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IA G+ YL S ++H+DL N+L+ D +N KISD GL R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGT---LADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V L D AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ IHRDL NIL++++ KI DFGL ++ ++
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 397 NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
+LGQG FG VY+G +A+K + S + EF NE +++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------FDATRSVQLDWKRRQSIINGIARG 502
VRLLG +GQ L+I E M L +L + + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ YL+ K +HRDL A N ++ +D KI DFG+ R
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 396 ENKLGQGGFGPVYKGTLA-----DGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V G+ +AVK L + G + + K E+ ++ L H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
V+ G C E G + LI E++P+ SL +L +++ K++ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +HRDL A N+L++ + KI DFGL + ++
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
++LG+G FG V G +AVK+L + ++F+ E+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G L L+ EY+P+ L L +LD R + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +HRDL A NIL++ + + KI+DFGLA++ +++
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG+G FG V G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ G C L LI EY+P SL +L ++D + + I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ IHRDL NIL++++ KI DFGL ++ ++
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 357 IRNHYAYNILRGGKQQAESQEFPLFPL-RLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
++ H+ GK + +P+ + + + +G+G FG V K +
Sbjct: 1 MKKHH---HHHHGKNNPDPTIYPVLDWNDIKFQ--------DVIGEGNFGQVLKARIKKD 49
Query: 416 KA---IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470
A+KR+ S ++F E+ ++ KL H N++ LLG C L L EY P
Sbjct: 50 GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 471 NKSLDVHL-------------FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
+ +L L + + L ++ +ARG+ YL S+ + IHR
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 166
Query: 518 DLKASNILLDDDMNPKISDFGLAR 541
DL A NIL+ ++ KI+DFGL+R
Sbjct: 167 DLAARNILVGENYVAKIADFGLSR 190
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYL 506
RLLG CL + LI + MP L ++ + ++ Q ++N IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAKGMNYL 133
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+++HRDL A N+L+ + KI+DFGLA++ G +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG+G FG V K T K +AVK L S L++ +E N++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL---------------------DVHLFDATRSVQL 487
+++L G C + LLLI EY SL + D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S I++G+ YL + +K++HRDL A NIL+ + KISDFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + ++EF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
IHRDL A N L+ ++ K++DFGL+R+ G+ A+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 57/241 (23%), Positives = 87/241 (36%), Gaps = 35/241 (14%)
Query: 326 SFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRL 385
S+ + + L+++G + + + K + + P
Sbjct: 2 SYYHHHHHHDYDIPTTEN-------LYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYC 54
Query: 386 ALEATNHFSDE-----------NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTS 427
T+ SD LG G FG VY+G ++ +AVK L S
Sbjct: 55 FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATR 483
Q +F E +I+K H+N+VR +G L+ ++ E M L L ++
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLA 540
L + IA G YL IHRD+ A N LL KI DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
Query: 541 R 541
R
Sbjct: 232 R 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V G +A+K + + EF E ++ L H+ LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + + + +I EYM N L +L + ++ + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L++D K+SDFGL+R ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +G+G FG VY G D A+K LSR T Q ++ F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
L+G L + ++ YM + L + R+ + K S +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ K +HRDL A N +LD+ K++DFGLAR
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 10/162 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E +G G G V G L +A+K L + + + ++F +E +++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G G+ +++ EYM N SLD L T Q + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
L +HRDL A N+L+D ++ K+SDFGL+R+ + + A T
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
C +I E+M +L +L + R ++ + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
IHR+L A N L+ ++ K++DFGL+R+ G+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 41/233 (17%)
Query: 328 LWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLAL 387
+ Y+ ++ + Q + + + N Y + I E EFP L+
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYE--------GNSYTF-IDPTQLPYNEKWEFPRNNLQF-- 50
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNL 440
LG G FG V + T +AVK L S + +E+ +
Sbjct: 51 --------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 441 IAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQLD 488
++ L QH+N+V LLG C G +L+I EY L + A +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ + +A+G+ +L + IHRD+ A N+LL + KI DFGLAR
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V G +AVK + + EF E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
C + + ++ EY+ N L +L + L+ + + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L+D D+ K+SDFG+ R +Q
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
++G G FG V+ G + +A+K + R ++F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
CLE + L+ E+M + L +L T+ + + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL A N L+ ++ K+SDFG+ R +Q
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L + + L + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
HKN++ LLG C + L +I EY +L +L + Q+ +K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +ARG+ YL + K IHRDL A N+L+ ++ KI+DFGLAR
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 456 CLEGQELL-LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D K+SDFGL +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V +G L +AVK + +S + ++EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 450 VRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIAR 501
+RLLG C+E + ++I +M L +L T + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G+ YL S +HRDL A N +L DDM ++DFGL++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 50/152 (32%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LLG CL + L++ YM + L + + K +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
K +HRDL A N +LD+ K++DFGLAR
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
LG G FG V+KG + +K + SG Q Q + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
VRLLG C L L+ +Y+P SL H+ L + + IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++HR+L A N+LL +++DFG+A + +
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
+G+G FG V++ +AVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQL 487
+V+LLG C G+ + L++EYM L+ L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I +A G+ YL S K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 456 CLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+E + L ++ EYM SL +L RS L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 515 IHRDLKASNILLDDDMNPKISDFGLAR 541
+HRDL A N+L+ +D K+SDFGL +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ +G G FG VYKG L +A+K L + + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+RL G + + +++I EYM N +LD L + + + ++ GIA G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ + +HRDL A NIL++ ++ K+SDFGL+R+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 49/160 (30%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
LG G FG VY+G ++ +AVK L S Q +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRQSIINGIARGIL 504
+VR +G L+ ++ E M L L ++ L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 505 YLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLAR 541
YL IHRD+ A N LL KI DFG+AR
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+LG G FG V+ G +AVK L + F E NL+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I EYM N SL L ++L + + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ D ++ KI+DFGLAR+ N+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 50/169 (29%), Positives = 67/169 (39%), Gaps = 26/169 (15%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG G FG V + T +AVK L + +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL---------------DVHLFDATRSVQLDWKRR 492
N+V LLG C G L+I EY L + LD +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
S +A+G+ +L + IHRDL A NILL KI DFGLAR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
LG+G FG V +AVK L S + + L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING------- 498
HKN++ LLG C + L +I EY +L +L A R L++ S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 499 -------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ARG+ YL + K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG+G FG V + L +AVK L + ++EF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 450 VRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIA 500
+L+G L + ++I +M + L L L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
G+ YL S IHRDL A N +L +DM ++DFGL+R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +G G FG V G L ++A+K L + + ++F E +++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL G + + ++++ EYM N SLD L Q + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +HRDL A NIL++ ++ K+SDFGL R+
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG VYKG +A+K L TS + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+++HRDL A N+L+ + KI+DFGLA++ G +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLG G FG V+ T +AVK + + ++ F E N++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
+ + + +I E+M SL L S + + IA G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ + KI+DFGLAR+ N+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 25/167 (14%)
Query: 397 NKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
LG+G FG V + + +AVK L + + +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 449 LVRLLGCCL-EGQELLLIYEYMPNKSL-------------DVHLFDATRSVQLDWKRRQS 494
+V LLG C G L++I E+ +L + L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + K IHRDL A NILL + KI DFGLAR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 54/165 (32%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 396 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL---SRTSGQGLQEFKNEVNLIAKLQHKN 448
KLG G FG V +G GK + AVK L + + + +F EVN + L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGIL 504
L+RL G L + ++ E P SL L + +A G+
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
YL E R IHRDL A N+LL KI DFGL R N +
Sbjct: 136 YL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG VY GTL D AVK L+R T + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LLG CL + L++ YM + L + + + K +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ K +HRDL A N +LD+ K++DFGLAR
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+ +LG G FG V +G K I A+K L T +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L+G C + L+L+ E L L + ++ +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL + KISDFGL++ G + +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 396 ENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 447
LGQG F ++KG + +K L + + F ++++KL HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+LV G C+ G E +L+ E++ SLD +L + + WK + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP--------KISDFGLAR 541
+IH ++ A NILL + + K+SD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 31/174 (17%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG G FG V T +AVK L + + +E+ ++ +L H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL------------DVHLFDATRSVQLDWKRRQSI 495
N+V LLG C + LI+EY L + + + + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 496 ING--------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 11/152 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E L L R LD ++ + YL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+ +HRD+ A N+L+ + K+ DFGL+R
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA---IAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +LG G FG V KG K +AVK L E E N++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
R++G C + +L+ E L+ +L ++ + K +++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+HRDL A N+LL KISDFGL++ ++N
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
LG+G FG VY+G + K +AVK + + ++F +E ++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E P L +L S+++ I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ +HRD+ NIL+ K+ DFGL+R
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 7/160 (4%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
K+G+G FG DG+ +K +SR S + +E + EV ++A ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
E L ++ +Y L +A + V + I + ++H+ KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+HRD+K+ NI L D ++ DFG+AR+ A I
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 17/176 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKN 448
F LG+GGFG V++ D A+KR+ ++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 449 LVRLLGCCLEGQE------------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
+VR LE L + + ++L + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
IA + +LH ++HRDLK SNI D K+ DFGL ++ +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
H+ KLG+GGF V L DG A+KR+ Q +E + E ++ H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 451 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
RL+ CL E L+ + +L + + L + ++ GI RG+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
+H HRDLK +NILL D+ P + D G
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 5/156 (3%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
LG+G +G VY G L++ IA+K + + Q E+ L L+HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
E + + E +P SL L ++ + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 518 DLKASNILLDDDM-NPKISDFGLARIFGGNQNQANT 552
D+K N+L++ KISDFG ++ G T
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 52/152 (34%), Positives = 82/152 (53%), Gaps = 6/152 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
HRDL+A+NIL+ +++ K++DFGLAR+ N+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 6/158 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
E + + ++ EYM SL L T L + + IA G+ Y+ R+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
HRDL+A+NIL+ +++ K++DFGLAR+ N+ A
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-30
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRTSGQGLQEFKNEVN 439
+L L+ N + +LG G FG V +G K +A+K L T +E E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++ +L + +VRL+G C + L+L+ E L L + ++ +++ +
Sbjct: 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 445
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ G+ YL +HR+L A N+LL + KISDFGL++ G + +
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 36/169 (21%), Positives = 75/169 (44%), Gaps = 8/169 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
+F E K+G+G F VY+ L DG +A+K++ + + E++L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILY 505
N+++ +E EL ++ E L + + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+H +++HRD+K +N+ + K+ D GL R F A++ +
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 24/192 (12%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ F + LGQG FG V K D + A+K++ T + L +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 449 LVRLLGCCLE-------------GQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQ 493
+VR LE L + EY N +L +D + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ I + Y+H IIHRDLK NI +D+ N KI DFGLA+ + + +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 554 IIAVDTWPQSMQ 565
+ ++
Sbjct: 177 SQNLPGSSDNLT 188
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 26/181 (14%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
F + +G GGFG V+K DGK +KR+ + ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 450 VRLLGC----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
V GC + + L + E+ +L+ + R +LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLAL 125
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ I +G+ Y+H K+I+RDLK SNI L D KI DFGL N + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181
Query: 554 I 554
Sbjct: 182 K 182
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 11/151 (7%)
Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V++G + A+A+K + TS ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L+G E + +I E L L R LD ++ + YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +HRD+ A N+L+ + K+ DFGL+R
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 43/161 (26%), Positives = 83/161 (51%), Gaps = 8/161 (4%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L G EL ++ EY+ SL D +D + ++ + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
++IHRD+K+ NILL D + K++DFG Q++ +T
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 8/161 (4%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
K+G+G G V G+ +AVK + Q + NEV ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ L G+EL ++ E++ +L D V+L+ ++ ++ + + + YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+IHRD+K+ +ILL D K+SDFG + + +
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ +LG G FG VYK G A K + S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYL 506
+V+LLG +L ++ E+ P ++D + Q + + + +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H +IIHRDLKA N+L+ + + +++DFG++ + ++
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
++G+G F VYKG +A + + + Q FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 455 CCLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+ ++L+ E M + +L +L R + K +S I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 511 RLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
IIHRDLK NI + + KI D GLA + +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNL 449
F+ K+G+G FG V+KG K +A+K + + +++ + E+ ++++ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ G L+ +L +I EY+ S D LD + +I+ I +G+ YLH +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
K IHRD+KA+N+LL + K++DFG+A Q + NT
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 8/165 (4%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
+G G +G K +DGK + K + Q +EVNL+ +L+H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 455 CCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
++ L ++ EY L + T+ Q LD + ++ + + H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++HRDLK +N+ LD N K+ DFGLARI + + A T +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 14/167 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
FSD ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
LH +IHRD+KA NILL + K+ DFG A AN+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
F KLG+G +G VYK G+ +A+K++ LQE E++++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 452 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
G + +L ++ EY S+ D+ R+ L +I+ +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ IHRD+KA NILL+ + + K++DFG+A + NT
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
I+H DLK +N L+ D K+ DFG+A +
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 181
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I+HR++K NI+ D K++DFG AR ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 22/162 (13%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAK 443
F K+G+G +G VYK G+ +A+K++ L E++L+ +
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKE 58
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARG 502
L H N+V+LL +L L++E++ D+ DA+ + +S + + +G
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ + H +++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 15/169 (8%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQ 445
E + + + ++G+G FG V++ G AVK++ L+ F+ E+ A L
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS 108
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
+V L G EG + + E + SL + + L R + G+ Y
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEY 165
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTN 553
LH +I+H D+KA N+LL D + + DFG A + +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
I+H DLK +N L+ D K+ DFG+A +
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 162
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
LGQG V++G G A+K + S + E ++ KL HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
+ +LI E+ P SL L + + + L ++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I+HR++K NI+ D K++DFG AR ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
++G GG V++ + A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ Q + ++ E N L+ L +D R+S + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
I+H DLK +N L+ D K+ DFG+A +
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 10/157 (6%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
L +GGF VY+ + G+ A+KRL + + EV + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 454 GCCL-------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
GQ L+ + L L L I R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
H + IIHRDLK N+LL + K+ DFG A
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
K+G+G +G VYK + G+ +A+KR+ L E++L+ +L H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V L+ + L L++E+M D+ L + + + + RG+ + H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+I+HRDLK N+L++ D K++DFGLAR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLA 540
+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+GGF ++ + + A K + ++ +E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
+ + ++ E +SL + + + L + + I G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLA 540
+IHRDLK N+ L++D+ KI DFGLA
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHK 447
F +G G +G VYKG + G+ A+K + +G +E K E+N++ K H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 448 NLVRLLGCCLEG------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
N+ G ++ +L L+ E+ S+ L T+ L + I I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
G+ +LH+ K+IHRD+K N+LL ++ K+ DFG++ + NT I
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 21/157 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+G+G +G V+K + +A+KR+ L + E+ L+ +L+HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+VRL ++L L++E+ D+ + + + LD + +S + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++HRDLK N+L++ + K+++FGLAR FG
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 20/156 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
K+G+G +G VYK G+ A+K++ L++ E++++ +L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+L + L+L++E++ D+ L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+++HRDLK N+L++ + KI+DFGLAR FG
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
+ LG+G F VYK + +A+K++ + + E K+ E+ L+ +L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTALREIKLLQELSHP 72
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N++ LL + L++++M D+ + S+ L ++ + +G+ YLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ I+HRDLK +N+LLD++ K++DFGLA+ FG
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKN 448
+ + + +G G V + +A+KR++ Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGIL--- 504
+V + EL L+ + + S+ D+ + +S I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 505 -YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YLH++ IHRD+KA NILL +D + +I+DFG++
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G F VY+ + G +A+K + + + G+ + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + L+ E N ++ +L + + + R ++ I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---SHGI 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
+HRDL SN+LL +MN KI+DFGLA
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNL 440
+ +++ F KLG G + VYKG G +A+K + S +G ++E ++L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56
Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIING 498
+ +L+H+N+VRL +L L++E+M N K L+ +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ +G+ + HE+ KI+HRDLK N+L++ K+ DFGLAR FG
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 9/168 (5%)
Query: 390 TNHFSDENKLGQG--GFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL 444
+ +G+G V G+ + V+R L S + + + E+++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
H N+V + EL ++ +M S L ++ I+ G+ + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
Y+H +HR +KAS+IL+ D +S + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 46/227 (20%), Positives = 72/227 (31%), Gaps = 17/227 (7%)
Query: 330 YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEA 389
+ H+ + + + +++ + P P +
Sbjct: 2 HHHHHHSSGVDLGTENL---YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ- 57
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKL-Q 445
F ++LG G +G V+K DG+ AVK + EV K+ Q
Sbjct: 58 --SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H VRL EG L L E SL H L + + + +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
LH ++H D+K +NI L K+ DFGL G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 19/164 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR 451
F ++ LG G G + + D + +AVKR+ + EV L+ + +H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED 509
+ Q + E L + + +++ G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 510 SRLKIIHRDLKASNILL-----DDDMNPKISDFGLARIFGGNQN 548
L I+HRDLK NIL+ + ISDFGL + ++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+G+G +G V+K G+ +A+K+ E E+ ++ +L+H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
NLV LL + L L++EY V + +SI + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ IHRD+K NIL+ K+ DFG AR+
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 21/186 (11%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT 426
G S L L ++ + + +G+G +G V K G+ +A+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-- 59
Query: 427 SGQGLQEFKN--------EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
+ E+ L+ +L+H+NLV LL C + + L++E++ +
Sbjct: 60 ----ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILD 112
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
LD++ Q + I GI + H IIHRD+K NIL+ K+ DFG
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 539 LARIFG 544
AR
Sbjct: 170 FARTLA 175
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 34/185 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQH 446
+ +++ +G G FG V++ L + +A+K++ + + FKN E+ ++ ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 447 KNLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-- 498
N+V L + L L+ EY+P V+ R+ + K +Q++
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY-----RASRHYAKLKQTMPMLLI 143
Query: 499 ------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQAN 551
+ R + Y+H + I HRD+K N+LLD K+ DFG A+I + N
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 552 TNIIA 556
+ I
Sbjct: 199 VSYIC 203
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 50/199 (25%), Positives = 73/199 (36%), Gaps = 27/199 (13%)
Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
+ P F L N E LG G G V G+ +AVKR+
Sbjct: 1 SRIANIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCD 53
Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV---HLFDATRSVQLD 488
E+ L+ + H N++R + L + E D+
Sbjct: 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKIS 535
S++ IA G+ +LH LKIIHRDLK NIL+ +++ IS
Sbjct: 114 EYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 536 DFGLARIFGGNQNQANTNI 554
DFGL + Q+ TN+
Sbjct: 171 DFGLCKKLDSGQSSFRTNL 189
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 14/165 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
N+++L + ++ E LFD + + II + GI Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 506 LHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+H+ I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNLIAKL 444
+ +KLG+G + VYKG +A+K + +G ++E V+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+H N+V L + L L++EY+ D+ + ++ + + + RG+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
Y H K++HRDLK N+L+++ K++DFGLAR
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 8e-24
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL-- 453
+LG GGFG V + G+ +A+K+ + +E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 454 ----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
LL EY L +L L +++++ I+ + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 510 SRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQ 547
+IIHRDLK NI+L + KI D G A+ +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 23/176 (13%)
Query: 388 EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QE 433
+T+ F + LG+G V + K AVK + T G +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 434 FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKR 491
EV+++ K+ H N+++L L+++ M L FD T V L K
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ I+ + I LH+ L I+HRDLK NILLDDDMN K++DFG + +
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
K+G+G +G VYK D K A+K++ +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 455 CCLEGQE--LLLIYEYMPN---KSLDVH--LFDATRSVQLDWKRRQSIINGIARGILYLH 507
L + + L+++Y + + H + VQL +S++ I GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFG 544
+ ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 36/170 (21%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHK 447
+ F + KLG G FG V+ + G +K +++ Q +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
N++++ + + ++ E L + R V + + ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMM 134
Query: 501 RGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+ Y H ++H+DLK NIL KI DFGLA +F ++
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 12/163 (7%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+++ EN +G+G +G V A K++ + + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++RL + ++ L+ E LF+ I+ + + Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+ L + HRDLK N L D K+ DFGLA F +
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 23/170 (13%)
Query: 398 KLGQGGFGPVY---------------KGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLI 441
L QG F + K L + + S + + FKNE+ +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSII 496
++++ + G E+ +IYEYM N S+ D + + + + II
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
+ Y+H + I HRD+K SNIL+D + K+SDFG +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
KLG+G +G VYK + +A+KR+ L+ + EV+L+ +LQH+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARGILYL 506
N++ L L LI+EY D+ D ++ + + +S + + G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA---ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFG 544
H + +HRDLK N+LL KI DFGLAR FG
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 369 GKQQAESQEFPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRL 423
G + Q A F + + +G+G V + A G AVK +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 424 SRTSGQGLQE--------FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
T+ + E + E +++ ++ H +++ L+ + L+++ M L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 475 DVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533
FD T V L K +SI+ + + +LH I+HRDLK NILLDD+M +
Sbjct: 188 ----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240
Query: 534 ISDFGLARIFGGNQ 547
+SDFG + +
Sbjct: 241 LSDFGFSCHLEPGE 254
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
+G+G F V + G+ AVK + + + G ++ K E ++ L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD-----ATRSVQLDWKRRQSIINGIARGILYL 506
LL L +++E+M L A + I + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANT 552
H+ IIHRD+K +LL ++ K+ FG+A G + A
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
L+ L + E++LI E++ LFD A ++ + + G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSG----GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQ 547
HE I+H D+K NI+ + KI DFGLA ++
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 31/167 (18%)
Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQ- 445
++G+G +G V+K G+ +A+KR+ +Q + EV ++ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70
Query: 446 --HKNLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIIN 497
H N+VRL C + L L++E++ D+ D + + + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 46/182 (25%), Positives = 67/182 (36%), Gaps = 27/182 (14%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL-Q 445
T F + K+G G FG V+K DG A+KR Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
H ++VR E +L+ EY SL + + R + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFGG 545
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 546 NQ 547
Q
Sbjct: 187 PQ 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
S LG G FG V+K A G +A K + + +E KNE++++ +L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGILYL 506
L +++L+ EY V LFD S L + I GI ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 507 HEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQN 548
H+ + I+H DLK NIL D KI DFGLAR + +
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKN----EVNLIAKLQ---HK 447
++G G +G VYK G +A+K + G G EV L+ +L+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 448 NLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIAR 501
N+VRL+ C + + L++E++ D+ D L + + ++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
G+ +LH + I+HRDLK NIL+ K++DFGLARI+
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+G FG VY +A+K L + +G Q + EV + + L+H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L G + + LI EY P ++ L ++ D +R + I +A + Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---S 127
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA 540
++IHRD+K N+LL KI+DFG +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
++D +G G FG VY+ L D G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 448 NLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--- 498
N+VRL E L L+ +Y+P V+ R + + +Q++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY-----RVARHYSRAKQTLPVIYVK 159
Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT 552
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ + + N
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214
Query: 553 NIIA 556
+ I
Sbjct: 215 SYIC 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 48/193 (24%), Positives = 74/193 (38%), Gaps = 22/193 (11%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
G + + P H S+ KLG G +G V A+K
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 423 LSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
+ +T S + EV ++ L H N+++L + + L+ E LFD
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFD 125
Query: 481 ATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKI 534
+ II + G+ YLH+ I+HRDLK N+LL + D KI
Sbjct: 126 --EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 535 SDFGLARIFGGNQ 547
DFGL+ +F +
Sbjct: 181 VDFGLSAVFENQK 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 390 TNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIA 442
+ FSD +LG+G F V + G A K ++ S + Q+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
KLQH N+VRL E L+++ + LF+ I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I Y H I+HR+LK N+LL K++DFGLA ++
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 12/164 (7%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
LV L + E+++IYE+M LF+ A ++ + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQN 548
HE +H DLK NI+ + K+ DFGL Q+
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 29/169 (17%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
K+GQG FG V+K G+ +A+K++ ++ K E+ ++ L+H+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76
Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
N+V L+ C + L++++ D+ + V+ + ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
G+ Y+H + KI+HRD+KA+N+L+ D K++DFGLAR F +N
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
D ++G+G +G V K G+ +AVKR+ T + ++ +++++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL- 504
+V+ G + + E M + S D + V + I+ I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 505 ---YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
+L E+ LKIIHRD+K SNILLD N K+ DFG
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 35/166 (21%), Positives = 72/166 (43%), Gaps = 19/166 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ LG+G FG V++ + K K + + G K E++++ +H+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGI 503
++ L +EL++I+E+ + +F+ T + +L+ + S ++ + +
Sbjct: 63 ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQ 547
+LH I H D++ NI+ + KI +FG AR
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLL 453
LG+G +G V + AVK L + G K E+ L+ +L+HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 454 G--CCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRR--QSIINGIARGILYLH 507
E Q++ ++ EY + + D + + +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
I+H+D+K N+LL KIS G+A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
++ LG+G FG V K + AVK +++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGI 503
N+++L + ++ E LFD ++ II + GI
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIKRKRFSEHDAARIIKQVFSGI 134
Query: 504 LYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
Y+H+ I+HRDLK NILL + D + KI DFGL+ F N
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ 445
++ + + LG+G FG V G+ AVK +S+ + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARG 502
H N+++L + L+ E LFD + II + G
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIISRKRFSEVDAARIIRQVLSG 138
Query: 503 ILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I Y+H+ KI+HRDLK N+LL D N +I DFGL+ F ++
Sbjct: 139 ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 41/187 (21%), Positives = 80/187 (42%), Gaps = 9/187 (4%)
Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG 428
+Q+ + F ++ + F ++LG G G V+K + G +A K +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 429 QGLQEF-KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
++ E+ ++ + +V G E+ + E+M SLD + +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE 130
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ + + +G+ YL E KI+HRD+K SNIL++ K+ DFG++
Sbjct: 131 QILGK--VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184
Query: 548 NQANTNI 554
+ AN+ +
Sbjct: 185 SMANSFV 191
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 33/188 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL-------SRTSGQGLQEFKNEVN 439
+ + F E GQG FG V G G ++A+K++ +R LQ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71
Query: 440 LIAKLQHKNLVRLLGCCLEGQE-------LLLIYEYMPNKSLDVHLF---DATRSVQLDW 489
+A L H N+V+L E L ++ EY+P +H R V
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQN 548
+ + + R I LH S + + HRD+K N+L+++ K+ DFG A+ + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 549 QANTNIIA 556
+ N I
Sbjct: 186 EPNVAYIC 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 46/177 (25%), Positives = 70/177 (39%), Gaps = 18/177 (10%)
Query: 382 PLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEF 434
+ A+ FSD +LG+G F V + G A K ++ S + Q+
Sbjct: 16 GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 435 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQ 493
+ E + KLQH N+VRL E L+++ + LF+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I I I Y H I+HR+LK N+LL K++DFGLA ++
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSR--------TSGQGLQEFKNEVNLIAKLQHKN 448
LG G G V K +A++ +S+ + E+ ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
E IIHRDLK N+LL ++D KI+DFG ++I G
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ I HRD+K N+LLD+ N KISDFGLA +F N
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE--------FKNEVNLIAKLQHKN 448
LG G G V K +A+K +S+ + E+ ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
++++ + ++ ++ E M L FD + +L + + + YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
E IIHRDLK N+LL ++D KI+DFG ++I G
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 41/172 (23%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVN-LIAKLQHK 447
+ +LG+G +G V K + G+ +AVKR+ T Q + +++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RQSIINGIARGIL-- 504
V G ++ + E M + SLD + V + + I+ IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLD----KFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
+LH S+L +IHRD+K SN+L++ K+ DFG++ + + +
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA 170
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 18/170 (10%)
Query: 390 TNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ F D E+ LG+G V L + AVK + + G EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 444 LQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
Q H+N++ L+ E L++E M S+ + + ++ +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVAS 122
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQN 548
+ +LH I HRDLK NIL + KI DF L N +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 33/204 (16%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
G++ Q + P + + KLG G +G V A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 423 LSR-------------TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
+ + + +E NE++L+ L H N+++L + + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 470 PNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
L F+ + + +I+ I GI YLH+ I+HRD+K NILL
Sbjct: 129 EGGEL----FE--QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILL 179
Query: 527 ---DDDMNPKISDFGLARIFGGNQ 547
+ +N KI DFGL+ F +
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDY 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 18/157 (11%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
LG+G +G V +A+AVK + E K E+ + L H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
EG L EY L FD + +R ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ I HRD+K N+LLD+ N KISDFGLA +F N
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 21/214 (9%), Positives = 42/214 (19%), Gaps = 36/214 (16%)
Query: 364 NILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR 422
++ Q L + L G V+ + + A+K
Sbjct: 35 AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94
Query: 423 L---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC----------------------- 456
+ S L+ A+L ++
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 457 ---LEGQELLLIYEYMPNKSLDV-HLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LL+ + D + + R L
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--- 211
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
++H N+ + D + D G
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G FG VY + +A+K L ++ +G++ + E+ + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
+ + + L+ E+ P L L R D +R + + +A + Y H K+
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKV 135
Query: 515 IHRDLKASNILLDDDMNPKISDFGLA 540
IHRD+K N+L+ KI+DFG +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH KI H DLK NI+L + K+ DFGLA
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G F V+ GK A+K + ++ +NE+ ++ K++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYL 506
L+ + + L FD R ++ R +I + + YL
Sbjct: 74 IYESTTHYYLVMQLVSGGEL----FD--RILE-----RGVYTEKDASLVIQQVLSAVKYL 122
Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
HE I+HRDLK N+L +++ I+DFGL+++
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 44/228 (19%), Positives = 73/228 (32%), Gaps = 48/228 (21%)
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--- 421
+ + +E F LE + + +GQG +G V A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 422 --RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP--------- 470
++ + + + ++ K EV L+ KL H N+ RL + Q + L+ E
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 471 --NKSLDVHLFDATRSVQLDWKRRQ--------------------------SIINGIARG 502
Q+ +I+ I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 503 ILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQN 548
+ YLH I HRD+K N L + K+ DFGL++ F N
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+ + +LG G F V K + G A K + G +E + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
++ H N++ L +++LI E + LFD + L + S I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126
Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH KI H DLK NI+L + K+ DFGLA
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 26/171 (15%), Positives = 54/171 (31%), Gaps = 22/171 (12%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
+ + LG+G F VY+ T + + +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIAR 501
++ L +L+ E +L ++L+ T + S +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP-----------KISDFGLAR 541
I +H+ +IIH D+K N +L + + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 23/172 (13%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
+H+ +LG G F V K GK A K S G +E + EVN++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGI 499
+++H N++ L +++LI E + L FD + + + I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD--FLAEKESLTEDEATQFLKQI 117
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
G+ YLH +I H DLK NI+L + K+ DFG+A
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL------SRTSGQGLQEFKNEVNLIA 442
+++ +LG G F V K + G A K + S G ++ + EV+++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFDA-TRSVQLDWKRRQSIING 498
++QH N++ L +++LI E V LFD L + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQ 547
I G+ YLH L+I H DLK NI+L KI DFGLA
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
N + ++G G G V+K G IAVK++ R+ + + +++++ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V+ G + ++ + E M + + + + I + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
E +IHRD+K SNILLD+ K+ DFG++
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 22/177 (12%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE--FKN--------- 436
+ ++ + + G +G V G ++G +A+KR+ T G +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
E+ L+ H N++ L + +L L+ E M D+ + + + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQH 135
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
Q + I G+ LHE ++HRDL NILL D+ + I DF LAR + N
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 23/189 (12%)
Query: 376 QEFPLFPLRLAL-EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ 429
Q + + L + F+D +G G + + A AVK + ++
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 430 GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQL 487
E+ ++ + QH N++ L +G+ + ++ E M L D R
Sbjct: 62 P----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF 113
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNP-KISDFGLARIF 543
+ +++ I + + YLH ++HRDLK SNIL + +I DFG A+
Sbjct: 114 SEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 544 GGNQNQANT 552
T
Sbjct: 171 RAENGLLMT 179
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+G+G F V + G+ +A+K + +T + LQ+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 456 CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
+ L LI EY + FD A ++ R + I++ + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH--- 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ +I+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 18/179 (10%)
Query: 385 LALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNE 437
+A F++E +LG+G F V + + G+ A ++ S + Q+ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 438 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSII 496
+ L+H N+VRL E LI++ + L F+ I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANT 552
I +L+ H+ + ++HR+LK N+LL K++DFGLA G Q
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 36/199 (18%)
Query: 371 QQAESQEFPLFPLRLALEATNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVK--R 422
S L L ++ +F++ +LG+G F V + + G+ A K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 423 LSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
R E +E+ ++ + ++ L E++LI EY +F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFS- 118
Query: 482 TRSVQLDWKR----------RQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DD 528
+ + +Q I G+ YLH+ I+H DLK NILL
Sbjct: 119 -LCLPELAEMVSENDVIRLIKQ-----ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169
Query: 529 DMNPKISDFGLARIFGGNQ 547
+ KI DFG++R G
Sbjct: 170 LGDIKIVDFGMSRKIGHAC 188
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 42/197 (21%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + + + +G G +G V + + + +A+K++ R F++ E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102
Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKR 491
+ ++ +L H ++V++L + EL ++ E D LF V L
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRT--PVYLTELH 157
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
++++ + G+ Y+H I+HRDLK +N L++ D + K+ DFGLAR +N +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 552 TNIIAVDTWPQSMQWEA 568
I+ ++
Sbjct: 215 QLPISPREDDMNLVTFP 231
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 25/180 (13%), Positives = 56/180 (31%), Gaps = 37/180 (20%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ--------- 445
LGQ + T G++ V R +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 446 -------------HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------ 486
+++ L+ +++ ++ + + +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 487 --LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 37/163 (22%), Positives = 68/163 (41%), Gaps = 16/163 (9%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
+ LG+G F K +A AVK +S+ + E+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+ L+ E + L F+ + I+ + + ++H+ +
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 513 KIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANT 552
++HRDLK N+L +D++ KI DFG AR+ + T
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 28/180 (15%), Positives = 54/180 (30%), Gaps = 37/180 (20%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ--------- 445
LGQ + T G++ V T +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 446 ----------------HKNLVRLLGCC--LEGQELLLIYEYMPNKSLDV--HLFD-ATRS 484
K ++R+ + +Y M + L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 485 VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
L R + + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 36/165 (21%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------SGQGLQEFKNEVNLIAKLQHKNL 449
LG G FG V+ K + VK + + L + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 450 VRLLGCCLEGQELLLIYEYMPNKS-----LDVH-----LFD-ATRSVQLDWKRRQSIING 498
+++ + N+ ++ H LF R +LD I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ + YL IIHRD+K NI++ +D K+ DFG A
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V G G +AVK L+R S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
+ ++ EY+ L FD V+ RR Q I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH-- 128
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R ++HRDLK N+LLD MN KI+DFGL+ +
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 46/188 (24%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------------------------SGQGL 431
+G+G +G V D A+K LS+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 432 QEFKNEVNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLD 488
++ E+ ++ KL H N+V+L+ L+ L +++E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 489 ----WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
Q +I GI YLH KIIHRD+K SN+L+ +D + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 545 GNQNQANT 552
G+ +
Sbjct: 189 GSDALLSN 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 28/162 (17%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
+LG+G VY+ K A+K L +T + + + E+ ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYLHE 508
E+ L+ E + L FD R V+ + + I + YLHE
Sbjct: 118 ETPTEISLVLELVTGGEL----FD--RIVE-----KGYYSERDAADAVKQILEAVAYLHE 166
Query: 509 DSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I+HRDLK N+L D KI+DFGL++I
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
LG G FG V G G +AVK L+R S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
++ ++ EY+ LFD + RR Q I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R ++HRDLK N+LLD MN KI+DFGL+ +
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 31/175 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + D +G G +G V G +A+K+L R F++ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ ++H+N++ LL + + L+ +M L + +L R
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
Q ++ + +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 44/201 (21%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+++ ++ +G+G +G VY K +A+K+++R F++ E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILRE 75
Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKR 491
+ ++ +L+ ++RL + + EL ++ E + D+ ++ L +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLK--KLFKTPIFLTEEH 130
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
++I+ + G ++HE IIHRDLK +N LL+ D + K+ DFGLAR ++
Sbjct: 131 IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 552 TNIIAVDTWPQSMQWEAYFLL 572
N + + P L
Sbjct: 188 VNDLEENEEPGPHNKNLKKQL 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 17/156 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQHK--NL 449
LG GGFG VY G ++D +A+K + + E N EV L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHE 508
+RLL +LI E P D LFD T L + +S + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 509 DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543
++HRD+K NIL+D + K+ DFG +
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 39/173 (22%), Positives = 65/173 (37%), Gaps = 40/173 (23%)
Query: 395 DENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRL 452
+ LG G G V + G+ A+K L + + + EV+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ--SIIN 497
L +YE M + + LF R + + R+ I+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMR 135
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
I I +LH I HRD+K N+L + D K++DFG A+ N
Sbjct: 136 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
LG+G FG V T + +A+K +SR + + E++ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
+++++ EY + LFD + + D RR Q II I Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
R KI+HRDLK N+LLDD++N KI+DFGL+ I
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKL----QHK 447
LG+GGFG V+ G L D +A+K + R EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 506
++RLL + +L+ E P + D LFD T L + + I +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIF 543
H ++HRD+K NIL+D K+ DFG +
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 28/197 (14%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ KLG+G +G V+K G+ +AVK++ F+N E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58
Query: 438 VNLIAKLQ-HKNLVRLLGCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
+ ++ +L H+N+V LL +++ L+++YM + L R+ L+ +Q
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY 113
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++ + + I YLH S ++HRD+K SNILL+ + + K++DFGL+R F + N
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 555 IAVDTWPQSMQWEAYFL 571
++++ ++ + L
Sbjct: 171 LSINENTENFDDDQPIL 187
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 45/200 (22%), Positives = 75/200 (37%), Gaps = 34/200 (17%)
Query: 368 GGKQQAESQEFPLFPLRLALEA-TNHFSDE-----NKLGQGGFGPVYKGT-LADGKAIAV 420
Q+FP F ++ L+ N D+ LG G G V + + A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLG----CCLEGQELLLIYEYMPNKSLD 475
K L + + EV L + ++VR++ + LL++ E + L
Sbjct: 93 KMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 476 VHLFDATRSVQLDWKR---RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILL---D 527
F R + R+ I+ I I YLH + I HRD+K N+L
Sbjct: 147 ---FS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKR 198
Query: 528 DDMNPKISDFGLARIFGGNQ 547
+ K++DFG A+ +
Sbjct: 199 PNAILKLTDFGFAKETTSHN 218
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 32/170 (18%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G F V T + A+K L + + E +++++L H V+
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + ++L Y N L ++ ++ S R +
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVSAL 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
YLH IIHRDLK NILL++DM+ +I+DFG A++ QA N
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 32/176 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ + HKN++ LL E Q++ ++ E M D +L + +LD +R
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHER 128
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 36/179 (20%), Positives = 83/179 (46%), Gaps = 31/179 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ +++ + +G+G +G V + +A+K++S F++ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75
Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
+ ++ + +H+N++ + + +++ ++ + M + L+ ++ L
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHI 130
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+ I RG+ Y+H + ++HRDLK SN+LL+ + KI DFGLAR+ + +
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 31/152 (20%), Positives = 61/152 (40%), Gaps = 17/152 (11%)
Query: 398 KLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL- 453
+ GG G +Y +G+ + +K L + Q E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 454 -GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ + Y EY+ +SL +L + + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ +++ DLK NI+L ++ K+ D G
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 32/175 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + +G G +G V G+ +A+K+LSR F++ E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ +QH+N++ LL + L+ +M L + ++
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEK 127
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
Q ++ + +G+ Y+H ++HRDLK N+ +++D KI DFGLAR
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 42/189 (22%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + + D LG GG G V+ K +A+K++ + E
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58
Query: 438 VNLIAKLQHKNLVRLL--------------GCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
+ +I +L H N+V++ G E + ++ EYM + L +
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE 113
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
L + + + + RG+ Y+H + ++HRDLK +N+ ++ +D+ KI DFGLARI
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 543 FGGNQNQAN 551
+ +
Sbjct: 171 MDPHYSHKG 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 40/170 (23%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKN 448
++ LG G G V + + A+K L + + EV L + Q +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ-- 493
+VR++ +YE + + LF R + R+
Sbjct: 73 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREAS 120
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLA 540
I+ I I YLH + I HRD+K N+L + K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
KLG GG VY +A+K + R + L+ F+ EV+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
E L+ EY+ +L ++ L + N I GI + H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
I+HRD+K NIL+D + KI DFG+A+
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 31/181 (17%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNE 437
++ F ++ LG+G +G V T G+ +A+K++ RT L+E K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIK-- 61
Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
++ +H+N++ + E+ +I E M L + L
Sbjct: 62 --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHI 114
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
Q I R + LH + +IHRDLK SN+L++ + + K+ DFGLARI + +
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 553 N 553
Sbjct: 172 P 172
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
+ + +G G G V + +A+K+LSR F+N E
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ + HKN++ LL E Q++ L+ E M ++ ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLC---QVIQMELDHER 165
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
++ + GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 43/216 (19%), Positives = 83/216 (38%), Gaps = 67/216 (31%)
Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
+ +S LG G FG V + + GK A+K++ + +KN E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 448 NLVRLLGC--------------------------------------CLEGQELLLIYEYM 469
N+++L+ + + L +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIING--------IARGILYLHEDSRLKIIHRDLKA 521
P +H + ++ + +SI + R + ++H L I HRD+K
Sbjct: 121 P---DTLH-----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 522 SNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIA 556
N+L++ D K+ DFG A+ ++ + I
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 31/170 (18%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
E + + + +G G +G V G +AVK+LSR F++ E
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRE 78
Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
+ L+ ++H+N++ LL E ++ L+ M L + + +L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
Q +I I RG+ Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 134 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
+G G FG + +AVK + R G + E + E+ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRLKI 514
L L +I EY L + +A R D R Q +++G++ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVS----YCH---SMQI 137
Query: 515 IHRDLKASNILLDDD--MNPKISDFGLARIF 543
HRDLK N LLD KI DFG ++
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 26/130 (20%), Positives = 45/130 (34%), Gaps = 3/130 (2%)
Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
+S + ++ + KN V L L + + ++L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
+ I IA + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 544 GGNQNQANTN 553
++ +
Sbjct: 215 DQDEEEQTVL 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 16/153 (10%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL 453
LG GG V+ L D + +AVK R F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 454 --GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
G E L Y EY+ +L + + KR +I + + + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ IIHRD+K +NI++ K+ DFG+AR
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 34/150 (22%), Positives = 58/150 (38%), Gaps = 10/150 (6%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQE-FKNEVNLIAKLQHKNLVR 451
+G+GG G VY+ + +A+K +S +S + + E +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+ +L + + L L L R +I+ I + H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
HRD+K NIL+ D + DFG+A
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 339 QEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEAT----NHFS 394
+ + + F + H ++ +S F F LEA + F
Sbjct: 132 ARARAGAGDGLFQPLLRAVLAHLGQAPF---QEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188
Query: 395 DENKLGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
D LG+GGFG V+ K T GK A K+L++ +G Q E ++AK+ +
Sbjct: 189 DFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYL 506
+V L +L L+ M + H+++ + R I G+ +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H+ II+RDLK N+LLDDD N +ISD GLA Q +
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 14/156 (8%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVR 451
LG+GGFG V + T GK A K+L + +G NE ++ K+ + +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L L+ M L H++ ++ R I G+ LH
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR--- 304
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+I++RDLK NILLDD + +ISD GLA Q
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 35/166 (21%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ- 445
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 446 HKNLVRLLGCCLEGQE--LLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARG 502
N++ L + L++E++ N D L+ L + + I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
+ Y H S I+HRD+K N+++D + ++ D+GLA + Q
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 24/189 (12%)
Query: 374 ESQEFPLFPLRLALEATNHFSDEN-----KLGQGGFGPVY----KGTLADGKAIAVKRLS 424
ES +F F +E H + + +G+GGFG VY T GK A+K L
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD 223
Query: 425 RT---SGQGLQEFKNEVNLIAKLQHKN---LVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
+ QG NE +++ + + +V + +L I + M L HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
++ + I G+ ++H +++RDLK +NILLD+ + +ISD G
Sbjct: 284 ---SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 539 LARIFGGNQ 547
LA F +
Sbjct: 338 LACDFSKKK 346
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
LG+G FG V + A + +AVK L + + +E+ ++ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 448 NLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N+V LLG C G L++I E+ +L +L +R + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ I DLK + + S F + + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+A+G+ +L + K IHRDL A NILL + KI DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 3e-13
Identities = 35/256 (13%), Positives = 72/256 (28%), Gaps = 54/256 (21%)
Query: 371 QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--- 427
Q F T K+G+G FG V++ AD +A+K ++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58
Query: 428 -----GQGLQEFKNEVNLIAKLQ---------HKNLVRLLGCCL----EGQELLLIYEYM 469
+ +E E+ + +L + + L LL +++
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 470 PNK----------------------SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+ + R+ +SI++ + +
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWE 567
L+ HRDL N+LL K+ + +II D ++ +
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII--DYTLSRLERD 234
Query: 568 AYFLLNLMFSVLEFFC 583
+ + + F
Sbjct: 235 GIVVFCDVSMDEDLFT 250
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 17/150 (11%), Positives = 43/150 (28%), Gaps = 16/150 (10%)
Query: 398 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVR 451
G ++ D + +A+ + LQE + ++++ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
+L L++ E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ S + + D + ++
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 32/163 (19%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG G FG V K + G A+K L + L++ NE ++ + LV+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + L ++ EY+ + HL +R AR
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTF 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
YLH L +I+RDLK N+L+D +++DFG A+ G
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 32/157 (20%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG G FG V+ + G+ A+K L + L++ +E +++ + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
+ G + Q++ +I +Y+ L L ++ Q N +A+ +
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAEVCLAL 119
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
YLH II+RDLK NILLD + + KI+DFG A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
+HF +G+G FG V T K A+K +++ E +N E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
L+H LV L + +++ ++ + + L HL ++V + + I + +
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
YL +IIHRD+K NILLD+ + I+DF +A +
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 34/170 (20%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V K T K A+K LS+ + F E +++A +V+
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + + L ++ EYMP L + + AR +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM------------SNYDVPEKWARFYTAEVVLAL 181
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANT 552
+H + IHRD+K N+LLD + K++DFG ++ + +T
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 32/170 (18%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G FG V K K A+K L++ E F+ E +++ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
L + L L+ +Y L L K + +AR I
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS----------KFEDRLPEEMARFYLAEMVIAI 188
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANT 552
+H+ L +HRD+K NIL+D + + +++DFG ++ Q++
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 45/161 (27%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L + EY L HL +R R + I + YLH S
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SE 267
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+++RDLK N++LD D + KI+DFGL + + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 16/162 (9%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
+G+G F V K T G+ A+K +++ E F+ E +++ + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L + L L+ EY L L + + R + I I +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR--- 180
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANT 552
L +HRD+K NILLD + +++DFG ++ ++
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLQEFKNEV-------NLIAKLQHK 447
LG+GG+G V+ K T A+ I A+K L + + + N++ +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
+V L+ G +L LI EY+ L + L R + I+ + +LH
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+ II+RDLK NI+L+ + K++DFGL + + +T
Sbjct: 139 Q---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
LGQG FG V+ K + +D + + A+K L + + + K E +++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
+L LI +++ L L ++ V + + + +A + +LH L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK NILLD++ + K++DFGL++ ++ +A +
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 43/161 (26%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
LG+G FG V K T G+ A+K L + E E ++ +H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
L L + EY L HL +R +R + I + YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
+++RD+K N++LD D + KI+DFGL + + T
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V K T G AVK L + + + ++V L H
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNH 83
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + E++ L H+ +S + D R + I +++L
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEIISALMFL 140
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H+ II+RDLK N+LLD + + K++DFG+ + N T
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V +K T + A+K L + + ++V L +H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L + + L + EY+ L H+ + D R I G+ +L
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H I++RDLK NILLD D + KI+DFG+ + + NT
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V KGT + AVK L + + ++V L +
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKK----DVVIQDDDVECTMVEKRVLALPGKP 401
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N++LD + + KI+DFG+ + + T
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
LG+G FG V KGT + AVK L + + + ++V L +
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKP 80
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L +L C L + EY+ L H+ + + IA G+ +L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
II+RDLK N++LD + + KI+DFG+ + + T
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G FG V K AVK L + L+ K E L+ ++H
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQK--KAILK--KKEEKHIMSERNVLLKNVKH 98
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L +L + +Y+ L HL R R + IA + YL
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYL 155
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
H L I++RDLK NILLD + ++DFGL + + + +T
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + C EG +++ E + SL+ LF+ S + K + + + I Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123
Query: 509 DSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
+ IHRD+K N L+ I DFGLA+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G + V K T + A+K + + L +++ H
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 126
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
HE II+RDLK N+LLD + + K++D+G+ + + +T
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 25/166 (15%)
Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
+G+G + V K T + A++ + + L +++ H
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV L C L + EY+ L H+ R +L + + I+ + YL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 169
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
HE II+RDLK N+LLD + + K++D+G+ + + +T
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 15/151 (9%)
Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
LG G +G V+ K + D + A+K L + + + + + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L +L LI +Y+ L HL ++ + Q + I + +LH+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHK- 177
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
L II+RD+K NILLD + + ++DFGL+
Sbjct: 178 --LGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
+ + EG +L+ + + SL+ L D R+ S+ + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR 118
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
+HE S +++RD+K N L+ + + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N F K+G G FG +Y GT + + +A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-------INGIAR 501
+ + +EG +L+ + + SL+ LF+ R+ S+ I R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFC-------SRKLSLKTVLMLADQMINR 115
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
+ ++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 27/166 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
+F K+G G FG + G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
+ ++ G+ ++ E + SL+ LFD R S+ + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR 117
Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
Y+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 39/181 (21%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI------AVKRLSRTSGQGLQEFK-----NEVN 439
+ +GQGGFG +Y + +++ VK +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 440 LIAKLQHKNLVRLLGCCL---EGQELLLIYEY----MP--NKSLDVHLFDATRSVQLDWK 490
I K ++ LG G Y M L +++A
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEAN-------A 146
Query: 491 RRQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARI 542
+R S + ++ IL Y+HE +H D+KASN+LL+ ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 543 F 543
+
Sbjct: 204 Y 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 33/168 (19%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ----------- 445
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 446 HKNLVRLLGC----CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIING 498
++++LL G +++++E L +L + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP------KISDFGLA 540
+ G+ Y+H R IIH D+K N+L++ +P KI+D G A
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 30/180 (16%), Positives = 66/180 (36%), Gaps = 37/180 (20%)
Query: 391 NHFSDENKLGQGGFGPVYKGT---------LADGKAIAVKRLSRTSGQGLQEFK------ 435
+ ++ + G +Y+ + ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 436 --NEVNLIAKLQHKNLV---RLLGCCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDW 489
+VN KL L+ +G + + L+ + +SL D + L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 490 KRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
+ S++ +A +L +LHE+ +H ++ A NI +D + ++ + +G A +
Sbjct: 159 R---SVLQ-VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 25/166 (15%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQ 445
+ + ++ +G+G FG V K + + +A+K Q EV L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMN 108
Query: 446 H------KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSII 496
+V L + L L++E L +L+D R+ + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLA 540
+ +L+L L IIH DLK NILL + KI DFG +
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 34/157 (21%), Positives = 64/157 (40%), Gaps = 27/157 (17%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHK------N 448
+G+G FG V K + +A+K + R Q E+ ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGILY 505
++ +L + + +E L ++L++ + + + I + +
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLA 540
LH + +IIH DLK NILL K+ DFG +
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 33/180 (18%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 391 NHFSDENKLGQGGFGPVYKG----TLADGKAIAVKRLSRTSGQGLQEFK-----NEVNLI 441
N + K+G GGFG +Y VK + +G E K + + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 442 AKLQHKNLVRLLG----------CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
K + + LG ++ E + L +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISG--------QNG 146
Query: 492 RQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
+ + +L Y+HE+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 7e-06
Identities = 66/473 (13%), Positives = 127/473 (26%), Gaps = 115/473 (24%)
Query: 119 PDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ-ECMVRFSDHSSS 177
D+V G F + + V VL+ F+ ++ E
Sbjct: 58 KDAVSGTLRL-FWTLLSKQEEMVQKFVEEVLRINYK----FLMSPIKTEQR--------- 103
Query: 178 IMDTSAPLCMKIFQNTYNVTKSLAQSFN--DVIAMPSLSSFRNATKRTNISNIIRLET-- 233
S +++ + + Q F +V + R A + + ++
Sbjct: 104 --QPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 234 -FGQCIPVLSVDDCRD-----CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK 287
G+ +++D C ++ I W+ P ++ +
Sbjct: 160 GSGK--TWVALDVCLSYKVQCKMDFKIFWL---------NLKNCNSPETVLEMLQKLLYQ 208
Query: 288 V-PAVGALAPSSAPGGKRGRAISIAIGTTLS------ALIV---VLFGSFLWYRRRRHAR 337
+ P + + S+ R +I + L L+V V + +A
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV------QNAKAWNAF 262
Query: 338 DQEEK-----RNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLF-------PLRL 385
+ K R Q FL H + + E + L P L
Sbjct: 263 NLSCKILLTTRFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQDL 318
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA--DG-KAIAVKRLSRTSGQGLQE--------- 433
E N + LA D K + +L+ L
Sbjct: 319 PREVLTT----NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 434 ------FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
F ++ L L L+ + +++++ + SL V+
Sbjct: 375 FDRLSVFPPSAHIPTIL----LS-LIWFDVIKSDVMVVVNKLHKYSL----------VEK 419
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS-NILLD---DDMNPKISD 536
K I I + + +HR + NI DD+ P D
Sbjct: 420 QPKESTISIPSIY--LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 35/247 (14%), Positives = 74/247 (29%), Gaps = 66/247 (26%)
Query: 326 SFLW--YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYA-YNILRGGKQQAESQEFPLFP 382
FL + + + ++ L+ + ++ +A YN+ R P
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---FAKYNVSR---------LQPYLK 139
Query: 383 LRLALEATNHFSDENKL---GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
LR AL + G G G K +A + V + + ++
Sbjct: 140 LRQALL---ELRPAKNVLIDGVLGSG---KTWVA----LDVCLSYKV----QCKMDFKIF 185
Query: 440 LIAKLQHKNLVRLLGCCLEGQELL-----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
+ L C + +L L+Y+ PN + + +
Sbjct: 186 WLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-- 233
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD-FGL-ARIFGGNQNQANT 552
RL + + + ++L + N K + F L +I + + T
Sbjct: 234 --------------LRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 553 NIIAVDT 559
+ ++ T
Sbjct: 279 DFLSAAT 285
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 36/151 (23%), Positives = 61/151 (40%), Gaps = 24/151 (15%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQH-----KN 448
K+G G FG V + + K AVK + + + K E +++ K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSIINGIARGILY 505
+V+ G + + LI+E L L++ + + I + + Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
L + + + H DLK NILLDD K
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLI 180
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.73 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.48 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.93 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.58 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.49 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 80.35 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.70 Aligned_cols=187 Identities=26% Similarity=0.468 Sum_probs=159.8
Q ss_pred CCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...++||+|+||+||+|++. ++..||||+++..+....++|.+|++++++++|||||+++|++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777899999999999999864 477899999988777778899999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 465 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
|||||++|+|.++|++.. ....++|..++.|+.||++||.|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 3456999999999999999999999985 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+|||+|+...............|++.|++|| .|+|++|+++|+|+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 9999999876655544444456777666655 478888899988874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=321.80 Aligned_cols=187 Identities=26% Similarity=0.438 Sum_probs=151.6
Q ss_pred CCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...++||+|+||+||+|++. +++.||||+++..+....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999998777778899999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
|||||++|+|.+++++... ...++|.+++.|+.||++||.|||+.+ ||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 246999999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
||+|||+|+...............|++.|++|| .|+|++|+++|+|+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHc
Confidence 999999999876655444444556776666655 578889999998875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=310.62 Aligned_cols=184 Identities=27% Similarity=0.433 Sum_probs=149.2
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.+++...++||+|+||+||+|++++ .||||+++.. +.+..++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567788999999999999999753 6999999754 34456789999999999999999999998865 56899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
||++|+|.++|+.. ...++|..++.|+.|||+||.|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999653 345999999999999999999999985 9999999999999999999999999999876554
Q ss_pred CcccceeeeeccCCCcch-------------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~ 581 (583)
.........||+.|++|| .|+|++|+++|+|+.+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg 233 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence 444445567888877776 3677788888887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.61 Aligned_cols=185 Identities=29% Similarity=0.408 Sum_probs=155.3
Q ss_pred CCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
+...++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|++.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455688999999999999863 46789999997553 34467899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 466 YEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
||||++|+|.++|..... ...++|..++.|+.|||+||.|||+++ ||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999965321 235899999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
||+|||+++...............|+..|++|| .|+|++|+++|||+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t 242 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHh
Confidence 999999999876554444444456676666655 578889999998875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=310.71 Aligned_cols=185 Identities=25% Similarity=0.351 Sum_probs=160.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999864 6899999999754 2334678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 45999999999999999999999986 999999999999999999999999999998766
Q ss_pred CCcccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
.........+||++|++||. |.|++|+++|+|+.+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 230 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 55555566789999888773 455566666666554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=312.17 Aligned_cols=182 Identities=23% Similarity=0.368 Sum_probs=158.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999965 69999999998665556678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.+ ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999854 24899999999999999999999986 999999999999999999999999999988655433
Q ss_pred ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ...+||++|+++| .|+|++|+++|+|+.+
T Consensus 227 ~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 266 (346)
T 4fih_A 227 R--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266 (346)
T ss_dssp B--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred c--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 2 3357888877766 3666777777777654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.30 Aligned_cols=186 Identities=21% Similarity=0.364 Sum_probs=151.3
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 367999999999999999999864 6999999999754 3445678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++... +...+++..+..|+.||+.||.|||+++ ||||||||+||||++++++||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999653 3345799999999999999999999986 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. .....+||++|+++| .|.|++|+++|+|+.+
T Consensus 179 ~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG 221 (350)
T 4b9d_A 179 VE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221 (350)
T ss_dssp HH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 22 123356788877766 3566666666666654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.64 Aligned_cols=182 Identities=23% Similarity=0.372 Sum_probs=159.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+.|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999965 69999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999854 24899999999999999999999986 999999999999999999999999999988655443
Q ss_pred ccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
. ...+||++|+++|. |+|++|+++|+|+.|
T Consensus 304 ~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 343 (423)
T 4fie_A 304 R--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343 (423)
T ss_dssp B--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred c--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 2 34688888887773 666777777777654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.31 Aligned_cols=184 Identities=22% Similarity=0.290 Sum_probs=148.2
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----eEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~e 467 (583)
+|...++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+++ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466788999999999999998 5899999999754322 123345666677899999999999998653 6899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
||++|+|.++|++. .++|..+.+++.|+++||.|||++ +.++||||||||+|||||+++++||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999652 489999999999999999999986 234699999999999999999999999999998
Q ss_pred cCCCCCcc--cceeeeeccCCCcch----------------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA--NTNIIAVDTWPQSMQ----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~--~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~l~~~ 581 (583)
........ .+...+||++|++|| .|+|++|+++|+|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg 214 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHC
Confidence 86554332 334467898888887 3678888888887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.37 Aligned_cols=180 Identities=26% Similarity=0.342 Sum_probs=151.5
Q ss_pred CccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY 466 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 466 (583)
...++||+|+||.||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999865 6889999999754 34446789999999999999999999999875 24589999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 545 (583)
|||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||||+||||+. ++++||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 45899999999999999999999974 35999999999999984 79999999999986543
Q ss_pred CCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
.. ....+||++|++|| .|.|++|+++|+|+.+
T Consensus 185 ~~----~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg 225 (290)
T 3fpq_A 185 SF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp TS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHS
T ss_pred Cc----cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 32 33467888888877 3778888888888765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.21 Aligned_cols=186 Identities=25% Similarity=0.359 Sum_probs=144.6
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC---------
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--------- 460 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------- 460 (583)
+|+..+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5788899999999999999864 689999999975543 34578999999999999999999999987543
Q ss_pred ---eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 461 ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 461 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
..|+||||+++|+|.+++.........++..++.|+.||++||+|||+++ |+||||||+||||+.++++||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 37999999999999999976554455678889999999999999999985 999999999999999999999999
Q ss_pred CCceecCCCCCcc----------cceeeeeccCCCcchh----------HHHHHHHHHHHhhh
Q 007969 538 GLARIFGGNQNQA----------NTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 538 Gla~~~~~~~~~~----------~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~ 580 (583)
|+|+.+..+.... .....+||++|++||. |.|++|+++|+|+.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9999886543321 1223568888888773 66667777776653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.75 Aligned_cols=180 Identities=23% Similarity=0.276 Sum_probs=149.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+.|...++||+|+||.||+|+.+ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999964 689999999975432 257999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecCCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 548 (583)
++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999653 35999999999999999999999985 99999999999999987 699999999998865432
Q ss_pred c---ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 Q---ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~---~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ......+||++|++|| .|+|++|+++|+|+.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 1 1233457888877776 3677788888888765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.51 Aligned_cols=181 Identities=22% Similarity=0.380 Sum_probs=140.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999864 69999999997542 233567999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+ +|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899998855 345999999999999999999999986 999999999999999999999999999876543
Q ss_pred CCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.. .....||++|++|| .|.|++|+++|+|+.+
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg 208 (275)
T 3hyh_A 166 NF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred Cc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence 32 22356777766655 3566666666666654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.31 Aligned_cols=183 Identities=25% Similarity=0.293 Sum_probs=147.0
Q ss_pred CCCCccccccccCceEEEEEEec----CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|+..++||+|+||+||+|+.. +++.||||++++.. .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999852 47899999997542 2234578899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35899999999999999999999986 9999999999999999999999999999765
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... ...+||++|++|| .|.|++|+++|+|+.+
T Consensus 178 ~~~~~~--~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 222 (304)
T 3ubd_A 178 DHEKKA--YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222 (304)
T ss_dssp ---CCC--CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCccc--cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhC
Confidence 443322 2356788777766 3667777777777654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=302.45 Aligned_cols=190 Identities=24% Similarity=0.341 Sum_probs=159.5
Q ss_pred HHcCCCCccccccccCceEEEEEEecC------CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCC-CCceeEEEEEEeC
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEG 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~ 459 (583)
...++|...++||+|+||+||+|++.. ++.||||+++.... ...++|.+|++++++++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 445788899999999999999998542 35899999986543 346789999999999965 8999999999765
Q ss_pred -CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 007969 460 -QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525 (583)
Q Consensus 460 -~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 525 (583)
+..++|||||++|+|.++|++... ...++|.+++.++.|||+||.|||+++ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 568999999999999999975321 345899999999999999999999985 999999999999
Q ss_pred EcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 526 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
|++++++||+|||+|+....+.....+....|++.|++|| .|+|++|+++|+|+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 9999999999999999887766655555567777666655 478888888888864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.20 Aligned_cols=184 Identities=20% Similarity=0.378 Sum_probs=148.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEe------CCe
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 461 (583)
++|...++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999864 69999999997543 3345678999999999999999999999764 357
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.|+|||||+ |+|.+++.+ ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 679998843 456999999999999999999999986 9999999999999999999999999999
Q ss_pred ecCCCCC--cccceeeeeccCCCcchh-----------HHHHHHHHHHHhhhh
Q 007969 542 IFGGNQN--QANTNIIAVDTWPQSMQW-----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~ 581 (583)
.+..... .......+||.+|+++|. |.|++|+++|+|+.+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence 8754322 222334678888887774 445555555555443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.89 Aligned_cols=147 Identities=25% Similarity=0.385 Sum_probs=131.1
Q ss_pred HcCCCCccccccccCceEEEEEEec----CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (583)
..++|.+.++||+|+||+||+|+.+ .++.||+|++.+... ..++.+|+++++.+ +||||+++++++.+++..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3567999999999999999999753 467899999976543 35788999999998 6999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCcee
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI 542 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~ 542 (583)
+||||+++|+|.+++. .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999882 3899999999999999999999986 9999999999999877 7999999999997
Q ss_pred cCCC
Q 007969 543 FGGN 546 (583)
Q Consensus 543 ~~~~ 546 (583)
....
T Consensus 168 ~~~~ 171 (361)
T 4f9c_A 168 THDT 171 (361)
T ss_dssp CTTC
T ss_pred cCCc
Confidence 6543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.91 Aligned_cols=181 Identities=27% Similarity=0.314 Sum_probs=149.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHH---HHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQ---EFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...++||+|+||+||+|+.+ +|+.||||++++.. ..... ...+++.+++.++|||||++++++.+++.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56888999999999999999865 69999999997531 11122 2344567778889999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||++||+|.++|.+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999653 35899999999999999999999986 999999999999999999999999999988
Q ss_pred CCCCCcccceeeeeccCCCcchh-----------HHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQW-----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~ 581 (583)
..... ...+||++|++||. |+|++|+++|+|+.|
T Consensus 343 ~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG 387 (689)
T 3v5w_A 343 SKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387 (689)
T ss_dssp SSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 65443 23567777777663 455566666666654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=290.55 Aligned_cols=183 Identities=22% Similarity=0.368 Sum_probs=158.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|.+.++||+|+||.||+|+.+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+++..++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57889999999999999999865 69999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC--CceEEEecCCceecCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 547 (583)
++|+|.+++.+ +...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 2345899999999999999999999986 9999999999999854 899999999999886554
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....+||++|+++| .|.|++|+++|+|+.|
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 3 23457888877766 3566777777777654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=263.88 Aligned_cols=196 Identities=38% Similarity=0.630 Sum_probs=167.0
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
...+...+++|...+.||+|+||.||+|+.++++.||||++........+.+.+|+.++++++||||+++++++..++..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33444577899999999999999999999888999999999877767778999999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 463 LLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999865432 235899999999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...............|+..|.++| .|.|++|+.+|+++.+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhC
Confidence 865443333333455666666655 5788888888888754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-29 Score=252.18 Aligned_cols=201 Identities=39% Similarity=0.594 Sum_probs=170.4
Q ss_pred CccccChHHHHHHcCCCCcc------ccccccCceEEEEEEecCCcEEEEEEeccC----CchhHHHHHHHHHHHhhCCC
Q 007969 377 EFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQH 446 (583)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~------~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H 446 (583)
....+...++...+++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678888999999998877 8999999999999997 6889999999753 22346789999999999999
Q ss_pred CCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 447 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
|||+++++++.+++..++||||+++++|.+++........++|..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
++++.+||+|||+++...............|+..|.++| .|.|++|+.+|+++.+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHC
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHC
Confidence 999999999999999876544333333345555555544 5788889999888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=273.88 Aligned_cols=191 Identities=20% Similarity=0.202 Sum_probs=157.7
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
......++|...++||+|+||+||+++.+ +++.||+|++++... ...+.+.+|+.++..++||||+++++++.+++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33445678999999999999999999976 478999999975321 22334889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999652 345899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
+....+.... .....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 223 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG 277 (437)
T 4aw2_A 223 LKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277 (437)
T ss_dssp EECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred hhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence 8876544332 22346777776665 3566777777777654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=257.61 Aligned_cols=204 Identities=38% Similarity=0.639 Sum_probs=169.3
Q ss_pred CccccChHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEE
Q 007969 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGC 455 (583)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~ 455 (583)
....++..+.....++|...++||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456788899999999999999999999999999988899999999976532 223478999999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 456 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 456 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
+..++..++||||+++|+|.+++.... ....++|..+..++.||+.||.|||+....+|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997644 2345999999999999999999999983334999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+|||+++.......... ....|+.+|.++| .|.|++|+++|+++.+
T Consensus 176 ~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp CCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred ccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 99999998764443322 2244666666655 4677788888887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=252.67 Aligned_cols=186 Identities=26% Similarity=0.455 Sum_probs=155.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|...++||+|+||.||+++.. +++.||+|++...+....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999965 68999999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999653 345899999999999999999999986 999999999999999999999999999987543322
Q ss_pred cc------------ceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 550 AN------------TNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~------------~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
.. .....|+..|.++ ..|.|++|+.+|+++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 218 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcC
Confidence 11 0123455554444 46788899999888753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=251.12 Aligned_cols=183 Identities=23% Similarity=0.392 Sum_probs=157.0
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45788999999999999999985 56899999999766555667899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++.+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999998653 4899999999999999999999985 99999999999999999999999999998765443
Q ss_pred cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... ...|+..|.++| .|.|++|+.+|+|+.+
T Consensus 172 ~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 212 (297)
T 3fxz_A 172 KRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (297)
T ss_dssp CBC--CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccC--CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 222 234555555444 5788888888888764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=252.95 Aligned_cols=193 Identities=23% Similarity=0.341 Sum_probs=160.4
Q ss_pred ccChHHHHHHcCC----------CCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC
Q 007969 380 LFPLRLALEATNH----------FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448 (583)
Q Consensus 380 ~~~~~~~~~~~~~----------~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n 448 (583)
.++.+++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4555555555433 555678999999999999976 79999999998776666788999999999999999
Q ss_pred ceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 007969 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD 528 (583)
Q Consensus 449 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 528 (583)
|+++++++..++..++||||+++++|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998843 35899999999999999999999985 999999999999999
Q ss_pred CCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 529 DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 529 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
++.+||+|||+++......... ....|+..|.++ ..|.|++|+.+|+|+.+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 237 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999876543321 223455554444 46788888888888754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=261.54 Aligned_cols=188 Identities=28% Similarity=0.420 Sum_probs=154.6
Q ss_pred cCCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (583)
.++|...+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+++++++ +||||+++++++..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356888899999999999999852 35579999997653 34467899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++..........+....++..|+++ ..|+|++|+++|+|+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 99999999999999987654433222223333344443 3678888888888865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=254.59 Aligned_cols=189 Identities=25% Similarity=0.356 Sum_probs=153.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--------
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-------- 460 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------- 460 (583)
++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46788899999999999999976 79999999997543 344678999999999999999999999986643
Q ss_pred -------------------------------------------------eEEEEEEcCCCCChhHHHhccCCCCCCCHHH
Q 007969 461 -------------------------------------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491 (583)
Q Consensus 461 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 491 (583)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999999999999998766556678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc----------cceeeeeccCC
Q 007969 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA----------NTNIIAVDTWP 561 (583)
Q Consensus 492 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~----------~~~~~~~~~~~ 561 (583)
++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......... ......|+..|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999985 9999999999999999999999999999886543211 11123455554
Q ss_pred Ccch----------hHHHHHHHHHHHhhhhc
Q 007969 562 QSMQ----------WEAYFLLNLMFSVLEFF 582 (583)
Q Consensus 562 ~~~~----------~~~~~~~~~l~~l~~~f 582 (583)
.++| .|.|++|+++|+++.++
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~ 273 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcC
Confidence 4444 57888888888887653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=255.04 Aligned_cols=183 Identities=23% Similarity=0.262 Sum_probs=153.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +|+.||+|++++. .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999865 6899999999754 2334567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998643 35899999999999999999999985 999999999999999999999999999875433
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... .....|+..|+++| .|+|++|+.+|+|+.+
T Consensus 159 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 201 (337)
T 1o6l_A 159 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp TCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcC
Confidence 221 22345555554444 5788899999988765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.55 Aligned_cols=186 Identities=26% Similarity=0.394 Sum_probs=152.5
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----eEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV 465 (583)
.++|...++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++..+. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 456888999999999999999875 78999999975533 3345677999999999999999999998743 47999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
|||+++|+|.+++... .++|..++.++.||+.||.|||+. ++.+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999552 389999999999999999999987 01139999999999999999999999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcchh---------------HHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSMQW---------------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~l~~~ 581 (583)
+++.+.............|+..|.++|. |.|++|+++|+|+.+
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 9998876554433444567777766663 667777777777653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=262.97 Aligned_cols=191 Identities=18% Similarity=0.193 Sum_probs=157.2
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
......++|...++||+|+||.||+++.+ +|+.||+|++++.. ....+.+.+|..++.+++||||+++++++.+++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33345678999999999999999999975 68999999997532 222345889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999996532 35899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch-----------------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ-----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~l~~~ 581 (583)
+......... .....|+..|+++| .|+|++|+++|+|+.+
T Consensus 210 ~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 210 LKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp EECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 9876544321 22345666666655 4566677777777654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=252.66 Aligned_cols=183 Identities=27% Similarity=0.403 Sum_probs=154.5
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+++++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999996 57999999999754 3345678899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998653 34899999999999999999999985 999999999999999999999999999877544
Q ss_pred CCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
... ....|+.+|.+ ...|.|++|+++|+|+.+
T Consensus 168 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 168 GKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp CGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred Ccc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence 321 12345544443 345777788888887754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=258.57 Aligned_cols=187 Identities=16% Similarity=0.142 Sum_probs=154.2
Q ss_pred HcCCCCccccccccCceEEEEEE------ecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC---CCCceeEEEEEEeC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEG 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 459 (583)
..++|...++||+|+||.||+|. ..+++.||+|+++... .+++..|++++++++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678889999999999999994 4568899999997653 356788888888886 99999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---------
Q 007969 460 QELLLIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------- 528 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--------- 528 (583)
+..++||||+++|+|.+++.... ....++|..++.|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996532 3456999999999999999999999985 999999999999998
Q ss_pred --CCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 529 --DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 529 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++.+||+|||+++.+.............|+.+|+++| .|.|++|+++|+|+.+
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 8999999999998765333322333455777766655 4788888888888764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.03 Aligned_cols=186 Identities=26% Similarity=0.352 Sum_probs=151.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999865 789999999975432 334678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3345999999999999999999999985 9999999999999999999999999999775443
Q ss_pred CcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.........|+..|.++| .|.|++|+++|+|+.+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 332233345555554444 4666677777776653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=263.29 Aligned_cols=188 Identities=20% Similarity=0.222 Sum_probs=155.4
Q ss_pred HHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 386 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.....++|...++||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678899999999999999999975 58899999997531 1223458899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++|+|.+++.+. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999998542 4899999999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch--------------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ--------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~ 581 (583)
........ ......|+..|+++| .|+|++|+++|+|+.+
T Consensus 217 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G 269 (410)
T 3v8s_A 217 KMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269 (410)
T ss_dssp ECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred eeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence 87654322 222345666665554 4667777777777654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=248.17 Aligned_cols=185 Identities=26% Similarity=0.360 Sum_probs=151.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467888999999999999999854 68999999986432 33457899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999653 35899999999999999999999985 99999999999999999999999999987754
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... ......|+..|.++| .|.|++|+.+|+++.+
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 3322 122345666655554 5788899999988764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=255.04 Aligned_cols=185 Identities=24% Similarity=0.345 Sum_probs=151.0
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (583)
..++|...++||+|+||.||+++.+ +++.||+|++++. .....+.+.+|..+++.+ +||||+++++++.+++..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467999999999999999999865 5899999999754 223456788999999988 7999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999653 34899999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... .+....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 220 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence 43322 223356777776665 4677778888777654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=251.63 Aligned_cols=183 Identities=25% Similarity=0.308 Sum_probs=153.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.+.|...++||+|+||.||+++.. +|+.||+|.+++.... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456888999999999999999865 6899999999765322 357899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecC
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 538 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 538 (583)
++||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999943 346999999999999999999999985 99999999999998877 79999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
+++........ ....|+.+|.+| ..|.|++|+++|+|+.+
T Consensus 165 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g 214 (361)
T 2yab_A 165 LAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214 (361)
T ss_dssp SCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 99987654321 123455554444 35777888888888765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=257.14 Aligned_cols=184 Identities=22% Similarity=0.310 Sum_probs=152.4
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|+||.||+++.+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 456888999999999999999975 57899999997642 23345688999999887 89999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998653 35899999999999999999999986 9999999999999999999999999998643
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... +....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 205 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G 249 (396)
T 4dc2_A 205 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249 (396)
T ss_dssp CTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 32221 22345666655554 5777888888888765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=250.40 Aligned_cols=188 Identities=28% Similarity=0.458 Sum_probs=148.4
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999987 58899999997653 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|.+++.+......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999965443334899999999999999999999984 249999999999999999999999999998654432
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. .....|+..|.++| .|.|++|+.+|+++.+
T Consensus 194 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 235 (309)
T 3p86_A 194 LS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHC
T ss_pred cc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 21 22234555554444 5788899999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=249.69 Aligned_cols=180 Identities=23% Similarity=0.323 Sum_probs=153.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+++.. +|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46788899999999999999875 68999999997542 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999653 35899999999999999999999985 999999999999999999999999999976432
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....|+..|.++| .|.|++|+.+|+|+.+
T Consensus 160 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 199 (318)
T 1fot_A 160 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199 (318)
T ss_dssp B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred c-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence 2 2234555555544 5788899999988765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=256.09 Aligned_cols=182 Identities=23% Similarity=0.340 Sum_probs=152.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999865 58899999997542 234578899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999954 345899999999999999999999986 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcc-------------hhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSM-------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~l~~~ 581 (583)
... ....|+.+|+++ ..|+|++|+++|+|+.+
T Consensus 169 ~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG 213 (384)
T 4fr4_A 169 TQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213 (384)
T ss_dssp CCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred Cce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhC
Confidence 321 123344444333 45777888888888765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=258.14 Aligned_cols=186 Identities=26% Similarity=0.400 Sum_probs=152.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+.. +++.||||.++.... ...++|.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456778899999999999999976 689999999976532 334578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999996532 34899999999999999999999985 9999999999999999999999999998764432
Q ss_pred CcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
.........++..+.+| ..|.|++|+.+|+++.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 310 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence 22111111223333333 3678888888888764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=251.47 Aligned_cols=186 Identities=24% Similarity=0.332 Sum_probs=154.2
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 462 (583)
...++|...+.||+|+||.||+++.+ +++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999975 58899999997542 23356788899999887 899999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999653 35899999999999999999999985 99999999999999999999999999986
Q ss_pred cCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....... +....|+.+|.++| .|+|++|+++|+|+.+
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 214 (345)
T 1xjd_A 168 NMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214 (345)
T ss_dssp CCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcC
Confidence 5432222 22345666555544 4777788888888764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=249.16 Aligned_cols=186 Identities=27% Similarity=0.458 Sum_probs=150.3
Q ss_pred cCCCCccccccccCceEEEEEEec----CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356778899999999999999974 3456999999865 34446789999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999543 345899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcc-cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQA-NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
...... ......++..|.++| .|+|++|+++|+++.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 249 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 543221 111222333344443 577888888888765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=247.24 Aligned_cols=185 Identities=23% Similarity=0.306 Sum_probs=154.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--eEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 466 (583)
++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999975 48999999997543 334677899999999999999999999998765 789999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCceEEEecCCcee
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARI 542 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla~~ 542 (583)
||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999977655555999999999999999999999985 9999999999999 8888999999999998
Q ss_pred cCCCCCcccceeeeeccCCCcc------------------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSM------------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~ 581 (583)
........ ...|+..|.++ ..|.|++|+++|+|+.+
T Consensus 166 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp CCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred cCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 76544321 12344444433 45788888888888764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=252.00 Aligned_cols=183 Identities=23% Similarity=0.315 Sum_probs=152.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...+.||+|+||.||+++.+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46788899999999999999975 58899999997542 33456788999999988 899999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998653 35899999999999999999999985 99999999999999999999999999986433
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... .....|+.+|.++| .|+|++|+++|+|+.+
T Consensus 163 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 206 (345)
T 3a8x_A 163 PGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206 (345)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence 2221 22345565555544 5778888888888764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=255.24 Aligned_cols=194 Identities=24% Similarity=0.331 Sum_probs=157.1
Q ss_pred HHHHHHcCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEE
Q 007969 384 RLALEATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGC 455 (583)
Q Consensus 384 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 455 (583)
.......++|...++||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 33444567899999999999999999973 2467899999986533 3457899999999999 79999999999
Q ss_pred EEeCC-eEEEEEEcCCCCChhHHHhccCC---------------------------------------------------
Q 007969 456 CLEGQ-ELLLIYEYMPNKSLDVHLFDATR--------------------------------------------------- 483 (583)
Q Consensus 456 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------- 483 (583)
+.+.+ ..++||||+++|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98765 48999999999999999976432
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 484 ------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 484 ------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 122899999999999999999999985 99999999999999999999999999998765554444
Q ss_pred ceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 552 TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 552 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.....++..|+++| .|.|++|+++|+|+.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 290 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHh
Confidence 44455555555554 577788888888764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=254.68 Aligned_cols=186 Identities=28% Similarity=0.472 Sum_probs=142.9
Q ss_pred cCCCCccccccccCceEEEEEEec----CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999865 5678999999765 33446789999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.+. ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 345899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcc-cceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 545 GNQNQA-NTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
...... .+....++..|.++ ..|.|++|+++|+++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt 245 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHh
Confidence 543221 11112233334444 3578888888888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=250.41 Aligned_cols=184 Identities=26% Similarity=0.331 Sum_probs=143.5
Q ss_pred cCCCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688899999999999999986 478999999997652 2334568899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998653 34889999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
........ .....|+.+|.++| .|.|++|+++|+|+.+
T Consensus 170 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 170 ESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence 65433221 11234555555544 5778888888888764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=244.13 Aligned_cols=183 Identities=20% Similarity=0.311 Sum_probs=153.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999865 58899999987543 3456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--CCceEEEecCCceecCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~ 546 (583)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998542 235899999999999999999999985 999999999999987 789999999999987654
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. .....++++|.++| .|.|++|+++|+|+.+
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 199 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 32 22344555555444 5777788888887754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-28 Score=250.22 Aligned_cols=180 Identities=22% Similarity=0.298 Sum_probs=154.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 68999999997542 234578899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999653 34899999999999999999999986 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....|+..|.++| .|+|++|+++|+|+.+
T Consensus 195 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 234 (350)
T 1rdq_E 195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred c-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence 2 2245665555544 5788888888888765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=244.10 Aligned_cols=183 Identities=23% Similarity=0.356 Sum_probs=146.3
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--------------------------hhHHHHHHHHHHHh
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------------------------QGLQEFKNEVNLIA 442 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 442 (583)
.++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467888999999999999999864 688999999975431 11356899999999
Q ss_pred hCCCCCceeEEEEEEe--CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 443 KLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 443 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999998765 2346899999999999999999999985 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcc-------------hhHHHHHHHHHHHhhhh
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM-------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~l~~~ 581 (583)
|+|||++.++.+||+|||+++......... ....|+..|.++ ..|.|++|+.+|+|+.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999999999999876543221 112344444333 35788888888888754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.04 Aligned_cols=189 Identities=26% Similarity=0.439 Sum_probs=154.5
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
..++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4577889999999999999999874 34789999998653 3346789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999976321 146899999999999999999999985 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
|+|||++.++.+||+|||+++...............++..|.++ ..|.|++|+.+|+|+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 99999999999999999999876543322222223344444443 4578888888888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=246.44 Aligned_cols=188 Identities=28% Similarity=0.420 Sum_probs=154.9
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688889999999999999985 245789999997653 34467899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 007969 463 LLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 521 (583)
++||||+++++|.+++.+... ...+++..++.++.||++||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 234899999999999999999999985 99999999
Q ss_pred CcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 522 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+||++++++.+||+|||+++...............++..|.++| .|.|++|+++|+|+.
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999876554433333333444444444 577788888888765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=253.71 Aligned_cols=188 Identities=29% Similarity=0.393 Sum_probs=154.8
Q ss_pred cCCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (583)
.++|...++||+|+||.||+|+.. .+..||||+++... ....+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888899999999999999852 23579999997653 34467899999999999 999999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 235899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
++++.+||+|||+++...............++..|.++ ..|+|++|+++|+++.
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 99999999999999987654333223233344444444 4578888888888765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=243.25 Aligned_cols=182 Identities=24% Similarity=0.312 Sum_probs=152.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
+.|...+.||+|+||.||+++.. +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999965 6899999999754321 3578999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecCC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl 539 (583)
+||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999943 346899999999999999999999985 99999999999999887 899999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
++........ ....|+..|.++| .|.|++|+++|+|+.+
T Consensus 165 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 213 (326)
T 2y0a_A 165 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213 (326)
T ss_dssp CEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9987543321 1234555555544 5777788888887754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.10 Aligned_cols=178 Identities=27% Similarity=0.358 Sum_probs=146.9
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
.+.||+|+||.||+|+.. +|+.||+|+++.......+++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999864 6899999999877666678899999999999999999999999999999999999999999
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCCceEEEecCCceecCCCCCcccc
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANT 552 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~ 552 (583)
.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--- 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--- 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence 9888643 235899999999999999999999986 9999999999999 67789999999999987654332
Q ss_pred eeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 553 NIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 553 ~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....|+.+|.++| .|.|++|+++|+|+.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 284 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC
Confidence 2234666666655 5777788888887754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=246.23 Aligned_cols=187 Identities=27% Similarity=0.497 Sum_probs=148.8
Q ss_pred cCCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
.++|...++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35678889999999999999984 35889999999877777778899999999999999999999998654 458
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996532 34899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCccc-ceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQAN-TNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
......... .....++..|. ....|.|++|+.+|+++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 213 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence 754432111 11112222222 3446788889999888764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=243.85 Aligned_cols=184 Identities=26% Similarity=0.435 Sum_probs=148.7
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997543 2235678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 787777542 345899999999999999999999985 9999999999999999999999999999875332
Q ss_pred CcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++.+|.+ ...|.|++|+.+|+++.+
T Consensus 174 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 216 (311)
T 3niz_A 174 RSYT--HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred cccc--CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhC
Confidence 2211 1233444433 345677788888887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.34 Aligned_cols=185 Identities=23% Similarity=0.267 Sum_probs=154.1
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (583)
..++|...+.||+|+||.||+++.+ +++.||+|++++.. ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3567889999999999999999976 47899999997542 23456788999999988 8999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999653 34899999999999999999999985 999999999999999999999999999865
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... +....|+..|+++| .|+|++|+++|+|+.+
T Consensus 172 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 172 IWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred ccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence 332221 22345666555544 5778888888888765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=248.85 Aligned_cols=189 Identities=25% Similarity=0.363 Sum_probs=153.5
Q ss_pred HcCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
..++|...+.||+|+||.||+|+. .++..||+|.+... .....+.+.+|+.++.++ +||||+++++++..++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999985 24568999999754 334467899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRS--------------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34899999999999999999999985 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
|+|||++.++.+||+|||+++...............++..|.++| .|.|++|+++|+|+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 999999999999999999999876554433333344454444444 578888888888864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.48 Aligned_cols=188 Identities=29% Similarity=0.388 Sum_probs=157.1
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45688889999999999999984 3467899999986543 3467899999999999 99999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR---------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976432 124899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++...............++..|.++| .|.|++|+++|+|+.
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 242 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 999999999999999887655443333344555555554 678888888888864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=241.43 Aligned_cols=182 Identities=25% Similarity=0.414 Sum_probs=147.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 68999999997543 2335788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++ ++.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 555555332 345899999999999999999999985 9999999999999999999999999999875432
Q ss_pred CcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~ 580 (583)
.... ...++.+|. ....|.|++|+.+|+|+.
T Consensus 156 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 156 RCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp SCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred cccc--CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 2211 123333333 344577778888888764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=237.46 Aligned_cols=184 Identities=27% Similarity=0.374 Sum_probs=153.5
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||+++.+++..||+|+++.... ..+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 456788899999999999999998888999999976543 3467999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999996532 34899999999999999999999985 999999999999999999999999999977554332
Q ss_pred ccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
... ...++..|.++ ..|.|++|+.+|+++.
T Consensus 161 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 200 (268)
T 3sxs_A 161 SSV-GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200 (268)
T ss_dssp ECC-SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHT
T ss_pred ccc-CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHc
Confidence 211 12222233333 4578888888888864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.75 Aligned_cols=189 Identities=24% Similarity=0.403 Sum_probs=137.3
Q ss_pred HcCCCCccccccccCceEEEEEEecCC----cEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g----~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
..++|...+.||+|+||.||+|+.... ..||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 456799999999999999999986543 27999999765 345578899999999999999999999999877654
Q ss_pred ------EEEEEcCCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceE
Q 007969 463 ------LLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (583)
Q Consensus 463 ------~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 533 (583)
++||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 2225899999999999999999999985 99999999999999999999
Q ss_pred EEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
|+|||+++...............++..|.+ ...|.|++|+++|+++.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 234 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence 999999988755443222222233333333 34577888888888765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=240.25 Aligned_cols=183 Identities=26% Similarity=0.412 Sum_probs=151.0
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46778899999999999999998899999999986543 34679999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999543 345899999999999999999999986 9999999999999999999999999998764332111
Q ss_pred cceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
. ....++..|. ....|.|++|+.+|+++.
T Consensus 164 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 202 (269)
T 4hcu_A 164 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202 (269)
T ss_dssp T-TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred c-cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhc
Confidence 1 1111222222 334678888888888764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=248.24 Aligned_cols=183 Identities=24% Similarity=0.333 Sum_probs=153.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999865 6899999999754 3344678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~ 543 (583)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999998843 345899999999999999999999985 9999999999999865 45999999999887
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... ....|+.+|.++| .|.|++|+++|+|+.+
T Consensus 182 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 226 (362)
T 2bdw_A 182 NDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226 (362)
T ss_dssp TTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHC
Confidence 644321 1234555555544 5777888888888765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=254.93 Aligned_cols=188 Identities=27% Similarity=0.382 Sum_probs=151.6
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356788899999999999999843 4668999999754 344456799999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---ceEEE
Q 007969 463 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS 535 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 535 (583)
++||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 2245899999999999999999999986 99999999999999554 59999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
|||+++...............++..|+++ ..|+|++|+++|+|+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999866433222222223334444444 3578888888888874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=248.95 Aligned_cols=184 Identities=21% Similarity=0.315 Sum_probs=155.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357888999999999999999865 6889999999877666667899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--CCceEEEecCCceecCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~ 546 (583)
+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988542 335899999999999999999999985 999999999999974 578999999999987654
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... ....|+..|.++| .|.|++|+++|+|+.+
T Consensus 205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 246 (387)
T 1kob_A 205 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246 (387)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred cce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence 322 2234565555544 4677788888877764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=248.22 Aligned_cols=184 Identities=21% Similarity=0.296 Sum_probs=148.7
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCC--CCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998754 33446789999999999976 9999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999653 35899999999999999999999985 99999999999997 57899999999998866
Q ss_pred CCCcccceeeeeccCCCcchh---------------------HHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQW---------------------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~l~~~ 581 (583)
...........|+.+|.+||. |.|++|+++|+|+.+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 554434445567777777764 566677777776543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=250.89 Aligned_cols=189 Identities=27% Similarity=0.383 Sum_probs=155.0
Q ss_pred HcCCCCccccccccCceEEEEEEecC------CcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 460 (583)
..++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45778889999999999999998642 2479999997653 34467899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 529 (583)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999986532 1345899999999999999999999985 9999999999999999
Q ss_pred CceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 530 MNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 530 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+.+||+|||+++...............++..|.++| .|.|++|+++|+|+.
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence 999999999999775544433333334444444444 678888888888864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=245.47 Aligned_cols=188 Identities=28% Similarity=0.423 Sum_probs=153.9
Q ss_pred cCCCCccccccccCceEEEEEEec--------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (583)
.++|...+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999863 46789999998653 34467899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975432 234899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++...............++..|.++| .|.|++|+.+|+++.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 999999999999999876554333333333444444444 577888888888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=243.49 Aligned_cols=182 Identities=26% Similarity=0.264 Sum_probs=146.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 79999999987543 23344556666666665 8999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+ +++|.+++.... ..++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 678988886543 35999999999999999999999985 999999999999999999999999999887543
Q ss_pred CCcccceeeeeccCCCcc---------hhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSM---------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~ 581 (583)
... ....|+..|.++ ..|.|++|+++|+++.+
T Consensus 211 ~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 211 GAG---EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp -------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHT
T ss_pred CCC---cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 221 122344444444 45888899999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=247.45 Aligned_cols=186 Identities=21% Similarity=0.306 Sum_probs=152.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+.|...+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999864 6899999998643 12235789999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEecCCc
Q 007969 465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLA 540 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla 540 (583)
||||+++++|.+++.+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988775432 3345899999999999999999999985 999999999999987654 999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+........ .....|+.+|.++| .|.|++|+++|+|+.+
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence 987654322 12234555555444 5777788888887754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=244.81 Aligned_cols=184 Identities=19% Similarity=0.210 Sum_probs=153.8
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788899999999999999995 5789999999875533 24688999999999 99999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-----eEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~~ 542 (583)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346999999999999999999999985 999999999999999887 99999999998
Q ss_pred cCCCCCcc-----cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA-----NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+....... ......|+..|.++| .|.|++|+++|+|+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 213 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcC
Confidence 75543321 123456777766654 4778888888887754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=257.73 Aligned_cols=184 Identities=22% Similarity=0.420 Sum_probs=140.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----Ce
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (583)
.++|...++||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999865 6899999999754 334467899999999999999999999999543 57
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5789888854 345999999999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCc-------------------------ccceeeeeccCCCcchh-----------HHHHHHHHHHHhhh
Q 007969 542 IFGGNQNQ-------------------------ANTNIIAVDTWPQSMQW-----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 542 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~ 580 (583)
........ ......+|+.+|+++|. |+|++|+++|+|+.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 87533211 11223466777777663 66777777777764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=247.60 Aligned_cols=186 Identities=24% Similarity=0.318 Sum_probs=145.9
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----e
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 461 (583)
.++|...++||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999995 578999999997653 233567899999999999999999999987653 3
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 49999999999999999653 35899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCc-ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQ-ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.+...... .......|+..|.++| .|.|++|+.+|+|+.+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 215 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 77543322 2223345666665555 5778888888887754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=261.20 Aligned_cols=185 Identities=27% Similarity=0.331 Sum_probs=156.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+++.. +|+.||+|++.+.. ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999875 68999999997542 23356789999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986533 334899999999999999999999985 99999999999999999999999999998765
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... ....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 339 ~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG 381 (576)
T 2acx_A 339 GQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381 (576)
T ss_dssp TCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred Cccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 4322 2235666666554 4778888888888765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=239.75 Aligned_cols=183 Identities=26% Similarity=0.424 Sum_probs=147.9
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999975432 2347889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 888888543 245899999999999999999999985 99999999999999999999999999987653322
Q ss_pred cccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++.+|. ....|.|++|+.+|+|+.+
T Consensus 156 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 156 KY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred cc--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 11 1123333333 3345777788888887654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=259.13 Aligned_cols=186 Identities=28% Similarity=0.393 Sum_probs=157.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788899999999999999975 68999999997542 233567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999875432 346999999999999999999999985 99999999999999999999999999998765
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... +....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 342 ~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp TCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence 4332 22346777776665 4778888888888765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-27 Score=239.97 Aligned_cols=186 Identities=27% Similarity=0.440 Sum_probs=138.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999865 68999999997553 2335788999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988886432 2245899999999999999999999985 9999999999999999999999999999875
Q ss_pred CCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... ...++.+|.+ ...|.|++|+++|+|+.+
T Consensus 160 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 205 (317)
T 2pmi_A 160 IPVNTFS--SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205 (317)
T ss_dssp SCCCCCC--CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCcccCC--CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 4322111 1233333333 345777788888887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=246.67 Aligned_cols=182 Identities=22% Similarity=0.259 Sum_probs=146.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999975 689999999976432 236789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--eEEEecCCceecCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARIFGGN 546 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~~~~~ 546 (583)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998653 34899999999999999999999986 999999999999987765 999999999854332
Q ss_pred CCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.. .....|+.+|+++| .+.|++|+++|+|+.+
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 21 22345666666655 4677777777777654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=248.98 Aligned_cols=188 Identities=15% Similarity=0.195 Sum_probs=153.0
Q ss_pred cCCCCcccccccc--CceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G--~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568889999999 99999999976 68999999997543 3445778899999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986532 345899999999999999999999985 9999999999999999999999999987653
Q ss_pred CCCC-----------------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 545 GNQN-----------------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.... +..|+...+.........|.|++|+++|+|+.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 233 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC
Confidence 2111 122222222112233456778888888888754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=254.03 Aligned_cols=184 Identities=23% Similarity=0.425 Sum_probs=149.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----Ce
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (583)
.++|...++||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467899999999999999999865 5889999999754 334467899999999999999999999999766 57
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999986 599998854 345899999999999999999999986 9999999999999999999999999999
Q ss_pred ecCCCCCc--------------------ccceeeeeccCCCcchh-----------HHHHHHHHHHHhhh
Q 007969 542 IFGGNQNQ--------------------ANTNIIAVDTWPQSMQW-----------EAYFLLNLMFSVLE 580 (583)
Q Consensus 542 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~ 580 (583)
........ ......+|+.+|.++|. |+|++|+++|+|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 87544321 11234567788777773 66777777777763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=260.09 Aligned_cols=185 Identities=25% Similarity=0.426 Sum_probs=153.7
Q ss_pred cCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|+... +..||||.++... ...++|.+|+.++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4557788999999999999999764 8899999997653 3467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....+..
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999997533 345899999999999999999999985 99999999999999999999999999998754432
Q ss_pred cccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
... ....++..+.++ ..|+|++|+.+|+|+.
T Consensus 374 ~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t 414 (495)
T 1opk_A 374 TAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414 (495)
T ss_dssp ECC-TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred eec-CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHh
Confidence 211 112223333333 4578888888888875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=250.98 Aligned_cols=184 Identities=24% Similarity=0.275 Sum_probs=145.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHH-HhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...+.||+|+||.||+++.+ +++.||+|++++... ...+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999975 588999999976532 234456777776 577899999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998653 35889999999999999999999986 9999999999999999999999999998754
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... +....|+..|+++| .|+|++|+++|+|+.+
T Consensus 191 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 235 (373)
T 2r5t_A 191 EHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235 (373)
T ss_dssp CCCCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcC
Confidence 33221 22345666665554 5778888888888764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=246.54 Aligned_cols=184 Identities=27% Similarity=0.454 Sum_probs=144.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...++||+|+||.||+|+.. +++ .|++|.+... .....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46788899999999999999854 344 4688888644 3345678999999999999999999999998764 789
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|+||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999996533 45899999999999999999999985 9999999999999999999999999999886
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
............++..|.++| .|.|++|+++|+++.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 655443333344444444444 578888888888765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=259.83 Aligned_cols=184 Identities=23% Similarity=0.254 Sum_probs=143.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+++.. +|+.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999864 6899999999753 333456788999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998653 358999999999999999999997 64 9999999999999999999999999998654
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... .....|+.+|+++| .|.|++|+++|+|+.+
T Consensus 301 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 345 (446)
T 4ejn_A 301 KDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhC
Confidence 33222 12245666655554 5788888888888754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-27 Score=238.54 Aligned_cols=185 Identities=22% Similarity=0.294 Sum_probs=146.6
Q ss_pred CCCCc-cccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSD-ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~-~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|.+ .++||+|+||.||+++. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 47899999999999985 46899999999877666678899999999995 79999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~~~ 544 (583)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999653 35899999999999999999999985 999999999999998776 9999999998764
Q ss_pred CCCCc-----ccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQ-----ANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~-----~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
..... .......|+..|.++| .|.|++|+++|+|+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g 222 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHC
Confidence 32211 1112234666666655 3566677777776643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-27 Score=236.48 Aligned_cols=183 Identities=22% Similarity=0.336 Sum_probs=156.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|+.. ++..|++|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346888899999999999999865 4779999999876666678999999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCceecCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~~ 545 (583)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999988653 34899999999999999999999986 9999999999999 8889999999999998765
Q ss_pred CCCcccceeeeeccCCCcc---------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM---------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++..|.++ ..|.|++|+.+|+++.+
T Consensus 162 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g 203 (277)
T 3f3z_A 162 GKMM---RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCG 203 (277)
T ss_dssp TSCB---CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHS
T ss_pred ccch---hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHC
Confidence 4322 123455555444 46788899999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-27 Score=254.85 Aligned_cols=183 Identities=25% Similarity=0.406 Sum_probs=153.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356888999999999999999975 79999999997542 22356789999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999843 346999999999999999999999985 99999999999999999999999999998755
Q ss_pred CCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....|+.+|.+ ...|.|++|+++|+|+.+
T Consensus 169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 212 (476)
T 2y94_A 169 GEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212 (476)
T ss_dssp TCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred cccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhC
Confidence 4321 12345555444 345677788888877754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=238.81 Aligned_cols=183 Identities=26% Similarity=0.405 Sum_probs=148.9
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||++...++..||+|++..... ..+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 456788899999999999999998888999999986543 3477999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN- 548 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 548 (583)
++++|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999653 234899999999999999999999985 99999999999999999999999999987643221
Q ss_pred ----------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 549 ----------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
+..|+...+ .......|.|++|+.+|+++.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t 216 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYS 216 (283)
T ss_dssp STTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHT
T ss_pred cccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHh
Confidence 111221111 123345678888888888864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=254.22 Aligned_cols=184 Identities=23% Similarity=0.279 Sum_probs=151.8
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688899999999999999985 468999999997553 234567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~ 543 (583)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999988653 35899999999999999999999985 99999999999998 5678999999999877
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....... ....|+.+|++|| .|.|++|+++|+|+.+
T Consensus 164 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G 209 (444)
T 3soa_A 164 EGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209 (444)
T ss_dssp CTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 6543321 1234555555544 5777888888888765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=237.80 Aligned_cols=181 Identities=27% Similarity=0.356 Sum_probs=145.3
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhh--CCCCCceeEEEEEEeC----CeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEG----QELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 463 (583)
.++|...++||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999998 6899999998754 23556667777666 7999999999997653 4589
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
+||||+++|+|.+++.. ..+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999943 35899999999999999999999 65 59999999999999999999999
Q ss_pred ecCCceecCCCCCccc--ceeeeeccCCCcch----------------hHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQAN--TNIIAVDTWPQSMQ----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~--~~~~~~~~~~~~~~----------------~~~~~~~~~l~~l~~~ 581 (583)
|||+++.......... .....|+..|.+|| .|.|++|+.+|+|+.+
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 9999988765443321 12235666665554 4667777777777654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=239.90 Aligned_cols=185 Identities=26% Similarity=0.444 Sum_probs=149.6
Q ss_pred CCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL 462 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 462 (583)
+.|...++||+|+||.||++++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4477889999999999999983 468899999997543 34467899999999999999999999999876 668
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996533 34899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCc-ccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 543 FGGNQNQ-ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 543 ~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
....... .......++..|.++| .|.|++|+.+|+++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 224 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH
Confidence 7654432 1122223444444444 578888888888875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=250.18 Aligned_cols=171 Identities=25% Similarity=0.337 Sum_probs=145.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--eEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 465 (583)
.++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 346888899999999999999975 48999999997543 234577889999999999999999999998765 78999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCceEEEecCCce
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR 541 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla~ 541 (583)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999985 9999999999999 888889999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcchh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQW 566 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (583)
........ ....|+..|.++|.
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~ 186 (396)
T 4eut_A 165 ELEDDEQF---VSLYGTEEYLHPDM 186 (396)
T ss_dssp ECCCGGGS---SCSSSCCTTCCHHH
T ss_pred EccCCCcc---ccccCCccccCHHH
Confidence 87654322 22456777777763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=250.31 Aligned_cols=183 Identities=21% Similarity=0.297 Sum_probs=148.0
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCC--CCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999999754 3345678999999999996 599999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
| +.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999999653 35899999999999999999999985 99999999999996 579999999999987655
Q ss_pred CCcccceeeeeccCCCcch---------------------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ---------------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~l~~~ 581 (583)
..........|+.+|++|| .|.|++|+++|+|+.+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G 263 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence 4433333456777776666 3566677777776543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=245.82 Aligned_cols=190 Identities=25% Similarity=0.387 Sum_probs=154.9
Q ss_pred HHcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
...++|...+.||+|+||.||+|+.. +++.||+|.+..... ....++.+|+.++++++||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34567888999999999999999854 367899999975533 34567999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceE
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT-------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 533 (583)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999986532 1245799999999999999999999985 99999999999999999999
Q ss_pred EEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
|+|||+++...............++..|.++| .|.|++|+.+|+++.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999998775444332222333444444443 577788888888765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=244.80 Aligned_cols=182 Identities=23% Similarity=0.360 Sum_probs=150.0
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36788899999999999999996 578999999997532 22346789999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+ +|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78898888553 35899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....|+.+|.+ ...|.|++|+++|+++.+
T Consensus 161 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (336)
T 3h4j_B 161 GNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204 (336)
T ss_dssp SBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHS
T ss_pred Cccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhC
Confidence 3321 11234444433 345677788888777654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=242.88 Aligned_cols=190 Identities=26% Similarity=0.411 Sum_probs=141.8
Q ss_pred HHcCCCCccccccccCceEEEEEEec----CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ- 460 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~- 460 (583)
...++|...+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 44567888999999999999999854 3458999999754 3344678999999999999999999999998754
Q ss_pred ----eEEEEEEcCCCCChhHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceE
Q 007969 461 ----ELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533 (583)
Q Consensus 461 ----~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 533 (583)
..++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 359999999999999998543 23356999999999999999999999985 99999999999999999999
Q ss_pred EEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
|+|||+++...............++..|.+ ...|.|++|+.+|+|+.
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 244 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHh
Confidence 999999988754433222222333333333 34578888888888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=244.43 Aligned_cols=185 Identities=26% Similarity=0.416 Sum_probs=148.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCc----EEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.++|...++||+|+||.||+|+.. +++ .|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 356788899999999999999864 344 38888886443 333467889999999999999999999986 45689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998643 345889999999999999999999985 999999999999999999999999999988
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.............++..|.+++ .|.|++|+.+|+++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 212 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHh
Confidence 6655444444455555555544 467788888888765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=244.76 Aligned_cols=181 Identities=24% Similarity=0.353 Sum_probs=137.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.+.|...++||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999976 57899999998653 346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCceecCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFGG 545 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~~~~ 545 (583)
+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999843 345899999999999999999999985 999999999999975 89999999999987654
Q ss_pred CCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
... .....|+..|.+ ...|.|++|+++|+|+.+
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 204 QVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 321 112334444443 346788888888888765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=251.28 Aligned_cols=179 Identities=27% Similarity=0.410 Sum_probs=148.2
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC-eEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~ 468 (583)
.++|...++||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356778899999999999999985 7899999998654 4578999999999999999999999988765 79999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccccc
Confidence 99999999997643 334799999999999999999999985 99999999999999999999999999996543221
Q ss_pred cccceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
. ..++..+. ....|.|++|+.+|+|+.
T Consensus 345 ~-----~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 345 T-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred C-----CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 1 12233333 344678889999998875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=239.49 Aligned_cols=175 Identities=21% Similarity=0.317 Sum_probs=138.6
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.++||+|+||.||+++.. +++.||||++.+. ....+.+|+.+++++. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6899999999754 3467789999999997 9999999999999999999999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---ceEEEecCCceecCCCCCcc
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~ 550 (583)
|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.........
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999653 45899999999999999999999985 99999999999997765 89999999999765433221
Q ss_pred cceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 551 NTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 551 ~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
. ...++.+|.++ ..|.|++|+++|+++.+
T Consensus 167 ~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 205 (325)
T 3kn6_A 167 K--TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred c--ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 1 12334444433 35788888888888764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=234.77 Aligned_cols=185 Identities=25% Similarity=0.351 Sum_probs=149.0
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
+|.....||+|+||.||+|+. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999995 4688999999987766667889999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCCceecCCCCCc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~ 549 (583)
+++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999976555556789999999999999999999985 999999999999987 899999999999987543221
Q ss_pred ccceeeeeccCCCc------------chhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQS------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~ 581 (583)
. ....++..+.+ ...|.|++|+.+|+|+.+
T Consensus 180 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 221 (295)
T 2clq_A 180 T--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred c--cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 1 12234444333 345666777777776643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=256.59 Aligned_cols=185 Identities=28% Similarity=0.413 Sum_probs=151.2
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..++|...++||+|+||.||+|..+++..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456688889999999999999999888999999998654 34688999999999999999999999986 5678999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 234789999999999999999999985 99999999999999999999999999997653221
Q ss_pred cccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.. .....++..+ .....|+|++|+.+|+++.
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 380 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHh
Confidence 11 1111122222 3345678888888888875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=243.64 Aligned_cols=192 Identities=23% Similarity=0.268 Sum_probs=156.2
Q ss_pred cccChHHHHHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-----CCCceeE
Q 007969 379 PLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----HKNLVRL 452 (583)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l 452 (583)
..+++.......++|...++||+|+||.||+|+. .+++.||||+++.. ....+.+..|++++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3344444455678899999999999999999997 46889999999753 334567788999999996 9999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----
Q 007969 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---- 528 (583)
Q Consensus 453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---- 528 (583)
++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 999999986543 335899999999999999999999985 999999999999976
Q ss_pred ---------------------CCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHH
Q 007969 529 ---------------------DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFS 577 (583)
Q Consensus 529 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~ 577 (583)
++.+||+|||+++....... ...|+..|.+ ...|.|++|+++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 78999999999987654322 1233444333 34578888999988
Q ss_pred hhhh
Q 007969 578 VLEF 581 (583)
Q Consensus 578 l~~~ 581 (583)
|+.+
T Consensus 252 ll~g 255 (360)
T 3llt_A 252 LYTG 255 (360)
T ss_dssp HHHS
T ss_pred HHHC
Confidence 8764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=234.05 Aligned_cols=185 Identities=26% Similarity=0.345 Sum_probs=151.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46788899999999999999975 68999999997543 34457899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999998843 345899999999999999999999985 99999999999999999999999999987643322
Q ss_pred cccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
........++..+.+ ...|.|++|+.+|+++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 204 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence 211222233333332 345677777777777654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=236.62 Aligned_cols=184 Identities=32% Similarity=0.486 Sum_probs=139.0
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+|+.. ..||+|+++... ....+.+.+|+.++++++||||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467888999999999999999864 369999997543 34467899999999999999999999965 4556899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999998543 345899999999999999999999985 9999999999999999999999999998765433
Q ss_pred CcccceeeeeccCCCcch-------------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~ 581 (583)
.........|+..|.++| .|.|++|+.+|+++.+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 221 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence 333333345555555544 4677777777777653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.48 Aligned_cols=191 Identities=25% Similarity=0.361 Sum_probs=150.2
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC--CCCCceeEEEEEEeC-
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCLEG- 459 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~- 459 (583)
........++|...++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344455678999999999999999999985 8999999986442 23455566665554 899999999999887
Q ss_pred ---CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCcEEEcCCCc
Q 007969 460 ---QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDMN 531 (583)
Q Consensus 460 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~ 531 (583)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. +.+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7899999999999999999542 4899999999999999999999871 124999999999999999999
Q ss_pred eEEEecCCceecCCCCCccc--ceeeeeccCCCcch----------------hHHHHHHHHHHHhhhh
Q 007969 532 PKISDFGLARIFGGNQNQAN--TNIIAVDTWPQSMQ----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~--~~~~~~~~~~~~~~----------------~~~~~~~~~l~~l~~~ 581 (583)
+||+|||+++.+........ .....|+..|.++| .|.|++|+++|+|+.+
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999999987754433211 12335666666655 5888899999988765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=244.83 Aligned_cols=192 Identities=25% Similarity=0.306 Sum_probs=149.8
Q ss_pred HHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-----CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
....++|...++||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 455667899999999999999999864 6889999998643 3445678999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhHHHhccC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 007969 461 ELLLIYEYMPNKSLDVHLFDAT-------------------------------------RSVQLDWKRRQSIINGIARGI 503 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~gL 503 (583)
..++||||+++|+|.+++.... ....+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999885211 011246777889999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCcEEEcCCC--ceEEEecCCceecCCCCCc--ccceeeeeccCCCc------------chhH
Q 007969 504 LYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARIFGGNQNQ--ANTNIIAVDTWPQS------------MQWE 567 (583)
Q Consensus 504 ~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~~~~~~~~------------~~~~ 567 (583)
.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......|+..|.+ ...|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999985 99999999999998776 8999999999976432211 11122234433333 3567
Q ss_pred HHHHHHHHHHhhhh
Q 007969 568 AYFLLNLMFSVLEF 581 (583)
Q Consensus 568 ~~~~~~~l~~l~~~ 581 (583)
.|++|+++|+|+.+
T Consensus 259 iwslG~il~el~~g 272 (345)
T 3hko_A 259 AWSAGVLLHLLLMG 272 (345)
T ss_dssp HHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHC
Confidence 78888888887754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=233.49 Aligned_cols=183 Identities=31% Similarity=0.445 Sum_probs=140.6
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCc----hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+|+.. ++.||||++..... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999974 88999999875432 2357889999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--------CCceEEEec
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------DMNPKISDF 537 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~kl~DF 537 (583)
|||+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999884 235899999999999999999999986455999999999999986 778999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
|+++........ ...++..|.++| .|.|++|+.+|+++.+
T Consensus 161 g~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 161 GLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred Cccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999876543322 223444444444 5777788888877654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=255.48 Aligned_cols=184 Identities=29% Similarity=0.426 Sum_probs=146.3
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||+|...++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45678889999999999999999888889999998654 235789999999999999999999999876 6789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999995422 234899999999999999999999985 999999999999999999999999999987543221
Q ss_pred ccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
. .....++..+.+ ...|.|++|+.+|+++.
T Consensus 337 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 376 (452)
T 1fmk_A 337 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred c-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHh
Confidence 1 111223333333 34678888888888875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=240.11 Aligned_cols=186 Identities=26% Similarity=0.425 Sum_probs=153.9
Q ss_pred CCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 463 (583)
++|...++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678889999999999999984 3688999999988777777889999999999999999999999874 46789
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996532 24899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCcc-cceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQA-NTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
....... ......++..|.++ ..|.|++|+.+|+++.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhC
Confidence 6443321 11222344444444 35778888888888753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=236.29 Aligned_cols=185 Identities=21% Similarity=0.358 Sum_probs=149.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46788899999999999999864 68899999997553 33467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCceecC
Q 007969 469 MPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (583)
Q Consensus 469 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 544 (583)
+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 22346899999999999999999999985 9999999999999 556889999999998765
Q ss_pred CCCCcccceeeeeccCCCcc---------hhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSM---------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..|.++ ..|.|++|+++|+++.+
T Consensus 179 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 179 SDEHS---TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp -----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred CcccC---cCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhC
Confidence 43321 123344444444 46788888888888754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=233.99 Aligned_cols=182 Identities=26% Similarity=0.363 Sum_probs=148.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+|+.. +++.||+|++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888899999999999999975 7899999999754 334467889999999999 999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----------------
Q 007969 466 YEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---------------- 528 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---------------- 528 (583)
|||+++++|.+++.+... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999865321 245899999999999999999999985 999999999999984
Q ss_pred ---CCceEEEecCCceecCCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhh
Q 007969 529 ---DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 529 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~ 580 (583)
...+||+|||+++........ .++..|.+ ...|.|++|+.+|++..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~------~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCC------CCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred cCCceEEEEcccccccccCCcccc------CCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 447999999999987654332 23333333 34566777777777654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=262.27 Aligned_cols=185 Identities=23% Similarity=0.269 Sum_probs=156.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 463 (583)
..++|...++||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567889999999999999999965 5889999999754 223456788999999988 7999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999653 35899999999999999999999985 999999999999999999999999999975
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... +....|+.+|+++| .|+|++|+++|+|+.+
T Consensus 493 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG 538 (674)
T 3pfq_A 493 IWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538 (674)
T ss_dssp CCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHS
T ss_pred ccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcC
Confidence 433322 33456777777665 4778888888888765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.87 Aligned_cols=185 Identities=26% Similarity=0.449 Sum_probs=140.9
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCC--eE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--EL 462 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~ 462 (583)
..++|...++||+|+||.||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568899999999999999999864 6899999999654 3344677889999999997 999999999998654 78
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 689888854 25899999999999999999999986 99999999999999999999999999998
Q ss_pred cCCCCC-------------------cccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQN-------------------QANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~-------------------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+..... ........|+.+|+++| .|.|++|+++|+|+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 643111 11112245666666555 4566677777776654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=240.05 Aligned_cols=191 Identities=25% Similarity=0.346 Sum_probs=155.6
Q ss_pred HHHcCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEEEEe
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE 458 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 458 (583)
....++|...++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34457889999999999999999974 3467899999986543 3456899999999999 79999999999987
Q ss_pred CC-eEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 007969 459 GQ-ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (583)
Q Consensus 459 ~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 524 (583)
.+ ..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceE
Confidence 54 58999999999999999975432 123789999999999999999999985 99999999999
Q ss_pred EEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 525 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 525 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+++.++.+||+|||+++...............++..|.++| .|.|++|+++|+++.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999876554433333344555555444 578888888888764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=232.42 Aligned_cols=184 Identities=27% Similarity=0.426 Sum_probs=146.6
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999986 478999999996542 223478999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999998643 345899999999999999999999985 999999999999999999999999999987533
Q ss_pred CCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++..+.+ ...|.|++|+.+|+++.+
T Consensus 166 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 166 HEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHS
T ss_pred CCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 2211 11223333333 345778888888888754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=246.39 Aligned_cols=184 Identities=25% Similarity=0.313 Sum_probs=151.4
Q ss_pred CCCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
++|...++||+|+||.||+++. .+++.||||++++.. ....+.+.+|+++++++ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999986 368999999997542 22345678899999999 69999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999653 34899999999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch------------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~ 581 (583)
.+........ ....|+..|.++| .|.|++|+++|+|+.+
T Consensus 208 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 208 EFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp ECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred ecccCCCCcc-cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence 7754332221 1234555554443 5677777777777654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=234.61 Aligned_cols=183 Identities=23% Similarity=0.358 Sum_probs=148.2
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...++||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999975 589999999865533 335678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988743 345899999999999999999999985 9999999999999999999999999999876433
Q ss_pred CcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++.+|. ....|.|++|+.+|+++.+
T Consensus 157 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 157 DYYD--DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccC--CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 2211 123333332 3446778888888888754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=243.91 Aligned_cols=187 Identities=21% Similarity=0.208 Sum_probs=147.6
Q ss_pred HcCCCCccccccccCceEEEEEEecC------CcEEEEEEeccCCchh-----------HHHHHHHHHHHhhCCCCCcee
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQG-----------LQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~ 451 (583)
..++|...++||+|+||.||+|...+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35678899999999999999998754 4789999987654221 123445666778889999999
Q ss_pred EEEEEEeC----CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 452 LLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 452 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
+++++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999764 4589999999 99999999653 345999999999999999999999985 99999999999999
Q ss_pred --CCCceEEEecCCceecCCCCCcc-----cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 528 --DDMNPKISDFGLARIFGGNQNQA-----NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 528 --~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.++.+||+|||+++.+....... ......|+..|+++| .|.|++|+++|+|+.+
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 88999999999999875432211 112334666666655 4788888888888764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=234.89 Aligned_cols=183 Identities=20% Similarity=0.303 Sum_probs=137.9
Q ss_pred cCCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...++||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567888999999999999998643 4579999987643 344678999999999999999999999974 457899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999653 335899999999999999999999985 9999999999999999999999999999875
Q ss_pred CCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhh
Q 007969 545 GNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVL 579 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~ 579 (583)
....... ....++..|.++ ..|.|++|+.+|+++
T Consensus 168 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 211 (281)
T 1mp8_A 168 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred ccccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHH
Confidence 4432211 112233333333 357888888888876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=242.62 Aligned_cols=188 Identities=23% Similarity=0.359 Sum_probs=155.7
Q ss_pred HHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--------hhHHHHHHHHHHHhhC-CCCCceeEEE
Q 007969 385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKL-QHKNLVRLLG 454 (583)
Q Consensus 385 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~g 454 (583)
......++|...++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445567888999999999999999975 699999999875431 1145678999999999 7999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998643 35899999999999999999999985 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCcc----------------hhHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQSM----------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~l~~~ 581 (583)
+|||+++.+...... ....|+..|.++ ..|.|++|+++|+|+.+
T Consensus 242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 999999987654322 123445444444 35778888888888754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=247.98 Aligned_cols=184 Identities=22% Similarity=0.333 Sum_probs=142.0
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--------chhHHHHHHHHHHHhhCCCCCceeEEEEEEe
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 458 (583)
...++|...++||+|+||.||+|... +++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999864 58999999997542 112235889999999999999999999975
Q ss_pred CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEE
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKIS 535 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~ 535 (583)
.+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5568999999999999988843 346899999999999999999999985 9999999999999654 459999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcch-------------hHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~ 581 (583)
|||+++....... .....|+.+|+++| .|.|++|+.+|+|+.+
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg 340 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHS
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999998754322 22345666655554 3566666666666654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=234.72 Aligned_cols=182 Identities=28% Similarity=0.437 Sum_probs=149.3
Q ss_pred CCccccccccCceEEEEEEec-----CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL 464 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 464 (583)
|...++||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477899999999999998643 57899999998653 34467899999999999999999999999884 67899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999542 3899999999999999999999986 9999999999999999999999999999886
Q ss_pred CCCCcc-cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQA-NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... ......++..|.++| .|.|++|+.+|+++.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 543321 122233444444443 4788888888888754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=238.14 Aligned_cols=187 Identities=27% Similarity=0.485 Sum_probs=152.8
Q ss_pred cCCCCccccccccCceEEEEEEe-----cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC--eE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--EL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~ 462 (583)
.++|...++||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34577889999999999999983 368899999998877777788999999999999999999999987654 67
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996532 35899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCccc-ceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQAN-TNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
......... .....++..+.++ ..|.|++|+.+|+++.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg 244 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhc
Confidence 765443211 1112233233333 46788888888888764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=238.37 Aligned_cols=185 Identities=23% Similarity=0.354 Sum_probs=150.2
Q ss_pred cCCCCccccccccCceEEEEEEecC-C-------cEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-G-------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+|+... + ..|++|++........+.+.+|+.++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3567888999999999999998643 3 4799999987766677889999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--------eE
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PK 533 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~k 533 (583)
.++||||+++++|.+++.+.. ..+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999996532 34899999999999999999999986 999999999999998887 99
Q ss_pred EEecCCceecCCCCC------cccceeeeeccCCCcchhHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQN------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 580 (583)
|+|||+++....... +..|+...+ ........|.|++|+.+|+++.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 162 LSDPGISITVLPKDILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp ECCCCSCTTTSCHHHHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHHHHHHT
T ss_pred eccCcccccccCccccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHHHHHHc
Confidence 999999976543221 222221111 0122344577778888888765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=240.24 Aligned_cols=179 Identities=28% Similarity=0.431 Sum_probs=148.4
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
+.|...++||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477889999999999999985 578999999997543 233567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||++ |+|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 67877775432 45899999999999999999999985 999999999999999999999999999876543
Q ss_pred CCcccceeeeeccCCCc-------------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS-------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~ 581 (583)
.. ..|+.+|.+ ...|.|++|+++|+|+.+
T Consensus 208 ~~------~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g 249 (348)
T 1u5q_A 208 NS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249 (348)
T ss_dssp CC------CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred Cc------ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 22 233433333 345788888888888754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=250.43 Aligned_cols=180 Identities=28% Similarity=0.393 Sum_probs=143.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (583)
.++|...++||+|+||.||+|+.. +++.||||++.+. .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999854 6889999999754 334467889999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999765 555552 23899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+....... .....|+.+|.++| .|.|++|+++|+|+.+
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 259 (464)
T 3ttj_A 212 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259 (464)
T ss_dssp -----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred eecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhC
Confidence 97754322 22345666666655 4788888888888754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=232.95 Aligned_cols=183 Identities=26% Similarity=0.396 Sum_probs=151.1
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...+.||+|+||.||++...+++.||+|++...... .+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 467788999999999999999988899999999865433 4689999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999653 235899999999999999999999985 9999999999999999999999999998764321110
Q ss_pred cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
. ....++..+ .....|.|++|+.+|+++.
T Consensus 162 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 200 (267)
T 3t9t_A 162 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200 (267)
T ss_dssp T-TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred c-ccccccccccChhhhcCCCccchhchhhhHHHHHHHhc
Confidence 0 011112222 2345678888888888865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=238.37 Aligned_cols=184 Identities=22% Similarity=0.338 Sum_probs=153.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...+.||+|+||.||+++.. +++.|++|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999975 5789999998754 234467889999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988543 35899999999999999999999985 99999999999999999999999999998753
Q ss_pred CCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
.... .....++..|.++ ..|.|++|+.+|+|+.+
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 237 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 3322 1223455554444 45788888888888754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=231.40 Aligned_cols=183 Identities=31% Similarity=0.470 Sum_probs=150.0
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4677889999999999999998888899999997653 235789999999999999999999999864 46899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999985421 125899999999999999999999985 9999999999999999999999999999876443221
Q ss_pred cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.....++..+.++| .|.|++|+.+|+++.
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 205 (279)
T 1qpc_A 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (279)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred -ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence 11123333444444 578888888888765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=233.93 Aligned_cols=186 Identities=26% Similarity=0.430 Sum_probs=154.6
Q ss_pred HcCCCCccccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
..++|...++||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34567888999999999999999764 8899999997543 346789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996533 345899999999999999999999985 9999999999999999999999999999876544
Q ss_pred CcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 548 NQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
..... ...++..|.++ ..|.|++|+.+|+++.
T Consensus 166 ~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 166 YTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp SEEET-TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccc-CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 32221 22333333333 4577888888888765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=242.46 Aligned_cols=184 Identities=21% Similarity=0.294 Sum_probs=152.0
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc--------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 459 (583)
..++|...++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346788899999999999999985 4688999999976531 1234678899999999999999999999999
Q ss_pred CeEEEEEEcCCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 460 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 460 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99998854 335899999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCcccceeeeeccCCCcc-----------hhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~ 581 (583)
+++........ ....|+..|.++ ..|.|++|+++|+++.+
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence 99987654322 123455544443 34777788888887653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=229.68 Aligned_cols=183 Identities=24% Similarity=0.329 Sum_probs=152.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999865 5899999999754 3344678899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~~ 543 (583)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888653 35899999999999999999999985 999999999999986655 999999999877
Q ss_pred CCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... ...++..|.+ ...|.|++|+.+|+++.+
T Consensus 159 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 203 (284)
T 3kk8_A 159 NDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203 (284)
T ss_dssp CSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHC
Confidence 6443321 1234444333 346788888888888764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=236.40 Aligned_cols=185 Identities=20% Similarity=0.231 Sum_probs=146.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
-++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999965 68899999997553 23357899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999653 35899999999999999999999985 99999999999999999999999999987654
Q ss_pred CCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..... .....++..|.++ ..|.|++|+.+|+++.+
T Consensus 187 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 187 EKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred ccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 33211 1112333333333 35788899999988764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=232.20 Aligned_cols=184 Identities=22% Similarity=0.337 Sum_probs=152.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356788899999999999999976 5789999998754 234467889999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999985 99999999999999999999999999998753
Q ss_pred CCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..+.++ ..|.|++|+.+|+++.+
T Consensus 168 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 211 (294)
T 2rku_A 168 DGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211 (294)
T ss_dssp TTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred Ccccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence 32211 123344444333 46788888888888754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-26 Score=230.76 Aligned_cols=184 Identities=18% Similarity=0.273 Sum_probs=152.1
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +|+|++++++++..+...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788899999999999999995 5789999999875432 34688999999999 79999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-----eEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~~ 542 (583)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999996532 35899999999999999999999985 999999999999987776 99999999998
Q ss_pred cCCCCCc-----ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-----ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....... .......|+..|.++| .|.|++|+.+|+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 214 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcC
Confidence 7654332 1223345666665554 4777788888877653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.96 Aligned_cols=185 Identities=28% Similarity=0.453 Sum_probs=141.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCc----EEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.++|...++||+|+||.||+|+.. +++ .|++|.+... .....+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 457888999999999999999854 344 4688887644 3445678999999999999999999999998765 78
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999996533 35899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
.............++..|.++ ..|.|++|+.+|+++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 654433333333344444444 3577888888888765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=259.48 Aligned_cols=184 Identities=28% Similarity=0.417 Sum_probs=150.1
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|...++||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45677889999999999999999888899999998654 235789999999999999999999999876 6789999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.... ...+++..++.|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999996422 234899999999999999999999985 999999999999999999999999999876532111
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
......++..+ .....|+|++|+++|+|+.
T Consensus 420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t 459 (535)
T 2h8h_A 420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459 (535)
T ss_dssp -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 01111122222 2344688889999998875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-26 Score=235.61 Aligned_cols=191 Identities=23% Similarity=0.313 Sum_probs=155.4
Q ss_pred ccChHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhh--CCCCCceeEEEEEE
Q 007969 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCL 457 (583)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~ 457 (583)
..+........++|...+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 445555566677899999999999999999998 5899999999644 34577888888887 78999999999998
Q ss_pred eCC----eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCcEE
Q 007969 458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNIL 525 (583)
Q Consensus 458 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlk~~NIL 525 (583)
... ..++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +. +|+||||||+|||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 875 789999999999999999542 4899999999999999999999 55 4999999999999
Q ss_pred EcCCCceEEEecCCceecCCCCCcc--cceeeeeccCCCcch----------------hHHHHHHHHHHHhhhh
Q 007969 526 LDDDMNPKISDFGLARIFGGNQNQA--NTNIIAVDTWPQSMQ----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 526 l~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~l~~~ 581 (583)
++.++++||+|||+++......... ......|+..|.++| .|.|++|+++|+|+.+
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999876544321 122234555555444 5677778888777654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-26 Score=232.45 Aligned_cols=185 Identities=28% Similarity=0.475 Sum_probs=146.6
Q ss_pred HcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc-----hhHHHHHHHHHHHhhC---CCCCceeEEEEEEeC
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-----QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG 459 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 459 (583)
..++|...++||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999995 4689999999874321 1234667777777766 499999999999876
Q ss_pred C-----eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEE
Q 007969 460 Q-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534 (583)
Q Consensus 460 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 534 (583)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5899999997 59999986533 334899999999999999999999986 999999999999999999999
Q ss_pred EecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 535 SDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 535 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+|||+++........ ....++.+|+++| .|.|++|+++|+|+.+
T Consensus 162 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 162 ADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp CSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred eeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence 999999877543322 1234555555544 5788888888888754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.85 Aligned_cols=181 Identities=26% Similarity=0.354 Sum_probs=142.2
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||.||+++.. ++.||+|++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 45778899999999999999984 788999999754 345789999999999999999999998774 4789999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-eEEEecCCceecCCCCCc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 549 (583)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~- 161 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT- 161 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc-
Confidence 9999999976554445889999999999999999999943235999999999999998886 79999999986643221
Q ss_pred ccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
...|+..|.+ ...|.|++|+.+|+++.+
T Consensus 162 ----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 199 (307)
T 2eva_A 162 ----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred ----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 1224444333 346788888888888754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=236.38 Aligned_cols=189 Identities=24% Similarity=0.339 Sum_probs=151.6
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 464 (583)
.++|...++||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788999999999999999996 5789999999987766677889999999999999999999999873 347899
Q ss_pred EEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
|+||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999886532 2456899999999999999999999985 999999999999999999999999998875
Q ss_pred CCC-------------------CCcccceeeeecc-CCCcchhHHHHHHHHHHHhhhh
Q 007969 544 GGN-------------------QNQANTNIIAVDT-WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~-------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..+..|+...+.. .......|.|++|+++|+|+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence 421 1122222221110 0123456888899999988754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=230.92 Aligned_cols=182 Identities=25% Similarity=0.340 Sum_probs=149.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...++||+|+||.||+++.. +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35778899999999999999976 689999999875422 13678999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecCC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl 539 (583)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999643 35899999999999999999999985 99999999999998877 899999999
Q ss_pred ceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
++........ ....++..+. ....|.|++|+.+|+++.+
T Consensus 159 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 207 (283)
T 3bhy_A 159 AHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHC
Confidence 9987543321 1122333333 3446788888888888754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=243.07 Aligned_cols=178 Identities=22% Similarity=0.292 Sum_probs=139.3
Q ss_pred CCCcc-ccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhh-CCCCCceeEEEEEEe----CCeEEE
Q 007969 392 HFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE----GQELLL 464 (583)
Q Consensus 392 ~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~l 464 (583)
+|... ++||+|+||.||+++.. +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+..++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 44444 68999999999999865 6889999999643 467788888754 589999999999876 567899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCce
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR 541 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~ 541 (583)
||||+++|+|.+++.+.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999996532 345899999999999999999999985 999999999999998 7899999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
........ ....|+.+|+++ ..|+|++|+++|+|+.+
T Consensus 213 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 259 (400)
T 1nxk_A 213 ETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhC
Confidence 76543221 123445554444 35788889999988765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=237.19 Aligned_cols=184 Identities=25% Similarity=0.413 Sum_probs=146.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888899999999999999975 589999999865433 23566889999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887643 235899999999999999999999985 999999999999999999999999999876543
Q ss_pred CCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++.+|.+ ...|.|++|+++|+++.+
T Consensus 178 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 221 (331)
T 4aaa_A 178 GEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred cccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence 2211 11234444433 345777888888887754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=231.44 Aligned_cols=182 Identities=26% Similarity=0.367 Sum_probs=148.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888899999999999999865 57799999986542 22246789999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998653 34899999999999999999999985 99999999999999999999999999866543
Q ss_pred CCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
... ....++..+.+ ...|.|++|+.+|+++.+
T Consensus 162 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (279)
T 3fdn_A 162 SRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHC
Confidence 321 11234444433 346788899999988764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=231.43 Aligned_cols=181 Identities=29% Similarity=0.447 Sum_probs=149.9
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE---------- 458 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 458 (583)
.++|...+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 346788899999999999999976 78999999997654 356789999999999999999999864
Q ss_pred ------CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 459 ------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 459 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
....++||||+++++|.+++.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 345899999999999999996532 345899999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
||+|||+++......... ...++..|.++ ..|.|++|+.+|+|+.+
T Consensus 162 kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 217 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217 (284)
T ss_dssp EECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred EECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhc
Confidence 999999999876543221 12344444444 46788888888888743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-26 Score=230.50 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=153.3
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.+.|...++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 345888899999999999999864 68999999997553 3446789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999843 35899999999999999999999985 9999999999999999999999999998876543
Q ss_pred CcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
... ....++..|.+ ...|.|++|+.+|+++.+
T Consensus 174 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (303)
T 3a7i_A 174 IKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215 (303)
T ss_dssp CCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence 221 11233333333 346788888888888764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=240.23 Aligned_cols=180 Identities=21% Similarity=0.345 Sum_probs=145.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...+.||+|+||.||+++.+ +++.||+|++.+... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456888899999999999999865 688999999976543 235788888888 79999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC----CceEEEecCCceec
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF 543 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~~ 543 (583)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999854 345899999999999999999999985 9999999999998433 35999999999987
Q ss_pred CCCCCcccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
....... ....++..|.++|. |+|++|+++|+|+.+
T Consensus 171 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 216 (342)
T 2qr7_A 171 RAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216 (342)
T ss_dssp BCTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcC
Confidence 6544322 22456777777763 455555555555543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=234.59 Aligned_cols=183 Identities=25% Similarity=0.322 Sum_probs=152.4
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...+.||+|+||.||+++.. +|+.||+|.+...... ..+++.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345788899999999999999965 6899999999754321 357899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecC
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG 538 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 538 (583)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999954 345899999999999999999999985 99999999999999888 79999999
Q ss_pred CceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
+++........ ....|+..|.+ ...|.|++|+.+|+++.+
T Consensus 165 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 214 (321)
T 2a2a_A 165 LAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214 (321)
T ss_dssp TCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence 99987654321 11234444333 346788888888888754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-26 Score=231.32 Aligned_cols=187 Identities=21% Similarity=0.307 Sum_probs=148.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC----chhHHHHHHHHHHHhhCCCCCceeEEEEEE--eCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~ 462 (583)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999964 68899999997542 234578999999999999999999999985 44578
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||++++ |.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 666665433 446899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCcccceeeeeccCCCc------------chhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQS------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~ 581 (583)
..............++..|.+ ...|.|++|+.+|+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence 754332222222334444333 346777888888887754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-26 Score=229.86 Aligned_cols=182 Identities=29% Similarity=0.505 Sum_probs=146.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchh-------HHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG-------LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+|+.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999864 78999999997543221 268899999999999999999999987665
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-----eEEEe
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISD 536 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~D 536 (583)
++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998888543 346899999999999999999999984 24999999999999988776 99999
Q ss_pred cCCceecCCCCCcccceeeeeccCCCc------------chhHHHHHHHHHHHhhhh
Q 007969 537 FGLARIFGGNQNQANTNIIAVDTWPQS------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~ 581 (583)
||+++...... ....++..|.+ ...|.|++|+.+|+++.+
T Consensus 173 fg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g 224 (287)
T 4f0f_A 173 FGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224 (287)
T ss_dssp CTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcC
Confidence 99998654321 11233333333 345777788888887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=232.43 Aligned_cols=187 Identities=20% Similarity=0.373 Sum_probs=143.9
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+|.. .+++.||+|++... .....+++.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 34688899999999999999986 47899999999753 234467899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999886422 3445899999999999999999999985 9999999999999999999999999998775
Q ss_pred CCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
..... .....++..+.++ ..|.|++|+.+|+++.+
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 232 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 43321 1123344444444 35788888888888754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=239.58 Aligned_cols=190 Identities=23% Similarity=0.360 Sum_probs=147.0
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCch-----------hHHHHHHHHHHHhhCCCCCcee
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVR 451 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~ 451 (583)
..++....++|...++||+|+||.||+|...+++.||||++...... ..+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 44566778999999999999999999999888999999999643221 2378999999999999999999
Q ss_pred EEEEEEeC-----CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 452 LLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 452 l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
+++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999653 36899999998 688877754 3346899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
+.++.+||+|||+++........ ....++.+|.+ ...|.|++|+.+|+++.+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 230 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhC
Confidence 99999999999999865443322 11233333333 345778888888888654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=243.49 Aligned_cols=183 Identities=27% Similarity=0.422 Sum_probs=137.5
Q ss_pred CCccccccccCceEEEEEEec--CC--cEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeEEEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIY 466 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~--~g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 466 (583)
|...++||+|+||.||+|+.. ++ ..||+|.++.. .....++|.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556789999999999999864 22 36899998754 33456789999999999999999999999765 45789999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ...+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999643 345889999999999999999999985 999999999999999999999999999876443
Q ss_pred CCcc--cceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 547 QNQA--NTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~--~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
.... ......++..|++ ...|.|++|+.+|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 291 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 2211 1111223333333 34678888888888875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-27 Score=236.31 Aligned_cols=186 Identities=23% Similarity=0.389 Sum_probs=148.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
..++|...+.||+|+||.||+|+.. +++.|++|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4567888999999999999999976 588999999987766677899999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999886532 34899999999999999999999985 9999999999999999999999999976432110
Q ss_pred CcccceeeeeccCCC---------------cchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQ---------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~l~~~ 581 (583)
. ......++..+. ....|.|++|+.+|+++.+
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 218 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence 0 001122333333 3346778888888887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=236.97 Aligned_cols=186 Identities=27% Similarity=0.463 Sum_probs=143.7
Q ss_pred cCCCCccccccccCceEEEEEEecC-----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
.++|...++||+|+||.||+|+... +..||+|.++... .....++.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3466778899999999999998643 2369999997653 344567999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999653 345899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCccc-ceeeeeccCCC----------cchhHHHHHHHHHHHhhh
Q 007969 544 GGNQNQAN-TNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~ 580 (583)
........ .....++..|. ....|.|++|+.+|+++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 245 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHc
Confidence 54432111 11112222233 334678888888888764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=230.84 Aligned_cols=184 Identities=26% Similarity=0.328 Sum_probs=152.5
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---------chhHHHHHHHHHHHhhCC-CCCceeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---------GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCL 457 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 457 (583)
..++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467888999999999999999975 68899999997543 122457889999999995 999999999999
Q ss_pred eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 458 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
.++..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999999653 35899999999999999999999985 999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCcc----------------hhHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQSM----------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~l~~~ 581 (583)
|+++......... ...++..+.++ ..|.|++|+.+|+++.+
T Consensus 169 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 169 GFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp TTCEECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cchhhcCCCcccc---cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 9999876443221 12344444333 45778888888887654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-26 Score=247.77 Aligned_cols=184 Identities=25% Similarity=0.383 Sum_probs=151.6
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-------------hhHHHHHHHHHHHhhCCCCCceeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------------QGLQEFKNEVNLIAKLQHKNLVRLLG 454 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g 454 (583)
..++|...++||+|+||.||+|+.. +++.||+|++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467889999999999999999965 578999999975421 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---c
Q 007969 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---N 531 (583)
Q Consensus 455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~ 531 (583)
++.+++..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988653 34899999999999999999999985 99999999999998776 6
Q ss_pred eEEEecCCceecCCCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 532 PKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
+||+|||+++.+...... ....|+.+|.+|| .|.|++|+++|+|+.+
T Consensus 188 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp EEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHS
T ss_pred EEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhC
Confidence 999999999987654322 2234666665554 5778888888888765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=256.28 Aligned_cols=177 Identities=25% Similarity=0.418 Sum_probs=141.6
Q ss_pred cccccCceEEEEEEec---CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 398 ~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
+||+|+||.||+|... ++..||||+++... ....++|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999998653 3456889999999999999999999999876 56899999999999
Q ss_pred hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc-c
Q 007969 474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-T 552 (583)
Q Consensus 474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 552 (583)
|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999542 345899999999999999999999985 99999999999999999999999999998754332211 1
Q ss_pred eeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 553 NIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 553 ~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
....++..|+++ ..|+|++|+++|+|+.
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 112223334433 4578888888888875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=239.90 Aligned_cols=183 Identities=23% Similarity=0.274 Sum_probs=151.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888899999999999999975 6899999999765 33446789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999999653 34899999999999999999999852 39999999999999999999999999997653221
Q ss_pred CcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
.....|+..|.++ ..|.|++|+++|+|+.+
T Consensus 187 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 226 (360)
T 3eqc_A 187 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226 (360)
T ss_dssp --------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred ----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 1123444444444 35778888888887754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=229.59 Aligned_cols=183 Identities=25% Similarity=0.421 Sum_probs=147.2
Q ss_pred CCCccc-cccccCceEEEEEEec---CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 392 HFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 392 ~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
+|...+ +||+|+||.||+|... ++..||+|+++... ....+++.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999853 57789999998653 34567899999999999999999999999 556789999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.+ ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999853 2345899999999999999999999985 999999999999999999999999999987654
Q ss_pred CCccc-ceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 547 QNQAN-TNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
..... .....++..|.++ ..|.|++|+.+|+++.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 208 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHc
Confidence 33211 1112233334443 3577778888888764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-26 Score=230.86 Aligned_cols=185 Identities=25% Similarity=0.395 Sum_probs=148.7
Q ss_pred HHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
...++|...++||+|+||.||+|... +|+.||+|.+.... ..+++.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567888999999999999999875 58999999997653 3478899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 345899999999999999999999985 999999999999999999999999999887544
Q ss_pred CCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++..|.+ ...|.|++|+.+|+|+.+
T Consensus 179 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 221 (314)
T 3com_A 179 MAKR--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221 (314)
T ss_dssp BSCB--CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred cccc--CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhC
Confidence 3221 11234444333 346888899999988764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=247.14 Aligned_cols=151 Identities=18% Similarity=0.205 Sum_probs=125.0
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHH---HHHhhCCCCCceeEE-------EE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEV---NLIAKLQHKNLVRLL-------GC 455 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 455 (583)
.++|...++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45678889999999999999996 46999999999743 334567899999 556666899999998 66
Q ss_pred EEeCC-----------------eEEEEEEcCCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007969 456 CLEGQ-----------------ELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKI 514 (583)
Q Consensus 456 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 514 (583)
+..++ ..++||||+ +|+|.+++..... ...++|..++.|+.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 6899999875321 123456888999999999999999985 9
Q ss_pred eeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 515 IHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 515 iHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+||||||+|||++.++.+||+|||+++...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=250.60 Aligned_cols=183 Identities=25% Similarity=0.390 Sum_probs=154.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346888899999999999999975 78999999996542 33467899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCcee
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI 542 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~ 542 (583)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998854 345899999999999999999999985 9999999999999 5678999999999988
Q ss_pred cCCCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
+...... ....|+.+|++|| .|.|++|+++|+|+.+
T Consensus 179 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 223 (484)
T 3nyv_A 179 FEASKKM---KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223 (484)
T ss_dssp BCCCCSH---HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccc---ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHC
Confidence 7654432 1224555555544 5788888888888765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-26 Score=247.07 Aligned_cols=182 Identities=24% Similarity=0.377 Sum_probs=148.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|...++||+|+||.||+|+.. ++..||+|++.+.. ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45888899999999999999975 68899999997553 3345789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~~ 544 (583)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999888553 34899999999999999999999985 9999999999999764 559999999999876
Q ss_pred CCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
..... ....|+.+|.+|| .|.|++|+++|+|+.+
T Consensus 191 ~~~~~---~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g 233 (494)
T 3lij_A 191 NQKKM---KERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAG 233 (494)
T ss_dssp TTBCB---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCccc---cccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhC
Confidence 54321 2235666666554 5778888888888765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=247.33 Aligned_cols=175 Identities=17% Similarity=0.236 Sum_probs=141.0
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--------chhHHHHHHHHHHHhhCC---------CCCceeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQ---------HKNLVRL 452 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l 452 (583)
.++|...++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34577889999999999999998 68999999997552 223478899999998885 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 007969 453 LGCCL------------------------------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502 (583)
Q Consensus 453 ~g~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 502 (583)
.+.+. .++..++||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 87753 26789999999999977666622 458999999999999999
Q ss_pred HHHHH-hCCCCCeeeCCCCCCcEEEcCCC--------------------ceEEEecCCceecCCCCCcccceeeeeccCC
Q 007969 503 ILYLH-EDSRLKIIHRDLKASNILLDDDM--------------------NPKISDFGLARIFGGNQNQANTNIIAVDTWP 561 (583)
Q Consensus 503 L~yLH-~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 561 (583)
|.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...|+..|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 775 99999999999999887 9999999999987542 24677777
Q ss_pred CcchhH--HHHHHHHHHHhh
Q 007969 562 QSMQWE--AYFLLNLMFSVL 579 (583)
Q Consensus 562 ~~~~~~--~~~~~~~l~~l~ 579 (583)
+++|.. .....+|+|+++
T Consensus 244 ~aPE~~~g~~~~~~Diwsl~ 263 (336)
T 2vuw_A 244 MDEDLFTGDGDYQFDIYRLM 263 (336)
T ss_dssp TCSGGGCCCSSHHHHHHHHH
T ss_pred cChhhhcCCCccceehhhhh
Confidence 776642 224567777754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=240.78 Aligned_cols=179 Identities=26% Similarity=0.436 Sum_probs=141.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
.++|...++||+|+||.||+|... +|+.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999864 6899999999654 2334578899999999999999999999997653
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899998854 34899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+....... ...++.+|.++| .|.|++|+++|+|+.+
T Consensus 176 ~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 222 (367)
T 1cm8_A 176 RQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222 (367)
T ss_dssp EECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccccC-----cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhC
Confidence 98654321 123444444443 5677788888877654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=232.56 Aligned_cols=184 Identities=27% Similarity=0.423 Sum_probs=141.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEE-----------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL----------- 457 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 457 (583)
.++|...++||+|+||.||+|+.. +++.||+|++...+....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367888999999999999999976 48999999998777677788999999999999999999999873
Q ss_pred ---eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceE
Q 007969 458 ---EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 533 (583)
Q Consensus 458 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 533 (583)
+....++||||++ |+|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 699998843 35899999999999999999999985 99999999999997 577999
Q ss_pred EEecCCceecCCCCCc-ccceeeeeccCCCcc-----------hhHHHHHHHHHHHhhhh
Q 007969 534 ISDFGLARIFGGNQNQ-ANTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 534 l~DFGla~~~~~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~ 581 (583)
|+|||+++........ .......++.++.++ ..|.|++|+.+|+++.+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhC
Confidence 9999999976532211 111112234444333 35777788888887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.94 Aligned_cols=184 Identities=27% Similarity=0.428 Sum_probs=141.5
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
..++|...++||+|+||.||+++.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467899999999999999999854 689999999975532 2245788999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-----cCCCceEEEecCCc
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLA 540 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~kl~DFGla 540 (583)
|||++ |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99998 5999988553 34899999999999999999999985 9999999999999 45566999999999
Q ss_pred eecCCCCCcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+......... ....++.+|. ....|.|++|+++|+|+.+
T Consensus 185 ~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 185 RAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 8775332221 1123343333 3445677788888877653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=232.31 Aligned_cols=183 Identities=28% Similarity=0.399 Sum_probs=145.9
Q ss_pred CCccccccccCceEEEEEEecC-C---cEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE-EEEE
Q 007969 393 FSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-LLIY 466 (583)
Q Consensus 393 ~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~ 466 (583)
|...++||+|+||.||+|+..+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556899999999999998532 2 3799999976543 4467899999999999999999999999876654 9999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999652 345899999999999999999999985 999999999999999999999999999866433
Q ss_pred CCcc--cceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 547 QNQA--NTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 547 ~~~~--~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
.... ......++..+ .....|.|++|+.+|+++.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 223 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhh
Confidence 2111 11111222222 2345688888888888876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=237.88 Aligned_cols=183 Identities=31% Similarity=0.465 Sum_probs=140.2
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHH--HhhCCCCCceeEEEEEEe-----CCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLE-----GQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~ 462 (583)
.++|...++||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 68999999997543 2344444444 556899999999987643 2367
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCcEEEcCCCceEEEe
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------RLKIIHRDLKASNILLDDDMNPKISD 536 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~kl~D 536 (583)
++||||+++|+|.+++... ..++..++.++.||++||.|||+.. +.+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 2489999999999999999999871 11399999999999999999999999
Q ss_pred cCCceecCCCCCc------ccceeeeeccCCCcch-----------------hHHHHHHHHHHHhhh
Q 007969 537 FGLARIFGGNQNQ------ANTNIIAVDTWPQSMQ-----------------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 537 FGla~~~~~~~~~------~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~l~~ 580 (583)
||+++.+...... .......|+..|.++| .|.|++|+++|+|+.
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 9999987643321 1111234666666665 356667777776653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=249.44 Aligned_cols=183 Identities=25% Similarity=0.390 Sum_probs=151.4
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||+++.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999965 6899999999643 2334678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~ 543 (583)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999888653 35899999999999999999999986 99999999999995 5568999999999877
Q ss_pred CCCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
...... ....|+.+|.+|| .|.|++|+++|+|+.+
T Consensus 175 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 218 (486)
T 3mwu_A 175 QQNTKM---KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCcc---CCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhC
Confidence 544321 1234555555544 5778888888888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=232.21 Aligned_cols=185 Identities=27% Similarity=0.399 Sum_probs=146.3
Q ss_pred CCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEe-CCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 464 (583)
.+|...++||+|+||.||+|+..+ +..+++|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998643 2368999997643 3446789999999999999999999999754 467899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++.+. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999642 345899999999999999999999985 9999999999999999999999999998775
Q ss_pred CCCCcc--cceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 545 GNQNQA--NTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~--~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
...... ......++..|.+ ...|.|++|+.+|+++.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 227 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 433211 1111223333333 34577888888888765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=228.05 Aligned_cols=183 Identities=23% Similarity=0.372 Sum_probs=148.4
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.++|...++||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457888999999999999999975 68999999997542 23356889999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999653 34899999999999999999999985 99999999999999999999999999987754
Q ss_pred CCCcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
..... ...++..+. ....|.|++|+.+|+++.+
T Consensus 164 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 207 (276)
T 2h6d_A 164 GEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHS
T ss_pred Cccee---cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhC
Confidence 33211 112222222 3456777788888887654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=233.22 Aligned_cols=182 Identities=22% Similarity=0.325 Sum_probs=148.2
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||.||+++.. +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 346788899999999999999965 6899999999876555556789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCceecCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~~ 545 (583)
+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999988653 34899999999999999999999985 9999999999999 7889999999999986543
Q ss_pred CCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...++..|. ....|.|++|+.+|+++.+
T Consensus 162 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (304)
T 2jam_A 162 GIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203 (304)
T ss_dssp BTTH----HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHS
T ss_pred Cccc----cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 2111 112233322 3456788888888888764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=235.89 Aligned_cols=185 Identities=25% Similarity=0.442 Sum_probs=146.2
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc--hhHHHHHHHHHHHhhCCCCCceeEEEEEEe--------C
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--------G 459 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 459 (583)
++|...++||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688899999999999999997 4789999999865432 235678899999999999999999999987 3
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
+..++||||+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 676666443 245899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcc--cceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQA--NTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
++.+....... ......|+.+|. ....|.|++|+++|+|+.+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 99875322211 111123333333 3445777788888887653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=235.84 Aligned_cols=190 Identities=23% Similarity=0.282 Sum_probs=148.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEe--------C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--------G 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--------~ 459 (583)
..+|...++||+|+||.||+++.. +++.||+|++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346888899999999999999964 68999999997776666788999999999996 9999999999953 3
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
...++|+||++ |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45899999995 799888876445567999999999999999999999873 2499999999999999999999999999
Q ss_pred ceecCCCCCccc----------ceeeeeccCCC-------------cchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQAN----------TNIIAVDTWPQ-------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~----------~~~~~~~~~~~-------------~~~~~~~~~~~~l~~l~~~ 581 (583)
++.......... .....++..|. ....|+|++|+++|+|+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 998754332110 00122333333 3346788888888887754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=237.07 Aligned_cols=188 Identities=27% Similarity=0.385 Sum_probs=146.9
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++..++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788899999999999999984 24678999999754 334467899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEE
Q 007969 463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKIS 535 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~ 535 (583)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245899999999999999999999985 999999999999984 5569999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
|||+++...............++..|.+ ...|.|++|+++|+|+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHc
Confidence 9999986643332221112223333333 44678888888888864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=238.51 Aligned_cols=185 Identities=26% Similarity=0.439 Sum_probs=143.3
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch-----hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
..++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567999999999999999999975 5899999999754221 134688999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||+++ +|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 88888754 2345889999999999999999999986 99999999999999999999999999987
Q ss_pred cCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+....... ....++.+|.++| .|.|++|+++|+|+.+
T Consensus 162 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 209 (346)
T 1ua2_A 162 FGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209 (346)
T ss_dssp TTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHC
Confidence 75433221 1123444444443 4667777777777643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=233.29 Aligned_cols=190 Identities=21% Similarity=0.300 Sum_probs=135.6
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
..++|...+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++..++..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999854 68899999987543 334567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 467 EYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 467 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988641 12345899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCCc---ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQ---ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~---~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
........ .......++..|.++| .|.|++|+++|+++.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence 76543211 1112234555444443 4667777777777643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=229.46 Aligned_cols=184 Identities=23% Similarity=0.333 Sum_probs=145.3
Q ss_pred cCCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4568888999999999999998543 3469999998653 34567899999999999999999999997654 5689
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999996532 34899999999999999999999985 9999999999999999999999999998775
Q ss_pred CCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
....... ....++..|.++ ..|.|++|+.+|+++.
T Consensus 165 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 165 DEDYYKA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccc-ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 4332211 112233333333 4678888888888764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=227.54 Aligned_cols=188 Identities=21% Similarity=0.324 Sum_probs=149.1
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC--CeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.+ ++.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46788899999999999999985 8899999997653 34467899999999999999999999999887 7789999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ .+|+||||||+||++++++.+||.|||++......
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 9999999999996532 335899999999999999999999873 34999999999999999999999999988664433
Q ss_pred CCc-----ccceeeeecc-CCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQ-----ANTNIIAVDT-WPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ..|+...+.. .......|.|++|+.+|+++.+
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 221 1111111110 1111236777788888887654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=227.93 Aligned_cols=181 Identities=23% Similarity=0.354 Sum_probs=150.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 57889999986532 223467899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998653 34899999999999999999999985 999999999999999999999999999876543
Q ss_pred CCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..+. ....|.|++|+.+|+++.+
T Consensus 168 ~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (284)
T 2vgo_A 168 RRR----TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208 (284)
T ss_dssp CBC----CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ccc----cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHC
Confidence 211 122333333 3446788899999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=227.40 Aligned_cols=183 Identities=26% Similarity=0.335 Sum_probs=149.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 463 (583)
..|...++||+|+||.||+|... ++..|++|.+... .....+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999864 6789999998754 34456789999999999999999999999875 35689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCcee
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~ 542 (583)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 35899999999999999999999874 2499999999999997 889999999999976
Q ss_pred cCCCCCcccceeeeeccCCCcc---------hhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSM---------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~ 581 (583)
...... ....|+..|.++ ..|.|++|+.+|+++.+
T Consensus 182 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g 225 (290)
T 1t4h_A 182 KRASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp CCTTSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccc----ccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhC
Confidence 544322 123344444443 46788888888888754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=234.88 Aligned_cols=187 Identities=25% Similarity=0.405 Sum_probs=148.7
Q ss_pred HHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe------C
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE------G 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------~ 459 (583)
...++|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 4567889999999999999999996 468999999997543 3357889999999999 79999999999987 4
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 67899999999999999996532 345899999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCc---------------chhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQS---------------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~ 581 (583)
++........ .....++..|.+ ...|.|++|+++|+|+.+
T Consensus 176 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 176 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred ceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence 9876533211 111233433333 335788888888888754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=231.06 Aligned_cols=185 Identities=30% Similarity=0.443 Sum_probs=145.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE---------- 458 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 458 (583)
.++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 346788899999999999999964 7899999999643 3445789999999999999999999999865
Q ss_pred ---CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 459 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35689999999999999999653 345788999999999999999999985 9999999999999999999999
Q ss_pred ecCCceecCCCCC------------cccceeeeeccCCCc-----------chhHHHHHHHHHHHhhh
Q 007969 536 DFGLARIFGGNQN------------QANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 536 DFGla~~~~~~~~------------~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~ 580 (583)
|||+++....... ........++..|.+ ...|.|++|+.+|+|+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999987653211 011112234444333 34567777888877764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=238.14 Aligned_cols=187 Identities=24% Similarity=0.353 Sum_probs=151.1
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchh-----------------HHHHHHHHHHHhhCCCCCceeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------------LQEFKNEVNLIAKLQHKNLVRL 452 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~H~niv~l 452 (583)
.++|...+.||+|+||.||+++. +++.||+|++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46789999999999999999999 89999999997542211 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEE
Q 007969 453 LGCCLEGQELLLIYEYMPNKSLDVH------LFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNIL 525 (583)
Q Consensus 453 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlk~~NIL 525 (583)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 532 224569999999999999999999998 74 999999999999
Q ss_pred EcCCCceEEEecCCceecCCCC--------CcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 526 LDDDMNPKISDFGLARIFGGNQ--------NQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 526 l~~~~~~kl~DFGla~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
++.++.+||+|||+++...... .+..|+...+...+.....|.|++|+++|+++.+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 9999999999999999864431 1122222211111112256788888888888754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=237.18 Aligned_cols=185 Identities=19% Similarity=0.186 Sum_probs=142.6
Q ss_pred cCCCCccccccccCceEEEEEEec----CCcEEEEEEeccCCch-----------hHHHHHHHHHHHhhCCCCCceeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVRLLG 454 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 454 (583)
.++|...++||+|+||.||+|+.. ++..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467888999999999999999975 5678999998765432 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 007969 455 CCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM 530 (583)
Q Consensus 455 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 530 (583)
++.. +...++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 999999985433 6899999999999999999999985 99999999999999887
Q ss_pred --ceEEEecCCceecCCCCCcc-----cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 531 --NPKISDFGLARIFGGNQNQA-----NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 531 --~~kl~DFGla~~~~~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.+||+|||+++.+....... ......|+..|.++| .|.|++|+++|+|+.+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999875332111 112335566655544 5677777777777653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=233.84 Aligned_cols=182 Identities=23% Similarity=0.321 Sum_probs=143.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc--------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 460 (583)
.++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356888999999999999999865 588999999975421 22346889999999999999999999987655
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEec
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDF 537 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DF 537 (583)
.++||||+++++|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998843 346899999999999999999999985 999999999999987654 999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCcc-------------hhHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQSM-------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~l~~~ 581 (583)
|+++........ ....|+..|.++ ..|.|++|+++|+++.+
T Consensus 162 g~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g 215 (322)
T 2ycf_A 162 GHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215 (322)
T ss_dssp TTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred ccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999987543211 112334444333 45677777888777654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=228.83 Aligned_cols=183 Identities=27% Similarity=0.400 Sum_probs=145.7
Q ss_pred CCCCccc-cccccCceEEEEEEe---cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDEN-KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~-~LG~G~fG~Vy~a~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|...+ .||+|+||.||+|.. .+++.||||+++... ....+++.+|+.++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999964 246789999997553 23367899999999999999999999999 5677899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999653 34899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcccc-eeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 545 GNQNQANT-NIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
........ ....++..+.++ ..|.|++|+.+|+++.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 54432211 112223333333 3577778888888765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-26 Score=235.97 Aligned_cols=184 Identities=21% Similarity=0.376 Sum_probs=149.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----CeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (583)
.++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999864 688999999975433 3457899999999999999999999999765 368
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589888854 24899999999999999999999986 99999999999999999999999999998
Q ss_pred cCCCCCcc-cceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA-NTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
........ ......|+.+|.++| .|.|++|+++|+|+.+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 228 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence 75433221 122234555554444 4677788888877654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=229.56 Aligned_cols=185 Identities=22% Similarity=0.263 Sum_probs=136.8
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc-hh-HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||+++. .+++.||+|++..... .. .+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45688889999999999999996 4789999999976532 22 233445555688889999999999999999999999
Q ss_pred EcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||++ |+|.+++... .....+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887776542 2345699999999999999999999997 5 9999999999999999999999999998775
Q ss_pred CCCCcccceeeeeccCCCcch--------------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ--------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~l~~~ 581 (583)
..... ....++..|.++| .|.|++|+++|+++.+
T Consensus 162 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (290)
T 3fme_A 162 DDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred ccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence 44322 1224555555544 4677788888777643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=226.70 Aligned_cols=164 Identities=10% Similarity=-0.021 Sum_probs=142.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+..+++++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999975 489999999976532 33578999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++++|.+++.+ . ....+...|+.||+.||.|||+++ |+||||||+|||+++++.+||+++|..
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~------ 176 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM------ 176 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc------
Confidence 99999999999833 1 355678899999999999999986 999999999999999999999966543
Q ss_pred CCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
.+.....|.|++|+++|+|+.+
T Consensus 177 -------------~~~~~~~Di~slG~il~elltg 198 (286)
T 3uqc_A 177 -------------PDANPQDDIRGIGASLYALLVN 198 (286)
T ss_dssp -------------TTCCHHHHHHHHHHHHHHHHHS
T ss_pred -------------CCCCchhHHHHHHHHHHHHHHC
Confidence 2346678899999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=229.55 Aligned_cols=190 Identities=26% Similarity=0.387 Sum_probs=149.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 464 (583)
.++|...+.||+|+||.||+++.. +++.|++|++... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 356888899999999999999875 6899999999754 33446789999999999999999999998865 568999
Q ss_pred EEEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987533 2345899999999999999999999974 1239999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
......... ....++..+.+ ...|.|++|+.+|+++.+
T Consensus 165 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 212 (279)
T 2w5a_A 165 ILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212 (279)
T ss_dssp HC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred eeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 765433211 11233444433 345778888888887754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=255.52 Aligned_cols=177 Identities=27% Similarity=0.398 Sum_probs=141.1
Q ss_pred ccccccCceEEEEEEec---CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999653 46789999998643 3346789999999999999999999999864 568899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+........
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999954 345899999999999999999999985 99999999999999999999999999998765433211
Q ss_pred -ceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 552 -TNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 552 -~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
.....++..|.+ ...|+|++|+++|+|+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 111223333333 34678888888888875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=234.86 Aligned_cols=183 Identities=26% Similarity=0.425 Sum_probs=142.6
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch-hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999975 6899999999754322 122456899999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 58888886532 35899999999999999999999986 99999999999999999999999999987653322
Q ss_pred cccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
.. ....++.+|. ....|.|++|+++|+|+.+
T Consensus 156 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 156 TY--DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cc--ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 11 1122333333 3445777788888887654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=233.28 Aligned_cols=184 Identities=29% Similarity=0.463 Sum_probs=145.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcE--EEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKA--IAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...+.||+|+||.||+|+.. ++.. +++|.++.. .....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999864 4554 499998754 233456789999999999 899999999999999999999
Q ss_pred EEcCCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
|||+++++|.+++.+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
||+|||+++....... .....++..|.+ ...|.|++|+++|+|+.
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 236 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence 9999999985432111 111222333333 34577888888888764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=238.80 Aligned_cols=179 Identities=28% Similarity=0.419 Sum_probs=132.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 460 (583)
.++|...++||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46788999999999999999985 46899999999754 334467889999999999999999999999754 5
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899888743 35899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+...... ....++.+|.++| .|.|++|+++|+|+.+
T Consensus 180 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 226 (367)
T 2fst_X 180 RHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHS
T ss_pred ccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhC
Confidence 8764321 1234555554444 5777788888887754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=256.15 Aligned_cols=177 Identities=18% Similarity=0.261 Sum_probs=147.1
Q ss_pred cCCCCccccccccCceEEEEEEec--CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe-----
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (583)
.++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 58999999997543 3445678999999999999999999999987654
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++++|.+++.. .++|..++.|+.||++||.|||+++ |+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999986 9999999999999986 89999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
...... ...|+.+|+++| .|.|++|+++|+|+.+
T Consensus 230 ~~~~~~------~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g 272 (681)
T 2pzi_A 230 RINSFG------YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLD 272 (681)
T ss_dssp ETTCCS------CCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSC
T ss_pred hcccCC------ccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhC
Confidence 875441 234666666655 5777788888877654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=238.85 Aligned_cols=180 Identities=28% Similarity=0.454 Sum_probs=129.4
Q ss_pred cccccccCceEEEEEEec---CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEEEEEcCC
Q 007969 396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP 470 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~ 470 (583)
.++||+|+||.||+|+.. +++.||+|++..... .+.+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999965 578999999975533 3578899999999999999999999965 578999999997
Q ss_pred CCChhHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCceEEEecCCc
Q 007969 471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA 540 (583)
Q Consensus 471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 540 (583)
++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4777766421 12235899999999999999999999986 9999999999999 77899999999999
Q ss_pred eecCCCCCc-ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQ-ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+.+...... .......|+.+|.++| .|.|++|+++|+|+.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 232 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence 987543221 2223345666665555 4566667777666543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=235.23 Aligned_cols=180 Identities=27% Similarity=0.378 Sum_probs=140.6
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
.++|...++||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467888999999999999999864 6889999999754 3344577899999999999999999999997654
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777773 23889999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
+....... .....|+.+|.++ ..|.|++|+++|+|+.+
T Consensus 175 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 222 (371)
T 2xrw_A 175 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 87654321 1123445544444 35788888888888764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=240.55 Aligned_cols=180 Identities=24% Similarity=0.370 Sum_probs=139.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC----C--eEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG----Q--ELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~--~~~ 463 (583)
.+|...++||+|+||.||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999975 589999999975432 234799999999999999999998642 1 367
Q ss_pred EEEEcCCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CceEEEecCCce
Q 007969 464 LIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLAR 541 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 541 (583)
+||||+++ +|.+.+.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55555432 123456999999999999999999999985 9999999999999965 678999999999
Q ss_pred ecCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.+....... ...++.+|+++| .|+|++|+++|+|+.+
T Consensus 206 ~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G 253 (420)
T 1j1b_A 206 QLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253 (420)
T ss_dssp ECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred hcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 875433221 134455544443 4677788888887754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.38 Aligned_cols=188 Identities=22% Similarity=0.295 Sum_probs=149.8
Q ss_pred HHHcCCCCcc-ccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCe
Q 007969 387 LEATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE 461 (583)
Q Consensus 387 ~~~~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 461 (583)
....+.|... ++||+|+||.||+++.. +++.||+|++.... .....++.+|+.++.+++ ||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445556665 88999999999999865 68999999997542 334678999999999995 6999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG 538 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 538 (583)
.++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999988542 2346899999999999999999999985 999999999999988 7899999999
Q ss_pred CceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
+++........ ....|+..|.+ ...|.|++|+++|+|+.+
T Consensus 180 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 180 MSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99987543321 12334444433 346788888888888754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=231.04 Aligned_cols=185 Identities=21% Similarity=0.292 Sum_probs=145.8
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCC--CCCceeEEEEEEeCCeEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~l 464 (583)
..++|...++||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ |+||+++++++..++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34568889999999999999999888999999999754 3345678999999999997 5999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||| +.+++|.+++.+. ..+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 6688999999653 35899999999999999999999985 999999999999975 899999999999876
Q ss_pred CCCCcccceeeeeccCCCcch---------------------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ---------------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~l~~~ 581 (583)
............|+..|.++| .|.|++|+.+|+|+.+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 544332223334555554444 4677777777777643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=225.59 Aligned_cols=186 Identities=22% Similarity=0.305 Sum_probs=146.3
Q ss_pred HHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEE-EeCCeEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLI 465 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV 465 (583)
...++|...+.||+|+||.||+|+. .+++.||||++...... +++.+|++++++++|+|++..++.+ ..++..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999995 57889999987654322 4688999999999988877776665 567788999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCcee
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI 542 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~ 542 (583)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 999999986432 35899999999999999999999985 9999999999999 8899999999999998
Q ss_pred cCCCCCcc-----cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA-----NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
........ ......|+..|.++| .|.|++|+.+|+++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 211 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcC
Confidence 76543321 222345565555554 4788888888888754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=227.98 Aligned_cols=177 Identities=19% Similarity=0.346 Sum_probs=146.5
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEe--CCeEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLI 465 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV 465 (583)
.++|...++||+|+||.||+|+. .+++.||+|+++... .+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 35688899999999999999985 578999999997543 467899999999997 9999999999988 5678999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFG 544 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~ 544 (583)
|||+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998883 2889999999999999999999986 99999999999999776 89999999999875
Q ss_pred CCCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
...... ...++.++ .....|.|++|+++|+|+.+
T Consensus 183 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 227 (330)
T 3nsz_A 183 PGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227 (330)
T ss_dssp TTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhC
Confidence 443321 11233322 33446778888888888754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.03 Aligned_cols=183 Identities=23% Similarity=0.386 Sum_probs=146.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----CeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 462 (583)
.++|...+.||+|+||.||+|+.. +|+.||||++.... .....++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999965 68999999997543 33456788999999999999999999998754 678
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888854 34899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCccc--------ceeeeeccCCCcch-----------hHHHHHHHHHHHhhh
Q 007969 543 FGGNQNQAN--------TNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 543 ~~~~~~~~~--------~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~ 580 (583)
......... .....|+.+|.++| .|.|++|+.+|+|+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 218 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh
Confidence 754322111 11124455444444 466777777777654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=239.83 Aligned_cols=184 Identities=21% Similarity=0.301 Sum_probs=151.5
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC-CCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|.+.++||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999995 56899999988755332 457899999999986 566666677778889999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 544 (583)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999996433 35899999999999999999999985 9999999999999 688999999999999886
Q ss_pred CCCCc-----ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQ-----ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... .......|+..|.++| .|+|++|+++|+|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG 209 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 54432 1223456777776665 4788899999888764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=223.51 Aligned_cols=184 Identities=22% Similarity=0.307 Sum_probs=150.1
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEE-EeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~e 467 (583)
.++|...+.||+|+||.||+|+. .+++.||||++...... +++.+|+.++++++|++++..+..+ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56788999999999999999996 57899999998755432 4689999999999988876666665 56778899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCceEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 544 (583)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999996432 35899999999999999999999985 9999999999999 588999999999999876
Q ss_pred CCCCcc-----cceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQA-----NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
...... ......|+..|.++| .|.|++|+.+|+++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 211 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 544321 123445666666654 4788888888887754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=224.73 Aligned_cols=168 Identities=24% Similarity=0.332 Sum_probs=142.4
Q ss_pred CCCCcc-ccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHH-hhCCCCCceeEEEEEEe----CCeEE
Q 007969 391 NHFSDE-NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLI-AKLQHKNLVRLLGCCLE----GQELL 463 (583)
Q Consensus 391 ~~~~~~-~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 463 (583)
++|... +.||+|+||.||++.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 7799999999999986 46899999999643 4677888887 55689999999999987 66789
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCc
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 540 (583)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999997633 345899999999999999999999985 999999999999998 789999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+...+.. .....|.|++|+.+|+|+.+
T Consensus 168 ~~~~~~~--------------~~~~~DiwslG~il~el~tg 194 (299)
T 3m2w_A 168 KETTGEK--------------YDKSCDMWSLGVIMYILLCG 194 (299)
T ss_dssp EECTTCG--------------GGGHHHHHHHHHHHHHHHHS
T ss_pred ccccccc--------------CCchhhHHHHHHHHHHHHHC
Confidence 8765422 34567888899999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=233.51 Aligned_cols=183 Identities=21% Similarity=0.321 Sum_probs=142.5
Q ss_pred HHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-------
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------- 459 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 459 (583)
...++|...++||+|+||.||+|+. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 5789999999875432 234799999999999999999998543
Q ss_pred -------------------------------CeEEEEEEcCCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007969 460 -------------------------------QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507 (583)
Q Consensus 460 -------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH 507 (583)
...++||||++ ++|.+.+... .....+++..+..++.||++||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999998 5777776532 23456999999999999999999999
Q ss_pred hCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceecCCCCCcccceeeeeccCCCc-----------chhHHHHHHHHH
Q 007969 508 EDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLM 575 (583)
Q Consensus 508 ~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l 575 (583)
+.+ |+||||||+|||++ .++.+||+|||+++.+....... ...++.+|.+ ...|.|++|+++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 985 99999999999998 68999999999999875443221 1233333333 345777788888
Q ss_pred HHhhhh
Q 007969 576 FSVLEF 581 (583)
Q Consensus 576 ~~l~~~ 581 (583)
|+|+.+
T Consensus 233 ~ell~g 238 (383)
T 3eb0_A 233 GELILG 238 (383)
T ss_dssp HHHHHS
T ss_pred HHHHhC
Confidence 887754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=226.88 Aligned_cols=179 Identities=27% Similarity=0.403 Sum_probs=140.4
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-CeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~ 468 (583)
.++|...+.||+|+||.||+++.+ |+.||+|.++... ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 356888899999999999999874 8899999997543 457899999999999999999999997655 478999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999986532 223789999999999999999999985 99999999999999999999999999987654321
Q ss_pred cccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
. ..++..+.+ ...|.|++|+.+|+++.
T Consensus 173 ~-----~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 173 T-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred C-----CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence 1 123333333 34677888888888764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=226.21 Aligned_cols=185 Identities=29% Similarity=0.391 Sum_probs=140.8
Q ss_pred cCCCCccccccccCceEEEEEEec--CCc--EEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~--~g~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...++||+|+||.||+|+.. +++ .||+|+++.. .....+++.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888899999999999999853 333 6899998754 3345678999999999999999999999998765 8
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
++|+||+++++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999986532 35899999999999999999999985 99999999999999999999999999998
Q ss_pred cCCCCCcc-cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 543 FGGNQNQA-NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 543 ~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
........ ......++..|.++| .|.|++|+.+|+++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 219 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 76544321 122233444444443 577778888888765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=236.22 Aligned_cols=181 Identities=21% Similarity=0.339 Sum_probs=141.9
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------eEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 464 (583)
.+|...++||+|+||.||+|+..++..||+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 458888999999999999999887777999988654322 247999999999999999999996543 3789
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceec
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF 543 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~ 543 (583)
||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655544433333456999999999999999999999985 99999999999999 7999999999999987
Q ss_pred CCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
....... ...++.+|.+ ...|.|++|+++|+|+.+
T Consensus 193 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 193 IAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp CTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 5443221 1233333333 345677788888887754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=236.60 Aligned_cols=182 Identities=16% Similarity=0.177 Sum_probs=146.5
Q ss_pred cCCCCccccccccCceEEEEEEecC---------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCcee---------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR--------- 451 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 451 (583)
.++|...++||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678899999999999999998763 789999998754 46789999999999999887
Q ss_pred ------EEEEEEe-CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 007969 452 ------LLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (583)
Q Consensus 452 ------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 524 (583)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778876 67899999999 999999997532 346999999999999999999999985 99999999999
Q ss_pred EEcCCC--ceEEEecCCceecCCCCCcc-----cceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 525 LLDDDM--NPKISDFGLARIFGGNQNQA-----NTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 525 Ll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
|++.++ .+||+|||+++.+....... ......|+..|.++ ..|.|++|+++|+|+.+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999998 99999999998775432211 11122455555544 45777788888887654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=228.86 Aligned_cols=185 Identities=25% Similarity=0.451 Sum_probs=146.6
Q ss_pred HcCCCCccccccccCceEEEEEEe--cCCcEEEEEEeccCCc--hhHHHHHHHHHHHhhC---CCCCceeEEEEEE----
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCL---- 457 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~---- 457 (583)
..++|...++||+|+||.||+++. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456788999999999999999997 4688999999874422 2234566777777666 8999999999987
Q ss_pred -eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEe
Q 007969 458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536 (583)
Q Consensus 458 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 536 (583)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999986543 334899999999999999999999985 99999999999999999999999
Q ss_pred cCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 537 FGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 537 FGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
||+++....... .....++..|.++ ..|.|++|+.+|+++.+
T Consensus 164 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 164 FGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp CCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 999987653221 1123344444444 36788888888888754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=223.27 Aligned_cols=184 Identities=25% Similarity=0.378 Sum_probs=152.2
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
..++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3457888999999999999999975 68999999986542 34467899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CceEEEecCCcee
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARI 542 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~ 542 (583)
+||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999888653 34899999999999999999999985 9999999999999764 4799999999987
Q ss_pred cCCCCCcccceeeeeccCCCc---------chhHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQS---------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~l~~~ 581 (583)
........ ...++..+.+ ...|.|++|+.+|+++.+
T Consensus 174 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g 218 (287)
T 2wei_A 174 FQQNTKMK---DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218 (287)
T ss_dssp BCCCSSCS---CHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHS
T ss_pred ecCCCccc---cccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhC
Confidence 75443211 1223334433 346888899999888754
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=192.08 Aligned_cols=103 Identities=19% Similarity=0.422 Sum_probs=91.8
Q ss_pred CCcccccCCCCccCCCChHHHHHHHHHhhhhhhhcc--CCCceeeccCC-CCCeEEEEEecCCCCChhchHHHHHHHHHH
Q 007969 71 EEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAG--KSLYYNASEGE-FPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147 (583)
Q Consensus 71 ~~~~~~~C~~~~~~~~s~f~~nl~~l~~~~l~~~~~--~~~~~~~~~g~-~~~~vyg~~~C~~Dl~~~~C~~Cl~~a~~~ 147 (583)
+.+.+..|++++|+++++|++||+.||+. |+++++ +.+|++...|. ++++|||++|||+|+++++|..||+.|+.+
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~-L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~ 81 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLAD-LRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR 81 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHH-HHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHH-HHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence 44567789988999999999999999999 888877 34566666554 458999999999999999999999999999
Q ss_pred HHhcCCCCccEEEEeecCceEEEEccCCC
Q 007969 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS 176 (583)
Q Consensus 148 ~~~~C~~~~~a~i~~~~~~C~lRy~~~~f 176 (583)
+++.||+++||+||++ +|+||||+++|
T Consensus 82 ~~~~C~~~~g~~i~~~--~C~lRY~~~~F 108 (108)
T 3a2e_A 82 IFSICNNAIGARVQLV--DCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTSBSSEEEEET--TEEEEEESSCC
T ss_pred HHHHCCCCceEEEECC--CEEEEEeCCcC
Confidence 9999999999999999 99999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=235.01 Aligned_cols=181 Identities=18% Similarity=0.224 Sum_probs=147.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhC------CCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~ 462 (583)
..+|...++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456888999999999999999865 5889999999754 23346778888888877 577999999999999999
Q ss_pred EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--eEEEecCCc
Q 007969 463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLA 540 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla 540 (583)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 68988886533 335899999999999999999999985 999999999999999987 999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
+....... ...++.+|+++ ..|.|++|+++|+|+.+
T Consensus 250 ~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG 295 (429)
T 3kvw_A 250 CYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295 (429)
T ss_dssp EETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHS
T ss_pred eecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhC
Confidence 87643321 12344444443 45788888888888765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=249.25 Aligned_cols=185 Identities=20% Similarity=0.304 Sum_probs=147.2
Q ss_pred HcCCCCccccccccCceEEEEEEecC----CcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
..++|...+.||+|+||.||+|+... +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34668888999999999999998642 4579999987653 334578999999999999999999999985 45689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999653 335899999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
......... ...++..|++|| .|.|++|+.+|+++.
T Consensus 542 ~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 587 (656)
T 2j0j_A 542 EDSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcceecc-CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 554332211 223344444444 578888888888763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=232.25 Aligned_cols=178 Identities=25% Similarity=0.430 Sum_probs=142.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE----
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL---- 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 462 (583)
.++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999864 68999999997642 33357889999999999999999999999877654
Q ss_pred --EEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 463 --LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 463 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 23899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+....... ...++.+|. ....|.|++|+.+|+|+.+
T Consensus 192 ~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 238 (371)
T 4exu_A 192 RHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccCcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 87643321 112333333 3346788899999888764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=236.18 Aligned_cols=185 Identities=13% Similarity=0.110 Sum_probs=128.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc---hhHHHHHHHHHHHhhC--CCCCceeEE-------EEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKL--QHKNLVRLL-------GCCL 457 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~~ 457 (583)
..|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34778899999999999999965 789999999987543 3355677885544444 699987755 4544
Q ss_pred eC-----------------CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 007969 458 EG-----------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKI 514 (583)
Q Consensus 458 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 514 (583)
.+ ...++||||++ |+|.+++..... .+.+..+ +.++.||++||.|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 33899999999 899999975422 2455555 788899999999999985 9
Q ss_pred eeCCCCCCcEEEcCCCceEEEecCCceecCCCCC-------cccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-------QANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 515 iHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
+||||||+|||++.++.+||+|||+++....... +..|+...+.........|.|++|+++|+|+.+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999997653321 112221111111223456777788888887654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=228.65 Aligned_cols=191 Identities=21% Similarity=0.270 Sum_probs=137.6
Q ss_pred HHHHHHcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe-
Q 007969 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE- 461 (583)
Q Consensus 384 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~- 461 (583)
.......++|...++||+|+||.||+|+.. +++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566789999999999999999999974 68999999986543 223466788888999999999999999976433
Q ss_pred ------EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCcEEEcC-CCce
Q 007969 462 ------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--EDSRLKIIHRDLKASNILLDD-DMNP 532 (583)
Q Consensus 462 ------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDlk~~NILl~~-~~~~ 532 (583)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987533333222234556899999999999999999999 664 999999999999997 8999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
||+|||+++......... ...++.+| .....|.|++|+++|+|+.+
T Consensus 172 kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g 228 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228 (360)
T ss_dssp EECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred EEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999876443221 11233332 33456778888888888754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=229.67 Aligned_cols=178 Identities=24% Similarity=0.427 Sum_probs=143.1
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe-----
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----- 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 461 (583)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888899999999999999864 68999999997542 2335688999999999999999999999987653
Q ss_pred -EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 462 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 462 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68877662 24899999999999999999999985 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
+....... ...++.+|.+ ...|.|++|+++|+|+.+
T Consensus 174 ~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 220 (353)
T 3coi_A 174 RHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred cCCCCCcc-----ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhC
Confidence 87643221 1233333333 346788889999888764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-26 Score=230.81 Aligned_cols=186 Identities=26% Similarity=0.421 Sum_probs=144.1
Q ss_pred HHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 388 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
...++|...+.||+|+||.||+|+..+ .+++|+++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345778899999999999999998753 49999987542 23346788999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
+||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999542 335899999999999999999999985 99999999999998 67999999999886532
Q ss_pred CCC---cccceeeeeccCCC-------------------cchhHHHHHHHHHHHhhhh
Q 007969 546 NQN---QANTNIIAVDTWPQ-------------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~---~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~ 581 (583)
... ........|+..|. ....|.|++|+++|+++.+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 239 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 111 11111122333333 3446778888888887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=224.32 Aligned_cols=181 Identities=18% Similarity=0.300 Sum_probs=148.1
Q ss_pred cCCCCccccccccCceEEEEEEe--cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC------CceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK------NLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~--~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||++.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788899999999999999986 36889999999754 23457788999999988765 49999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-------------
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD------------- 528 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~------------- 528 (583)
.++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999886533 345899999999999999999999985 999999999999987
Q ss_pred ------CCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 529 ------DMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 529 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
++.+||+|||+++....... ...|+.+|.+ ...|.|++|+.+|+++.+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 67899999999987654321 1233443333 346788888888888765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=232.18 Aligned_cols=182 Identities=22% Similarity=0.291 Sum_probs=145.0
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC--------CCCceeEEEEEE---
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKNLVRLLGCCL--- 457 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 457 (583)
.++|...++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47799999999999999999985 46889999999754 334577899999999985 788999999987
Q ss_pred -eCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC------
Q 007969 458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM------ 530 (583)
Q Consensus 458 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~------ 530 (583)
.+...++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 445789999999 55666665442 2345899999999999999999999972 399999999999999775
Q ss_pred -------------------------------------------ceEEEecCCceecCCCCCcccceeeeeccCCCcc---
Q 007969 531 -------------------------------------------NPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM--- 564 (583)
Q Consensus 531 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~--- 564 (583)
.+||+|||+++....... ...|+.+|+++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCcccCChhh
Confidence 799999999987754321 12344444444
Q ss_pred -------hhHHHHHHHHHHHhhhh
Q 007969 565 -------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 565 -------~~~~~~~~~~l~~l~~~ 581 (583)
..|.|++|+++|+|+.+
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg 289 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATG 289 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhC
Confidence 45778888888888764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=224.23 Aligned_cols=185 Identities=22% Similarity=0.284 Sum_probs=140.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHH-HHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999975 68999999997653 333456666666 777889999999999999999999999
Q ss_pred EcCCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 467 EYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 467 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77776642 12245689999999999999999999997 5 999999999999999999999999999877
Q ss_pred CCCCCcccceeeeeccCCC--------------cchhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQ--------------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~l~~~ 581 (583)
....... ...|+..+. ....|.|++|+++|+|+.+
T Consensus 177 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (327)
T 3aln_A 177 VDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred ccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHC
Confidence 5432211 112333322 3346788888888888754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=236.32 Aligned_cols=182 Identities=25% Similarity=0.274 Sum_probs=136.8
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998776668999999998653 235678999999886 89999999999999999999999995
Q ss_pred CCChhHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-------------CceE
Q 007969 471 NKSLDVHLFDATRSV----QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-------------MNPK 533 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~~k 533 (583)
|+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996543211 1133456789999999999999985 9999999999999754 5899
Q ss_pred EEecCCceecCCCCCcc--cceeeeeccCCCcch-----------------hHHHHHHHHHHHhhh
Q 007969 534 ISDFGLARIFGGNQNQA--NTNIIAVDTWPQSMQ-----------------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~--~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~l~~ 580 (583)
|+|||+++......... ......|+.+|+++| .|+|++|+++|+++.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence 99999999876543221 122345666666555 677888888888765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=227.91 Aligned_cols=185 Identities=22% Similarity=0.299 Sum_probs=142.1
Q ss_pred HHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCch------hHHHHHHHHHHHhhC----CCCCceeEEEE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKL----QHKNLVRLLGC 455 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~ 455 (583)
....++|...++||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999986 46889999999755321 223456799999888 89999999999
Q ss_pred EEeCCeEEEEEEc-CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceE
Q 007969 456 CLEGQELLLIYEY-MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK 533 (583)
Q Consensus 456 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 533 (583)
+...+..++|+|| +++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9998999999999 7899999999653 35899999999999999999999985 99999999999999 899999
Q ss_pred EEecCCceecCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 534 ISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 534 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
|+|||+++........ ...++..|.++| .|.|++|+++|+++.+
T Consensus 181 l~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 235 (312)
T 2iwi_A 181 LIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235 (312)
T ss_dssp ECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred EEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC
Confidence 9999999987653321 233555555443 5667777777777654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=223.01 Aligned_cols=180 Identities=22% Similarity=0.272 Sum_probs=131.1
Q ss_pred cCCCCcc-ccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEE
Q 007969 390 TNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL 463 (583)
Q Consensus 390 ~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 463 (583)
.++|... +.||+|+||.||+|+.. +++.||||++.... +........+..++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999976 68999999997542 122222334667799999999999976 44589
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCc
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 540 (583)
+||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996533 346999999999999999999999985 999999999999976 456999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+....... ....++.+|.++| .|.|++|+.+|+++.+
T Consensus 179 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (336)
T 3fhr_A 179 KETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHS
T ss_pred eecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 87654322 1234455555544 4667777777777654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-25 Score=226.18 Aligned_cols=185 Identities=22% Similarity=0.283 Sum_probs=149.4
Q ss_pred HHHcCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCch------hHHHHHHHHHHHhhCC--CCCceeEEEEEE
Q 007969 387 LEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQ--HKNLVRLLGCCL 457 (583)
Q Consensus 387 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~ 457 (583)
....++|...++||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34467799999999999999999985 46899999999754321 2345778999999996 599999999999
Q ss_pred eCCeEEEEEEcCCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEE
Q 007969 458 EGQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKIS 535 (583)
Q Consensus 458 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~ 535 (583)
.++..++|+|++.+ ++|.+++.+. ..+++..++.++.||++||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999998653 35899999999999999999999985 99999999999999 78999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
|||+++........ ...|+..|.++| .|.|++|+.+|+++.+
T Consensus 193 Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 245 (320)
T 3a99_A 193 DFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245 (320)
T ss_dssp CCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred eCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHC
Confidence 99999987543221 223444444443 4667777777777643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=219.38 Aligned_cols=183 Identities=20% Similarity=0.293 Sum_probs=130.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCch-h-HHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-G-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.++|...++||+|+||.||+++.. +|+.||||++...... . .+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356778899999999999999975 6899999999765332 2 233445556788889999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
||+ ++.+..+.... ...+++..+..++.||+.||.|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 45555554322 34589999999999999999999984 5 99999999999999999999999999987654
Q ss_pred CCCcccceeeeeccCCCcc---------------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM---------------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~l~~~ 581 (583)
.... ....++..+.++ ..|.|++|+++|+|+.+
T Consensus 178 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 178 DKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred Cccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 3321 122344444433 35777788888887754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-25 Score=235.86 Aligned_cols=182 Identities=21% Similarity=0.270 Sum_probs=138.0
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
..+|...++||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+++..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3457788999999999976555567999999999754332 357899999999 799999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCceEEEecCCceec
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIF 543 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~~ 543 (583)
++ |+|.+++.... ..+.+.....++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 69999986543 23445566789999999999999985 999999999999943 346889999999987
Q ss_pred CCCCCc-ccceeeeeccCCCcch-------------hHHHHHHHHHHHhhh
Q 007969 544 GGNQNQ-ANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~-~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~ 580 (583)
...... .......|+.+|+++| .|+|++|+++|+++.
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence 543221 1222345566655544 467778888877765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=244.00 Aligned_cols=186 Identities=25% Similarity=0.331 Sum_probs=151.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe------CCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 461 (583)
.++|...++||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999864 6899999998764 34456789999999999999999999999765 667
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---eEEEecC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFG 538 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFG 538 (583)
.++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999977655556899999999999999999999985 999999999999997664 9999999
Q ss_pred CceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
+++......... ...|+.+|. ....|.|++|+.+|+++.+
T Consensus 170 ~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 170 YAKELDQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp CCCBTTSCCCCC---CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred cccccccccccc---cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence 999875443211 122333332 3346788899999998765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=220.51 Aligned_cols=181 Identities=19% Similarity=0.292 Sum_probs=145.8
Q ss_pred cCCCCccccccccCceEEEEEEec-CC-cEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC------ceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||.||+++.. ++ +.||+|+++.. ....+.+.+|+.++++++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467889999999999999999864 34 68999999754 334567889999999997765 9999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---------------
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--------------- 526 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl--------------- 526 (583)
.++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 666766665432 245899999999999999999999985 9999999999999
Q ss_pred ----cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 527 ----DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 527 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
+.++.+||+|||+++....... ...|+..|.++ ..|.|++|+++|+|+.+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 6788999999999987543322 12344444443 46788888888888765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-24 Score=222.79 Aligned_cols=184 Identities=22% Similarity=0.296 Sum_probs=146.8
Q ss_pred HcCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CC-----CceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HK-----NLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~ 461 (583)
..++|...++||+|+||.||+|+.. +++.||||+++.. ....+++..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999865 6889999999754 233567788999888885 55 49999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCceEEEecCC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGL 539 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGl 539 (583)
.++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999986543 24589999999999999999999953 22599999999999994 578899999999
Q ss_pred ceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
++....... ...++.+|.+ ...|.|++|+++|+|+.+
T Consensus 208 a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 208 SCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp CEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 998754321 1233333333 446788888888888764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=224.49 Aligned_cols=181 Identities=18% Similarity=0.282 Sum_probs=146.5
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-----------CCCceeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCL 457 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 457 (583)
.++|...++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788899999999999999986 46899999999753 334567889999999886 899999999998
Q ss_pred eCC----eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEc-----
Q 007969 458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLD----- 527 (583)
Q Consensus 458 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~----- 527 (583)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899999986533 34589999999999999999999997 5 99999999999994
Q ss_pred -CCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 528 -DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 528 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
..+.+||+|||+++....... ...++..|.+ ...|.|++|+++|+|+.+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 231 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhC
Confidence 445899999999987754322 1233444433 346788888888888765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-25 Score=242.47 Aligned_cols=156 Identities=15% Similarity=0.175 Sum_probs=118.6
Q ss_pred ccccCceEEEEEE-ecCCcEEEEEEeccCC----------chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEEE
Q 007969 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----------GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 399 LG~G~fG~Vy~a~-~~~g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 466 (583)
.+.|.+|.+..++ .--|+.+++|++.+.. ....++|.+|+++|+++ +|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666665554 2347889999997541 22356799999999999 7999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||++|++|.++|.+ ..+++.. +|+.||+.||.|||+++ ||||||||+||||++++++||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999954 3346654 58899999999999996 999999999999999999999999999987655
Q ss_pred CCcccceeeeeccCCCcch
Q 007969 547 QNQANTNIIAVDTWPQSMQ 565 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~ 565 (583)
.... ...+|+++|+.+|
T Consensus 393 ~~~~--~t~vGTp~YmAPE 409 (569)
T 4azs_A 393 CSWP--TNLVQSFFVFVNE 409 (569)
T ss_dssp -CCS--HHHHHHHHHHHHH
T ss_pred Cccc--cCceechhhccHH
Confidence 4332 2345666666555
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-23 Score=228.70 Aligned_cols=158 Identities=17% Similarity=0.200 Sum_probs=123.1
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCc--h------hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--Q------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~--~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
...++||+|+||.||++.. .++.+++|+...... . ..+++.+|++++++++||||+++..++..++..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 578889998754321 1 134689999999999999999777777787888999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++++|.+++.+ +..++.||++||.|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4689999999999999985 999999999999999 999999999998866
Q ss_pred CCCcc-----cceeeeeccCCCcchhHH
Q 007969 546 NQNQA-----NTNIIAVDTWPQSMQWEA 568 (583)
Q Consensus 546 ~~~~~-----~~~~~~~~~~~~~~~~~~ 568 (583)
..... ......|+.+|+++|.+.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHH
Confidence 44332 224567888998888654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=216.60 Aligned_cols=181 Identities=17% Similarity=0.136 Sum_probs=130.9
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCC-CCce---------e-----
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQH-KNLV---------R----- 451 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H-~niv---------~----- 451 (583)
..|...++||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466778999999999999994 5799999999984422 336789999999999987 3211 1
Q ss_pred -------EEEEEEe-----CCeEEEEEEcCCCCChhHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 007969 452 -------LLGCCLE-----GQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515 (583)
Q Consensus 452 -------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 515 (583)
+..+... ....+++|+++ +++|.+++.. ......++|..++.|+.||++||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356666654 7899988842 122345889999999999999999999985 99
Q ss_pred eCCCCCCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch--------------------hHHHHHHHHH
Q 007969 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ--------------------WEAYFLLNLM 575 (583)
Q Consensus 516 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l 575 (583)
||||||+||||+.++.+||+|||+++..... .....| ..|+++| .|+|++|+++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999876433 112233 4444443 4677778888
Q ss_pred HHhhhh
Q 007969 576 FSVLEF 581 (583)
Q Consensus 576 ~~l~~~ 581 (583)
|+|+.+
T Consensus 308 ~elltg 313 (413)
T 3dzo_A 308 YWIWCA 313 (413)
T ss_dssp HHHHHS
T ss_pred HHHHHC
Confidence 777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=195.97 Aligned_cols=145 Identities=17% Similarity=0.163 Sum_probs=116.2
Q ss_pred hHHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCc------------------hhHHHHHHHHHHHhhC
Q 007969 383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKL 444 (583)
Q Consensus 383 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l 444 (583)
+.........|...++||+|+||.||+|+..+|+.||+|.++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555666778899999999999999997799999999964321 1345789999999999
Q ss_pred CCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 007969 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524 (583)
Q Consensus 445 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NI 524 (583)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 566665433 45699999999999987 411 123469999999999999986 99999999999
Q ss_pred EEcCCCceEEEecCCceecCC
Q 007969 525 LLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 525 Ll~~~~~~kl~DFGla~~~~~ 545 (583)
|++ ++.+||+|||+++....
T Consensus 225 Ll~-~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp EEE-TTEEEECCCTTCEETTS
T ss_pred EEE-CCcEEEEECCCCeECCC
Confidence 999 99999999999986543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=177.65 Aligned_cols=139 Identities=19% Similarity=0.196 Sum_probs=107.2
Q ss_pred CCCccccccccCceEEEEEEe-cCCcE--EEEEEeccCCch------------------------hHHHHHHHHHHHhhC
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKA--IAVKRLSRTSGQ------------------------GLQEFKNEVNLIAKL 444 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l 444 (583)
.|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356678999999999999997 68888 999987543111 113678999999999
Q ss_pred CCCCc--eeEEEEEEeCCeEEEEEEcCCC-C----ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 007969 445 QHKNL--VRLLGCCLEGQELLLIYEYMPN-K----SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKIIH 516 (583)
Q Consensus 445 ~H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH 516 (583)
+|+++ +.++.. +..++||||+.+ | +|.+.... .++.....++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88754 444432 356899999942 4 66655422 234456789999999999999 775 999
Q ss_pred CCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 517 RDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 517 rDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||||+|||+++ .+||+|||+|.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999987643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-18 Score=146.09 Aligned_cols=94 Identities=20% Similarity=0.323 Sum_probs=76.1
Q ss_pred eEeccCcccccchhhhhHhhhc-----c---CCCCccceecccccccCcceEEEEEeeccCCChhhHHHHHHHHHHHHhh
Q 007969 188 KIFQNTYNVTKSLAQSFNDVIA-----M---PSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQR 259 (583)
Q Consensus 188 ~~~~~~~~~~~~~~~~f~~~~~-----~---~~~~~~~~a~~~~~~~~~~~~y~laQC~~Dls~~~C~~CL~~~~~~~~~ 259 (583)
...||..+.+ .... |+..+. | ++.+..+|+++.....+..+||||+||+|||++++|++||+.++.++++
T Consensus 7 ~~~Cn~~~~t-~~s~-f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~ 84 (108)
T 3a2e_A 7 SSACNTQKIP-SGSP-FNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFS 84 (108)
T ss_dssp EEEECSSBCC-TTCT-HHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHH
T ss_pred eeecCCCccC-CCCh-HHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHH
Confidence 5567766655 2233 544443 2 4445677888766656678999999999999999999999999999999
Q ss_pred hcCCCCCCcceEeccccccccccccc
Q 007969 260 CFDPPGMGFGRILFPSCIMGFELYRY 285 (583)
Q Consensus 260 ~~~~~~~~~g~v~~~~C~lrye~~~f 285 (583)
+|+ ++.||+|+.++|++|||.++|
T Consensus 85 ~C~--~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 85 ICN--NAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HTT--SBSSEEEEETTEEEEEESSCC
T ss_pred HCC--CCceEEEECCCEEEEEeCCcC
Confidence 999 999999999999999999876
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=8.5e-17 Score=167.19 Aligned_cols=146 Identities=14% Similarity=0.134 Sum_probs=104.0
Q ss_pred HHHHHHcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCc--------------hhHHH--------HHHHHHHH
Q 007969 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------------QGLQE--------FKNEVNLI 441 (583)
Q Consensus 384 ~~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~Ei~~l 441 (583)
..+.....-|.+.++||+|+||.||+|...+|+.||||+++.... ..... ..+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444556889999999999999999998999999998753210 00111 23466667
Q ss_pred hhCCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 007969 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (583)
Q Consensus 442 ~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 521 (583)
.++.+.++....-+... ..++||||+++++|..+.. . .....++.||+.+|.|||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 77754443322222222 2379999999988865431 1 123567899999999999986 99999999
Q ss_pred CcEEEcCCC----------ceEEEecCCceec
Q 007969 522 SNILLDDDM----------NPKISDFGLARIF 543 (583)
Q Consensus 522 ~NILl~~~~----------~~kl~DFGla~~~ 543 (583)
.|||+++++ .+.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998876 4899999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=6.2e-12 Score=124.48 Aligned_cols=146 Identities=16% Similarity=0.087 Sum_probs=114.6
Q ss_pred HcCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEE
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 467 (583)
.-..|.....++.|+.+.||+.... +..+++|............+.+|+++++.+. |.++++++++....+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456777778888889999999864 6899999987532222346889999999884 7788999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-------------------------------------- 509 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------- 509 (583)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 1122346788999999999981
Q ss_pred ------------------CCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 510 ------------------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 510 ------------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
.+..++|+|++|.|||++++..+.|+||+.+...
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 1134899999999999988767789999988654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.5e-11 Score=118.33 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=99.8
Q ss_pred cccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC--ceeEEEEEEeCCeEEEEEEcCCCCChhHH
Q 007969 400 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKSLDVH 477 (583)
Q Consensus 400 G~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 477 (583)
+.|..+.||+....+|+.+++|..... ....+.+|+++++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998877888999987654 2246788999999886444 567899888888899999999998874
Q ss_pred HhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 007969 478 LFDATRSVQLDWKRRQSIINGIARGILYLHEDS----------------------------------------------- 510 (583)
Q Consensus 478 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 510 (583)
.. . .+ ...++.++++.|..||...
T Consensus 104 ~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 21 1 11 1256777888888888642
Q ss_pred --------CCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 511 --------RLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 511 --------~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
+..++|+|++|.||+++++..++|+||+.+....
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1129999999999999888777899999987553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.5e-10 Score=114.01 Aligned_cols=143 Identities=14% Similarity=0.244 Sum_probs=107.8
Q ss_pred ccccccccCceEEEEEEecCCcEEEEEEec--cCC-chhHHHHHHHHHHHhhCC--CCCceeEEEEEEeC---CeEEEEE
Q 007969 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTS-GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEG---QELLLIY 466 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 466 (583)
..+.|+.|.+..||+....+ ..+++|+.. ... ......+.+|..+++.+. +.+++++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 578888765 322 122356788999999987 56688999988776 4589999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------------------------------------ 510 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 510 (583)
||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123678888899999999999999731
Q ss_pred -------------------CCCeeeCCCCCCcEEEcCCCc--eEEEecCCceec
Q 007969 511 -------------------RLKIIHRDLKASNILLDDDMN--PKISDFGLARIF 543 (583)
Q Consensus 511 -------------------~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~~ 543 (583)
+..++|+|+++.|||+++++. +.|+||+++...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999987753 699999999854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=2.3e-07 Score=93.64 Aligned_cols=138 Identities=20% Similarity=0.231 Sum_probs=99.9
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCC--ceeEEEEEEeCC---eEEEEEEcC
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN--LVRLLGCCLEGQ---ELLLIYEYM 469 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~ 469 (583)
.+.++.|....||+.. ..+++|..... .....+.+|.++++.+. +.. +++++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999853 46888875432 34567899999998883 333 455555543333 348899999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------- 509 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 509 (583)
+|.+|..... ..++..++..++.++++.|..||..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 1356777778888888888888861
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC--CCceEEEecCCceecC
Q 007969 510 ---------------SRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFG 544 (583)
Q Consensus 510 ---------------~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~ 544 (583)
.++.++|+|++|.||++++ +..+.|+||+.+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1234899999999999998 5678999999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-06 Score=86.97 Aligned_cols=138 Identities=20% Similarity=0.152 Sum_probs=94.2
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCC---CceeEEEEEE-eCCeEEEEEEcCCC
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCL-EGQELLLIYEYMPN 471 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~ 471 (583)
.+.++.|....||+. +..+++|.-. .......+.+|.+++..+.+. .+++++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346778888899987 5667888743 223456789999999999752 4667777764 34567899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------------------------------------------ 509 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 509 (583)
..+...... .++......++.++++.|..||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123344444444444444444432
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC---CCc-eEEEecCCceecC
Q 007969 510 ---------------SRLKIIHRDLKASNILLDD---DMN-PKISDFGLARIFG 544 (583)
Q Consensus 510 ---------------~~~~iiHrDlk~~NILl~~---~~~-~kl~DFGla~~~~ 544 (583)
.+..++|+|+++.||+++. ++. +.|+||+.+....
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2234799999999999987 344 5899999887654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.4e-06 Score=84.28 Aligned_cols=136 Identities=16% Similarity=0.145 Sum_probs=96.9
Q ss_pred ccccCce-EEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEcCCCCChh
Q 007969 399 LGQGGFG-PVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475 (583)
Q Consensus 399 LG~G~fG-~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 475 (583)
+..|..| .||+-... ++..+.+|+-... ...++.+|...++.+. +-.+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3445444 68987754 4567888876433 3457888999998884 455789999999999999999999998876
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 007969 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------------- 509 (583)
Q Consensus 476 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 509 (583)
+..... ......+..+++..|.-||..
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 654221 112234555566666666642
Q ss_pred ---------CCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 510 ---------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 510 ---------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
.++-++|+|+.+.|||+++++.+-|+||+.+....
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 11227999999999999988888899999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.1e-06 Score=88.48 Aligned_cols=79 Identities=8% Similarity=0.010 Sum_probs=55.5
Q ss_pred ccc-cccCceEEEEEEec-------CCcEEEEEEeccCC---chhHHHHHHHHHHHhhCC-C--CCceeEEEEEEeC---
Q 007969 397 NKL-GQGGFGPVYKGTLA-------DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEG--- 459 (583)
Q Consensus 397 ~~L-G~G~fG~Vy~a~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 459 (583)
+.| +.|....+|+.... ++..+++|.-.... ......+.+|..+++.+. + ..+++++++..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999988764 26678888765432 101245778888888874 2 4678888887655
Q ss_pred CeEEEEEEcCCCCChh
Q 007969 460 QELLLIYEYMPNKSLD 475 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~ 475 (583)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.1e-05 Score=77.81 Aligned_cols=142 Identities=17% Similarity=0.241 Sum_probs=82.4
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC--CCCceeEEE------EEEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLG------CCLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g------~~~~~~~~~lV~e~ 468 (583)
+.|+.|..+.||+....+| .+++|+.... . .++..|..++..+. .-.+++++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 4889988752 1 33344555555442 123444443 12346778999999
Q ss_pred CCCCChh--------------HHHhccCC----C-------CCCCHHHHH------------------------------
Q 007969 469 MPNKSLD--------------VHLFDATR----S-------VQLDWKRRQ------------------------------ 493 (583)
Q Consensus 469 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~------------------------------ 493 (583)
++|..+. ..+|.... . ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221111 0 012343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 494 -SIINGIARGILYLHE----------DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 494 -~i~~~ia~gL~yLH~----------~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
.+...+..++.+|++ ..+..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 111223445667763 12346999999999999988889999999988643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=4.1e-05 Score=80.07 Aligned_cols=75 Identities=11% Similarity=0.161 Sum_probs=50.5
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccCCc-------hhHHHHHHHHHHHhhCCC--C-CceeEEEEEEeCCeEEE
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQH--K-NLVRLLGCCLEGQELLL 464 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~-niv~l~g~~~~~~~~~l 464 (583)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 468899998653211 123567788888887742 3 34566654 4455689
Q ss_pred EEEcCCCC
Q 007969 465 IYEYMPNK 472 (583)
Q Consensus 465 V~e~~~~g 472 (583)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=7.4e-05 Score=74.45 Aligned_cols=80 Identities=19% Similarity=0.215 Sum_probs=59.5
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-C--CCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV~e 467 (583)
......+.+|.|..+.||+.++.+|+.+.+|+-..........|..|.+.|+.+. . ..+++++++ . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 3444567889999999999999999999999876554444457889999988884 2 245566654 2 2378999
Q ss_pred cCCCCCh
Q 007969 468 YMPNKSL 474 (583)
Q Consensus 468 ~~~~gsL 474 (583)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00022 Score=72.01 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=94.3
Q ss_pred ccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC---CCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
..+.|+.|....+|+... ++..+++|+-... ....+..|.+.++.+. ...+++++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999886 4678888876543 3567889999888884 36788999998888899999999998
Q ss_pred CChhH-----------HHhccCC--C-----------------CCCCHHHHH---HHHH----------------HHHHH
Q 007969 472 KSLDV-----------HLFDATR--S-----------------VQLDWKRRQ---SIIN----------------GIARG 502 (583)
Q Consensus 472 gsL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~ia~g 502 (583)
..+.. .||.... . -.-+|.... ++.. .+..-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 2232211 0 012465432 1111 11111
Q ss_pred -HHHHHh-CCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 503 -ILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 503 -L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2345799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00029 Score=74.21 Aligned_cols=73 Identities=12% Similarity=0.141 Sum_probs=46.0
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccC----C---c--hhHHHHHHHHHHHh-hCCCCCceeEEEEEEeCCeEEEE
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT----S---G--QGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~----~---~--~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 465 (583)
.+.||.|....||+... +++.++||..... . . .....+..|+..+. ...+..+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 4678999943211 0 1 12233444443332 22335677777765 5667999
Q ss_pred EEcC-CC
Q 007969 466 YEYM-PN 471 (583)
Q Consensus 466 ~e~~-~~ 471 (583)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0022 Score=64.53 Aligned_cols=143 Identities=15% Similarity=0.108 Sum_probs=81.2
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC--CCceeEEEE------EEeCCeEEEEEEc
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGC------CLEGQELLLIYEY 468 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~------~~~~~~~~lV~e~ 468 (583)
+.|+.|....+|+....+| .+++|...... ..+++..|+.++..+.. -.+++++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4566788889999887666 57888876521 12345567777766632 123444421 1234667999999
Q ss_pred CCCCChhH--------------HHhccCCC------CC---CCHHHHHH------------HHHHHHHHHHHHHhC----
Q 007969 469 MPNKSLDV--------------HLFDATRS------VQ---LDWKRRQS------------IINGIARGILYLHED---- 509 (583)
Q Consensus 469 ~~~gsL~~--------------~l~~~~~~------~~---l~~~~~~~------------i~~~ia~gL~yLH~~---- 509 (583)
++|..+.. .+|..... .. ..|...+. +...+...+.++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 12211110 00 12332111 011244455555532
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 510 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 233599999999999999876678999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0028 Score=64.13 Aligned_cols=143 Identities=16% Similarity=0.141 Sum_probs=73.7
Q ss_pred ccccccCceE-EEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC--CCCceeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 397 NKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 397 ~~LG~G~fG~-Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
+.|+.|.... +|+....++..+++|....... .++..|+.++..+. .-.+++++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455454333 6676654467777776543221 23345566666553 234667777644333 78999997766
Q ss_pred hhHHHhc---------------------cCCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 007969 474 LDVHLFD---------------------ATRS--VQLDWKRRQ-------S-------------IINGIARGILYLH--- 507 (583)
Q Consensus 474 L~~~l~~---------------------~~~~--~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 507 (583)
+.+.+.. .... ..++..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6433321 1000 111111100 0 0011112222221
Q ss_pred hCCCCCeeeCCCCCCcEEEcCC----CceEEEecCCceecC
Q 007969 508 EDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIFG 544 (583)
Q Consensus 508 ~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~~~ 544 (583)
...+..++|+|+.+.||+++.+ ..+.|+||+.+....
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1123469999999999999875 689999999988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0051 Score=61.97 Aligned_cols=143 Identities=15% Similarity=0.146 Sum_probs=83.1
Q ss_pred ccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC--CCceeEEEE-----EEeCCeEEEEEEcC
Q 007969 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGC-----CLEGQELLLIYEYM 469 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~e~~ 469 (583)
..|+ |....||+....+|+.+++|...... .....+..|..++..+.. -.+++++.. ....+..++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77789999887778789999986331 123566778887777642 234555543 22355678999999
Q ss_pred CCCChh-----H---------HHhccC------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 007969 470 PNKSLD-----V---------HLFDAT------RSVQLDWKRR----QSI---------------INGIARGILYLHE-- 508 (583)
Q Consensus 470 ~~gsL~-----~---------~l~~~~------~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~-- 508 (583)
+|..+. . .+|... .....++... ..+ ...+...+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885432 0 011110 0111222211 001 0111122333322
Q ss_pred --CCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 509 --DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 509 --~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
..+..++|+|+++.|||++ + .+.|+||+.+...
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1234589999999999999 4 8999999887754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.001 Score=70.21 Aligned_cols=72 Identities=14% Similarity=0.220 Sum_probs=48.9
Q ss_pred ccccccCceEEEEEEecC--------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCCeEEEEEE
Q 007969 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e 467 (583)
+.|+.|-...+|+....+ ++.+++|+..... ..+.+.+|..+++.+...+ .+++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467778889999998753 4788898874321 1245668998888885333 3677776532 28999
Q ss_pred cCCCCCh
Q 007969 468 YMPNKSL 474 (583)
Q Consensus 468 ~~~~gsL 474 (583)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0025 Score=63.67 Aligned_cols=139 Identities=12% Similarity=0.140 Sum_probs=75.1
Q ss_pred cccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcC-CCCC
Q 007969 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM-PNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gs 473 (583)
.+.|+.|....+|+. ..+++|+-....... .+..+|..+++.+....+ +++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 457888765432211 123567777776642222 466654 343457899999 6644
Q ss_pred hhH------------------HHhccCCC--CCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCC
Q 007969 474 LDV------------------HLFDATRS--VQLD-WKRRQSIIN--------------GIARGI----LYLHE-DSRLK 513 (583)
Q Consensus 474 L~~------------------~l~~~~~~--~~l~-~~~~~~i~~--------------~ia~gL----~yLH~-~~~~~ 513 (583)
+.. -+|..... ...+ +.....+.. .+...+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 01111100 0011 111111100 011111 11211 22345
Q ss_pred eeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 514 IIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 514 iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56677899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0042 Score=64.29 Aligned_cols=142 Identities=17% Similarity=0.238 Sum_probs=82.4
Q ss_pred ccccccCceEEEEEEec--------CCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEE
Q 007969 397 NKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~--------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|..|-...+|+.... +++.+++|+--.. ........+|.++++.+. +.-.+++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777888988864 2468888875332 223456678999988874 3223667766543 28999
Q ss_pred cCCCCChhHH-----------------HhccCC--CCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 007969 468 YMPNKSLDVH-----------------LFDATR--SVQLD--WKRRQSIINGIAR-------------------GILY-- 505 (583)
Q Consensus 468 ~~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------gL~y-- 505 (583)
|++|..|..- ||.... ..... |....++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655310 111110 11122 3444444433321 2233
Q ss_pred --HHhC-CCCCeeeCCCCCCcEEEcCC----CceEEEecCCceec
Q 007969 506 --LHED-SRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF 543 (583)
Q Consensus 506 --LH~~-~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~~ 543 (583)
|... .+..++|+|+.+.|||++++ +.+.|+||..+...
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 3221 23458999999999999876 78999999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.007 Score=64.28 Aligned_cols=74 Identities=14% Similarity=0.074 Sum_probs=47.3
Q ss_pred cccccccCceEEEEEEecC-CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc-eeEEEEEEeCCeEEEEEEcCCCCC
Q 007969 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKS 473 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 473 (583)
.+.|+.|-...+|+....+ +..+++|+......... +-.+|..++..+...++ +++++.+. + .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567778889999998765 47788887644322111 12578888888864444 57777662 2 25999998754
Q ss_pred h
Q 007969 474 L 474 (583)
Q Consensus 474 L 474 (583)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.014 Score=59.26 Aligned_cols=32 Identities=22% Similarity=0.371 Sum_probs=28.5
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0083 Score=61.65 Aligned_cols=73 Identities=12% Similarity=0.148 Sum_probs=43.4
Q ss_pred ccccccCceEEEEEEecC---------CcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCC-ceeEEEEEEeCCeEEEEE
Q 007969 397 NKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 466 (583)
+.|+.|-.-.+|+....+ +..+++|+....... ..+...|.+++..+...+ .+++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 456777778899988654 267888876543221 122367787777774333 45676554 2 26899
Q ss_pred EcCCCCCh
Q 007969 467 EYMPNKSL 474 (583)
Q Consensus 467 e~~~~gsL 474 (583)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.48 E-value=0.33 Score=50.77 Aligned_cols=73 Identities=12% Similarity=0.179 Sum_probs=46.6
Q ss_pred ccccccCceEEEEEEecC--------CcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEE
Q 007969 397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|..|-.-.+|+....+ ++.+++|+-...... .-+-.+|..+++.+. +.-.+++++.+ .+ ++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 456667788899988753 578888886443222 112357888877774 22245666533 22 68999
Q ss_pred cCCCCCh
Q 007969 468 YMPNKSL 474 (583)
Q Consensus 468 ~~~~gsL 474 (583)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.93 E-value=0.16 Score=34.55 Aligned_cols=7 Identities=57% Similarity=0.776 Sum_probs=2.6
Q ss_pred hhhhhcc
Q 007969 327 FLWYRRR 333 (583)
Q Consensus 327 ~~~~~rr 333 (583)
+++.|||
T Consensus 32 ~~~~RRr 38 (44)
T 2ks1_B 32 GLFMRRR 38 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.58 E-value=2.7 Score=39.39 Aligned_cols=86 Identities=6% Similarity=0.009 Sum_probs=62.2
Q ss_pred CCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCc
Q 007969 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-YLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 445 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiHrDlk~~N 523 (583)
.||++ -..+-.+++...+.++.-+++.=...+ ..++...+++++..|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 344446677777777766444333333 13678899999998877766 5553 5888999999
Q ss_pred EEEcCCCceEEEecCCceec
Q 007969 524 ILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~ 543 (583)
+++|.++.|+|.-.|+-..+
T Consensus 115 L~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp EEECTTCCEEESCCEETTTB
T ss_pred EEEeCCCcEEEEEcCCcccC
Confidence 99999999999988875544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.57 E-value=0.17 Score=53.63 Aligned_cols=61 Identities=8% Similarity=0.082 Sum_probs=18.7
Q ss_pred ccccccccCceEEEEEEecC-CcEEEE------EEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe
Q 007969 395 DENKLGQGGFGPVYKGTLAD-GKAIAV------KRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458 (583)
Q Consensus 395 ~~~~LG~G~fG~Vy~a~~~~-g~~vav------K~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 458 (583)
..++|| ||.||+|.+.. ..+||| |..+.. +.+....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999864 367888 766543 22334578899999999999999999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.49 E-value=2.3 Score=39.71 Aligned_cols=88 Identities=9% Similarity=0.024 Sum_probs=63.1
Q ss_pred CCCCCceeEEEEEEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 007969 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523 (583)
Q Consensus 444 l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~N 523 (583)
..||+++.. .+-.+.+...+.++.-+.+.=...+ ..++...+++++..|+..-.+++. -+|--|.|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 367888866 4556666666666654432212122 236789999999999888866654 4889999999
Q ss_pred EEEcCCCceEEEecCCceec
Q 007969 524 ILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 524 ILl~~~~~~kl~DFGla~~~ 543 (583)
++++.++.|+|.--|+-..+
T Consensus 110 L~f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp EEECTTSCEEESCCEETTTB
T ss_pred EEEcCCCCEEEEEccCccCC
Confidence 99999999999888765444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.35 E-value=0.23 Score=33.72 Aligned_cols=7 Identities=29% Similarity=0.695 Sum_probs=2.6
Q ss_pred hhhhhcc
Q 007969 327 FLWYRRR 333 (583)
Q Consensus 327 ~~~~~rr 333 (583)
+++.|||
T Consensus 31 ~~~~RRR 37 (44)
T 2l2t_A 31 AVYVRRK 37 (44)
T ss_dssp HHHHHTT
T ss_pred HHHhhhh
Confidence 3333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 583 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-48
Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 6/166 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ ++G G FG VYKG A+ + ++ + Q LQ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+G Q L ++ ++ SL HL + + + I A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IIHRDLK++NI L +D+ KI DFGLA + ++
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 6/166 (3%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ + +LG G FG VYK A K + S + L+++ E++++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+LL L ++ E+ ++D + + R L + Q + + YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
KIIHRDLKA NIL D + K++DFG++ + ++ I
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-46
Identities = 57/170 (33%), Positives = 82/170 (48%), Gaps = 6/170 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+LG G FG V+ G +AVK L + S F E NL+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
RL + + +I EYM N SL L ++L + + IA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
IHRDL+A+NIL+ D ++ KI+DFGLAR+ N+ A W
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 4e-46
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
FSD ++G G FG VY + + + +A+K++S + Q Q+ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H N ++ GC L L+ EY + D+ L ++ +G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
LH +IHRD+KA NILL + K+ DFG A I + T
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-46
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 7/161 (4%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQH 446
+ F ++LG G G V+K + G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+V G E+ + E+M SLD L A R + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
+ KI+HRD+K SNIL++ K+ DFG++ +
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 3e-44
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 8/182 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+ ++KLG G +G VY+G +AVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V+LLG C +I E+M +L +L + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWE 567
+ IHRDL A N L+ ++ K++DFGL+R+ G+ A+ W P+S+ +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 568 AY 569
+
Sbjct: 192 KF 193
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-43
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 8/181 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ + ++G G FG V+ G + +A+K + R ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G CLE + L++E+M + L +L + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEA 568
+IHRDL A N L+ ++ K+SDFG+ R +Q ++T W P+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 569 Y 569
Y
Sbjct: 179 Y 179
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-43
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 6/165 (3%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+ +LG G FG V G +A+K + S EF E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L G C + + + +I EYM N L +L + + ++ + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
+ +HRDL A N L++D K+SDFGL+R ++ ++
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 8e-43
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQG-LQEFKNEVN 439
+L L+ N + +LG G FG V +G +A+K L + + + +E E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
++ +L + +VRL+G C + + L+L+ E L L + ++ +++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT 559
+ G+ YL +HRDL A N+LL + KISDFGL++ G + +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-42
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 12/185 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNL 449
+ +G G +G K +DGK + K L S Q +EVNL+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYL 506
VR ++ L ++ EY L + T+ Q LD + ++ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 507 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSM 564
H D ++HRDLK +N+ LD N K+ DFGLARI + + A P M
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA----FVGTPYYM 181
Query: 565 QWEAY 569
E
Sbjct: 182 SPEQM 186
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 1e-42
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 388 EATNHFSDE---------NKLGQGGFGPVYKGTLA----DGKAIAVKRL-SRTSGQGLQE 433
EA F+ E +G G FG V G L +A+K L S + + ++
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
F +E +++ + H N++ L G + +++I E+M N SLD L Q +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLV 131
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
++ GIA G+ YL + +HRDL A NIL++ ++ K+SDFGL+R + +
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 8/181 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
E KLGQG FG V+ GT +A+K L + + F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
+L + + ++ EYM SL L T + + IA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEA 568
R+ +HRDL+A+NIL+ +++ K++DFGLAR+ N+ A W P++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 569 Y 569
+
Sbjct: 191 F 191
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 41/184 (22%), Positives = 76/184 (41%), Gaps = 15/184 (8%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
+ +G+G FG V++G G+ +AVK S + + E+ L+H+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 456 CLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-- 509
+ +L L+ +Y + SL +L + + + A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 510 ---SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQW 566
+ I HRDLK+ NIL+ + I+D GLA + + + M
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 567 EAYF 570
E
Sbjct: 182 EVLD 185
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-41
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 10/189 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
+G+G FG V G G +AVK + + Q F E +++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+LLG +E + L ++ EYM SL +L RSV L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEAY 569
+HRDL A N+L+ +D K+SDFGL + Q+ + P++++ + +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA--PEALREKKF 177
Query: 570 FLLNLMFSV 578
+ ++S
Sbjct: 178 STKSDVWSF 186
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-41
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 395 DENKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNL 449
++ +LG G FG V KG K +AVK L + E E N++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
VR++G C E + +L+ E L+ +L + K +++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT 559
+HRDL A N+LL KISDFGL++ ++N
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 12/163 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
+ ++G+G F VYKG + +A L + + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 453 LGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ ++L+ E M + +L +L R + K +S I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 509 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQA 550
+ IIHRDLK NI + + KI D GLA + + +A
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 172
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
++ K+GQG G VY +A G+ +A+++++ + NE+ ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V L L G EL ++ EY+ SL + + D + ++ + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
++IHRD+K+ NILL D + K++DFG Q++ +T +
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 54/199 (27%), Positives = 76/199 (38%), Gaps = 26/199 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
N S LG G FG V + T +AVK L ++ + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---------------ATRSVQL 487
L H N+V LLG C G L+I EY L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
D + S +A+G+ +L IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 548 NQANTNIIAVDTWPQSMQW 566
N + + +
Sbjct: 200 NYVVKGNARLPVKWMAPES 218
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 1e-39
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 31/204 (15%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAK 443
N+ +G+G FG V++ +AVK L + +Q +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-------------------- 483
+ N+V+LLG C G+ + L++EYM L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 484 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L + I +A G+ YL E K +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 543 FGGNQNQANTNIIAVDTWPQSMQW 566
A+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPES 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 8/165 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKN 448
+ LG+G +G V +A+AVK + E K E+ + L H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+ G EG L EY L + + + Q + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
+ I HRD+K N+LLD+ N KISDFGLA +F N + N
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (365), Expect = 3e-39
Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 8/182 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+H+ +LG G FG V++ T A G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
V L + E+++IYE+M L + D ++ + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWE 567
+H DLK NI+ + K+ DFGL Q+ T A P+ + +
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 568 AY 569
Sbjct: 201 PV 202
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 13/184 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
HF +G+G FG VY GTL D AVK L+R + G + +F E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 447 KNLVRLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
N++ LLG CL + L++ YM + L + + T + + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ 565
+ + K +HRDL A N +LD+ K++DFGLAR + + N + M
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 566 WEAY 569
E+
Sbjct: 203 LESL 206
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 46/187 (24%), Positives = 70/187 (37%), Gaps = 31/187 (16%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
+ LG G FG V T +AVK L + + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--------------------AT 482
L H+N+V LLG C + LI+EY L +L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 483 RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
L ++ +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 543 FGGNQNQ 549
+ N
Sbjct: 214 IMSDSNY 220
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-38
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 10/161 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH 446
F LG+G FG VY +A+K L + + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
N++RL G + + LI EY P ++ L ++ D +R + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
H ++IHRD+K N+LL KI+DFG + ++
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
+ + + +G G FG VYKG L +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
H N++RL G + + +++I EYM N +LD L + + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT 559
YL + +HRDL A NIL++ ++ K+SDFGL+R+ + T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 38/173 (21%), Positives = 77/173 (44%), Gaps = 5/173 (2%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
+ +++ + +G+G +G V + +A+K++S Q Q E+ ++ +
Sbjct: 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63
Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
+H+N++ + + Y+ + L+ ++ L + I RG+
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAV 557
Y+H ++HRDLK SN+LL+ + KI DFGLAR+ + + V
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 21/177 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-Q 445
N ++ +G+G FG V K + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
H N++ LLG C L L EY P+ +L L + + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+ARG+ YL + + IHRDL A NIL+ ++ KI+DFGL+R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (354), Expect = 1e-37
Identities = 50/186 (26%), Positives = 77/186 (41%), Gaps = 13/186 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ- 445
N FS +G+GGFG VY AD GK A+K L + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 446 --HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+V + +L I + M L HL + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS 563
++H +++RDLK +NILLD+ + +ISD GLA F + A+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 177
Query: 564 MQWEAY 569
+ AY
Sbjct: 178 QKGVAY 183
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (353), Expect = 2e-37
Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 8/191 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
+++ +LG G FG V++ A G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ L + E++LI E++ L + A ++ + + G+ ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWE 567
I+H D+K NI+ + KI DFGLA ++ T A P+ + E
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 568 AYFLLNLMFSV 578
M+++
Sbjct: 204 PVGFYTDMWAI 214
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 50/171 (29%), Positives = 69/171 (40%), Gaps = 13/171 (7%)
Query: 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
KLG G FG V +G ++AVK L + + + +F EVN + L H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+RL G L + ++ E P SL L +A G+ YL
Sbjct: 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
+ IHRDL A N+LL KI DFGL R N + +
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-37
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 12/182 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
F LG+G F V LA + A+K L + + E +++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
V+L + ++L Y N L ++ D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWE 567
IIHRDLK NILL++DM+ +I+DFG A++ QA N + Q + E
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYVSPE 180
Query: 568 AY 569
Sbjct: 181 LL 182
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 12/180 (6%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG VYKG + +G+ +A+K L TS + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ RLLG CL + LI + MP L ++ + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQW 566
+++HRDL A N+L+ + KI+DFGLA++ G + + + V +++
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 39/176 (22%), Positives = 69/176 (39%), Gaps = 11/176 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQ 445
+G+G FG V++G A+A+K + ++E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H ++V+L+G E + +I E L L S LD ++ + Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP 561
L + +HRD+ A N+L+ + K+ DFGL+R + + W
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-36
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAK 443
+ +LGQG FG VY+G +A+K ++ S + EF NE +++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSII 496
++VRLLG +GQ L+I E M L +L + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
IA G+ YL+ + K +HRDL A N ++ +D KI DFG+ R
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 557 VDTW---PQSMQWEAYFLLNLMFS 577
+ P+S++ + + ++S
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWS 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 37/175 (21%), Positives = 75/175 (42%), Gaps = 9/175 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
LG+G FG V++ + K K + + G K E++++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
+EL++I+E++ + + T + +L+ + S ++ + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 517 RDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEAY 569
D++ NI+ + KI +FG AR N P+ Q +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
++D +G G FG VY+ L D G+ +A+K++ + + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 452 LLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
L E L L+ +Y+P V + L + + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 506 LHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANT 552
+H I HRD+K N+LLD D K+ DFG A+ + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 7e-34
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 19/193 (9%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QEFKNEVNLI 441
++ + LG+G V + K AVK + T G + EV+++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 442 AKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
K+ H N+++L L+++ M L +L T V L K + I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
I LH+ L I+HRDLK NILLDDDMN K++DFG + + + + ++
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175
Query: 561 PQSMQWEAYFLLN 573
E N
Sbjct: 176 LAPEIIECSMNDN 188
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-33
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 25/198 (12%)
Query: 391 NHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
+ LG+G FG V + A + +AVK L + + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 444 -LQHKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLF-------------DATRSVQLD 488
H N+V LLG C + G L++I E+ +L +L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +A+G+ +L K IHRDL A NILL + KI DFGLAR + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 549 QANTNIIAVDTWPQSMQW 566
+ + +
Sbjct: 190 YVRKGDARLPLKWMAPET 207
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (319), Expect = 3e-33
Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 17/184 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
F LG G FG V+ +G+ A+K L + + ++ +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++R+ G + Q++ +I +Y+ L L + R K + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQW 566
II+RDLK NILLD + + KI+DFG A+ + P +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGTPDYIAP 170
Query: 567 EAYF 570
E
Sbjct: 171 EVVS 174
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (316), Expect = 4e-33
Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+ K+G+G +G VYK G+ A+K RL + E++++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+L + L+L++E++ + L+ +S + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEA 568
+++HRDLK N+L++ + KI+DFGLAR FG + I+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDV 171
Query: 569 YF 570
Sbjct: 172 LM 173
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 26/199 (13%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLI 441
+ LG+G FG V +AVK L + + L + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 442 AKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQL 487
+ +HKN++ LLG C + L +I EY +L +L QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
K S +ARG+ YL K IHRDL A N+L+ +D KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 548 NQANTNIIAVDTWPQSMQW 566
T + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEA 208
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
+F K+G+G +G VYK G+ +A+K RL + E++L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+V+LL +L L++E++ DA+ + +S + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQWEA 568
+++HRDLK N+L++ + K++DFGLAR FG + E
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV----VTLWYRAPEI 173
Query: 569 YF 570
Sbjct: 174 LL 175
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 3e-31
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 11/163 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHK 447
+ + + LG G F V K +A+K +++ + +G + +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+V L G L LI + + L + + + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQ 547
+ I+HRDLK N+L D+D ISDFGL+++
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-31
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-----FKNEVNLIAKLQHKNLV 450
+ LG+G F VYK + +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
LL + L++++M + S+ L ++ + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTW--PQSMQWEA 568
I+HRDLK +N+LLD++ K++DFGLA+ FG ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 569 Y 569
Y
Sbjct: 178 Y 178
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 43/188 (22%), Positives = 82/188 (43%), Gaps = 17/188 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHK 447
+ + K+GQG FG V+K G+ +A+K++ + + E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
N+V L+ C + L++++ + + V+ + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDT 559
G L+ R KI+HRD+KA+N+L+ D K++DFGLAR F +N
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 560 WPQSMQWE 567
E
Sbjct: 184 TLWYRPPE 191
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (297), Expect = 2e-30
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
++ + LG GG V+ L + +AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 446 HKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
H +V + G ++ EY+ +L + + KR +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP 561
+ + H+ IIHRD+K +NI++ K+ DFG+AR + N + T
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT-A 178
Query: 562 QSMQWE 567
Q + E
Sbjct: 179 QYLSPE 184
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 11/169 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK-LQ 445
F LG+G FG V+ + A+K L + ++ E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
H L + + L + EY+ L H+ + D R I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
LH I++RDLK NILLD D + KI+DFG+ + + NT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC 164
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 44/191 (23%), Positives = 84/191 (43%), Gaps = 13/191 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKL 444
A + ++G+G +G V+K G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 445 ---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIING 498
+H N+VRL C + + + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVD 558
+ RG+ +LH +++HRDLK NIL+ K++DFGLARI+ + +
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 559 TWPQSMQWEAY 569
P+ + +Y
Sbjct: 182 RAPEVLLQSSY 192
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 40/165 (24%), Positives = 63/165 (38%), Gaps = 10/165 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
N F LG+G FG V A G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
L L L + EY L HL +R +R + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
+++RD+K N++LD D + KI+DFGL + +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
E + D +G G +G V G +A+K+L R S + E+ L+ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 445 QHKNLVRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
+H+N++ LL + + L+ +M + + +L R Q ++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
+ +G+ Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 7e-28
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 17/181 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
+ F LG G FG V G A+K L + + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
LV+L + L ++ EY+ + HL R + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQW 566
H L +I+RDLK N+L+D +++DFG A+ G + P+++
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEALAP 207
Query: 567 E 567
E
Sbjct: 208 E 208
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 7e-28
Identities = 39/167 (23%), Positives = 64/167 (38%), Gaps = 15/167 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE------FKNEVNLIAK 443
+ + LG GGFG VY G ++D +A+K + + E EV L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 444 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
+ ++RLL +LI E T L + +S +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
+ + H ++HRD+K NIL+D + K+ DFG +
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-27
Identities = 39/174 (22%), Positives = 76/174 (43%), Gaps = 9/174 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
+ K+G+G +G V+K + +A+K RL E+ L+ +L+HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
N+VRL ++L L++E+ + + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWP 561
++HRDLK N+L++ + K+++FGLAR FG + ++ + P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 5e-27
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAK 443
+++ +LG G F V K + G A K + + G ++ + EV+++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+QH N++ L +++LI E + L L + L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQ 547
++ L+I H DLK NI+L D P KI DFGLA
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 6e-27
Identities = 38/183 (20%), Positives = 71/183 (38%), Gaps = 13/183 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
N + K+G G FG +Y GT +A G+ +A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 450 VRLLG-CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + C EG +++ E + D+ F + + K + + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 509 DSRLKIIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ 565
IHRD+K N L I DFGLA+ + + + + +
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 566 WEA 568
+ +
Sbjct: 179 YAS 181
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 108 bits (271), Expect = 7e-27
Identities = 29/185 (15%), Positives = 70/185 (37%), Gaps = 15/185 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
H+ ++G+G FG +++GT L + + +A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
+ + EG +L+ + + D+ + K + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 509 DSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFGGNQNQANTNIIAVDTWPQS 563
+++RD+K N L+ + + DFG+ + + + + +
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 564 MQWEA 568
++ +
Sbjct: 177 ARYMS 181
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 40/183 (21%), Positives = 67/183 (36%), Gaps = 18/183 (9%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLL 453
LG G G V + + A+K L + + EV L + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 454 GCC----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
+ LL++ E + L + D + I+ I I YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 510 SRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAVDTWPQSMQW 566
+ I HRD+K N+L K++DFG A+ + + P+ +
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 567 EAY 569
E Y
Sbjct: 188 EKY 190
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIA 442
+F LG G +G V+ GK A+K L + + + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 443 KLQHK-NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
++ LV L +L LI +Y+ L HL R + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
+L L +L II+RD+K NILLD + + ++DFGL++ F ++ +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (259), Expect = 4e-25
Identities = 32/162 (19%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN 448
+ + KLG+G + V++ + + + + VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
++ L + + L++E++ N L + + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 507 HEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ 547
H + I+HRD+K N+++D + ++ D+GLA + Q
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-24
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 447
+ + +G G G V + +A+K+LSR + + E+ L+ + HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 448 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
N++ LL E Q++ L+ E M V +LD +R ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
GI +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 2e-23
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
E + + + +G G +G V G +AVK+LSR S + E+ L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRLLGCCLEGQELLLI-YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
+H+N++ LL + L Y+ + L + + +L Q +I I RG+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 6e-23
Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQ--------GLQEFKNEVNLIAKLQH 446
+G+G V+ VK ++ TS + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
+ L +L G + Y + N ++ + L DA ++ + +++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
+ I+H DL N+L+ + I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 29/184 (15%), Positives = 61/184 (33%), Gaps = 20/184 (10%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
KLG G F V+ + + +A+K + + ++E+ L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 455 CCLEGQELLLIYEYMPNKSLDV-------------HLFDATRSVQLDWKRRQSIINGIAR 501
LL + + L + + I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAVDTW 560
G+ Y+H R IIH D+K N+L++ D + +A + GN + +
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADL--GNACWYDEHYTNSIQT 192
Query: 561 PQSM 564
+
Sbjct: 193 REYR 196
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.98 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.98 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.98 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.98 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.16 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-36 Score=296.30 Aligned_cols=169 Identities=28% Similarity=0.386 Sum_probs=144.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|+..++||+|+||+||+|+.+ +|+.||||++.... .+..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999964 68999999997553 23356789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++. ....+++..+..++.||++||.|||+++ |+||||||+|||+++++++||+|||+|+....+..
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3446999999999999999999999985 99999999999999999999999999998865544
Q ss_pred cccceeeeeccCCCcch
Q 007969 549 QANTNIIAVDTWPQSMQ 565 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~~ 565 (583)
.......+||+.|++||
T Consensus 159 ~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp ECCBCCCCSCGGGSCTH
T ss_pred cccccceeeCcCccCHh
Confidence 44444567777777766
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-35 Score=292.29 Aligned_cols=184 Identities=30% Similarity=0.478 Sum_probs=148.1
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|...++||+|+||+||+|+++ ..||||+++.. +....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999874 36999999754 44557889999999999999999999998754 56899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|.+++... ...++|..++.|+.||++||.|||+++ |+||||||+||||+.++++||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999643 245899999999999999999999985 9999999999999999999999999999876544
Q ss_pred CcccceeeeeccCCCcch-------------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~ 581 (583)
.........|+..|++|| .|+|++|+.+|+|+.+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg 205 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHC
Confidence 443444456666555544 4788888888888754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=290.04 Aligned_cols=182 Identities=24% Similarity=0.393 Sum_probs=155.9
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|...++||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688999999999999999985 469999999998765556788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+..+...
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988754 24899999999999999999999985 999999999999999999999999999987654432
Q ss_pred ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. ....|++.|++|| .|.|++|+.+|+|+.|
T Consensus 173 ~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG 212 (293)
T d1yhwa1 173 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (293)
T ss_dssp B--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred c--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhC
Confidence 2 2234555544444 5777788888888764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=290.63 Aligned_cols=183 Identities=26% Similarity=0.415 Sum_probs=147.1
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999889999999997643 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|.+++... ...++|..++.|+.||++||.|||+.+ |+||||||+|||+|+++++||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999998643 345899999999999999999999985 9999999999999999999999999999876544332
Q ss_pred cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
. ....|+..|++|| .|+|++|+.+|+++.
T Consensus 159 ~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 159 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred e-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHH
Confidence 2 2345565555554 588888999888864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=292.93 Aligned_cols=184 Identities=24% Similarity=0.391 Sum_probs=156.4
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
+.|+..++||+|+||.||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46788899999999999999964 68999999998777777789999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.+.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++++||+|||+|+........
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999876532 35899999999999999999999986 999999999999999999999999999876432211
Q ss_pred ccceeeeeccCCCcch---------------hHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQ---------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~ 581 (583)
.....|++.|++|| .|.|++|+.+|+|+.+
T Consensus 167 --~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg 211 (288)
T d2jfla1 167 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211 (288)
T ss_dssp --HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS
T ss_pred --ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC
Confidence 12245565555555 4677788888887754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=289.50 Aligned_cols=183 Identities=31% Similarity=0.469 Sum_probs=153.1
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||.||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4677789999999999999999888999999997653 345789999999999999999999998754 56799999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|.+++.... ...++|..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+....+....
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999998875432 235899999999999999999999985 9999999999999999999999999999886544332
Q ss_pred cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.+ ...|+..|++|| .|+|++|+++|+|+.
T Consensus 167 ~~-~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 167 RE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp CT-TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cc-ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHh
Confidence 22 245555555555 578888888888875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-35 Score=292.01 Aligned_cols=185 Identities=26% Similarity=0.426 Sum_probs=155.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
.++|...++||+|+||+||+|+.. +++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 346778899999999999999975 58899999997553 3467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+++|+|.+++.+.. ...++|..++.|+.||++||.|||+++ |+||||||+||||++++++||+|||+|+....+..
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999986533 456899999999999999999999985 99999999999999999999999999998766544
Q ss_pred cccceeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 549 QANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 549 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
...+ ...|+..++++ ..|.|++|+.+|+|+.
T Consensus 171 ~~~~-~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 171 TAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp EEET-TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred eeec-cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 3322 23444444443 4677888888888765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=289.30 Aligned_cols=185 Identities=25% Similarity=0.351 Sum_probs=152.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999864 6899999999753 2234578999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988543 35899999999999999999999985 999999999999999999999999999988765
Q ss_pred CCcccceeeeeccCCCcchh----------HHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQW----------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~ 581 (583)
..........||..|++||. |.|++|+++|+|+.+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g 206 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence 54444445677877777663 566666666666543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=283.67 Aligned_cols=181 Identities=26% Similarity=0.376 Sum_probs=153.5
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|+..+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 45788899999999999999975 6899999998743 2233567899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ..+++..+..++.||++||.|||+++ |+||||||+|||+++++++||+|||+|+....+
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999643 35899999999999999999999985 999999999999999999999999999877544
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ....|++.|++|| .|.|++|+.+|+|+.+
T Consensus 160 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G 200 (263)
T d2j4za1 160 RR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200 (263)
T ss_dssp CC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcC
Confidence 32 2344565555544 5777788888887765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=293.48 Aligned_cols=183 Identities=22% Similarity=0.272 Sum_probs=154.5
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|+..++||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467888999999999999999964 6899999999755 33445789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|.+++.+. ..+++..+..++.||++||.|||++. +|+||||||+||||++++++||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999653 35899999999999999999999742 39999999999999999999999999999774322
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....+||.+|++|| .|.|++|+++|+|+.+
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G 199 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred ----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 22357777777766 3567777777777654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=285.83 Aligned_cols=189 Identities=26% Similarity=0.386 Sum_probs=143.1
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEe--CCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 465 (583)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999864 68999999997553 3446779999999999999999999999975 4568999
Q ss_pred EEcCCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+++ ..+|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 3456999999999999999999999864 13599999999999999999999999999998
Q ss_pred cCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+..+... .....|+++|++|| .|.|++|+++|+|+.+
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg 210 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhC
Confidence 7654332 22356677666665 4566677777766554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-34 Score=288.56 Aligned_cols=185 Identities=27% Similarity=0.431 Sum_probs=141.4
Q ss_pred CCCCccccccccCceEEEEEEecC-C---cEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...++||+|+||+||+|+.+. + ..||||++... .....++|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346677899999999999998752 3 36899998755 444567899999999999999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++... ...++|.+++.++.||++||.|||+++ |+||||||+||||++++++||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988543 345899999999999999999999985 99999999999999999999999999998765
Q ss_pred CCCcccc---eeeeeccCCCcc----------hhHHHHHHHHHHHhhh
Q 007969 546 NQNQANT---NIIAVDTWPQSM----------QWEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~~---~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~ 580 (583)
....... ....++..|++| ..|+|++|+++|+|+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t 228 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence 4332211 112334434433 3678889999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-33 Score=275.12 Aligned_cols=184 Identities=25% Similarity=0.386 Sum_probs=155.3
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++|+..++||+|+||+||+|+.++++.||||++++... ..++|.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 367899999999999999999998889999999986543 4578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|..++.... ..+++..+.+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999875433 35899999999999999999999985 999999999999999999999999999877554332
Q ss_pred ccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
... ...++..|++ .+.|.|++|+.+|+|..
T Consensus 157 ~~~-~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 157 SSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp CCC-CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eec-ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 221 2234443333 44678888888888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=282.50 Aligned_cols=185 Identities=28% Similarity=0.471 Sum_probs=146.4
Q ss_pred CCCCccccccccCceEEEEEEecCC-----cEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
+.|+..++||+|+||.||+|.+++. ..||||+++... ....++|.+|+.++++++|||||+++|++.+++..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987542 379999997553 3445689999999999999999999999999999999
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+.++++.+++.+. ...++|..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999887543 345899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcc-cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQA-NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
...... ......|+..|++|| .|+|++|+++|+|..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t 208 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 208 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHh
Confidence 543322 222334565555555 688889999998865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-33 Score=286.70 Aligned_cols=183 Identities=22% Similarity=0.367 Sum_probs=155.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|.+.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47888999999999999999864 68999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCceEEEecCCceecCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~~~~~ 547 (583)
++|+|.+++.+. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999998542 345999999999999999999999986 99999999999995 46789999999999886544
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
. .....|+.+|+++| .|.|++|+++|+|+.|
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 3 23456777777666 3566666666666544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-33 Score=285.64 Aligned_cols=178 Identities=28% Similarity=0.450 Sum_probs=149.8
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc---hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.|+..++||+|+||+||+|+. .+++.||||+++.... ...+++.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999985 4688999999975532 335679999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||++++++||+|||+|+......
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence 9999999876643 345999999999999999999999986 9999999999999999999999999999765432
Q ss_pred CcccceeeeeccCCCcch-------------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ-------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~l~~~ 581 (583)
. ..||+.|++|| .|.|++|+.+|+|+.+
T Consensus 170 ~------~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 170 S------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp C------CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred c------cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 2 34555554444 5677777777777654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=287.10 Aligned_cols=188 Identities=26% Similarity=0.361 Sum_probs=154.0
Q ss_pred cCCCCccccccccCceEEEEEEecC-C-----cEEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD-G-----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|...++||+|+||+||+|+... + ..||+|++... .....+.+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3568888999999999999998642 2 36999998654 344467899999999998 89999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 007969 462 LLLIYEYMPNKSLDVHLFDATR--------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA 521 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~ 521 (583)
.++||||+++|+|.++++.... ...++|..++.++.||++||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975432 135899999999999999999999985 99999999
Q ss_pred CcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 522 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+|||++.++++||+|||+|+...............|+..|++|| .|+|++|+++|+|+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 99999999999999999999876655544434455666666655 478888888888764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-33 Score=276.86 Aligned_cols=180 Identities=26% Similarity=0.341 Sum_probs=149.5
Q ss_pred CccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe----CCeEEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY 466 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 466 (583)
..+++||+|+||+||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999965 6889999998754 34446789999999999999999999999875 34689999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~ 545 (583)
||+++|+|.+++.+. ..+++..+..++.||++||.|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999653 35899999999999999999999874 3599999999999996 578999999999986544
Q ss_pred CCCcccceeeeeccCCCcch---------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ---------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~ 581 (583)
.. .....||+.|++|| .|.|++|+++|+|+.+
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHS
T ss_pred Cc----cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHC
Confidence 32 22356777776665 4778888888888754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-33 Score=279.10 Aligned_cols=184 Identities=24% Similarity=0.410 Sum_probs=149.5
Q ss_pred CCCCccc-cccccCceEEEEEEec---CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...+ +||+|+||.||+|..+ ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 5999999999999764 35579999997653 3456789999999999999999999999865 468999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999988432 346999999999999999999999985 99999999999999999999999999998865
Q ss_pred CCCccc-ceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 546 NQNQAN-TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 546 ~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
...... .....|+..+++|| .|+|++|+.+|+++.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt 207 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHh
Confidence 543322 22234555444444 578889999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-33 Score=278.40 Aligned_cols=177 Identities=27% Similarity=0.393 Sum_probs=144.0
Q ss_pred ccccccCceEEEEEEecC---CcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCCC
Q 007969 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 471 (583)
++||+|+||+||+|.+++ ++.||||+++.. +....++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999999754 33346789999999999999999999999865 457899999999
Q ss_pred CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCccc
Q 007969 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551 (583)
Q Consensus 472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 551 (583)
|+|.+++.+. ..++|..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+........
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998653 45899999999999999999999985 99999999999999999999999999998865544322
Q ss_pred -ceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 552 -TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 552 -~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.....|+..|++|| .|+|++|+.+|+++.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt 205 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhh
Confidence 23345555555544 578888888888764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-33 Score=285.69 Aligned_cols=183 Identities=23% Similarity=0.267 Sum_probs=155.5
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999996 47999999999754 2334678899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998653 35899999999999999999999986 999999999999999999999999999976543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
... ....+||++|++|| .|.|++|+++|+|+.|
T Consensus 159 ~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G 201 (337)
T d1o6la_ 159 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp TCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred Ccc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHC
Confidence 332 22356777666555 4677777887777754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-33 Score=283.97 Aligned_cols=190 Identities=26% Similarity=0.449 Sum_probs=156.5
Q ss_pred HcCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCe
Q 007969 389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 389 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 461 (583)
..++|+..++||+|+||+||+|+.+ +++.||||+++.... +..++|.+|++++++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4567999999999999999999864 357899999976543 346789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 007969 462 LLLIYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 520 (583)
.++||||+++|+|.++++... ....++|..++.|+.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996432 1234899999999999999999999985 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 521 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
|+|||||.++++||+|||+++...............++..|++ .+.|+|++|+++|+|+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 9999999999999999999997755444333333444444433 456889999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-33 Score=280.30 Aligned_cols=183 Identities=29% Similarity=0.428 Sum_probs=147.0
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcCC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP 470 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 470 (583)
++|...++||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ ++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4688899999999999999999888899999997553 345789999999999999999999999854 56899999999
Q ss_pred CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCcc
Q 007969 471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550 (583)
Q Consensus 471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 550 (583)
+|+|..++.... ...++|..++.|+.||+.||.|||+.+ |+||||||+|||||+++++||+|||+++....+....
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998886532 235999999999999999999999985 9999999999999999999999999999875544332
Q ss_pred cceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 551 NTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 551 ~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
.+ ...|+..|++ .+.|+|++|+++|+|+.
T Consensus 171 ~~-~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t 209 (285)
T d1fmka3 171 RQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ec-cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence 22 2344444444 44678889999998865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=7.2e-33 Score=280.56 Aligned_cols=183 Identities=22% Similarity=0.296 Sum_probs=137.7
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
.+.|...++||+|+||+||+|+.. +++.||||++.+... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999965 689999999975532 334578899999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCceEEEecCCceecC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFG 544 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~~ 544 (583)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999954 345999999999999999999999985 99999999999994 57899999999999775
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... ....+||+.|++|| .|.|++|+++|+|+.+
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g 205 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC
Confidence 4432 22345777666655 4666677777776654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.98 E-value=6e-33 Score=286.29 Aligned_cols=183 Identities=22% Similarity=0.327 Sum_probs=154.8
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|.+.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999986 479999999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCceEEEecCCceecCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~~~~~ 547 (583)
++|+|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 2345899999999999999999999985 99999999999998 67899999999999887654
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ....|+..|+++| .|.|++|+++|+|+.|
T Consensus 184 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 184 IV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp CE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred ce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence 32 2344555555444 4667777777777654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=1.2e-32 Score=280.08 Aligned_cols=180 Identities=24% Similarity=0.328 Sum_probs=152.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 45888899999999999999964 6999999999754 2334678999999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+++|+|..++.. ...+++.....++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988854 335788999999999999999999985 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ...|++.|++|| .|.|++|+++|+|+.|
T Consensus 158 ~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 158 TY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp BC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred cc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 22 245666555544 4677788888887764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.98 E-value=2e-32 Score=273.19 Aligned_cols=182 Identities=26% Similarity=0.351 Sum_probs=153.2
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCch---------hHHHHHHHHHHHhhCC-CCCceeEEEEEEeC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG 459 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 459 (583)
++|+..++||+|+||+||+|+. .+|+.||||++++.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999986 47899999999765321 1346889999999997 99999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCC
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 539 (583)
+..++||||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 35999999999999999999999985 99999999999999999999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcch----------------hHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQ----------------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~l~~~ 581 (583)
++.+...... ....|+..+.+++ .|.|++|+++|+|+.+
T Consensus 157 a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 157 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence 9988654322 2234555555544 4677788888777754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-32 Score=271.20 Aligned_cols=182 Identities=24% Similarity=0.315 Sum_probs=151.4
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc------hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|...++||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+.++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688899999999999999996 4689999999975421 23578999999999999999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----ceEEEecCC
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL 539 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl 539 (583)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999653 35999999999999999999999985 99999999999998776 599999999
Q ss_pred ceecCCCCCcccceeeeeccCCC----------cchhHHHHHHHHHHHhhhh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQ----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~ 581 (583)
++......... ...++..|+ ....|.|++|+.+|+|+.+
T Consensus 164 a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g 212 (293)
T d1jksa_ 164 AHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212 (293)
T ss_dssp CEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred hhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC
Confidence 99875443221 123333333 3446777788888887754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-32 Score=276.34 Aligned_cols=184 Identities=27% Similarity=0.454 Sum_probs=147.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCc----EEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
++|+..++||+|+||+||+|+.. +|+ .||+|+++.. +.+..++|.+|+.++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999864 343 6899998754 345578899999999999999999999999865 5678
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
++||+.+|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999999887653 346899999999999999999999985 9999999999999999999999999999887
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.......+....|+..|++|| .|+|++|+.+|+|+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence 666555555556777766655 578888888888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=271.90 Aligned_cols=182 Identities=20% Similarity=0.312 Sum_probs=151.7
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
++|.+.++||+|+||+||+|+.. +++.||||+++.... ....+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56888999999999999999865 688999999976543 3456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC--CceEEEecCCceecCCCC
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 547 (583)
++|+|.+++.+. ...+++.++..|+.||++||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999542 235899999999999999999999985 9999999999999854 589999999999875544
Q ss_pred CcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ....++.++++++ .|.|++|+++|+|+.+
T Consensus 159 ~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 159 NF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp EE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred cc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 22 2234555554444 3677777777777754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=5.1e-32 Score=279.20 Aligned_cols=180 Identities=22% Similarity=0.298 Sum_probs=154.3
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 466 (583)
++|...++||+|+||.||+|+.+ +|+.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999864 6999999999743 2234578899999999999999999999999999999999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 546 (583)
||+.+|+|..++.+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998653 35899999999999999999999985 999999999999999999999999999987543
Q ss_pred CCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 547 QNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.. ...|++.|++|| .|.|++|+++|+|+.|
T Consensus 195 ~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG 234 (350)
T d1rdqe_ 195 TW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp BC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC
Confidence 22 245666665555 4677788888887764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=271.68 Aligned_cols=184 Identities=22% Similarity=0.292 Sum_probs=145.5
Q ss_pred CCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----eEEEEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIYE 467 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~e 467 (583)
.|...++||+|+||.||+|++ +|+.||||+++..... ......|+..+.+++||||++++|++.+.+ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 466778999999999999997 5889999999754322 122334555667789999999999998653 6899999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
|+++|+|.+++++. .++|..++.++.|++.||.|||+. +..+|+||||||+||||+.++++||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999652 489999999999999999999974 124699999999999999999999999999998
Q ss_pred cCCCCCcc--cceeeeeccCCCcchh----------------HHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQA--NTNIIAVDTWPQSMQW----------------EAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~~--~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~l~~~ 581 (583)
........ ......|+..|++||. |.|++|+++|+|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg 214 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhC
Confidence 86544322 2344567777777653 677777777777653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.1e-31 Score=278.20 Aligned_cols=181 Identities=27% Similarity=0.308 Sum_probs=146.9
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHH---HHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEF---KNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|.+.++||+|+||.||+|+.. +|+.||||++.+.. ......+ .+|+.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999965 69999999986431 1112233 44577788889999999999999999999
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999653 35889999999999999999999985 999999999999999999999999999987
Q ss_pred CCCCCcccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
...... ...|++.|++|| .|.|++|+++|+|+.|
T Consensus 158 ~~~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG 202 (364)
T d1omwa3 158 SKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202 (364)
T ss_dssp SSSCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhC
Confidence 654322 234555544444 4566677777776654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-32 Score=274.04 Aligned_cols=188 Identities=24% Similarity=0.354 Sum_probs=145.6
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC-C
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 460 (583)
.++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 457888999999999999999853 34689999997543 34456788888888887 689999999998765 4
Q ss_pred eEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 527 (583)
..++||||+++|+|.++++.... ...++|..++.++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975321 235899999999999999999999985 99999999999999
Q ss_pred CCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 528 DDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 528 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+++++||+|||+|+...............|+..|++|| .|+|++|+++|+|+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 99999999999999876655544444556776665554 578888888888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.5e-32 Score=272.66 Aligned_cols=189 Identities=25% Similarity=0.379 Sum_probs=156.8
Q ss_pred cCCCCccccccccCceEEEEEEec------CCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL 462 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 462 (583)
.++|...++||+|+||.||+|.+. +++.||||++++.. .+....|.+|+.++++++||||++++|++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356778899999999999999863 35789999997653 34456799999999999999999999999999999
Q ss_pred EEEEEcCCCCChhHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 463 LLIYEYMPNKSLDVHLFDA-------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 463 ~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
++||||+++|+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||+|+++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988642 22345799999999999999999999984 9999999999999999999999
Q ss_pred ecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 536 DFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 536 DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
|||+++...............++..|+++ ..++|++|+.+|+|+.+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhC
Confidence 99999987655544444444555555444 45888899999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.8e-32 Score=267.89 Aligned_cols=184 Identities=20% Similarity=0.303 Sum_probs=139.8
Q ss_pred cCCCCccccccccCceEEEEEEecC----CcEEEEEEeccCCc-hhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 464 (583)
.++|...+.||+|+||.||+|+... +..||||+++.... ...+.|.+|++++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3467888999999999999998643 35789999975533 34678999999999999999999999986 467899
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecC
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 544 (583)
||||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987543 345899999999999999999999985 9999999999999999999999999999876
Q ss_pred CCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 545 GNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
.......+ ...|++.|++++ .|.|++|+.+|+|+.
T Consensus 160 ~~~~~~~~-~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt 204 (273)
T d1mp8a_ 160 DSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred CCcceecc-ceecCcccchhhHhccCCCCCccccccchHHHHHHHh
Confidence 54433222 344555555444 478888888888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=271.48 Aligned_cols=185 Identities=28% Similarity=0.469 Sum_probs=149.0
Q ss_pred CCCCccccccccCceEEEEEEecC-Cc--EEEEEEeccC-CchhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 465 (583)
++|+..++||+|+||.||+|++++ |. .||||+++.. .....++|.+|+++++++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999998753 43 5788988654 344567899999999999 799999999999999999999
Q ss_pred EEcCCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCce
Q 007969 466 YEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 532 (583)
|||+++|+|.++++.. .....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 23456999999999999999999999985 9999999999999999999
Q ss_pred EEEecCCceecCCCCCcccceeeeeccCCCcc----------hhHHHHHHHHHHHhhhh
Q 007969 533 KISDFGLARIFGGNQNQANTNIIAVDTWPQSM----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 533 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~l~~~ 581 (583)
||+|||+++........ ....|+..|+++ ..|+|++|+++|+|+.+
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence 99999999866433221 123344444443 35788899999888653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=270.57 Aligned_cols=183 Identities=23% Similarity=0.345 Sum_probs=152.0
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccCC---chhHHHHHHHHHHHh-hCCCCCceeEEEEEEeCCeEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI 465 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 465 (583)
++|...++||+|+||+||+|+.. +++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999865 68999999997532 233566777777765 68999999999999999999999
Q ss_pred EEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCC
Q 007969 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545 (583)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 545 (583)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999653 34899999999999999999999985 99999999999999999999999999997654
Q ss_pred CCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
..... ....|+.+|+++| .|.|++|+++|+|+.|
T Consensus 156 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 156 GDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp TTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 43322 2245666655544 4677788888888765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.5e-32 Score=267.82 Aligned_cols=184 Identities=28% Similarity=0.385 Sum_probs=142.8
Q ss_pred CCCCccccccccCceEEEEEEec--CC--cEEEEEEeccC---CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~--~g--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 463 (583)
++|+..+.||+|+||.||+|++. ++ ..||||++++. ..+..++|.+|+.++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 45788899999999999999853 22 37899998754 334467899999999999999999999999764 678
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+||||+++|++.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887653 235899999999999999999999985 999999999999999999999999999998
Q ss_pred CCCCCccc-ceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 544 GGNQNQAN-TNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 544 ~~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
........ .....++.++++++ .|.|++|+.+|+|+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt 209 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence 66554332 23334555555544 789999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=2.2e-31 Score=265.83 Aligned_cols=186 Identities=23% Similarity=0.299 Sum_probs=146.4
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC---chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----e
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~ 461 (583)
.++|.+.+.||+|+||.||+|+. .+|+.||||++++.. ....+.|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36788999999999999999985 479999999997543 334567999999999999999999999997643 4
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++||||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 79999999999999988553 35899999999999999999999985 9999999999999999999999999998
Q ss_pred ecCCCCC-cccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQN-QANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~-~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
....... ........|+..|++|| .|.|++|+++|+|+.|
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG 210 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 210 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhC
Confidence 7654332 22333456777766665 4566677777666654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.9e-31 Score=266.97 Aligned_cols=180 Identities=27% Similarity=0.435 Sum_probs=147.0
Q ss_pred cccccccCceEEEEEEecCC----cEEEEEEeccC-CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-CeEEEEEEcC
Q 007969 396 ENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM 469 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~g----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 469 (583)
.++||+|+||+||+|++.++ ..||||++++. +....++|.+|++++++++||||++++|++... +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 36899999754 445568899999999999999999999998764 6899999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988643 345789999999999999999999985 999999999999999999999999999987544332
Q ss_pred c--cceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 550 A--NTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~--~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
. ......|+..|+++| .|.|++|+.+|+++.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t 229 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHH
Confidence 2 112234554444444 578888888888865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=269.04 Aligned_cols=178 Identities=25% Similarity=0.403 Sum_probs=141.9
Q ss_pred cccccccCceEEEEEEec-CCcEEEEEEeccCCch-----hHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEcC
Q 007969 396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 469 (583)
.++||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999964 6899999999754322 1346899999999999999999999999999999999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
+++++..+. .....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988777665 33456889999999999999999999986 999999999999999999999999999877654332
Q ss_pred ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 550 ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 550 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
.. ..+|+.+|+++| .|.|++|+++|+|+.+
T Consensus 157 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 197 (299)
T d1ua2a_ 157 YT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197 (299)
T ss_dssp CC--CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred cc--ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC
Confidence 22 245666666655 3555566666665543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=265.37 Aligned_cols=178 Identities=28% Similarity=0.404 Sum_probs=140.6
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-CeEEEEEEcC
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM 469 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 469 (583)
++|...++||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++||||++++|++.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35667789999999999999984 7899999997543 347899999999999999999999999654 5689999999
Q ss_pred CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCCc
Q 007969 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549 (583)
Q Consensus 470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 549 (583)
++|+|.+++.+.. ...++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~ 159 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCcc
Confidence 9999999996532 234899999999999999999999985 999999999999999999999999999976543321
Q ss_pred ccceeeeeccCC----------CcchhHHHHHHHHHHHhhh
Q 007969 550 ANTNIIAVDTWP----------QSMQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 550 ~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~l~~ 580 (583)
..++..+ ...+.|.|++|+.+|+|+.
T Consensus 160 -----~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t 195 (262)
T d1byga_ 160 -----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHH
Confidence 1223333 3445678888888888864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-31 Score=269.48 Aligned_cols=188 Identities=29% Similarity=0.388 Sum_probs=156.6
Q ss_pred cCCCCccccccccCceEEEEEEe------cCCcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEEEEeCCe
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 461 (583)
.++|+..++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35778889999999999999985 2456899999986543 4456799999999999 69999999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 462 LLLIYEYMPNKSLDVHLFDAT---------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
.++||||+++|+|.++++... ....+++..+..++.||++||.|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 1235899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++...............|+..|++++ .|.|++|+.+|+|+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 999999999999999887655544444455665544444 578888888888764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=4.2e-31 Score=265.03 Aligned_cols=183 Identities=25% Similarity=0.404 Sum_probs=150.0
Q ss_pred CCCCccccccccCceEEEEEEecCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
++|...++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999997653 23367899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 548 (583)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887776663 3456999999999999999999999985 99999999999999999999999999988754332
Q ss_pred cccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 549 QANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 549 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
... ...++..| .....|.|++|+.+|+|+.|
T Consensus 156 ~~~--~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G 197 (286)
T d1ob3a_ 156 KYT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred ccc--eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence 211 12233222 33456778888888888754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.6e-31 Score=265.77 Aligned_cols=184 Identities=24% Similarity=0.428 Sum_probs=147.7
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999986 579999999996543 2336789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
|+.++.+ +++.. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++++||+|||+|+....+.
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544 44433 23445999999999999999999999985 9999999999999999999999999999876543
Q ss_pred CcccceeeeeccCCCc-----------chhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNIIAVDTWPQS-----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~ 581 (583)
.... ...|+..|.+ ...|.|++|+.+|+|+.|
T Consensus 157 ~~~~--~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G 199 (298)
T d1gz8a_ 157 RTYT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199 (298)
T ss_dssp BCTT--CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ccce--eecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence 3222 2244444433 345677778888877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-31 Score=267.85 Aligned_cols=188 Identities=29% Similarity=0.395 Sum_probs=151.0
Q ss_pred cCCCCccccccccCceEEEEEEecC--------CcEEEEEEeccCCc-hhHHHHHHHHHHHhhC-CCCCceeEEEEEEeC
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG 459 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 459 (583)
.++|.+.++||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3567888999999999999998532 24799999976543 4467899999999998 799999999999999
Q ss_pred CeEEEEEEcCCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 007969 460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526 (583)
Q Consensus 460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 526 (583)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975432 245899999999999999999999985 9999999999999
Q ss_pred cCCCceEEEecCCceecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhh
Q 007969 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLE 580 (583)
Q Consensus 527 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~ 580 (583)
+.++.+||+|||+++...............++..|++ .++|.|++|+++|+|+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 9999999999999998865544433333445444433 44688889999998874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-30 Score=266.03 Aligned_cols=179 Identities=22% Similarity=0.299 Sum_probs=143.0
Q ss_pred CCCCcc-ccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhC-CCCCceeEEEEEEe----CCeEE
Q 007969 391 NHFSDE-NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQELL 463 (583)
Q Consensus 391 ~~~~~~-~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~ 463 (583)
++|.+. +.||+|+||.||+|+. .+++.||||++++. +.+.+|++++.++ +|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467665 4699999999999986 56899999999643 5678899987655 89999999999875 35689
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCceEEEecCCc
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA 540 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 540 (583)
+|||||++|+|.+++.+.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999996532 345999999999999999999999985 999999999999975 567999999999
Q ss_pred eecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+........ ....|+++|++|| .|.|++|+++|+|+.+
T Consensus 162 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg 209 (335)
T d2ozaa1 162 KETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 209 (335)
T ss_dssp EECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTS
T ss_pred eeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhC
Confidence 987654432 2345666665555 3555566666665543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=259.94 Aligned_cols=166 Identities=23% Similarity=0.337 Sum_probs=137.4
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCc------hhHHHHHHHHHHHhhCC--CCCceeEEEEEEeCCe
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 461 (583)
++|.+.++||+|+||.||+|+. .+|+.||||++.+... ...+++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999986 4789999999975421 11245778999999996 8999999999999999
Q ss_pred EEEEEEcCCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCceEEEecCC
Q 007969 462 LLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGL 539 (583)
Q Consensus 462 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGl 539 (583)
.++||||+.+ +++.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999986 6777777542 35899999999999999999999985 999999999999985 47999999999
Q ss_pred ceecCCCCCcccceeeeeccCCCcchh
Q 007969 540 ARIFGGNQNQANTNIIAVDTWPQSMQW 566 (583)
Q Consensus 540 a~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (583)
|+....... ....||..|++||+
T Consensus 158 a~~~~~~~~----~~~~GT~~y~aPE~ 180 (273)
T d1xwsa_ 158 GALLKDTVY----TDFDGTRVYSPPEW 180 (273)
T ss_dssp CEECCSSCB----CCCCSCGGGSCHHH
T ss_pred ceecccccc----cccccCCCcCCHHH
Confidence 987654322 23457777666663
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=252.35 Aligned_cols=185 Identities=23% Similarity=0.359 Sum_probs=152.5
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCCeEEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 467 (583)
++|...++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788899999999999999996 478999999996543 3346789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceecCCCC
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 547 (583)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345889999999999999999999985 9999999999999999999999999999876443
Q ss_pred Cccccee---------eeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 548 NQANTNI---------IAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 548 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
....... ......+.....|.|++|+++|+|+.+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g 198 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence 3211110 011111234567888899999988764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-29 Score=259.09 Aligned_cols=180 Identities=24% Similarity=0.381 Sum_probs=140.9
Q ss_pred CCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------CeEEE
Q 007969 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELLL 464 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 464 (583)
.|...++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677889999999999999975 699999999976532 234799999999999999999998653 24799
Q ss_pred EEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceec
Q 007969 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF 543 (583)
Q Consensus 465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~ 543 (583)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433344556999999999999999999999985 99999999999999775 8999999999987
Q ss_pred CCCCCcccceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQANTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
........ ..|+..++ ....|.|++|+++|+|+.+
T Consensus 174 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g 219 (350)
T d1q5ka_ 174 VRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219 (350)
T ss_dssp CTTSCCCS---CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred cCCccccc---ccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence 65433221 23333332 3445677777777777654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-29 Score=258.17 Aligned_cols=185 Identities=21% Similarity=0.343 Sum_probs=143.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC-chhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC----eEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELL 463 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 463 (583)
+++|...++||+|+||+||+|+. .+|+.||||++++.. ....+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688899999999999999985 579999999997654 344678999999999999999999999997643 335
Q ss_pred EEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+++||+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55566779999999854 24899999999999999999999985 999999999999999999999999999976
Q ss_pred CCCCCcc-cceeeeeccCCC-----------cchhHHHHHHHHHHHhhhh
Q 007969 544 GGNQNQA-NTNIIAVDTWPQ-----------SMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 544 ~~~~~~~-~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 581 (583)
....... ......|+..|+ ....|.|++|+++|+|+.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g 209 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence 5432211 112223333332 3345677777777777654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-29 Score=253.27 Aligned_cols=186 Identities=24% Similarity=0.425 Sum_probs=144.3
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEe--------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-------- 458 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 458 (583)
.++|.+.++||+|+||+||+|+. ++|+.||||++... .....+++.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 35788899999999999999996 47999999998644 23345788999999999999999999999865
Q ss_pred CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecC
Q 007969 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538 (583)
Q Consensus 459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 538 (583)
+...++||||++++.+..+. .....+++.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34589999999888776554 23345889999999999999999999985 9999999999999999999999999
Q ss_pred CceecCCCCCc--ccceeeeeccCCCcch-----------hHHHHHHHHHHHhhhh
Q 007969 539 LARIFGGNQNQ--ANTNIIAVDTWPQSMQ-----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 539 la~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~ 581 (583)
+++.+...... .......|+.+|+++| .|.|++|+.+|+|..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g 218 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhC
Confidence 99887643321 1222234555554444 4666677777777654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.2e-29 Score=255.09 Aligned_cols=179 Identities=26% Similarity=0.435 Sum_probs=140.0
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeCC------
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ 460 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 460 (583)
.++|...++||+|+||+||+|+. .+|+.||||++++. +....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788899999999999999996 46999999999754 3344678899999999999999999999997654
Q ss_pred eEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCc
Q 007969 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540 (583)
Q Consensus 461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 540 (583)
..++||||+ +.+|..+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 5677766643 34999999999999999999999986 999999999999999999999999999
Q ss_pred eecCCCCCcccceeeeeccCC-----------CcchhHHHHHHHHHHHhhhh
Q 007969 541 RIFGGNQNQANTNIIAVDTWP-----------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~ 581 (583)
+........ ..++.+| .....|.|++|+++|+|+.+
T Consensus 169 ~~~~~~~~~-----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 169 RQADSEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp EECCSSCCS-----SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred eccCCcccc-----ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 987543321 2233333 33445677788888887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.7e-29 Score=255.83 Aligned_cols=184 Identities=24% Similarity=0.318 Sum_probs=149.1
Q ss_pred CCCCccccccccCceEEEEEEe----cCCcEEEEEEeccCC----chhHHHHHHHHHHHhhCCC-CCceeEEEEEEeCCe
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 461 (583)
++|...++||+|+||+||+|+. .+|+.||||.+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5588899999999999999984 247899999987542 2335678899999999976 899999999999999
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.+++|||+.+|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 4678899999999999999999985 9999999999999999999999999999
Q ss_pred ecCCCCCcccceeeeeccCC------------CcchhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWP------------QSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~ 581 (583)
.+......... ...|+..+ .....|+|++|+.+|+|+.|
T Consensus 178 ~~~~~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 178 EFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp ECCGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred hhccccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence 87543332211 12233332 33345777788888888754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.4e-29 Score=250.37 Aligned_cols=184 Identities=24% Similarity=0.420 Sum_probs=142.6
Q ss_pred cCCCCccccccccCceEEEEEEe-cC-CcEEEEEEeccCCc--hhHHHHHHHHHHHhhC---CCCCceeEEEEEEe----
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-AD-GKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE---- 458 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 458 (583)
.++|...++||+|+||+||+|+. ++ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46789999999999999999986 34 66799999965422 2233566777776655 89999999999863
Q ss_pred -CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEec
Q 007969 459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537 (583)
Q Consensus 459 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 537 (583)
....++++||++++++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 246899999999887765443 33445899999999999999999999985 999999999999999999999999
Q ss_pred CCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 538 GLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 538 Gla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
|+++...... ......||..|++|| .|.|++|+++|+|+.+
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g 211 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHC
Confidence 9998764332 222345666665555 4667777777777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=3.5e-28 Score=244.41 Aligned_cols=184 Identities=18% Similarity=0.269 Sum_probs=150.0
Q ss_pred cCCCCccccccccCceEEEEEEec-CCcEEEEEEeccCCchhHHHHHHHHHHHhhCCC-CCceeEEEEEEeCCeEEEEEE
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 467 (583)
.++|.+.++||+|+||+||+|+.. +|+.||||++..... .+.+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367889999999999999999964 689999999865432 2457889999999965 899999999999999999999
Q ss_pred cCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCceEEEecCCcee
Q 007969 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARI 542 (583)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~ 542 (583)
|+ +++|.+++.... ..+++.+...++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 689988886533 35899999999999999999999986 999999999999974 57899999999998
Q ss_pred cCCCCCc-----ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 543 FGGNQNQ-----ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 543 ~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+...... .......||+.|+++| .|.|++|+.+|+|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg 209 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhC
Confidence 7643322 2234457888877776 3566677777776653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=3.9e-28 Score=248.04 Aligned_cols=176 Identities=19% Similarity=0.348 Sum_probs=141.6
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeC--CeEEEEE
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIY 466 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 466 (583)
++|.+.++||+|+||+||+|+. .+|+.||||+++... .+++.+|++++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999996 468999999997543 467899999999995 99999999999754 5689999
Q ss_pred EcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-ceEEEecCCceecCC
Q 007969 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG 545 (583)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~ 545 (583)
||+++++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 34899999999999999999999986 99999999999998655 699999999998765
Q ss_pred CCCcccceeeeeccCCCcc-----------hhHHHHHHHHHHHhhhh
Q 007969 546 NQNQANTNIIAVDTWPQSM-----------QWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~ 581 (583)
..... ...++..+.++ ..|.|++|+.+|+++.+
T Consensus 183 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g 226 (328)
T d3bqca1 183 GQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226 (328)
T ss_dssp TCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence 43321 12333333333 34566666666666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=9.1e-28 Score=242.08 Aligned_cols=183 Identities=22% Similarity=0.302 Sum_probs=142.7
Q ss_pred CCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCcee-EEEEEEeCCeEEEEEEc
Q 007969 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR-LLGCCLEGQELLLIYEY 468 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~ 468 (583)
++|++.++||+|+||.||+|+. .+|+.||||++...... +++..|++++++++|+|++. +.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5789999999999999999986 46899999998765332 46789999999998776554 55556777889999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCceEEEecCCceecCC
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGG 545 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~~~ 545 (583)
+ +++|...+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 45665555432 345899999999999999999999986 99999999999985 456799999999998865
Q ss_pred CCCc-----ccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 546 NQNQ-----ANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 546 ~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
.... .......|+..|+++| .|.|++|+.+|+|..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg 209 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhC
Confidence 4332 2334456787776665 3566677777776543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.5e-28 Score=247.92 Aligned_cols=184 Identities=26% Similarity=0.348 Sum_probs=143.2
Q ss_pred cCCCCccccccccCceEEEEEEe-cCCcEEEEEEeccCC--chhHHHHHHHHHHHhhCCCCCceeEEEEEEeC-----Ce
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE 461 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 461 (583)
.++|...++||+|+||+||+|+. .+|+.||||++++.. ....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46789999999999999999985 579999999997553 34456789999999999999999999998643 34
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677788889999999843 34999999999999999999999986 9999999999999999999999999998
Q ss_pred ecCCCCCc-------ccceeeeeccCCCcchhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQ-------ANTNIIAVDTWPQSMQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 581 (583)
........ ..++... ...+.....|.|++|+++|+|+.+
T Consensus 170 ~~~~~~~~~~g~~~y~apE~~~-~~~~~~~~~DiwSlGv~l~~ll~g 215 (348)
T d2gfsa1 170 HTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTG 215 (348)
T ss_dssp CCTGGGSSSCHHHHTSCHHHHT-TCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccCcccccccccccccCchhhc-CCccCCcccchhhhhHHHHHHHhC
Confidence 66432211 1111111 111334456777788888888765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.6e-27 Score=243.53 Aligned_cols=179 Identities=28% Similarity=0.392 Sum_probs=135.8
Q ss_pred CCCCccccccccCceEEEEEEec-CCcEEEEEEeccC--CchhHHHHHHHHHHHhhCCCCCceeEEEEEEeC------Ce
Q 007969 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE 461 (583)
Q Consensus 391 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 461 (583)
++|.+.++||+|+||+||+|+.. +|+.||||++.+. +....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999965 6999999999754 334456789999999999999999999999643 67
Q ss_pred EEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEEecCCce
Q 007969 462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541 (583)
Q Consensus 462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 541 (583)
.|+||||+.++.+. .+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554 442 24899999999999999999999986 9999999999999999999999999998
Q ss_pred ecCCCCCcccceeeeeccCCCc----------chhHHHHHHHHHHHhhhh
Q 007969 542 IFGGNQNQANTNIIAVDTWPQS----------MQWEAYFLLNLMFSVLEF 581 (583)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~ 581 (583)
........ ....++..+++ ...|.|++|+.+|+++.+
T Consensus 168 ~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g 214 (355)
T d2b1pa1 168 TAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhC
Confidence 77543321 12233333333 335677788888887765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=5e-23 Score=212.46 Aligned_cols=182 Identities=18% Similarity=0.226 Sum_probs=138.8
Q ss_pred CCCccccccccCceEEEEEEe-cCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-----------CCCceeEEEEEEe-
Q 007969 392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCLE- 458 (583)
Q Consensus 392 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~- 458 (583)
+|.+.++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999986 479999999997553 23467788999888875 5789999998865
Q ss_pred -CCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC------c
Q 007969 459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM------N 531 (583)
Q Consensus 459 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~------~ 531 (583)
....+++++++..+..............+++..+..++.||++||.|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 3567777777766655444444455567899999999999999999999832 599999999999998665 3
Q ss_pred eEEEecCCceecCCCCCcccceeeeeccCCCcch----------hHHHHHHHHHHHhhhh
Q 007969 532 PKISDFGLARIFGGNQNQANTNIIAVDTWPQSMQ----------WEAYFLLNLMFSVLEF 581 (583)
Q Consensus 532 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~ 581 (583)
+||+|||.++....... ...|+..++++| .|.|++|+++++|+.+
T Consensus 171 ~kl~dfg~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 225 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225 (362)
T ss_dssp EEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred eeEeecccccccccccc-----cccccccccChhhccccCCCccccccchHHHHHHHHHC
Confidence 99999999987654332 234444444444 5666777777777654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.2e-21 Score=183.66 Aligned_cols=135 Identities=18% Similarity=0.197 Sum_probs=106.7
Q ss_pred CccccccccCceEEEEEEecCCcEEEEEEeccCCc------------------hhHHHHHHHHHHHhhCCCCCceeEEEE
Q 007969 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQHKNLVRLLGC 455 (583)
Q Consensus 394 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 455 (583)
.+.++||+|+||.||+|+..+|++||||+++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999988999999998753210 012344678889999999999988865
Q ss_pred EEeCCeEEEEEEcCCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCceEEE
Q 007969 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535 (583)
Q Consensus 456 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 535 (583)
.. .+++|||+++..+.. +++.....++.|++.+|.|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 32 379999998865532 333445678999999999999986 9999999999999965 48999
Q ss_pred ecCCceecCCC
Q 007969 536 DFGLARIFGGN 546 (583)
Q Consensus 536 DFGla~~~~~~ 546 (583)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999877543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=3.7e-07 Score=87.37 Aligned_cols=145 Identities=17% Similarity=0.101 Sum_probs=99.1
Q ss_pred cCCCCccccccccCceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEEc
Q 007969 390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY 468 (583)
Q Consensus 390 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 468 (583)
-..|...+..+-++...||+... ++..+.+|+...........+.+|...+..+. +--+.+++.+...++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34454444433344578998865 45667888887654444456778888887774 55578889888888999999999
Q ss_pred CCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007969 469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-------------------------------------- 510 (583)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 510 (583)
+++.++....... .. ...++.++++.|..||+..
T Consensus 92 l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998876543110 11 2234455555566666420
Q ss_pred ------------------CCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 511 ------------------RLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 511 ------------------~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
+..++|+|+.|.|||+++++.+-|+||+.+...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 112789999999999998877789999988754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.6e-05 Score=75.18 Aligned_cols=132 Identities=17% Similarity=0.145 Sum_probs=86.9
Q ss_pred cccccC-ceEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCC--CCCceeEEEEEEeCCeEEEEEEcCCCCCh
Q 007969 398 KLGQGG-FGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSL 474 (583)
Q Consensus 398 ~LG~G~-fG~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL 474 (583)
.+..|. -..||+...+++..+.+|.-..... ..+..|...++.+. .-.+++++++..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 3679999888888889997654432 34677777777663 34577889888888889999999988665
Q ss_pred hHHHhccCCCCCCCHHHHHHHHHHHHHHH---------------------------------------------------
Q 007969 475 DVHLFDATRSVQLDWKRRQSIINGIARGI--------------------------------------------------- 503 (583)
Q Consensus 475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL--------------------------------------------------- 503 (583)
.+.. +... .++.+++..|
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 0000 0111222222
Q ss_pred HHHHhC----CCCCeeeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 504 LYLHED----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 504 ~yLH~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
..+... .++.++|+|+.|.|||++++..+-|+||+.+..-
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 222221 1123799999999999998877889999988764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.40 E-value=0.00024 Score=71.73 Aligned_cols=76 Identities=12% Similarity=0.190 Sum_probs=49.3
Q ss_pred cccccccCceEEEEEEecC-CcEEEEEEeccC-------CchhHHHHHHHHHHHhhC-CC--CCceeEEEEEEeCCeEEE
Q 007969 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-------SGQGLQEFKNEVNLIAKL-QH--KNLVRLLGCCLEGQELLL 464 (583)
Q Consensus 396 ~~~LG~G~fG~Vy~a~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l-~H--~niv~l~g~~~~~~~~~l 464 (583)
.+.||.|..-.||+....+ ++.|+||.-... -+...++...|.+.+..+ .+ ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 678999965321 111234556788877766 23 345666654 4556689
Q ss_pred EEEcCCCCC
Q 007969 465 IYEYMPNKS 473 (583)
Q Consensus 465 V~e~~~~gs 473 (583)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0036 Score=60.88 Aligned_cols=136 Identities=15% Similarity=0.138 Sum_probs=78.2
Q ss_pred eEEEEEEecCCcEEEEEEeccCCchhHHHHHHHHHHHhhCCCCCc--eeEE-----EEEEeCCeEEEEEEcCCCCChh--
Q 007969 405 GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL--VRLL-----GCCLEGQELLLIYEYMPNKSLD-- 475 (583)
Q Consensus 405 G~Vy~a~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~e~~~~gsL~-- 475 (583)
=.||+.+.++|+.+++|.-+.. ....+++..|++.+..|....+ +..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987644 2234667888888877743222 2221 1123456789999999874431
Q ss_pred ---HH---------Hhc------cCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCCe
Q 007969 476 ---VH---------LFD------ATRSVQLDWK----------------------RRQSIINGIARGILYL-HEDSRLKI 514 (583)
Q Consensus 476 ---~~---------l~~------~~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~~~i 514 (583)
.+ +|. ......+++. .....+.++...+.-+ .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 111 0011112211 1112222222222222 12223458
Q ss_pred eeCCCCCCcEEEcCCCceEEEecCCceec
Q 007969 515 IHRDLKASNILLDDDMNPKISDFGLARIF 543 (583)
Q Consensus 515 iHrDlk~~NILl~~~~~~kl~DFGla~~~ 543 (583)
||+|+.+.|||++++ ..++||+.+..-
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred ecCCCCcccEEEeCC--ceEEechhcccC
Confidence 999999999999754 458999988754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.81 E-value=0.0075 Score=60.23 Aligned_cols=72 Identities=14% Similarity=0.182 Sum_probs=46.9
Q ss_pred ccccccCceEEEEEEecCC--------cEEEEEEeccCCchhHHHHHHHHHHHhhCC-CCCceeEEEEEEeCCeEEEEEE
Q 007969 397 NKLGQGGFGPVYKGTLADG--------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE 467 (583)
Q Consensus 397 ~~LG~G~fG~Vy~a~~~~g--------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 467 (583)
+.|+-|--=.+|+...+++ +.|.++..- ... ...+..+|..+++.+. +.=.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677777788999886543 456665554 222 2345568888888874 4334577777643 58999
Q ss_pred cCCCCCh
Q 007969 468 YMPNKSL 474 (583)
Q Consensus 468 ~~~~gsL 474 (583)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.16 E-value=0.49 Score=44.45 Aligned_cols=31 Identities=29% Similarity=0.324 Sum_probs=27.8
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEEecCCcee
Q 007969 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542 (583)
Q Consensus 512 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 542 (583)
..+||+|+.+.||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3599999999999999988889999998874
|